228
MOH/P/IKN/01.16 (AR)

MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

MOH/P/IKN/01.16 (AR)

Page 2: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the
Page 3: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

MALAYSIAN NATIONALCANCER REGISTRY REPORT

2007-2011

MOH/P/IKN/01.16 (AR)

Azizah Ab M *, Nor Saleha I.T**, Noor Hashimah A***, Asmah Z.A****, Mastulu W*****

*Penang State Health Department, ** Disease Control Division, MOH, ***Kelantan State Health Department, ****Perak State Health Department, *****Sarawak State Health Department

Non Communicable Disease Sector Disease Control Division

Ministry Of Health MALAYSIA

National Cancer Institute Ministry Of Health

PutrajayaMALAYSIA

Page 4: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

Published by the National Cancer Institute,Ministry of Health, No 4, Jalan P7, Presint 7,62250 Putrajaya, MALAYSIATel: (603) 88925555Fax: (603) 88925625© National Cancer Registry, June 2015

http://nci.moh.gov.my

Year of Publication: 2016Copyright © Ministry of Health MalaysiaAll rights reserved. This report may not be reproduced,in whole or in part, in any form or means, electronic or mechanical, including photocopying, without written permission from publisher

Page 5: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

EDITORIAL BOARD:

CHIEF EDITOR: Dr. Azizah Ab Manan, MBBS, MPH

Public Health Physician & State Epidemiologist (NCDC), Penang State Health Department

EDITORS: Dr. Nor Saleha Ibrahim Tamin, MD, MPH

Public Health Physician & Senior Principal Assistant Director (Head of Cancer Unit)Non-Communicable Disease Sector, Ministry Of Health

Dr. Noor Hashimah Abdullah, MD, MPHPublic Health Physician & State Epidemiologist (NCDC), Kelantan State Health Department

Dr. Asmah Zainal Abidin, MD, MPHPublic Health Physician & State Epidemiologist (NCDC), Perak State Health Department

Mastulu WahabMedical Record Assistant, Sarawak State Health Department

SUPPORTING EDITORS:Dr. Misliza Ahmad, MBBS, MPH

Public Health Physician & State Epidemiologist (NCDC) Wilayah Persekutuan Kuala Lumpur & Putrajaya State Health Department

Dr. Renuga K. RamanMedical Officer & Coordinator of Cancer Registry Unit, National Cancer Institute, Putrajaya

Dr. Nabihah AliMedical Officer, Cancer Registry Unit, National Cancer Institute, Putrajaya

Dr. Puteri Nureylia AmirMedical Officer, Cancer Registry Unit, National Cancer Institute, Putrajaya

Wan Roslida OthmanStatistician, Health Informatic Centre, Ministry Of Health, Putrajaya

SUPPORTING STAFF:Dr. Ruzawati Zahri

Medical Officer (NCDC), Pahang State Health Department

Salina Asha’ariStaff Nurse, Cancer Registry Unit, National Cancer Institute, Putrajaya

Nik Zanariah Nik ManAdministrator Assistant, Kelantan State Health Department

Muhammad Izzat Mat IsaAssistant Medical Officer, Kuala Lumpur & Putrajaya State Health Department

Mohd Hafiz IshakAssistant Environmental Health Officer, Selangor State Health Department

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 6: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

CONTENTSPREFACEFOREWORDMESSAGEACKNOWLEDGEMENT SECRETARIATLIST OF TABLES LIST OF FIGURESLIST OF APPENDICES 1.0 OVERVIEW 2.0 INTRODUCTION 3.0 BACKGROUND 3.1. Geography 3.2. Population 3.3. Health status, socioeconomic and health facilities 3.4. Cancer Death Certification 4.0 METHODS 4.1. Sources of data 4.2. Data collection 4.3. Registration procedure 4.4. Quality control 4.5. Description of statistical methods 5.0 RESULTS 5.1. Overall cancer incidence 5.2. Cancer trends 5.3. Incidence of ten most common cancers 5.4. Age variations 5.5. Age groups and cancers 5.6. Ethnic variations 5.7. Staging 5.8. Data Quality 6.0 INCIDENCE SUMMARY TABLES: All Sites, 2007-2011 7.0 COMMENTARY ON 15 SELECTED CANCER SITES 7.1. Female Breast C50 7.2. Colorectal C18-C21 7.3. Trachea, Bronchus, Lung C33-C34 7.4. Lymphoma C81-C85, C96 7.5. Nasopharynx C11 7.6. Leukaemia C91-C95 7.7. Cervix Uteri C53 7.8. Liver C22 7.9. Ovary C56 7.10. Stomach C16 7.11. Prostate C61 7.12. Other skin C44 7.13. Thyroid C73 7.14. Brain, nervous system C70-C72 7.15. Corpus Uteri C54 REFERENCESAPPENDICES

iiiiivvixxi

xiiixv

1

2

2357

888

1111

1315161821232829

31

333639424447505356596265676971

7374

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 7: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

ii

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

PREFACE

This is the first 5-year report of the Malaysian National Cancer Registry (MNCR) since it was established in all states in 2007 under the Public Health Division, Ministry of Health. The report is based on new cancers diagnosed for the period of 1st January 2007 through to 31st December 2011 and registered by state registries. The data reported in this report were as they stood on 1st June 2015.

The cancer registry database is dynamic, and the data are continually updated in the light of the most recent available information. Accordingly, the numbers in this report for the earlier years may vary slightly from those in previous publications.

The value of cancer registries will be enhanced when they are linked with other well established international databases as these will help to profile the different types of cancers and how such cancers are linked with the specific environmental, socio-cultural, ethnic and other related characteristic inherent in a specific population or defined geographical area. In this report we made the international comparisons with Singapore (Singapore Cancer Registry, Interim Report: Trends in Cancer Incidence in Singapore 2009 – 2013) and with other countries (Cancer Incidence in Five Continents Volume X, 2014).

The registry collects and disseminates reliable population-based cancer data to assist in the planning of services and in the prevention and treatment of cancer. In addition, timely, accurate, reliable and validated information on cancers occurring in the country is crucial in the planning of effective preventive and management strategies for cancer. There will also be research opportunities for those who are keen to study more about the aetiology of common cancers in our population or to look for more innovative ways of diagnosing or treat patients with specific cancers.

Much time and effort has been put into accuracy, completeness and data quality, in the process of collecting the data and in preparing this report. We sincerely hope that the data in this report would be used as a referencematerial.

We wish to record our thanks to all participating hospitals, clinics, institutions, and laboratories for their corporation and regular notifications to the respective state cancer registries. We also wish to extend our appreciation to Health Informatics Centre (HIC), Ministry of Health for their assistance in active searching of cancer data. Lastly, our deep appreciation to National Cancer Institute staff especially Dr Gerard Lim Chin Chye and Cancer Registry Unit for giving us the full support during the preparation of this report.

Page 8: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

FOREWORD

Staff from both central and state agencies have worked hard, in ensuring the validity of the data which has been gathered. Appreciation is mentioned particularly to Dr. Azizah Abd Manan, Dr. Nor Saleha, Dr. Noor Hashimah, and Dr. Asmah Zainal Abidin and other state epidemiology officers and staff, staff of Cancer Registry Unit of National Cancer Institute (NCI), Health Informatic Centre (PIK) and all who have been contributing in one way or another towards the production of this report. Special mention is made to Dr. Noor Hashimah for allowing the use of her template in the analysis of the data.

Much time and effort has been put into the process of collecting data and ensuring its accuracy, completeness and quality by the National Cancer Registry. It is hoped that this report can provide an insight on cancer incidence in Malaysia which can be used by the health authorities, service providers and researchers. Cancer Registries are crucial in any Cancer Control Programme as the data in the Cancer Registries are needed in developing strategies in primary, secondary and tertiary prevention, as well as health care planning and planning for patient care and research.

The following actions can be taken to improve the future reports: establishing closer rapport with all the Source Data Providers (SDP’s), providing feedback regularly to respective SDP’s including their performance, regular road shows and strengthening human resource. To strengthen and sustain population based cancer registries according to international standards requires meticulous planning, cooperation of medical institutions, dedicated andcommitted personnel, and adequate resources.

We look forward to further developments of the National Cancer Registry.

Thank you.

DR. GERARD LIM CHIN CHYEHead of Department, Department of Radiotherapy and Oncology National Cancer Institute, Putrajaya

In 2002, the National Cancer Registry (NCR) was operating under the ClinicalResearch Centre (CRC). In 2007, the NCR and the Regional Cancer Registries were merged and managed by the Non-Communicable Disease Sector, Disease Control Division of the Ministry of Health.

This will be the first Report of the National Cancer Registry that is published after the National Cancer Institute took over as the secretariat on 1st January 2015. The National Cancer Registry will be reporting on Cancer Incidence of Malaysia. Much work has already been carried out by the Disease Control Division of the Ministry of Health, together with the State Epidemiology officers and staff of the State Health Departments.

iii

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 9: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

iv

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

FOREWORD

risk factors and advances in cancer care.

The Government will intensify its efforts to increase quality of health care by targeting the areas that has lack of access to health services by uplifting the capacity of healthcare facilities, and trained health personnel.

Regional Cancer Registries such as Penang, Johor, Kelantan, Pahang, Melaka, Sabah and Sarawak have each published a 5-year report. The Penang Cancer Registry has published its third 5-year report since it wasestablished in 1994; its report has also been included in the Cancer Incidence in Five Continents Volume IX, 2007 and Volume X, 2014.

We thank all the physicians, epidemiologists, pathologists, statisticians and data managers in hospitals, State Cancer Registries and Ministry of Health who have effortlessly collaborated and cooperated in supporting the Malaysia Cancer Registry. Our special thanks for this publication go to all our data managers who have worked so meticulously to compile the present information. We are also grateful to all of our close collaborators and look forward to continue this effort.

I would also like to acknowledge and place on record the excellent teamwork by members of the Cancer Unit of Disease Control Division, Health Informatics Centre (Pusat Informatik Kesihatan), the State Epidemiology Officers (NCDC) and staff, and Cancer Registry Unit of National Cancer Institute who have been involved in producing, gathering and processing the data for the Malaysia Cancer Registry. The close rapport between the source data providers, experts and staff of the NCR is one of the main reasons for the success of the NCR. We look forward to continuation of these efforts in providing reliable national data on cancer.

Thank you.

This 5-year Malaysian National Cancer Registry (MNCR) report, which covers the years 2007 to 2011, is another milestone in the development of healthcare services in this country, whereby it will enable us to appreciate the overallcancer incidence and burden in Malaysia.

The report from this registry will facilitates the planning and institutionalisation of appropriate measures and the distribution of cancer care. The overall benefits derived from this result will be reflected in our ability to provideeffective healthcare services which is in line with the 11th Malaysia Plan(RMK-11). Cancer trends represent a subtle interplay between incidence,mortality and survival. These patterns are altering due to many interacting causes such as early detection, screening programmes, changing exposure to

Page 10: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

v

MESSAGE

In 2013, World Health Organization (WHO) had launched the global action plan for the prevention and control of non-communicable disease 2013-2020 that aims to reduce premature mortality from cancer and other NCDCs by 25%. The World Health Organization Members State agreed that among the indicators of progress in the fight against NCDCs is the need to record “cancer incidence, by type of cancer, per 100,000 populations”, thus placing an onus on countries to establish population- based cancer registries and to report on the progress.

The National Cancer Registry provides important epidemiological data of cancers, cancer burdens, trending and high risk group identification. The National Cancer Registry is one of the key priorities in the National CancerControl Blueprint 2008-2015. Previously the National Cancer Registry was run by the Disease Control Division at the Ministry of Health until 2014. Since January 2015, the NCR is now within the jurisdiction of the National Cancer Institute, Putrajaya. Data for the year 2015 and onwards will be handled and managed by the NCI, Cancer Registry Unit.

Cancer registration should never be a goal in itself. The global objective is to improve the quality of life for cancer survivors and outcome of cancer treatments. Registration takes into account prognostic variables and allowsindividual feedback to all cancer centres on process and outcome indicators. Joint venture researches and the use of cancer registry data by researchers show that the effort invested by all authorities involved in public health has been successful. Let us continue this path to be at par with international examples on population- based cancer researches.

Thank you.

DATUK SERI DR. S. SUBRAMANIAMMinister of Health, MALAYSIA

Cancer constitutes an enormous burden on societies globally. The occurrence of cancer is increasing because of growth and aging of the population, as well as anincreasing prevalence of established risk factors such as smoking, overweight, physical inactivity and changing reproductive patterns associated with urbanization and economic development. According to WHO, cancer is among the leadingcauses of morbidity and mortality worldwide with approximately 14 million newcases and 8.2 million cancer related deaths in 2012. More than 60% of the world’s total new annual cases occur in Africa, Asia and Central and South America. These regions account of 70% of the world’s cancer deaths. It is expected that annual cancer cases will escalate from 14 million in 2012 to 22 million within the next 2 decades.

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 11: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

vi

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

ACKNOWLEDGEMENT

We would like to express gratitude to all individuals and organisations that have directly or indirectly contributed to the Malaysian National Cancer Registry Report, 2007-2011.

We would like to thank especially the following:

The Honourable Minister of Health Malaysia, Y.B. Datuk Seri Dr. S. Subramaniam. Director General of Health Malaysia, YBhg. Datuk Dr. Noor Hisham Bin Abdullah. Deputy Director General of Health Malaysia (Public Health), YBhg. Datuk Dr. Lokman Hakim b. Sulaiman. Deputy Director General of Health Malaysia (Medical), YBhg. Datuk Dr. Jeyaindran Tan Sri Sinnadurai. Deputy Director General of Health Malaysia (Research & Technical Support), YBhg. Datuk Dr. Shahnaz Bt. Murad. Head of Department, Department of Radiotherapy and Oncology, National Cancer Institute, Putrajaya, Dr. Gerard Lim Chin Chye. Deputy Director Health Informatics Centre, Planning Division, Ministry of Health, Malaysia, Dr. Md. Khadzir b Sheikh Haji Ahmad State Health Directors. Deputy State Directors. Oncologists, pathologists, other disciplines specialists, palliative care professionals, and all other members of the medical profession from various government, universities, non-government and private centres. Director of National Registration Department. Medical record departments of all hospitals. All hospitals, institutions, public and private clinics.

We also would like to express our gratitude to all states Epidemiology Officers (NCDCC), Medical Officers,Statisticians, Paramedics, Assistant Record Officers and Clerical Staff at all State Cancer Registries, forcontinuously collecting and contributing data to the National Cancer Registry.

Epidemiologist and Medical Officer of State Cancer Registries:

Dr. Zulhizzam Hj. Abdullah Public Health Physician & State Epidemiologist (NCDC), Perlis State Health Department

Dr. Husna Hakimah Tajau Rahim Medical Officer (NCDC), Perlis State Health Department

Dr. Shahrul Bariyah Ahmad Public Health Physician & State Epidemiologist (NCDC), Kedah State Health Department

Dr. Muhamad Fadhil Mohamad Marzuki Medical Officer (NCDC), Kedah State Health Department

Dr. Azizah Ab Manan Public Health Physician & State Epidemiologist (NCDC), Penang State Health Department

Dr. Muhammad Ihsan Suhaidi Medical Officer (NCDC), Penang State Health Department

1.2.3.4.5.

6.

7.

8.9.10.

11.12.13.

1.

2.

3.

Page 12: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

vii

Dr. Asmah Zainal Abidin Public Health Physician & State Epidemiologist (NCDC), Perak State Health Department

Dr. Norli Abd Jabbar Public Health Physician & State Epidemiologist (NCDC), Selangor State Health Department

Dr. Ozrinalifah Omar Medical Officer (NCDC), Selangor State Health Department

Dr. Misliza Ahmad Public Health Physician & State Epidemiologist (NCDC), WP. Kuala Lumpur (WPKL) & Putrajaya State Health Department

Dr. Khalijah Mohd Yusof Public Health Physician & State Epidemiologist (NCDC), Negeri Sembilan State Health Department

Dr. Murni Hayati Baharom Medical Officer (NCDC), Negeri Sembilan State Health Department

Dr. Suhaila Osman Public Health Physician & State Epidemiologist (NCDC), Melaka State Health Department

Dr. Yusmah Muhamad Public Health Physician & State Epidemiologist (NCDC), Johor State Health Department

Dr. Rahayu Othman Medical Officer (NCDC), Johor State Health Department

Dr. Fatimah A. Majid Public Health Physician & State Epidemiologist (NCDC), Pahang State Health Department

Dr. Ruzawati Zahri Medical Officer (NCDC), Pahang State Health Department

Dr. Fatimah Muda Public Health Physician & State Epidemiologist (NCDC), Terengganu State Health Department

Dr. Noor Hashimah Abdullah Public Health Physician & State Epidemiologist (NCDC), Kelantan State Health Department

Dr. Hashimah Basri Public Health Physician & State Epidemiologist (NCDC), Sarawak State Health Department

Dr. Nirmal Kaur A/P Sadhu Singh Public Health Physician & State Epidemiologist (NCDC), Sabah State Health Department

Dr. Nafisah Ahmad Medical Officer (NCDC), Sabah State Health Department

Dr. Wan Mohd Harith Wan Mustapa Medical Officer (NCDC), W.P. Labuan State Health Department

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 13: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

viii

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Special gratitude to all stakeholders for their support and valuable comments on the report:

Dato’ Dr. Abd Jamil Abdullah National Advisor for Surgery, Sultanah Nur Zahirah Hospital

Dr. Arni Talib National Advisor for Pathology, Kuala Lumpur Hospital

Dr. Azura Daniel Head of Department, Department of Radiotherapy & Oncology, Kuala Lumpur Hospital

Dato’ Dr. Chang Kian Meng National Advisor for Hematology, Ampang Hospital

Prof. Dr. Cheong Soon Keng Dean of Medical & Health Science Faculty, Tunku Abdul Rahman University

Dato’ Dr. Fitjerald Henry National Advisor for Colorectal Surgery, Selayang Hospital

Assc. Prof. Dato’ Dr. Fuad Ismail Head of Department, Department of Radiotherapy & Oncology, Universiti Kebangsaan Malaysia Medical Centre

Dato’ Dr. Ghazali Ismail National Advisor for Gynaecology Oncology, Sultan Ismail Hospital

Dr. Goh Pik Pin Director of National Clinical Research Centre

Dr. Hishamshah Mohd Ibrahim National Advisor for Paediatric Oncology, Kuala Lumpur Hospital

Dr. Jamaiyah Haniff Head of Unit, Malaysia Health Care Performance

Dr. Jamalul Azizi Abdul Rahaman National Advisor for Respiratory Medicine, Serdang Hospital

Dr. Krishnan Raman National Advisor for Hepatobiliary Surgery, Selayang Hospital

Dr. Lim Teck Onn Senior Consultant, ClinResearch Sdn. Bhd.

Dr. Matin Mellor Abdullah President of Malaysian Oncology Society, Subang Jaya Medical Centre

Dr. Mohd Roslan Haron National Advisor for Radiotherapy & Oncology, Sultan Ismail Hospital

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

Page 14: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

ix

Dato’ Dr. Muhammad Radzi Abu Hassan National Advisor for Gastroenterology, Sultanah Bahiyah Hospital

Dato’ Sri Dr. N. Premchandran National Advisor for Orthopaedic Surgery, Tengku Ampuan Hafzan Hospital

Dr. Nor Aina Emran National Advisor for Breast and Endocrine Surgery, Kuala Lumpur Hospital

Prof. Dr. Nur Aishah Mohd Taib Breast Surgeon, Department of Surgery, University Malaya Medical Centre

Dr. Richard Lim Boon Leong National Advisor for Palliative Medicine, Selayang Hospital

Dato’ Dr. Rohan Malek Dato’ Dr. Johan Thambu National Advisor for Urology, Selayang Hospital

Dr. Saunthari Somasundram President of National Cancer Society of Malaysia

Datin Dr. Siti Sabzah Mohd Hashim National Advisor for Otolaryngology, Sultanah Bahiyah Hospital

Prof. Dr. Teo Soo Hwang Cancer Research Initiatives Foundation (CARIF), Subang Jaya Medical Centre

Gratitude also to the international reviewers:

Mr. Les Mery (International Agency for Research on Cancer, Lyon, France) Global Programme Manager, Global Initiative for Cancer Registry Development.

Dr. Suleeporn Sangrajrang (NCI Bangkok, Thailand) Medical Scientist, Expert Level Deputy Director, Health System Development, National Cancer Institute, Thailand.

To all others who had contributed directly and indirectly towards this report.

17.

18.

19.

20.

21.

22.

23.

24.

25.

1.

2.

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 15: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

x

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

SECRETARIAT

The National Cancer Registry (NCR) previously was under the Non-Communicable Disease Sector, DiseaseControl Division, at the Ministry of Health. Since January 2015, its secretariat had been transferred to the National Cancer Institute in Putrajaya.

Secretariat of the National Cancer Registry (2007 - 2014)

Dr. Chong Chee Kheong Director of Non-Communicable Disease Sector, Disease Control Division, Ministry of Health

Dr. Zainal Ariffin Omar Deputy Director of Non-Communicable Disease Sector, Disease Control Division, Ministry of Health

Dr. Nor Saleha Ibrahim Tamin Head of Cancer Unit, Non-Communicable Disease Sector, Disease Control Division, Ministry of Health

Dr. Renuga K. Raman (2013-2014) Senior Assistant Director

Puan Raja Rohanira Raja Taib Administrative Assistant

Puan Dayang Pujiah Awang Shamsudin Administrative Assistant

Secretariat of the National Cancer Registry (Starting from 1st January 2015 until present)

Dr. Asmayani Khalib Director of National Cancer Institute Dr. Gerard Lim Chin Chye Head of Radiotherapy and Oncology Department, National Cancer Institute

Dr. Renuga K. Raman Medical Officer & Coordinator of Cancer Registry Unit, National Cancer Institute

Dr. Nabihah Ali Medical Officer of Cancer Registry Unit, National Cancer Institute

Dr. Puteri Nureylia Amir Medical Officer of Cancer Registry Unit, National Cancer Institute

Salina Asha’ari Staff Nurse of Cancer Registry Unit, National Cancer Institute

1.

2.

3.

4.

5.

6.

.

1.

2.

3.

4.

5.

6.

Page 16: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

xi

LIST OF TABLES

Malaysian population, 2011Malaysian citizens by sex, 2011Malaysian citizens by ethnic groups, 2011Malaysian population by state and area of land coverage, 2011Gross domestic product (GDP) per capita, Malaysia, 2007-2011Health facilities and number of Doctors in Malaysia, 2007-2011Number of new cancer cases, Crude Rate (CR), Age-standardised rate (ASR), Cumulative Risk (CumR) and Lifetime Risk by sex, Malaysia, 2007-2011Incidence summary by major ethnic groups and sex, Malaysia, 2007-2011Incidence summary by state and sex, Malaysia, 2007-2011ASR by sex comparing Malaysia, Penang, Sarawak Cancer Registry 2007-2011 and Globocan 2012Ten most common cancers, all residents, Malaysia, 2007-2011Ten most common cancers in Malaysia by sex, all residents, 2007-2011Age-standardised rates for ten most common cancer in males by ethnicity, Malaysia, 2007-2011Age-standardised rates for ten most common cancer in females by ethnicity, Malaysia, 2007-2011Ten most common cancers in Malaysia, Malay residents by sex, 2007-2011Ten most common cancers in Malaysia, Chinese residents by sex, 2007-2011Ten most common cancers in Malaysia, Indian residents by sex, 2007-2011Ten most common cancers in Malaysia, other ethnic groups by sex, 2007-2011Staging for all cancer types, Malaysia, 2007-2011Quality IndicatorSummary of all cancer sites 2007-2011 by sex, year and ethnicSummary of all cancer sites 2007-2011 by statesFemale Breast: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011Female Breast: Incidence summary by ethnicity, Malaysia, 2007-2011Female Breast: Incidence summary by year, Malaysia, 2007-2011Colorectal: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Colorectal: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Colorectal: Incidence summary by year and sex, Malaysia, 2007-2011Trachea, Bronchus, Lung: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74),Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Trachea, Bronchus, Lung: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Trachea, Bronchus, Lung: Incidence summary by year and sex, Malaysia, 2007-2011Lymphoma: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Lymphoma: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Lymphoma: Incidence summary by year and sex, Malaysia, 2007-2011Nasopharynx: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Nasopharynx: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Nasopharynx: Incidence summary by year and sex, Malaysia, 2007-2011Leukaemia: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Leukaemia: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Leukaemia: Incidence summary by year and sex, Malaysia, 2007-2011

Table 1Table 2Table 3Table 4Table 5Table 6Table 7

Table 8Table 9Table 10Table 11Table 12Table 13Table 14Table 15Table 16Table 17Table 18Table 19Table 20Table 21Table 22Table 23

Table 24Table 25Table 26

Table 27Table 28Table 29

Table 30Table 31Table 32

Table 33Table 34Table 35

Table 36Table 37Table 38

Table 39Table 40

Page44445613

13131416172323242526272830313133

333336

363639

393942

424244

444447

4747

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 17: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

xii

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Cervix Uteri: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) andCumulative Risk (CumR), Malaysia, 2007-2011Cervix Uteri: Incidence summary by ethnicity, Malaysia, 2007-2011Cervix Uteri: Incidence summary by year, Malaysia, 2007-2011Liver: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Liver: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Liver: Incidence summary by year and sex, Malaysia, 2007-2011Ovary: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011Ovary: Incidence summary by ethnicity, Malaysia, 2007-2011 Ovary: Incidence summary by year, Malaysia, 2007-2011Stomach: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Stomach: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Stomach: Incidence summary by year and sex, Malaysia, 2007-2011Prostate: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) andCumulative Risk (CumR), Malaysia, 2007-2011Prostate: Incidence summary by ethnicity, Malaysia, 2007-2011Prostate: Incidence summary by year, Malaysia, 2007-2011Other skin: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Other skin: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Other skin: Incidence summary by year and sex, Malaysia, 2007-2011Thyroid: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Thyroid: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Thyroid: Incidence summary by year and sex, Malaysia, 2007-2011Brain, Nervous system: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Brain, Nervous system: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Brain, Nervous system: Incidence summary by year and sex, Malaysia, 2007-2011Corpus Uteri: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) andCumulative Risk (CumR), Malaysia, 2007-2011Corpus Uteri: Incidence summary by ethnicity, Malaysia, 2007-2011Corpus Uteri: Incidence summary by year, Malaysia, 2007-2011

Table 41

Table 42Table 43Table 44

Table 45Table 46Table 47

Table 48Table 49Table 50

Table 51Table 52Table 53

Table 54Table 55Table 56

Table 57Table 58Table 59

Table 60Table 61Table 62

Table 63Table 64Table 65

Table 66Table 67

Page50

505053

535356

565659

595962

626265

656567

676769

696971

7171

Page 18: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

xiii

LIST OF FIGURES

Map of MalaysiaPopulation pyramid, Malaysia, all residents, 2011Perinatal, Neonatal, Infant and Maternal mortality rates in MOH Hospitals, Malaysia, 2007-2011Number of medically certified and non-medically certified cancer death, Malaysia, 2007-2011Certified and uncertified cancer death, Malaysia, 2007-2011Outline of registration proceduresAge-standardised rate (ASR) by state and sex, Malaysia, 2007-2011Annual Age-standardised rate (ASR) by sex, Malaysia, 2007-2011Percentage of ten most common cancers, all residents, Malaysia, 2007-2011Age-standardised rate (ASR) for ten common cancer by sex, Malaysia, 2007-2011Age-specific incidence rate by sex, all sites, Malaysia, 2007-2011Age-specific incidence rate for ten common sites, males, Malaysia 2007-2011Age-specific incidence rate for ten common sites, females, Malaysia, 2007-2011 Common cancers among 0-14 years age group by sex, Malaysia, 2007-2011Common cancers among 15-24 years age group by sex, Malaysia, 2007-2011Common cancers among 25-59 years age group by sex, Malaysia, 2007-2011Common cancers among 60-74 years age group by sex, Malaysia, 2007-2011Common cancers in 75 years and above age group by sex, Malaysia, 2007-2011 Age-standardised rate (ASR) for ten common cancers in Malays by sex, Malaysia, 2007-2011 Age-standardised rate (ASR) for ten common cancers in Chinese by sex, Malaysia, 2007-2011Age-standardised rate (ASR) for ten common cancers in Indians by sex, Malaysia, 2007-2011Age-standardised rate (ASR) for ten common cancers in other ethnic groups by sex, Malaysia, 2007-2011All sites: International comparisons- Age standardised ratesFemale Breast: Age-specific incidence rate, Malaysia, 2007-2011Female Breast: Stage Female Breast: Age-standardised rate (ASR) by state, Malaysia, 2007-2011Female Breast: International comparisons- Age standardised ratesColorectal: Age-specific incidence rate by sex, Malaysia, 2007-2011Colorectal: Stage by sexColorectal: Age -standardised rate (ASR) by state and sex, Malaysia, 2007-2011Colorectal: International comparisons- Age standardised ratesTrachea, Bronchus, Lung: Age -specific incidence rate by sex, Malaysia, 2007-2011Trachea, Bronchus ,Lung: Stage by sexTrachea, Bronchus, Lung: Age -standardised rate (ASR) by state and sex, Malaysia, 2007-2011Trachea, Bronchus, Lung: International comparisons- Age standardised rates Lymphoma: Age-specific incidence rate by sex, Malaysia, 2007-2011Lymphoma: Stage by sexLymphoma: Age -standardised rate (ASR) by state and sex, Malaysia, 2007-2011Nasopharynx: Age-specific incidence rate by sex, Malaysia, 2007-2011Nasopharynx: Stage by sexNasopharynx: Age -standardised rate (ASR) by state and sex, Malaysia, 2007-2011Nasopharynx: International comparisons- Age-standardised ratesLeukaemia: Age-specific incidence rate by sex, Malaysia, 2007-2011Leukaemia types: Age-specific incidence rate, males, Malaysia, 2007-2011Leukaemia types: Age-specific incidence rate, females, Malaysia, 2007-2011Leukaemia: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011Leukaemia: International comparisons- Age-standardised rates Cervix Uteri: Age-specific incidence rate ,Malaysia, 2007-2011

Figure 1Figure 2Figure 3Figure 4Figure 5Figure 6Figure 7Figure 8Figure 9Figure 10Figure 11Figure 12Figure 13Figure 14Figure 15Figure 16Figure 17Figure 18Figure 19Figure 20Figure 21Figure 22Figure 23Figure 24Figure 25Figure 26Figure 27Figure 28Figure 29Figure 30Figure 31Figure 32Figure 33Figure 34Figure 35Figure 36Figure 37Figure 38Figure 39Figure 40Figure 41Figure 42Figure 43Figure 44Figure 45Figure 46Figure 47Figure 48

Page3357710141516181819202121212222242526273234343435373737384040404143434345454546474848484951

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 19: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

xiv

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Cervix Uteri: Stage Cervix Uteri: Age-standardised rate (ASR) by state, Malaysia 2007-2011Cervix Uteri: International comparisons- Age-standardised ratesLiver: Age-specific incidence rate by sex, Malaysia, 2007-2011Liver: Stage by sexLiver: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011Liver: International comparisons- Age-standardised ratesOvary: Age-specific incidence rate, Malaysia, 2007-2011Ovary: Stage Ovary: Age-standardised rate (ASR) by state, Malaysia, 2007-2011 Ovary: International comparisons- Age-standardised ratesStomach: Age-specific incidence rate by sex, Malaysia, 2007-2011Stomach: Stage by sexStomach: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011Stomach: International comparisons- Age-standardised rates Prostate: Age-specific incidence rate, Malaysia, 2007-2011Prostate: StageProstate: Age-standardised rate (ASR) by state, Malaysia, 2007-2011Prostate: International comparisons- Age-standardised rates Other Skin: Age-specific incidence rate by sex, Malaysia, 2007-2011Other Skin: Stage by sexOther Skin Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011Thyroid: Age-specific incidence rate by sex, Malaysia, 2007-2011Thyroid: Stage by sexThyroid: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011Brain, Nervous system: Age-specific incidence rate by sex, Malaysia, 2007-2011Brain, Nervous system: Stage by sexBrain, Nervous system: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011Corpus Uteri: Age-specific incidence rate, Malaysia, 2007-2011Corpus Uteri: StageCorpus Uteri: Age-standardised rate (ASR) by state, Malaysia, 2007-2011

Figure 49Figure 50Figure 51Figure 52Figure 53Figure 54Figure 55Figure 56Figure 57Figure 58Figure 59Figure 60Figure 61Figure 62Figure 63Figure 64Figure 65Figure 66Figure 67Figure 68Figure 69Figure 70Figure 71Figure 72Figure 73Figure 74Figure 75Figure 76Figure 77Figure 78Figure 79

Page51515254545455575757586060606163636364666666686868707070727272

Page 20: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

xv

LIST OF APPENDICES

Person-years at risk by sex, ethnic and age group, Malaysian residents, 2007-2011Person-years at risk by sex, state and age group, Malaysian residents, 2007-2011Person-years at risk, all Malaysian, 2007-2011Person-years at risk, Malay residents, Malaysia, 2007-2011Person-years at risk, Chinese residents, Malaysia, 2007-2011Person-years at risk, Indian residents, Malaysia, 2007-2011Person-years at risk, Others residents, Malaysia, 2007-2011Incidence summary table, all residents, males, Malaysia, 2007-2011Incidence summary table, all residents, females, Malaysia, 2007-2011Incidence summary table, Malay males, Malaysia, 2007-2011Incidence summary table, Malay females, Malaysia, 2007-2011Incidence summary table, Chinese males, Malaysia, 2007-2011Incidence summary table, Chinese females, Malaysia, 2007-2011Incidence summary table, Indian males, Malaysia, 2007-2011Incidence summary table, Indian females, Malaysia, 2007-2011Incidence summary table, Others males, Malaysia, 2007-2011Incidence summary table, Others females, Malaysia, 2007-2011Incidence summary table of 15 selected cancer sites by state and sex, Malaysia, 2007-2011Number of new cancer cases by sites and age group, all residents, males, Malaysia, 2007-2011Number of new cancer cases by sites and age group, all residents, females, Malaysia, 2007-2011Cancer incidence by sites and age group, all residents, males, Malaysia, 2007-2011Cancer incidence by sites and age group, all residents, females, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Malay males, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Malay females, Malaysia, 2007-2011Cancer incidence by sites and age group, Malay males, Malaysia, 2007-2011Cancer incidence by sites and age group, Malay females, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Chinese males, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Chinese females, Malaysia, 2007-2011Cancer incidence by sites and age group, Chinese males, Malaysia, 2007-2011Cancer incidence by sites and age group, Chinese females, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Indian males, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Indian females, Malaysia, 2007-2011Cancer incidence by sites and age group, Indian males, Malaysia, 2007-2011Cancer incidence by sites and age group, Indian females, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Others males, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Others females, Malaysia, 2007-2011Cancer incidence by sites and age group, Others males, Malaysia, 2007-2011Cancer incidence by sites and age group, Other females, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Selangor, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Selangor, all residents, females, 2007-2011Cancer incidence by sites and age group, Selangor, all residents, males, 2007-2011Cancer incidence by sites and age group, Selangor, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Johor, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Johor, all residents, females, 2007-2011Cancer incidence by sites and age group, Johor, all residents, males, 2007-2011Cancer incidence by sites and age group, Johor, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Sabah, all residents, males, 2007-2011

Appendix 1Appendix 2Appendix 3Appendix 4Appendix 5Appendix 6Appendix 7Appendix 8Appendix 9Appendix 10Appendix 11Appendix 12Appendix 13Appendix 14Appendix 15Appendix 16Appendix 17Appendix 18Appendix 19Appendix 20Appendix 21Appendix 22Appendix 23Appendix 24Appendix 25Appendix 26Appendix 27Appendix 28Appendix 29Appendix 30Appendix 31Appendix 32Appendix 33Appendix 34Appendix 35Appendix 36Appendix 37Appendix 38Appendix 39Appendix 40Appendix 41Appendix 42Appendix 43Appendix 44Appendix 45Appendix 46Appendix 47

Page7475787980818283848586878889909192939899100101102103104105106107108109110111112113114115116117118119120121122123124125126

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 21: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

xvi

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Number of new cancer cases by sites and age group, Sabah, all residents, females, 2007-2011Cancer incidence by sites and age group, Sabah, all residents, males, 2007-2011Cancer incidence by sites and age group, Sabah, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Sarawak, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Sarawak, all residents, females, 2007-2011Cancer incidence by sites and age group, Sarawak, all residents, males, 2007-2011Cancer incidence by sites and age group, Sarawak, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Perak, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Perak, all residents, females, 2007-2011Cancer incidence by sites and age group, Perak, all residents, males, 2007-2011Cancer incidence by sites and age group, Perak, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Kedah, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Kedah, all residents, females, 2007-2011Cancer incidence by sites and age group, Kedah, all residents, males, 2007-2011Cancer incidence by sites and age group, Kedah, all residents, females, 2007-2011Number of new cancer cases by sites and age group, WPKL & Putrajaya, all residents, males, 2007-2011Number of new cancer cases by sites and age group, WPKL & Putrajaya, all residents, females, 2007-2011Cancer incidence by sites and age group, WPKL & Putrajaya, all residents, males, 2007-2011Cancer incidence by sites and age group, WPKL & Putrajaya, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Kelantan, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Kelantan, all residents, females, 2007-2011Cancer incidence by sites and age group, Kelantan, all residents, males, 2007-2011Cancer incidence by sites and age group, Kelantan, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Penang, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Penang, all residents, females, 2007-2011Cancer incidence by sites and age group, Penang, all residents, males, 2007-2011Cancer incidence by sites and age group, Penang, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Pahang, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Pahang, all residents, females, 2007-2011Cancer incidence by sites and age group, Pahang, all residents, males, 2007-2011Cancer incidence by sites and age group, Pahang, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Terengganu, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Terengganu, all residents, females, 2007-2011Cancer incidence by sites and age group, Terengganu, all residents, males, 2007-2011Cancer incidence by sites and age group, Terengganu, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Negeri Sembilan, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Negeri Sembilan, all residents, females, 2007-2011Cancer incidence by sites and age group, Negeri Sembilan, all residents, males, 2007-2011Cancer incidence by sites and age group, Negeri Sembilan, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Melaka, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Melaka, all residents, females, 2007-2011Cancer incidence by sites and age group, Melaka, all residents, males, 2007-2011Cancer incidence by sites and age group, Melaka, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Perlis, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Perlis, all residents, females, 2007-2011Cancer incidence by sites and age group, Perlis, all residents, males, 2007-2011

Appendix 48Appendix 49Appendix 50Appendix 51Appendix 52Appendix 53Appendix 54Appendix 55Appendix 56Appendix 57Appendix 58Appendix 59Appendix 60Appendix 61Appendix 62Appendix 63

Appendix 64

Appendix 65Appendix 66Appendix 67Appendix 68Appendix 69Appendix 70Appendix 71Appendix 72Appendix 73Appendix 74Appendix 75Appendix 76Appendix 77Appendix 78Appendix 79Appendix 80Appendix 81Appendix 82Appendix 83

Appendix 84

Appendix 85Appendix 86Appendix 87Appendix 88Appendix 89Appendix 90Appendix 91Appendix 92Appendix 93

Page127128129130131132133134135136137138139140141142

143

144145146147148149150151152153154155156157158159160161162

163

164165166167168169170171172

Page 22: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

xvi

Cancer incidence by sites and age group, Perlis, all residents, females, 2007-2011Number of new cancer cases by sites and age group, W.P. Labuan, all residents, males, 2007-2011Number of new cancer cases by sites and age group, W.P. Labuan, all residents, females, 2007-2011Cancer incidence by sites and age group, W.P. Labuan, all residents, males, 2007-2011Cancer incidence by sites and age group, W.P. Labuan, all residents, females, 2007-2011Morphologically verified cases by histology types, all sites, Malaysia, 2007-2011Cancer Notification FormExplanatory notes for completing Cancer Notification Form

Appendix 94Appendix 95Appendix 96

Appendix 97Appendix 98Appendix 99Appendix 100Appendix 101

Page173174175

176177178201202

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 23: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

1

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

The first five year report of the Malaysian National Cancer Registry attempts to provide information on cancerincidence from 2007 to 2011 on cases which were reported and recorded in thirteen states and two federalterritories. This report will serve as a baseline by which future reports will be compared with. It is recommended that in this report, caution is advised in the interpretation of the incidence of cancer rather than focusing on the absolute numbers and rates of the burden of cancer. The profile of cancer should be looked at in terms of distribution by age, ethnicity, sex and geography. The incidence varies between states partialy due to the difference of population structure, for example the incidence rates in Penang are among the highest and this could be due to higherproportion of Chinese in Penang compared to other states.

A total number of 103,507 new cancer cases were diagnosed in Malaysia during the period of 2007 to 2011. Of these 46,794 (45.2%) were reported in males and 56,713 (54.8%) in females. The age standardised incidence rates (ASR) for males and females were 86.9 and 89.0 per 100,000 population in males and females respectively. The ASR in Chinese males were 112.9 per 100,000 population while in females were 126.2 per 100,000population, Malay males were 70.7 per 100,000 population and females were 81.9 per 100,000 population, Indian males were 70.4 per 100,000 population and females were 110.1 per 100,000 population. The five most common cancers among males were cancers of the colorectal, lung, nasopharynx, lymphoma and prostate. Among females, the five most common were cancers of the breast, colorectal, cervix uteri, ovary and lung.

Further analysis was done based on six regional registries which were established before 2007 (Penang, Kelantan, Pahang, Johor, Sabah, Sarawak). The ASR were higher compared to the incidence based on all state registries which were 100.0 per 100,000 population in males and 109.0 per 100,000 population in females. As the period of coverage of the report begins in 2007, and since registries generally require several years of operation before they attain adequate levels of data quality (defined as completeness of case ascertainment, accuracy and timeliness of reporting), the main concern is underreporting in the nine new registries, for this more time would be required for other registries to mature.

The stage of cancer at the time of diagnosis was reported based on information provided by the notifying clinician. The staging system was based on the TNM Classification System for most tumour sites. In total 51.0% of recorded cases had reports on staging, of those cases whose staging was recorded, 17.1% in stage I, 23.6% in stage II, 23.0% in stage III and 35.8% in stage IV.

1.0 OVERVIEW

1.1 Cancer Incidence

1.2 Staging

Page 24: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

2

Ministry of Health has started its population-based cancer registry in 1993. It was started with regionalpopulation-based cancer registries to ensure long term sustainability. Penang was chosen as a pilot location in 1994 to cover northern region. Following this, other regional registries were established in Sarawak, Kelantan,Pahang, Johor and Sabah. Since 2007 all states in Malaysia had set up their own population-based registries which were headed by National Cancer Registry in the Ministry of Heatlh under the Non-Communicable Disease Sector, Disease Control Division. The secretariat for the NCR has been transferred to the National Cancer Institute (NCI) since 1st January 2015.

Cancer is one of the leading causes of death in Malaysia today. This report aims to provide an epidemiological profile of cancer, which is important in the National Cancer Control Programme. Cancer represents a tremendous burden on patients, families and the society they live in. Besides financial cost, cancer has an importantpsychosocial effect on patients and their families. Specification of cancer incidence with varying degrees of confidence is fundamental for cancer control. These data do not only establish the burden of disease as it may impinge upon public health and clinical services planning, they also indicate in many instances, causative relationships, the impact of socioeconomic differences and priorities that maybe accorded to particular cancer control options.

This is the first five year national report which covers the period of 2007-2011. This MNCR report follows reports for 2003-2005, 2006, 2007 and 2008. The initial reports only covered cancer incidence among all residents inPeninsular Malaysia. Meanwhile the subsequent reports in 2007 and 2008 covered residents in all states inMalaysia. This 2007-2011 report applied to Malaysian citizens living in Malaysia at the time of diagnosis. Thepopulation denominator used was the 2009 intercensal population. The Segi World Standard Population (1960) was applied as a reference in calculating the ASR.

Malaysia covers an area of about 330,289 sq. km, consisting of Peninsular Malaysia and East Malaysia (Sabah, Sarawak and Federal Territory of Labuan). It is separated by the South China Sea and has its frontier with Thailand, Singapore, Indonesia and Brunei.

Peninsular Malaysia is located south of Thailand, north of Singapore and east of the Indonesian Island ofSumatera. East Malaysia comprises most of the northern part of Borneo and shares borders with Brunei andIndonesia. Located near the equator, Malaysia’s climate is categorised as equatorial, being hot and humidthroughout the year.

Malaysia is divided into thirteen states and three Federal Territories. Eleven states and two Federal Territories are found in Peninsular Malaysia meanwhile, two states and one Federal Territory are found in East Malaysia.

The Peninsular Malaysia consists of the following states (from north to south): Perlis, Kedah, Pulau Pinang(Penang), Perak, Selangor, Federal Territory of Kuala Lumpur and Putrajaya (WPKL & Putrajaya), Negeri Sembilan, Melaka, Johor, Pahang, Terengganu and Kelantan. The East Malaysia consists of Sabah, Sarawak and Federal Territory Labuan (W.P. Labuan).

2.0 INTRODUCTION

3.0 BACKGROUND

3.1 Geography

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 25: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

3

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Figure 2: Population pyramid, Malaysia, all residents, 2011Source: Dept. of Statistics Malaysia

Figure 1: Map of Malaysia

The estimated Malaysian population in 2011 was 29.1 million including the non-citizens. The population pyramid and its distribution of ethnic, sex and age group is shown in Figure 2, Table 2 and Table 3 respectively. Overall, there were 50.7% males and 49.3% females (Table 2). The ethnic distribution was as follows: Malay 54.7%,Chinese 24.3%, Indian 7.3%, other Bumiputera 12.8% and others 0.9%. In addition, there were almost 2.5 million non-citizens (8.4%) in Malaysia (Table 1). Intercensal Population Estimates are data that will be reviewed every ten years after Population and Housing Census is conducted using the final data on births and deaths. The projection is calculated yearly and used the cohort-component method which contained births, deaths, internal andinternational migration of the reference year. These estimates provide an overview of the growth and potential changes in population in terms of structure and compositions.

3.2 Population

SOUTH CHINA SEA

BORNEO

SARAWAK

Eastern RegionPetunjuk:

Northern RegionCentral RegionSouthern Region

East Malaysia

Page 26: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

4

Table 1: Malaysian population, 2011

Table 2: Malaysian citizens by sex, 2011

Table 3: Malaysian citizens by ethnic groups, 2011

CitizenshipCitizenNon-citizenTotal

SexMaleFemaleTotal

EthnicMalayChineseIndian*OthersTotal

Numbers26,617,1002,445,000

29,062,100

Numbers13,489,10013,127,800

26,616,100

Numbers14,551,3006,471,1001,939,7003,654,800

26,616,900

%91.68.4

100.0

%50.749.3

100.0

%54.724.37.3

13.7100.0

Source: Dept. of Statistics Malaysia

Source: Dept. of Statistics Malaysia

* Other Bumiputera and Others Source: Dept. of Statistics Malaysia

Table 4: Malaysian population by state and area of land coverage, 2011

State

Selangor

Johor

Sabah

Sarawak

Perak

Kedah

Kelantan

W.P. Kuala Lumpur

Penang

Pahang

Terengganu

Negeri Sembilan

Melaka

Perlis

W.P. Labuan

W.P. Putrajaya

TOTAL

5,126,200

3,131,700

2,446,700

2,399,000

2,326,800

1,898,700

1,578,200

1,544,800

1,493,700

1,446,300

1,055,100

985,300

797,600

230,300

81,200

75,500

26,616,900

2,869,200

1,792,300

232,300

578,400

1,264,500

1,481,200

1,492,400

692,300

648,700

1,067,800

1,019,500

584,500

521,300

202,700

31,100

73,000

14,551,300

1,460,900

1,049,900

298,300

589,300

701,500

256,900

52,800

659,800

674,900

232,900

26,900

226,900

210,700

18,900

10,100

500

6,471,100

685,900

220,200

10,400

7,200

285,700

137,300

4,600

159,200

159,000

64,000

2,800

151,000

47,700

3,100

700

900

1,939,700

73,800

54,900

1,801,500

1,217,100

66,300

4,700

17,700

18,700

6,400

75,300

3,800

19,500

13,600

1,100

37,700

1,000

3,413,100

36,400

14,400

104,300

7,000

8,800

18,700

10,600

14,600

4,600

6,300

2,100

3,600

4,200

4,600

1,600

0

3,413,100

7,930

18,987

73,620

124,450

21,005

9,425

15,105

243

1,031

35,965

12,955

6,657

1652

795

92

49

329,961

56.0

57.2

9.5

24.1

54.3

78.0

94.6

44.8

43.4

73.8

96.6

59.3

65.4

88.0

38.3

96.7

28.5

33.5

12.2

24.6

30.1

13.5

3.3

42.7

45.2

16.1

2.5

23.0

26.4

8.2

12.4

0.7

13.4

7.0

0.4

0.3

12.3

7.2

0.3

10.3

10.6

4.4

0.3

15.3

6.0

1.3

0.9

1.2

1.4

1.8

73.6

50.7

2.8

0.2

1.1

1.2

0.4

5.2

0.4

2.0

1.7

0.5

46.4

1.3

0.7

0.5

4.3

0.3

0.4

1.0

0.7

0.9

0.3

0.4

0.2

0.4

0.5

2.0

2.0

0.0

Total

EthnicsArea (Km²)Malay

Numbers Numbers Numbers Numbers Numbers% % % % %Chinese Indian OthersOther Bumiputera

Note: The added total may differ due to rounding Source: Dept. of Statistics Malaysia

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 27: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

5

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Figure 3: Perinatal, Neonatal, Infant and Maternal mortality rates in MOH Hospitals, Malaysia, 2007-2011

The health status of Malaysia has also been enhanced by improvement in health infrastructure and health services. Since Independence in 1957, changes in disease pattern in relation to lifestyle related conditions are occurring. Life expectancy in Malaysia at birth for both sexes has increased over the years, rising from 56 years for males and 58 for females in 1957 to 72.2 years for males and 76.8 years for females in 2011. Over the same period, the crude death rate fell from 12.4 per 1,000 population to 4.7. The average crude birth rate from 2007 to 2011 was 17.66 per 1,000 population and the crude of natural increase in average from 2007 to 2011 was 13.04 per 1,000 population (Department of Statistics Malaysia, Time Series Data). A decrease in perinatal, infant and maternal mortality rates from 2007 to 2011 are viewed in Figure 3. The gross domestic product (GDP) per capita 2007-2011 in Malaysia is depicted in Table 5.

3.3 Health Status, Socioeconomic and Health Facilities.

* Health Facts source Health Informatics Centre, MOH

Table 5: Gross domestic product (GDP) per capita, Malaysia, 2007-2011

YearGDP per capita, Malaysia (USD

20077,241

20088,487

20097,312

20109,069

201110,427

* World Development Indicators, World Bank

Page 28: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

6

Table 6: Health facilities and number of Doctors in Malaysia, 2007-2011

No. of Medical OfficerGovernment (MOH)Government (non-MOH)PrivateTotalDoctor: Population ratioHospitalsGovernment (MOH)Government (non-MOH)PrivateTotalHospitals BedsGovernment (MOH)Government (non-MOH)PrivateTotalHealth Clinics1Malaysia ClinicsGovernment (MOH)Private (GP)Total

2007

12,2732,0259,440

23,7381:1,145

1366

229371

37,2932,908

11,72251,923

NA2,8302,9925,822

2008

13,0962,000

10,00625,102

1:1,105

1367

246389

37,9343,245

12,16553,344

NA2,8246,3719,195

2009

17,3022,890

10,34430,5361:927

1368

245389

38,0573,523

12,61954,199

NA2,8186,3079,125

2011

22,4373,408

10,76236,6071:791

1388

263409

38,3943,322

14,07355,789

1092,8496,5899,547

2010

19,4293,000

10,55032,9791:859

1378

254399

37,7933,690

13,57655,059

532,8336,4429,328

Private Hospitals: Private Hospitals, Private Maternity Home, Private Nursing Home And HospiceGovernment (MOH) Health Clinics: Health Clinic, Community Clinic, Maternal and Child Health ClinicGovernment (non-MOH) Hospitals: Army Hospitals, University Hospitals1Malaysia Clinic: initiated in 2010Source: Health Indicators Ministry of Health Malaysia, Health Facts Ministry of Health Malaysia

The following table provides an overview of the health delivery system in Malaysia. An overall number of health facilities and doctors treating all types of diseases are seen in Table 6. From 2007 to 2011 the number of doctorsto the population ratio had increased from 1:791 to 1:1,145. Gradual increases in a total number of hospitals were from 371 in 2007 to 409 in 2011. Whereas, there was also increase in hospital beds (Government MOH,Government Non-MOH, and Private) from 51,923 in 2007 to 55,789 in 2011. Other public health facilities include 1Malaysia Clinics, Government (MOH) and Private (GP), form a total of 5,822 in 2007 and have increased to 9,547 by the year 2011.

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 29: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

7

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Figure 4: Number of medically certified and non-medically certified cancer death, Malaysia, 2007-2011

Figure 5: Certified and uncertified cancer death, Malaysia, 2007-2011

A total of 64,275 medically certified and non-medically certified cancer deaths were reported by the NationalRegistration Department of the period 2007 to 2011. Over the years, the numbers of medically certified cancer deaths have gradually increased. However, the number of non-medically certified cancer death remained relatively unchanged (Figure 4). Medically Certified Death was certified by medical practitioners with Malaysian Medical Council, which involves medical officers, district health officers and coroners. Non-medically Certified Deathcertified by persons such as policemen, medical assistants and other informants. The proportion of medicallycertified cancer death is 64.3% and non-medically certified cancer death is 35.7% (Figure 5).

3.4 Cancer Death Certification

Source: Department of Statistic, Malaysia

Source: Department of Statistic, Malaysia

Page 30: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

8

The registry sought to obtain basic epidemiological and clinical data on all cases of cancer diagnosed in Malaysia since 1st January 2007, regardless of citizenship, place of stay and basis of diagnosis. The registry receivednotifications from all data source providers in government and private health facilities (hospitals, clinics,laboratories, Hospice, National Registration Department and Health Informatics, MOH) in Malaysia. The National Cancer Registry team consolidated information from all state registries.

Case registration is based primarily on voluntary notifications. All identified data providers were asked to provide information concerning cancer on the standardised forms as attached in Appendix 100 and were sent to therespective registries. Patient confidentiality was maintained at all times. Both passive and active case findingmethods were used by the registries.

Passive notification – registry relies on other healthcare workers to complete notification forms and forward them to the registry.

Active search – collecting at source, whereby registry staff would visit the sources of data to extract the required information and record it onto forms, or to obtain copies of the relevant information.

To ensure completeness of the data, active case finding and routine checks were done using government andprivate hospital discharge records, as well as pathology records from the public and private laboratories. These were supplemented by case detection from death records supplied by the National Registration Department. Any cancer case detected from pathology and death records were then checked with previously registered cases. If they were not yet notified, reminders were sent to the person in-charge for more information. Additional missing data for these cases were also sought by registry staff by searching the relevant hospital records.

Every item relating to the patient were collated and updated. The registry registered all new cases of cancerdiagnosed in Malaysia. Multiple sources of data had assisted in optimising completeness of collection; however, this could create problem of multiple notification of a patient. This issue was addressed by cross checking names, age, date of birth and National Registration Identity Card numbers (NRIC) using CanReg4 software prior to the case registration. Identification card number is a unique number given to each Malaysian citizen and permanent resident. Children below 12 years of age are registered under their mother’s identification card number. In this report, the population is divided into 5 ethnic groups which are ‘Malay’, ‘Chinese’, ‘Indian’, ‘Other Bumiputera’ and ‘Others’. ‘Other Bumiputera’ refers to indigenous peoples, natives of Sarawak and Sabah meanwhile, ‘Others’ refers to ethnic groups which are not mentioned in other ethnic groups. The CanReg program accommodates comparison of essential variables across cases. 80% conformity is the standard used to trigger a further check of duplication. If the patient has been registered before, a check will be done along with the previous notifications to ascertain if it was a new primary. If the cancer is a new primary, the case is registered with a new registration number and if it is not, the records are updated.

Data from hospital discharges and reports from laboratories and death list from National Registration Department (NRD) were also sent to the registry and the same procedures were followed as described above.

4.0 METHODS

4.1 Sources of data

4.2. Data Collection

4.3. Registration Procedure

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 31: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

9

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Every effort was made to ensure that all the variables were completed. In the event if there was incompleteinformation, the notification forms with incomplete information were sent back to the respective data providers for further clarification and returned back to the registry upon completion. If there were no clarification, or incomplete forms returned, registries staff would visit the source providers to obtain the required information and to decide whether the case can be registered or not. For most cases the staging used was TNM Classification System. However, for cases with other staging classifications the registry staff assisted in converting it to TNM Classification System too.

Death certificate list were obtained from the National Registration Department, government and private hospitals in the same procedures as explained earlier. Those with mention of cancer on death certificate were identified, and transcripts of associated reports or certificates were used by the registry. If no information was available, then the case would be registered as Death Certificate Only (DCO). All updated information collected on hardcopies, either passively or actively, were entered into the computer database. Electronic data maintained in the cancer registry databases were subjected to on-going quality control.

Page 32: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

10

Figure 6: Outline of registration procedure NRIC: National Ragistration Identification Card, RN: Registration Number, ICD-O: International Classification of Disease for Oncology

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 33: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

11

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

The number of new cancer cases (incidence cases) observed in the population during a defined period, divided by the number of population at risk in the same period. It is usually expressed per 100,000.

CR = N / P x 100,000 N – Total number of new cancer cases P – Person-years at risk

4.5 Description of statistical methods

4.5.1 Crude incidence rate (CR)

In order to achieve a high validity and accuracy of data the Malaysian National Cancer Registry (MNCR) has used the same five common indices as indicated in the Cancer Incidence in Five Continents (CI5), Vol X, which are (a) Internal consistency; (b) Histological verification; (c) Death certificate only (DCO); (d) Other and unspecified cases (ill-defined cases ) and (e) Age unknown.

All data supplied for this report were coded to ICD-O-3 and then were converted to ICD-10 for analysis and report writing. To ensure data comparability, all cases notified to the registry must follow the IARC rules.

4.4 Quality control

Incidence rate in a specified five-year age group; calculated by dividing the number of cancer cases in the five-year age group by the Malaysian population in the particular age group and multiply by 100,000.

AR = N / P x 100,000 N - Number of new cancer occurring in the i age group P – Person-years at risk in the i age group

4.5.2 Age-specific rate (AR)

i ththi

i i

Since the incidence of cancer depends heavily on the age structure of the population, there is a need for age adjustment for comparative analysis. The age-standardised incidence rate is a summary measure, indicating the rate that a population would have if it had a standard age structure.

It is calculated by summing the age-specific rates weighting to the world standard population; the calculated incidence rate is then called the World Standardised incidence rate. It is also expressed per 100,000.

ASR = ∑ (AR x P ) / total world standard population AR - Age specific rate in the i age class P - The number in the i age class of world standard population

4.5.3 Age-standardised rate (ASR)

thth

ii.std

i.stdi

As with any measurement of a population, incidence rates have a certain amount of chance variation. The index measure of this variability is known as the standard error and is computed as follows:

SE = √ ∑ d (w /y ) d - Number of cases of the cancer of interest in the age class i w - Standard world population for age class i y - Person-years at risk for age class i

4.5.4 Standard error (SE)

ii

i

i i i i 2

Page 34: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

12

ASRs are subject to random variation around the true underlying rate. 95% confidence limits are endpoints of a range in which the true rate would be expected to fall 95% of the time. 95%CLs are computed from the standard error (SE) of the ASR using the following formula: 95% CL = ASR ± (1.96 x SE)

4.5.5 95% Confidence Limit of ASR (95% CL)

Cumulative risk is defined as a probability that an individual would develop cancer during a certain age period, in the absence of any competing cause of death. The age period over which the risk is accumulated in this report is 0-74 years. The precise mathematical relationship between the cumulative rate and the cumulative risk is:

CumR = 100 x [1 – exp (- CR74/100)] exp - exponential

4.5.7 Cumulative risk (CumR)

Lifetime risk is defined as the likelihood that a person who is free of a certain type of cancer will develop or die from that type of cancer during his or her lifetime. Lifetime risk estimates are usually expressed as the odds of developing cancer (‘1 in x’) or as a percentage.

4.5.8 Lifetime risk

Cumulative rate is the weighted sum of age-specific incidence rates until completion of 74 years of age. The weighting used in this calculation is based simply on the widths of the age groups, i.e. multiplying the five-year age-sex specific rates per person by 5 and summing over age groups from 0-4 to 70-74. CR74 is necessary in order to ascertain the cumulative risk and is expressed in percentages.

CR74 = 5 x ∑ (d /y ) x 100 i - 5-year age groups d – Number of cases in age class i y – Person-years at risk of age class i

4.5.6 Cumulative rate (CR74)

ii

i i i

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 35: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

13

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

A total of 103,507 new cancer cases were diagnosed in Malaysia for the period of 2007- 2011.

The age-standardised rates (ASR) were 86.9 per 100,000 males and 99.3 per 100,000 females. The cumulative risk (CumR) was 9.8 for males and 10.6 for females, representing the risks of males and females in Malaysia developing cancer before the age of 75, in the absence of other causes of death. The lifetime risk for males was 1 in 10 and 1 in 9 for females (Table 7). The incidence was highest among Chinese for both sexes (ASR: 112.9 per 100,000 population in male and 126.2 per 100,000 populations in female).

A comparison of age-standardised rates in Table 9 ranging from 51 to 151 per 100,000 in males and 42 to 158 per 100,000 in females are due to the difference in population structure and size. The small population in Labuan could also contribute to the limitation of the report and the rates could fluctuate in such instances.

5.0 RESULTS

5.1 Overall cancer incidence

SexMalesFemalesBoth

Number46,79456,713

103,507

%45.254.8

100.0

CR71.489.0

ASR86.999.3

CR7410.311.2

CumR9.8

10.6

Lifetime Risk109

Table 7: Number of new cancer cases, Crude Rate (CR), Age-standardised rate (ASR), Cumulative Risk (CumR) and Lifetime Risk by sex, Malaysia, 2007-2011

Ethnicity

MalayChineseIndianOthers*

18,75720,424

2,6794,934

24,18822,1144,7985,613

70.7112.970.480.5

81.9126.2110.189.6

53.1124.4

56.055.0

69.5143.2101.264.4

8.012.58.19.2

8.713.212.29.7

Number NumberMale Female

ASR ASRCumR CumRCR CR

* Other Bumiputera and Others: ‘Other Bumiputera’ includes indigenous peoples, natives of Sarawak and natives of Sabah while ‘Others’ other than mentioned before not including missing ethnicity.

Table 8: Incidence summary by major ethnic groups and sex, Malaysia, 2007-2011

State

SelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan

6,2617,2023,5224,5494,4652,7742,2772,1055,2452,1931,6681,9171,811

40553

8,4848,1104,0455,1855,5043,5653,3072,2816,0852,4991,9772,5282,214

49551

49.391.858.976.477.959.659.554.8

144.160.963.779.094.246.226.5

69.2109.469.890.396.676.788.359.6

166.673.679.1

106.9110.286.426.8

71.3109.093.685.774.766.573.168.0

150.575.183.189.1

104.772.850.9

89.7118.7105.3100.288.477.0

101.265.8

157.882.693.8

108.9108.184.941.7

Number NumberMale Male

ASR ASRCR CR

Table 9: Incidence summary by state and sex, Malaysia, 2007-2011

Page 36: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

14

The cancer incidence reported in this publication is different from the estimates of WHO publication in Globocan 2012. The incidence rate reported by Globocan was higher compared to MNCR. The WHO Globocan data was an estimate with the purpose of comparing the distribution of cancer cases in the world. This comparison was done among countries using best available data for the respective countries. The estimation of ASR for Malaysia was based on Penang and Sarawak Registries where the ethnic distributions were not similar to the national distribution.

State

Malaysian National Cancer Registry (total of 15 states)Globocan 2012Penang Cancer RegistrySarawak Cancer Registry

86.9144.9150.585.7

99.3143.4157.8100.2

ASRFemaleMale

*Globocan 2012: Simple mean of the incidence rates recorded in Peninsular Malaysia, Penang (2006), Penang (2004-2008) and Sarawak (1998-2002)

Table 10: ASR by sex comparing Malaysia, Penang, Sarawak Cancer Registry 2007-2011 and Globocan 2012

Figure 7: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Selang

orJo

hor

Sabah

Sarawak

Perak

Kedah

Kelanta

n

Penan

g

Pahan

g

Tereng

ganu

Negeri

Sem

bilan

Melaka

Perlis

W.P.

Labu

an

WPKL &

Putr

ajaya

200Males Females

180

160

140

120

100

80

60

40

20

0

Inci

denc

e pe

r 100

,000

State

Page 37: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

15

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

The annual cancer incidence in Malaysia varied over the 5 years (2007-2011) in males between 80.9 and 90.2, and in females between 93.8 and 102.6.

5.2 Cancer trends

Figure 8: Annual age-standardised rate (ASR) by sex, Malaysia, 2007-2011

2007 2008 2009 2010 20110

40

20

60

80 89.7 90.2 87.9

98.4 98.8 93.8

85.4 80.9

102.6

Male Female

102.3100

120

140

160

180

200

Year

Inci

denc

e pe

r 100

,000

Page 38: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

16

The three most common cancers among Malaysian residents were breast followed by colorectal and lung (Table 11 and Figure 9). The most common cancer among male and female residents was colorectal and breast respectively (Table 12 and Figure 10).

5.3 Incidence of ten most common cancers

Figure 9: Percentage of ten most common cancers, all residents, Malaysia, 2007-2011

Table 11: Ten most common cancers, all residents, Malaysia, 2007-2011

ICD-10C50C18-C21C33-C34C81-C85,C96C11C91-C95C53C22C56C16

SitesBreastColorectalTrachea, Bronchus, LungLymphomaNasopharynxLeukaemiaCervix UteriLiverOvaryStomachOthersTotal

Number18,34313,69310,6085,3745,0904,5734,3524,1283,4723,461

30,413103,507

%17.713.210.25.24.94.44.24.03.43.3

29.4100.0

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 39: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

17

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Table 12: Ten most common cancers in Malaysia by sex, all residents, 2007-2011

C18-C21C33-C34C11C81-C85,C96C61C22C91-C95C16C67C44

C50C18-C21C53C56C33-C34C81-C85,C96C54C91-C95C73C16

ColorectalTrachea, Bronchus, LungNasopharynxLymphomaProstateLiverLeukaemiaStomachBladderOther SkinOthersTotal

BreastColorectalCervix UteriOvaryTrachea, Bronchus, LungLymphomaCorpus UteriLeukaemiaThyroidStomachOthersTotal

7,6467,4153,7853,1713,1323,0542,5492,0141,4771,384

11,16746,794

18,2066,0474,3523,4723,1932,2032,1812,0241,7231,447

11,86556,713

16.315.88.16.86.76.55.44.33.23.0

23.9100.0

32.110.77.76.15.63.93.83.63.02.6

20.9100.0

11.711.35.84.84.84.73.93.12.32.1

71.4

28.69.56.85.45.03.53.43.22.72.3

89.0

14.614.46.45.56.65.64.23.92.92.7

86.9

31.111.17.65.96.03.83.83.42.92.6

99.3

ICD-10

Male

Female

Sites Number % CR ASR

Page 40: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

18

Figure 10: Age-standardised rate (ASR) for ten common cancers by sex, Malaysia 2007-2011

Male Female

The incidence of cancer increased for both males and females after the age of 30 years (Figure 11). The incidence rate in males exceeded the incidence rate in females after the age of 60 years.

5.4 Age variations

Figure 11: Age-specific incidence rate by sex, all sites, Malaysia, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site

s

Incidence per 100,000

Colorectal

Lymphoma

Nasopharynx

Leukaemia

Liver

Prostate

Stomach

Bladder

Other Skin

Trachea,Bronchus,Lung

10 15 20

14.6

14.4

6.6

6.4

5.6

5.5

4.2

3.9

2.9

2.7

0 5

.0

Page 41: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

19

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Figure 12: Age-specific incidence rate for ten common sites, males, Malaysia, 2007-2011

Page 42: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

20

Figure 13: Age-specific incidence rate for ten common sites, females, Malaysia, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 43: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

21

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

The five most common cancers by sex in each of the five broad age groups are shown in Figures 14-18.

In children below age of 14 years, main cancers in both sexes were leukaemia (47.1% in males, 45.5% in females) followed by brain, nervous system (13.8% in males, 16.0% in females) and lymphoma (11.3% in males, 8.4% in females). Childhood cancer age 0 to 18 years old comprised of 3,829 cases, 2,131 (55.7%) cases were males and 1,698 (44.3%) cases were females.

In the 15-24 year age group, the most common cancers in males were leukaemia (23.0%) followed by lymphoma (20.9%) and bone cancer (9.4%). While in females, the most common cancers were lymphoma (17.7%) wasfollowed by leukaemia (15.3%) and ovarian cancer (14.5%).

In the group aged 25-59 years, colorectal cancer was the most common cancer in males (16.0%), followed bynasopharyngeal cancer (13.7%), and lung cancer (13.4%). The most common cancers seen in females were breast (40.7%), cervix uteri (8.9%) and colorectal cancers (7.6%).

5.5 Age groups and cancers

Figure 14: Common cancers among 0-14 years age group by sex, Malaysia, 2007-2011

Figure 16: Common cancers among 25-59 years age group by sex, Malaysia, 2007-2011

Male

Male Female

Female

Male Female

Figure 15: Common cancers among 15-24 years age group by sex, Malaysia, 2007-2011

Page 44: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

22

In the 60-74 year age group, the most common cancers in males were lung (19.8%), colorectal (18.3%) and prostate cancers (10.4%). In females the most common cancers were breast (24.4%), colorectal (15.4%) and lung cancers (8.8%).

In the group aged 75 years and above, cancer of the lung remained the most common cancer among males (19.1%) followed by colorectal (19.1%) and prostate cancers (14.5%). In females, colorectal cancer (21.3%) was followed by cancer of the breast (14.5%) and lung (10.3%).

Figure 17: Common cancers among 60-74 years age group by sex, Malaysia, 2007-2011

Figure 18: Common cancers in 75 years and above age group by sex, Malaysia, 2007-2011

Male

Male

Female

Female

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Other skin

Page 45: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

23

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

ColorectalTrachea, Bronchus, LungNasopharynxLymphomaProstateLiverLeukaemiaStomachBladderOther Skin

BreastColorectalCervix UteriOvaryTrachea, Bronchus, LungLymphomaCorpus UteriLeukaemiaThyroidStomach

Sites

Sites

Ethnic Groups

Ethnic Groups

11.312.6

3.35.65.34.54.41.73.32.0

Malay

27.28.15.15.84.43.73.33.53.31.1

Malay

21.118.811.05.09.07.74.05.62.83.8

Chinese

41.517.19.86.38.53.74.93.42.14.1

Chinese

The incidences of cancer among the ethnic groups for ten common cancers are shown in Table 13 and Table 14. In males, the incidence of colorectal, lung, nasopharynx, prostate, and liver cancers were more common inChinese whereas leukaemia and bladder cancers were more common in Malays. In females, the incidence of breast, colorectal, ovarian and lung cancers were more common in Chinese whereas leukaemia and thyroid cancer were more common in Malays.

5.6 Ethnic variations

Table 13: Age-standardised rates for ten most common cancers in males by ethnicity, Malaysia, 2007-2011

Table 14: Age-standardised rates for ten most common cancers in females by ethnicity, Malaysia, 2007-2011

Indian

10.37.61.14.26.13.13.85.22.51.3

Indian

37.18.77.66.13.13.04.83.02.53.2

Others*

9.411.99.96.73.85.83.87.11.82.6

Others*

14.37.4

12.04.97.44.52.53.23.24.9

* Other Bumiputera and Others

* Other Bumiputera and Others

Page 46: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

24

Among Malay males, the most common cancers were lung, colorectal, lymphoma, prostate and liver cancers, whereas among Malay females, breast, colorectal, ovarian, cervix uteri and lung cancers were the most common.

Table 15: Ten most common cancers in Malaysia, Malay residents by sex, 2007-2011

C33-C34C18-C21C81-C85,C96C91-C95C22C61C11C67C70-C72C44

C50C18-C21C56C53C33-C34C81-C85,C96C91-C95C73C54C70-C72

Trachea, Bronchus, LungColorectalLymphomaLeukaemiaLiverProstateNasopharynxBladderBrain, Nervous systemOther SkinOthersTotal

BreastColorectalOvaryCervix UteriTrachea, Bronchus, LungLymphomaLeukaemiaThyroidCorpus UteriBrain, Nervous systemOthersTotal

3,0942,8721,6391,4191,1951,163

959781612504

4,51918,757

8,2252,2311,7541,5021,1871,1421,1191,023

964566

4,47524,188

16.515.38.77.66.46.25.14.23.32.7

24.1100.0

34.09.27.36.24.94.74.64.24.02.3

18.5100.0

8.88.14.64.03.43.32.72.21.71.4

53.1

23.66.45.04.33.43.33.22.92.81.6

69.5

12.611.35.64.44.55.33.33.31.92.0

70.7

27.28.15.85.14.43.73.53.33.31.8

81.9

ICD-10

Male

Female

Sites Number % CR ASR

Figure 19: Age-standardised rate (ASR) for ten common cancers in Malays by sex, Malaysia, 2007-2011

Male Female

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 47: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

25

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Among Chinese males, the most common cancers were colorectal, lung, nasopharynx, prostate and liver cancers, whereas among Chinese females, breast, colorectal, cervix uteri, lung and ovarian cancers were the most common.Table 16: Ten most common cancers in Malaysia, Chinese residents by sex, 2007-2011

C18-C21C33-C34C11C61C22C16C81-C85,C96C44C91-C95C25

C50C18-C21C53C33-C34C56C54C16C81-C85,C96C11C91-C95

ColorectalTrachea, Bronchus, LungNasopharynxProstateLiverStomachLymphomaOther SkinLeukaemiaPancreasOthersTotal

BreastColorectalCervix UteriTrachea, Bronchus, LungOvaryCorpus UteriStomachLymphomaNasopharynxLeukaemiaOthersTotal

3,8253,3902,1041,5891,4161,001

908687657516

4,33120,424

7,3333,0231,7321,4861,107

853725639611527

4,07822,114

18.716.610.37.86.94.94.43.43.22.5

21.2100.0

33.213.77.86.75.03.93.32.92.82.4

18.4100.0

23.320.612.89.78.66.15.54.24.03.1

124.4

47.519.611.29.67.25.54.74.14.03.4

143.2

21.118.811.09.07.75.65.03.84.02.8

112.9

41.517.19.88.56.34.94.13.73.53.4

126.2

ICD-10

Male

Female

Sites Number % CR ASR

Figure 20: Age-standardised rate (ASR) for ten common cancers in Chinese by sex, Malaysia, 2007-2011

Male Female

Page 48: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

26

Among Indian males, the most common cancers were colorectal, lung, prostate, stomach and lymphoma, whereas among Indian females, breast, colorectal, cervix uteri, mouth and ovarian cancers were the most common.Table 17: Ten most common cancers in Malaysia, Indian residents by sex, 2007-2011

C18-C21C33-C34C61C16C81-C85,C96C91-C95C22C03-C06C15C32

C50C18-C21C53C03-C06C56C54C15C16C91-C95C81-C85,C96

ColorectalTrachea, Bronchus, LungProstateStomach LymphomaLeukaemiaLiverMouthOesophagusLarynxOthersTotal

BreastColorectalCervix UteriMouthOvaryCorpus UteriOesophagusStomachLeukaemiaLymphomaOthersTotal

3892701881871871711141079890

8782,679

1,705364327287277204145137137130

1,0854,798

14.510.17.07.07.06.44.34.03.73.4

32.8100.0

35.57.66.86.05.84.33.02.92.92.7

22.6100.0

8.15.63.93.93.93.62.42.22.01.9

56.0

36.07.76.96.15.84.33.12.92.92.7

101.2

10.37.66.15.24.23.83.12.92.72.3

70.4

37.18.77.67.56.14.83.63.23.03.0

110.1

ICD-10

Male

Female

Sites Number % CR ASR

FemaleMale

Figure 21: Age-standardised rate (ASR) for ten common cancers in Indians by sex, Malaysia, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 49: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

27

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

In other ethnic groups, the most common cancers among males were nasopharynx, lung, colorectal, lymphoma and stomach, whereas among females, breast, cervix uteri, colorectal, lung and ovarian cancers were the most common.Table 18: Ten most common cancers in Malaysia, other ethnic groups by sex, 2007-2011

C11C33-C34C18-C21C81-C85,C96C16C22C91-C95C61C44C70-C72

C50C53C18-C21C33-C34C56C81-C85,C96C16C11C91-C95C73

NasopharynxTrachea, Bronchus, LungColorectalLymphomaStomachLiverLeukaemiaProstateOther SkinBrain, Nervous systemOthersTotal

BreastCervix UteriColorectalTrachea, Bronchus, LungOvaryLymphomaStomachNasopharynxLeukaemiaThyroidOthersTotal

678661560437397329302192148113

1,1174,934

943791429393334292273268241210

1,4395,613

13.713.411.38.98.06.76.13.93.02.3

22.6100.0

16.814.17.67.06.05.24.94.84.33.7

25.6100.0

7.67.46.24.94.43.73.42.11.61.3

55.0

10.89.14.94.53.83.33.13.12.82.4

64.4

9.911.99.46.77.15.83.83.82.61.5

80.5

14.312.07.47.44.94.54.94.03.23.2

89.6

ICD-10

Male

Female

Sites Number % CR ASR

Figure 22: Age-standardised rate (ASR) for ten common cancers in other ethnic groups by sex, Malaysia, 2007-2011

Male Female

Page 50: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

28

Table 19: Staging for all cancer types, Malaysia, 2007-2011 5.7 Staging

C00

C01-C02

C03-C06

C07-C08

C09

C10

C11

C12-C13

C14

C15

C16

C17

C18-C21

C22

C23-C24

C25

C30-C31

C32

C33-C34

C37-C38

C40-C41

C43

C44

C45

C46

C47;C49

C50

C51C52C53C54C55C56C57C58C60C61C62C63C64

C65

C66

C67

C68

C69

C70-C72

C73

C74

C75

C81-C85;C96

C90

C91-C95

LIP

TONGUE

MOUTH

SALIVARY GLAND

TONSIL

OTHER OROPHARYNX

NASOPHARYNX

HYPOPHARYNX

PHARYNX UNSPEC

OESOPHAGUS

STOMACH

SMALL INTESTINE

COLORECTAL

LIVER

GALLBLADDER

PANCREAS

NOSE,SINUSES ETC.

LARYNX

TRACHEA,BRONCHUS,LUNG

OTHER THORACIC ORGANS

BONE

MELANOMA OF SKIN

OTHER SKIN

MESOTHELIOMA

KAPOSI SARCOMA

CONNECTIVE TISSUE

BREAST

VULVAVAGINA

CERVIX UTERICORPUS UTERI

UTERUS UNSPECOVARY

OTHER FEMALE GENITALPLACENTA

PENISPROSTATE

TESTISOTHER MALE GENITAL

KIDNEY

RENAL PELVIS

URETER

BLADDER

OTHER URINARY ORGANS

EYE

BRAIN,NERVOUS SYSTEM

THYROID

ADRENAL GLAND

OTHER ENDOCRINE

LYMPHOMA

MULTIPLE MYELOMA

LEUKAEMIA

OTHER & UNSPEC

ICD-10 SITES SEX TOTALSTAGENUMBER

WITH RECORDED

STAGE

%I II III IV% % % %

MFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFFFFFFFFFMMMMMFMFMFMFMFMFMFMFMFMFMFMFMFMF

Grand Total

3055461401391525273226127688130

3,7851,305172863720737429

2,0131,44715489

7,6466,0473,0541,074413409

1,041788270138825113

7,4153,193167123493365167155

1,3841,045

2219172

434378137

18,206123124

4,3522,181580

3,4724265115

3,132496319014341381911

1,477400171010467

1,1761,060549

1,723474510951

3,1712,203396348

2,5492,024746654

103,507

1534

2722212103041179474335514

2,07265286461810

3652038236496537

4,2633,3721,22141214719353540713265

50962

4,1891,769

6238

1841376058

43631913820

1368973

11,9386461

2,7941,442272

2,358251440

1,59223514

50424287

127

68817556

2414

43336121367116172712

1,3239315638

168132253242

52,794

50.061.859.055.153.757.942.941.658.348.567.946.754.750.050.053.548.650.049.547.340.944.942.241.655.855.840.038.435.647.251.451.648.947.161.754.956.555.437.130.937.337.535.937.431.530.559.142.111.80.0

31.323.553.365.652.049.264.266.146.967.959.521.534.850.847.445.255.955.861.587.563.263.646.643.829.460.023.120.936.834.138.838.934.037.824.823.541.742.314.110.96.66.5

33.937.051.0

71039362647242111382

2437010312

2214735948

44832812437152235292319

12416

1495575

242697

2191701000

402116

2,373911

66866411672985

102491056

78484434

205480084

9311147

24513

106

219152911--

3219

9,029

27

62574453282813474

513193261042

6552

130107116

1,006845134392028654334109916

290125108

411475

90642100

241925

4,4131515

1,00028647

309406

388462

98592031

182373241

787455

1550180

328250118--

2636

12,445

28

6452495330171516115

602195221363

99552111491411

1,2941,0751696929266870201011715

967344168

1822131341372300

229

202,753

2112

61228851

760614

297243

65260232

121320011

637533761243

314199125--

3430

12,135

49

1077691

15135283510293

714194282073

17982

4093343612

1,5151,124794267831173672655526

16915

2,7831,245

2917

10175313386488420

504012

2,3991923

51420458

56078

20658603

2631092130

1805824118

19910178

195141153

4623302414--

161157

18,885

46.729.414.316.312.415.520.522.314.99.1

14.514.311.710.711.66.55.6

20.06.06.98.99.16.2

21.610.59.7

10.29.0

10.211.46.57.1

17.429.224.425.83.63.111.313.213.019.015.012.150.253.37.70.00.00.0

29.423.621.919.914.118.023.946.042.630.932.035.725.015.644.742.915.519.850.057.125.057.129.827.40.00.0

33.328.621.530.722.136.56.3

17.637.050.016.616.316.128.9

--

12.67.9

17.1

13.320.622.825.821.017.423.929.817.612.112.728.624.829.630.221.722.220.017.825.615.816.516.916.223.625.111.09.5

13.614.512.110.625.815.419.425.86.97.1

16.121.122.310.211.78.6

20.620.115.412.50.00.0

17.621.334.237.023.424.635.819.817.313.116.00.0

15.024.419.614.319.424.425.00.0

25.014.326.521.160.033.316.77.1

18.020.525.823.10.05.9

29.60.0

24.826.919.621.1

--

10.314.923.6

13.323.523.523.523.317.425.618.120.348.520.035.729.129.925.628.333.330.027.127.125.623.021.529.730.431.913.816.719.713.512.717.215.215.423.024.223.119.425.821.19.8

16.121.722.49.411.615.437.50.00.0

16.210.127.423.132.819.721.920.018.832.224.07.1

10.018.710.221.412.910.70.0

28.625.028.617.618.30.00.04.27.1

14.520.815.511.36.311.814.825.023.721.421.413.2

--

13.412.422.9

26.726.539.334.443.349.729.929.847.330.352.721.434.529.832.643.538.930.049.040.449.751.555.432.435.533.365.064.856.560.668.665.141.740.033.224.266.470.446.844.754.954.751.756.919.715.061.550.0

100.00.0

36.844.916.420.129.737.718.414.121.323.728.057.150.041.325.521.452.245.025.014.325.00.0

26.233.140.066.745.857.146.028.036.629.187.564.718.525.034.935.442.936.8

--

63.664.935.8

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 51: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

29

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Summary table for all cancer sites is shown in Table 19. A total of 103,507 new cancer cases were reported, of whom 52,794 (51.0%) had reports on staging. Of the patients whose stages were reported, 9,029 (17.1%) were in stage I, 12,445 (23.6%) in stage II, 12,135 (23.0%) in stage III and 18,885 (35.8%) in stage IV. Thus at the time of diagnosis, 31,020 (58.8%) had advanced cancers (classified as either stage III or IV).

The Data Quality in this report were measured through data completeness, comparability and validity. Validity can be defined as the proportion of cases in a data-set which truly have the reported attribute. The Malaysian National Cancer Registry (MNCR) has used the same five common indices as indicated in the Cancer Incidence in Five Continents (CI5), Vol X, which are (a) internal consistency; (b) histological verification; (c) death certificate only (DCO); (d) other and unspecified cases (ill-defined cases ) and (e) age unknown.

Internal consistency: The MNCR uses the IARC/IACR CHECK program to perform consistency checks on the cancer notifications. All cases queried are checked by the registry staff, using the software program, before incorporating relevant items into the database.

Histological verification: The accuracy of the stated diagnosis is likely to be higher if there is histological confirmation by a pathologist or cytology/haematology confirmation. As the MNCR does not distinguish between histology and cytology/haematology verification, morphologically verified (MV) is used rather than histological verification. For cancers with specified sites, the morphologically verified proportion was 96.6% of all cases for both sexes.

Death Certificate Only (DCO): All the death notified by the public, private health facilities to the registry was traced and checked with the National Registry Departments. For cancer with specified sites, the DCO percentage was 0.3% of total cases for both sexes. Other and unspecified cases (ill-defined cases): For this category, the percentage was 2.7% (1.6% for males and 1.1% for females) A low proportion of cases that are assigned to this category generally imply a better diagnostic precision in determining the site of primary cancer.

Age unknown: If there are a large number of cases with age unknown, several of the figures and graphs from the data-set would not be accurate. In this report, all the ages were known.

5.8 Data Quality

(a)

(b)

(c)

(d)

(e)

Page 52: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

30

Table 20: Quality indicator

C00C01-C02C03-C06C07-C08C09C10C11C12-C13C14C15C16C17C18-C21C22C23-C24C25C30-C31C32C33-C34C37-C38C40-C41C43C44C45C46C47;C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-C72C73C74C75C81-C85,C96C88C90C91-C95

LipTongueMouthSalivary glandsTonsilOther OropharynxNasopharynxHypopharynxPharynx unspec.OesophagusStomachSmall intestineColorectalLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea,Bronchus,LungOther Thoracic organsBoneMelanoma of SkinOther SkinMesotheliomaKaposi sarcomaConnective,Soft tissueBreastVulvaVaginaCervix UteriCorpus UteriUterus unspec.OvaryOther Female GenitalPlacentaPenisProstateTestisOther male genitalKidneyRenal PelvisUreterBladderOther Urinary organsEyeBrain, Nervous systemThyroidAdrenal glandOther EndocrineLymphomaImmunoproliferative dis.Multiple MyelomaLeukaemiaOther & unspecifiedAll Sites Total

85862916499195111

5,09025857

1,1663,461242

13,6934,128822

1,829408938

10,608290858322

2,4294119812

18,343123124

4,3522,181580

3,4724265115

3,13249631

1,3352130

1,87727171

2,2362,272

92160

5,37412744

4,5731,388

103,507

85854913487192110

5,02425254

1,1463,377240

13,4903,260779

1,573400924

9,826284802320

2,4234118781

18,258123123

4,3242,171575

3,4083962114

3,08948831

1,3022029

1,84226155

1,9252,249

87153

5,34811

7254,5701,08299,984

100.099.199.797.698.599.198.797.794.798.397.699.298.579.094.886.098.098.592.697.993.599.499.8100.094.796.299.5100.099.299.499.599.198.292.995.499.198.698.4100.097.595.296.798.196.390.686.199.094.695.699.591.797.499.978.096.6

0100100111803537141031060000017002100000200200100101001001

116282

0.00.10.00.00.50.00.00.41.80.10.20.00.30.90.10.20.20.00.30.00.70.00.00.00.00.00.10.00.00.00.00.00.00.00.00.00.10.00.00.10.00.00.10.00.00.40.00.00.00.00.00.00.08.40.3

ICD-10 SITE TOTAL QUALITY INDICATORMV % DCO %

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 53: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

31

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

The table below explains the incidence by year, sex, ethnic group and states.

Table 21: Summary of all cancer sites 2007-2011 by sex, year and ethnic

Table 22: Summary of all cancer sites 2007-2011 by states

6.0 INCIDENCE SUMMARY TABLES : All sites, 2007-2011

Year20072008200920102011EthnicAll ResidentsMalayChineseIndianOther

8,9699,3839,4959,5719,376

46,79418,75720,4242,6794,934

11,03511,34411,21611,67211,446

56,71324,18822,1144,7985,613

70.872.572.571.968.6

71.453.1

124.456.055.0

89.589.788.090.187.2

89.069.5

143.2101.264.4

89.790.287.985.480.9

86.970.7

112.970.480.5

102.6102.398.498.893.8

99.381.9

126.2110.189.6

10.110.19.99.79.3

9.88.0

12.58.19.2

10.810.910.610.610.0

10.68.7

13.212.29.7

(87.8 , 91.6)(88.3 , 92.0)(86.1 , 89.7)(83.7 , 87.2)(79.2 , 82.5)

(86.1 , 87.7)(69.7 , 71.8)

(111.4 , 114.5)(67.6 , 73.2)(78.2 , 82.8)

(100.6 , 104.5)(100.4 , 104.2)(96.5 , 100.2)(97.0 , 100.6)(92.0 , 95.5)

(98.4 , 100.1)(80.8 , 82.9)

(124.5 , 127.9)(106.9 , 113.3)(87.2 , 92.0)

FemaleNo. CR ASR (ASR 95% CL) CumR

MaleNo. CR ASR (ASR 95% CL) CumR

SelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuN.SembilanMelakaPerlisW.P. Labuan

6,2617,2023,5224,5494,4652,7742,2772,1055,2452,1931,6681,9171,811

40553

8,4848,1104,0455,1855,5043,5653,3072,2816,0852,4991,9772,5282,214

49551

49.391.858.976.477.959.659.554.8

144.160.963.779.094.246.226.5

69.2109.469.890.396.676.788.359.6

166.673.679.1

106.9110.286.426.8

71.3109.093.685.774.766.573.168.0

150.575.183.189.1

104.772.850.9

89.7118.7105.3100.288.477.0

101.265.8

157.882.693.8

108.9108.184.941.7

8.512.210.89.58.37.48.67.5

15.98.69.59.9

11.38.46.1

10.012.411.310.59.28.2

11.17.1

16.18.79.8

11.611.38.74.9

(69.4 , 73.2)(106.5 , 111.6)(90.3 , 96.8)(83.2 , 88.3)(72.5 , 76.9)(64.0 , 69.1)(70.0 , 76.2)(65.0 , 70.9)

(146.4 , 154.6)(71.9 , 78.2)(79.0 , 87.2)(85.1 , 93.2)(99.8 , 109.6)(65.7 , 80.0)(36.0 , 65.8)

(87.7 , 91.7)(116.1 , 121.3)(101.9 , 108.8)(97.5 , 103.0)(86.1 , 90.8)(74.4 , 79.5)(97.6 , 104.7)(63.1 , 68.6)

(153.8 , 161.8)(79.4 , 85.9)(89.6 , 98.0)

(104.6 , 113.2)(103.6 , 112.7)(77.4 , 92.5)(28.7 , 54.7)

FemaleNo. CR ASR (ASR 95% CL) CumR

MaleNo. CR ASR (ASR 95% CL) CumR

Page 54: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

32

**The highest incidence from CI5 Volume X *The lowest incidence from CI5 Volume X NB: Singapore (2009-2013 report)Note: International comparisons of age standardised rates of selected countries according to ethnicities and sex.

Figure 23: All Sites: International comparisons – Age standardised rates

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 55: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

33

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Female breast cancer was accounted for 32.1% of all cancer among females in Malaysia. The incidence of breast cancer was highest among Chinese followed by Indian and Malay.

The cumulative risk (CumR) was highest among Chinese and lowest among Malay. The lifetime risk was 1 in 30, while for Chinese was 1 in 22, Indian 1 in 24 and Malay 1 in 35. The percentage of breast cancer detected at stage I and II was 56.9%.

In this section, cancers are reviewed focussing on ethnic variations, staging, Age-specific incidence rate as well as annual and state distributions. International comparisons were made with Singapore (Singapore Cancer Registry, Interim Report: Trends in Cancer Incidence in Singapore 2009-2013) and other countries (Cancer Incidence in Five Continents Volume X, 2014). Fifteen most common cancers (male and female combined) were selected.

7.0 COMMENTARY ON 15 SELECTED CANCER SITES

7.1 Female Breast (ICD-10: C50)

SexFemale

No.18,206

CR28.6

ASR31.1

CR743.4

CumR3.4

(ASR 95%CL)(30.7, 31.6)

EthnicMalayChineseIndian

No.8,2257,3331,705

CR23.647.536.0

ASR27.241.537.1

CR742.94.64.2

CumR2.94.54.2

Year20072008200920102011

No.3,5793,6433,5013,7173,766

CR29.028.827.528.728.7

ASR32.332.029.930.830.4

CR743.53.53.33.43.4

CumR3.43.53.33.33.3

Table 23: Female Breast: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011

Table 24: Female Breast: Incidence summary by ethnicity, Malaysia, 2007-2011

Table 25: Female Breast: Incidence summary by year, Malaysia, 2007-2011

Page 56: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

34

Figure 24: Female Breast: Age-specific incidence rate, Malaysia, 2007-2011

Figure 25: Female Breast: Stage

Figure 26: Female Breast: Age-standardised rate (ASR) by state, Malaysia, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 57: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

35

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Figure 27: Female Breast: International comparisons – Age-standardised rates

** The highest incidence from CI5, Volume X *The lowest incidence from CI5, Volume X NB: Singapore (2009-2013 report)

Page 58: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

36

Colorectal cancer was the most common cancer in male and second in female. The incidence of colorectal cancer increases with age and highest among Chinese for males and females. The lifetime risk for males was 1 in 56. It was 1 in 39 for Chinese, 1 in 72 for Malay and 1 in 82 for Indian. The lifetime risk for females was 1 in 74; forChinese 1 in 49, Indian 1 in 91 and Malay 1 in 100. The male to female ASR ratio was 1.3:1.

The percentage of colorectal cancer detected at stage I and II was only 34.1% and 34.8% respectively for both male and female.

7.2 Colorectal (ICD10: C18-C21)

SexMaleFemaleBoth

No.7,6466,047

13,693

CR11.79.5

ASR14.611.1

CR741.81.4

CumR1.81.3

(ASR 95%CL)(14.2, 14.9)(10.8, 11.4)

EthnicMalayChineseIndian

Year20072008200920102011

Male

Male

Female

Female

No.2,8723,825

389

No.1,3711,4831,5661,6331,593

No.2,2313,023

364

No.1,1241,1941,2531,2511,225

CR8.1

23.38.1

CR10.811.512.012.311.7

CR6.4

19.67.7

CR9.19.49.89.79.3

ASR11.321.110.3

ASR14.114.615.014.914.0

ASR8.1

17.18.7

ASR11.111.311.611.010.4

CR741.42.61.2

CR741.71.81.91.91.7

CR741.02.11.1

CR741.41.41.41.31.3

CumR1.42.51.2

CumR1.71.81.81.91.7

CumR1.02.01.1

CumR1.31.31.41.31.3

Table 26: Colorectal: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011

Table 27: Colorectal: Incidence summary by ethnicity and sex, Malaysia, 2007-2011

Table 28: Colorectal: Incidence summary by year and sex, Malaysia, 2007-2011

%55.844.2

100.0

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 59: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

37

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Figure 28: Colorectal: Age-specific incidence rate by sex, Malaysia, 2007-2011

Figure 29: Colorectal: Stage by sex

Figure 30: Colorectal: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

Page 60: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

38

Figure 31: Colorectal: International comparisons by sex – Age-standardised rates

** The highest incidence from CI5, Volume X *The lowest incidence from CI5, Volume X NB: Singapore (2009-2013 report)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 61: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

39

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Lung cancer is the second most common cancer among males and fifth among females in Malaysia. The incidence increased with age and the peak of age-specific incidence rate was at the age of 70 and above.

The lifetime risk for males was 1 in 55. For Indian, Malay and Chinese, it was 1 in 103, 1 in 62 and 1 in 43,respectively. The lifetime risk for females was 1 in 135. For Indian it was 1 in 255, 1 in 185 for Malay and 1 in 97 for Chinese. The male to female ASR ratio was 2.4:1.

Most of lung cancer cases were detected at late stage (stage III and stage IV) for both sexes.

7.3 Trachea, Bronchus, Lung (ICD-10: C33-C34)

SexMaleFemaleBoth

No.7,4153,193

10,608

CR11.35.0

ASR14.46.0

CR741.80.7

CumR1.80.7

(ASR 95%CL)(14.1, 14.8)(5.8, 6.2)

EthnicMalayChineseIndian

Year20072008200920102011

Male

Male

Female

Female

No.3,0943,390

270

No.1,4741,5041,4991,4931,445

No.1,1871,486

127

No.596658649658632

CR8.8

20.65.6

CR11.611.611.411.210.6

CR3.49.62.7

CR4.85.25.15.14.8

ASR12.618.87.6

ASR15.515.414.513.913.0

ASR4.48.53.1

ASR6.16.36.06.05.4

CR741.62.41.0

CR742.02.01.91.81.7

CR740.51.00.4

CR740.80.80.80.80.6

CumR1.62.31.0

CumR2.02.01.81.71.7

CumR0.51.00.4

CumR0.80.80.80.80.6

Table 29: Trachea, Bronchus, Lung: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011

Table 30: Trachea, Bronchus, Lung: Incidence summary by ethnicity and sex, Malaysia, 2007-2011

Table 31: Trachea, Bronchus, Lung: Incidence summary by year and sex, Malaysia, 2007-2011

%69.930.1

100.0

Page 62: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

40

Figure 32: Trachea, Bronchus, Lung: Age-specific incidence rate by sex, Malaysia, 2007-2011

Figure 33: Trachea, Bronchus, Lung: Stage by sex

Figure 34: Trachea, Bronchus, Lung: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 63: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

41

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Figure 35: Trachea, Bronchus, Lung: International comparisons – Age-standardised rates

** The highest incidence from CI5, Volume X *The lowest incidence from CI5, Volume X NB: Singapore (2009-2013 report)

Page 64: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

42

Lymphoma ranked fourth in males and sixth in females. Malay males had the higher rate compared to Chinese and Indian.

The lifetime risk for males was 1 in 167; 1 in 229 for Indian, 1 in 177 for Chinese and 1 in 165 for Malay. The lifetime risk for females was 1 in 247; 1 in 285 for Indian, 1 in 253 for Malay and 1 in 248 for Chinese.

7.4 Lymphoma (ICD10: C81-C85; C96)

SexMaleFemaleBoth

No.3,1712,2035,374

CR4.83.5

ASR5.53.8

CR740.60.4

CumR0.60.4

(ASR 95%CL)(5.3, 5.7)(3.6, 3.9)

EthnicMalayChineseIndian

Year20072008200920102011

Male

Male

Female

Female

No.1,639

908187

No.532659664641675

No.1,142

639130

No.358480431477457

CR4.65.53.9

CR4.25.15.14.84.9

CR3.34.12.7

CR2.93.83.43.73.5

ASR5.65.04.2

ASR4.95.95.75.35.5

ASR3.73.73.0

ASR3.34.23.73.93.6

CR740.60.60.4

CR740.50.70.60.60.6

CR740.40.40.4

CR740.30.50.40.40.4

CumR0.60.60.4

CumR0.50.70.60.60.6

CumR0.40.40.4

CumR0.30.50.40.40.4

Table 32: Lymphoma: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011

Table 33: Lymphoma: Incidence summary by ethnicity and sex, Malaysia, 2007-2011

Table 34: Lymphoma: Incidence summary by year and sex, Malaysia, 2007-2011

%59.041.0

100.0

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 65: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

43

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Figure 38: Lymphoma: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

Figure 36: Lymphoma: Age-specific incidence rate by sex, Malaysia, 2007-2011

Figure 37: Lymphoma: Stage by sex

Stage 1 16%

Stage 2 25% Stage 3

24%

Stage 4 35%

Male (n = 1,323)

Stage 1 16%

Stage 2 27%

Stage 3 22%

Stage 4 35%

Female (n = 931)

Page 66: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

44

Nasopharynx was the fifth most common cancer in Malaysian population and third most common in males. The lifetime risk for males was 1 in 143 and for females was 1 in 417. The incidence in males increased at the age of 25 years old and peaked at the age of 65 years old.

Most of nasopharynx cancer cases in males were detected at stage III and IV (63.6%).

7.5 Nasopharynx (ICD10:C11)

SexMaleFemaleBoth

No.3,7851,3055,090

CR5.82.0

ASR6.42.2

CR740.70.2

CumR0.70.2

(ASR 95%CL)(6.1, 6.6)(2.1, 2.3)

EthnicMalayChineseIndian

Year20072008200920102011

Male

Male

Female

Female

No.959

2,10444

No.762857791689686

No.40161125

No.281264244268248

CR2.7

12.80.9

CR6.06.66.05.25.0

CR1.24.00.5

CR2.32.11.92.11.9

ASR3.3

11.01.1

ASR6.97.46.65.65.4

ASR1.33.50.6

ASR2.52.32.02.22.0

CR740.41.20.1

CR740.80.80.70.60.6

CR740.10.40.1

CR740.30.30.20.20.2

CumR0.41.20.1

CumR0.80.80.70.60.6

CumR0.10.40.1

CumR0.30.30.20.20.2

Table 35: Nasopharynx: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011

Table 36: Nasopharynx: Incidence summary by ethnicity and sex, Malaysia, 2007-2011

Table 37: Nasopharynx: Incidence summary by year and sex, Malaysia, 2007-2011

%74.425.6

100.0

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 67: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

45

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Figure 41: Nasopharynx: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

Figure 39: Nasopharynx: Age-specific incidence rate by sex, Malaysia, 2007-2011

Figure 40: Nasopharynx: Stage by sex

0

5

10

15

20

25

0- 5-

Inci

denc

e per

100

,000

Age group (years)

Male Female

10- 15- 20- 25- 30- 35- 40- 45- 50- 55- 60- 65- 70- 75+

Page 68: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

46

Figure 42: Nasopharynx: International comparisons – Age-standardised rates

** The highest incidence from CI5, Volume X * The lowest incidence from CI5, Volume X

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 69: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

47

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Leukaemia is the sixth most common cancer in Malaysian population and seventh most common in males and eighth most common in females. It is the most common cancer among 0-14 years old. Malay had the highest rate followed by Chinese and Indian in both sexes. The lifetime risk for males was 1 in 275 and for females was 1 in 348.

7.6 Leukaemia (ICD-10: C91-C95)

SexMaleFemaleBoth

No.2,5492,0244,573

CR3.93.2

ASR4.23.4

CR740.40.3

CumR0.4 0.3

(ASR 95%CL)(4.0, 4.4)(3.2, 3.5)

EthnicMalayChineseIndian

Year20072008200920102011

Male

Male

Female

Female

No.1,419

657171

No.484525554517469

No.1,119

527137

No.374421431428370

CR4.04.03.6

CR3.84.14.23.93.4

CR3.23.42.9

CR3.03.33.43.32.8

ASR4.44.03.8

ASR4.14.44.54.23.7

ASR3.53.43.0

ASR3.23.63.63.53.0

CR740.40.40.3

CR740.40.40.40.40.3

CR740.30.30.3

CR740.30.30.30.30.3

CumR0.40.30.3

CumR0.40.40.40.40.3

CumR0.30.30.3

CumR0.30.30.30.30.3

Table 38: Leukaemia: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011

Table 39: Leukaemia: Incidence summary by ethnicity and sex, Malaysia, 2007-2011

Table 40: Leukaemia: Incidence summary by year and sex, Malaysia, 2007-2011

%55.744.3

100.0

Figure 43: Leukaemia: Age-specific incidence rate by sex, Malaysia, 2007-2011

Page 70: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

48

Figure 44: Leukaemia types: Age-specific incidence rate, males, Malaysia, 2007-2011

Figure 45: Leukaemia types: Age-specific incidence rate, females, Malaysia, 2007-2011

Figure 46: Leukaemia: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 71: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

49

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Figure 47: Leukaemia: International comparisons – Age-standardised rates

** The highest incidence from CI5, Volume X * The lowest incidence from CI5, Volume X

Page 72: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

50

Cancer of the cervix uteri was the third most common cancer in females. The lifetime risk was 1 in 116. Chinese had higher incidence rate followed by Indian and Malay. The cumulative risk (CumR) for Chinese was 1.2, Indian 0.9 and Malay 0.6. The incidence rate over the five years was found to have decreased from 8.4 to 6.5.

Almost 60% of cervix uteri cancer cases were detected at stage I and II.

7.7 Cervix Uteri (ICD-10:C53)

SexFemale

No.4,352

CR6.8

ASR7.6

CR740.9

CumR0.9

(ASR 95%CL)(7.3, 7.8)

Table 41: Cervix Uteri: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011

Table 42: Cervix Uteri: Incidence summary by ethnicity, Malaysia, 2007-2011

Table 43: Cervix Uteri: Incidence summary by year, Malaysia, 2007-2011

EthnicMalayChineseIndian

No.1,5021,732

327

CR4.3

11.26.9

ASR5.19.87.6

CR740.61.20.9

CumR0.61.20.9

Year20072008200920102011

No.895937884841795

CR7.37.46.96.56.1

ASR8.38.47.67.16.5

CR740.91.00.90.80.7

CumR0.90.90.90.80.7

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 73: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

51

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Figure 48: Cervix Uteri: Age-specific incidence rate, Malaysia, 2007-2011

Figure 49: Cervix Uteri: Stage

Figure 50: Cervix Uteri: Age-standardised rate (ASR) by state, Malaysia, 2007-2011

Page 74: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

52

Figure 51: Cervix Uteri: International comparisons – Age-standardised rates

** The highest incidence from CI5, Volume X *The lowest incidence from CI5, Volume X NB: Singapore (2009-2013 report)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 75: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

53

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Liver cancer is the eighth most common cancer among Malaysian population and sixth most common cancer among males. The incidence of liver cancer increased with age and higher in males compared to females. Chinese were found to have higher incidence rate compared to Malay and Indian. The lifetime risk was 1 in 144 for males and 1 in 418 for females.

Most of liver cancer cases were detected at late stage (stage III and stage IV) for both sexes.

7.8 Liver (ICD-10:C22)

EthnicMalayChineseIndian

Male FemaleNo.

1,1951,416

114

No.47741158

CR3.48.62.4

CR1.42.71.2

ASR4.57.73.1

ASR1.72.31.5

CR740.50.90.4

CR740.20.30.2

CumR0.50.90.4

CumR0.20.30.2

Table 45: Liver: Incidence summary by ethnicity and sex, Malaysia, 2007-2011

Year20072008200920102011

Male FemaleNo.544570658692590

No.201218219207229

CR4.34.45.05.24.3

CR1.61.71.71.61.7

ASR5.55.56.16.15.1

ASR2.02.12.11.82.0

CR740.70.70.70.70.6

CR740.20.30.30.20.2

CumR0.70.70.70.70.6

CumR0.20.30.30.20.2

Table 46: Liver: Incidence summary by year and sex, Malaysia, 2007-2011

SexMaleFemaleBoth

No.3,0541,0744,128

CR4.71.7

ASR5.62.0

CR740.70.2

CumR0.70.2

(ASR 95%CL)(5.4, 5.8)(1.9, 2.1)

Table 44: Liver: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011

%74.026.0

100.0

Page 76: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

54 Figure 54: Liver: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

Figure 52: Liver: Age-specific incidence rate by sex, Malaysia, 2007-2011

Figure 53: Liver: Stage by sex

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 77: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

55

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Figure 55: Liver: International comparisons – Age-standardised rates

** The highest incidence from CI5, Volume X * The lowest incidence from CI5, Volume X

Page 78: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

56

Ovary cancer was ninth most common cancer in all residents and fourth in female. The incidence was highest among Chinese followed by Indian and Malay. The lifetime risk was 1 in 158. For Chinese 1 in 147, Indian 1 in 153 and Malay 1 in 159. Forty four per cent of ovary cancer cases were detected at stage I and II.

7.9 Ovary (ICD10: C56)

SexFemale

No.3,472

CR5.4

ASR5.9

CR740.6

CumR0.6

(ASR 95%CL)(5.7, 6.1)

Table 47: Ovary: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) andCumulative Risk (CumR), Malaysia, 2007-2011

Table 48: Ovary: Incidence summary by ethnicity, Malaysia, 2007-2011

Table 49: Ovary: Incidence summary by year, Malaysia, 2007-2011

EthnicMalayChineseIndian

No.1,7541,107

277

CR5.07.25.8

ASR5.86.36.1

CR740.60.70.7

CumR0.60.70.7

Year20072008200920102011

No.709615739695714

CR5.74.95.85.45.4

ASR6.45.46.35.75.7

CR740.70.60.70.60.6

CumR0.70.60.70.60.6

Page 79: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

5.1

6.4 6.1 6.1 5.9

5.0

3.5

5.3

8.6

5.0

8.1

7.1 7.8

3.9

1.7

0

2

4

6

8

10

Inci

denc

e pe

r 100

,000

State

57

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Figure 56: Ovary: Age-specific incidence rate, Malaysia, 2007-2011

Figure 57: Ovary: Stage

Figure 58: Ovary: Age-standardised rate (ASR) by state, Malaysia, 2007-2011

Page 80: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

58

Figure 59: Ovary: International comparisons – Age-standardised rates

** The highest incidence from CI5, Volume X *The lowest incidence from CI5, Volume NB: Singapore (2009-2013 report)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 81: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

59

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Cancer of the stomach was eighth most common cancer in males and tenth in females. The incidence of stomach cancer increased with age. The incidence was highest among Chinese followed by Indian and Malay for both sexes.

The lifetime risk for males was 1 in 215 and for females was 1 in 326. For males, it was 1 in 156 for Chinese and Indian, and 1 in 489 for Malay. For females, it was 1 in 223 for Chinese, 1 in 268 for Indian and 1 in 733 for Malay.

Most of stomach cancer cases were detected at late stage (stage III and stage IV) for both sexes.

7.10 Stomach (ICD10: C16)

EthnicMalayChineseIndian

Male FemaleNo.429

1,001187

No.312725137

CR1.26.13.9

CR0.94.72.9

ASR1.75.65.2

ASR1.14.13.2

CR740.20.60.6

CR740.10.40.4

CumR0.20.60.6

CumR0.10.40.4

Table 51: Stomach: Incidence summary by ethnicity and sex, Malaysia, 2007-2011

Year20072008200920102011

Male FemaleNo.373388418411424

No.306291278319253

CR2.93.03.23.13.1

CR2.52.32.22.51.9

ASR3.93.94.03.83.7

ASR3.02.72.52.82.1

CR740.50.50.50.50.4

CR740.40.30.30.30.2

CumR0.50.50.50.50.4

CumR0.40.30.30.30.2

Table 52: Stomach: Incidence summary by year and sex, Malaysia, 2007-2011

SexMaleFemaleBoth

No.2,0141,4473,461

CR3.12.3

ASR3.92.6

CR740.50.3

CumR0.50.3

(ASR 95%CL)(3.7, 4.1)(2.5, 2.8)

Table 50: Stomach: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011

%58.241.8

100.0

Page 82: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

60 Figure 62: Stomach: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

Figure 61: Stomach: Stage by sex

Figure 60: Stomach: Age-specific incidence rate by sex, Malaysia, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 83: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

61

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Figure 63: Stomach: International comparisons – Age-standardised rates

** The highest incidence from CI5, Volume X * The lowest incidence from CI5, Volume X

Page 84: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

62

Prostate cancer was fifth in male and eleventh most common cancer in all residents. The incidence of prostate cancer increased with age. The incidence was highest among Chinese followed by Indian and Malay. The lifetime risk was 1 in 117. It was 1 in 86 for Chinese, 1 in 124 for Indian and 1 in 146 for Malay. The percentage of prostate cancer detected at stage I and II was 40%.

7.11 Prostate (ICD10: C61)

SexMale

No.3,132

CR4.8

ASR6.6

CR740.9

CumR0.9

(ASR 95%CL)(6.3, 6.8)

Table 53: Prostate: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) andCumulative Risk (CumR), Malaysia, 2007-2011

Table 54: Prostate: Incidence summary by ethnicity, Malaysia, 2007-2011

Table 55: Prostate: Incidence summary by year, Malaysia, 2007-2011

EthnicMalayChineseIndian

No.1,1631,589

188

CR3.39.73.9

ASR5.39.06.1

CR740.71.20.8

CumR0.71.20.8

Year20072008200920102011

No.575621608651677

CR4.54.84.64.95.0

ASR6.66.86.46.56.5

CR740.90.80.80.90.9

CumR0.90.80.80.90.9

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 85: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

63

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Figure 66: Prostate: Age-standardised rate (ASR) by state, Malaysia, 2007-2011

Figure 64: Prostate: Age-specific incidence rate, Malaysia, 2007-2011

Figure 65: Prostate: Stage

Page 86: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

64

Figure 67: Prostate: International comparisons – Age-standardised rates

** The highest incidence from CI5, Volume X *The lowest incidence from CI5, Volume X NB: Singapore (2009-2013 report)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 87: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

65

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Skin cancer other than melanoma ranked twelve among all residents, ten most common cancer in males andfourteenth in females. The cumulative risk (CumR) for males was 0.3 and females 0.2. The incidence rate was highest among Chinese in both sexes.

The lifetime risk for males was 1 in 317. Among Chinese male, it was 1 in 237, Malay 1 in 402 and Indian 1 in 642. The lifetime risk for females was 1 in 466. For Chinese female, it was 1 in 388, Indian 1 in 627 and Malay was 1 in 633.

Staging was reported for 436 cases in males and 319 cases in females. Of these 71% were diagnosed at stage I and II in males and 73% in females.

7.12 Other Skin (ICD10: C44)

EthnicMalayChineseIndian

Male FemaleNo.504687

45

No.36344659

CR1.44.20.9

CR1.02.91.2

ASR2.03.81.3

ASR1.32.51.5

CR740.20.40.2

CR740.20.30.2

CumR0.20.40.2

CumR0.20.30.2

Table 57: Other skin: Incidence summary by ethnicity and sex, Malaysia, 2007-2011

Year20072008200920102011

Male FemaleNo.288259276283278

No.189200178255223

CR2.32.02.12.12.0

CR1.51.61.42.01.7

ASR3.02.62.72.62.5

ASR1.81.91.62.21.9

CR740.40.30.30.30.3

CR740.20.20.20.20.2

CumR0.40.30.30.30.3

CumR0.20.20.20.20.2

Table 58: Other skin: Incidence summary by year and sex, Malaysia, 2007-2011

SexMaleFemaleBoth

No.1,3841,0452,429

CR2.11.6

ASR2.71.9

CR740.30.2

CumR0.30.2

(ASR 95%CL)(2.5, 2.8)(1.8, 2.0)

Table 56: Other skin: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011

%57.043.0

100.0

Page 88: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

66 Figure 70: Other Skin: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

Figure 69: Other Skin: Stage by sex

Figure 68: Other skin: Age-specific incidence rate by sex, Malaysia, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 89: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

67

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Thyroid cancer was ranked seventeenth among males and ninth among females. The incidence rate was thehighest among Malays in both sexes.

The lifetime risk was 1 in 884 for males and 1 in 336 for females, whereas among Malay males 1 in 734 and females 1 in 284.

Staging was reported for 213 cases in males and 671 cases in females, 48% were diagnosed at stage I and II in males and 60% in females.

7.13 Thyroid (ICD10: C73)

EthnicMalayChineseIndian

Male FemaleNo.312142

30

No.1,023

371119

CR0.90.90.6

CR2.92.42.5

ASR1.10.80.7

ASR3.32.12.5

CR740.10.10.1

CR740.40.20.3

CumR0.10.10.1

CumR0.40.20.3

Table 60: Thyroid: Incidence summary by ethnicity and sex, Malaysia, 2007-2011

Year20072008200920102011

Male FemaleNo.137108100108

96

No.345352327352347

CR1.10.80.80.80.7

CR2.82.82.62.72.6

ASR1.31.00.90.90.8

ASR3.03.02.72.82.7

CR740.10.10.10.10.1

CR740.30.30.30.30.3

CumR0.10.10.10.10.1

CumR0.30.30.30.30.3

Table 61: Thyroid: Incidence summary by year and sex, Malaysia, 2007-2011

SexMaleFemaleBoth

No.549

1,7232,272

CR0.82.7

ASR1.02.9

CR740.10.3

CumR0.10.3

(ASR 95%CL)(0.9, 1.0)(2.7, 3.0)

Table 59: Thyroid: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011

%24.275.8

100.0

Page 90: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

68 Figure 73: Thyroid: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

Figure 72: Thyroid: Stage by sex

Figure 71: Thyroid: Age-specific incidence rate by sex, Malaysia, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 91: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

69

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Cancer of the brain and nervous system were ranked as eleventh most common cancer in males and thirteenth in females. Chinese have the highest incidence rate followed by Malay and Indian in both sexes.

The lifetime risk for males was 1 in 533, of these Chinese was 1 in 480, 1 in 550 in Malay and 1 in 587 in Indian. Whereas, for females was 1 in 563, Chinese 1 in 530, Malay 1 in 560 and Indian 1 in 636. 39% was detected at stage I and II in males and 51% in females.

7.14 Brain, Nervous system (ICD10: C70-C72)

EthnicMalayChineseIndian

Male FemaleNo.612368

83

No.56630578

CR1.72.21.7

CR1.62.01.6

ASR1.92.11.8

ASR1.81.91.7

CR740.20.20.2

CR740.20.20.2

CumR0.20.20.2

CumR0.20.20.2

Table 63: Brain, Nervous system: Incidence summary by ethnicity and sex, Malaysia, 2007-2011

Year20072008200920102011

Male FemaleNo.271248214223220

No.227226169202236

CR2.11.91.61.71.6

CR1.81.81.31.61.8

ASR2.42.11.81.71.7

ASR2.02.01.41.71.9

CR740.20.20.20.20.2

CR740.20.20.10.20.2

CumR0.20.20.20.20.2

CumR0.20.20.10.20.2

Table 64: Brain, Nervous system: Incidence summary by year and sex, Malaysia, 2007-2011

SexMaleFemaleBoth

No.1,1761,0602,236

CR1.81.7

ASR1.91.8

CR740.20.2

CumR0.20.2

(ASR 95%CL)(1.8, 2.1)(1.7, 1.9)

Table 62: Brain, Nervous system: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74),Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011

%52.647.4

100.0

Page 92: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

70Figure 76: Brain, Nervous system: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

Figure 75: Brain, Nervous system: Stage by sex

Figure 74: Brain, Nervous system: Age-specific incidence rate by sex, Malaysia, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 93: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

71

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Corpus uteri cancer was the seventh most common cancer in females. The incidence was highest among Chinese followed by Indian and Malay. The lifetime risk was 1 in 224, 1 in 170 for Indian, 1 in 175 for Chinese and 1 in 263 for Malay.

Staging was reported for 1,442 cases, of which 66% were diagnosed at stage I and II

7.15 Corpus Uteri (ICD10: C54)

SexFemale

No.2,181

CR3.4

ASR3.8

CR740.4

CumR0.4

(ASR 95%CL)(3.7, 4.0)

Table 65: Corpus Uteri: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011

Table 66: Corpus Uteri: Incidence summary by ethnicity, Malaysia, 2007-2011

Table 67: Corpus Uteri: Incidence summary by year, Malaysia, 2007-2011

EthnicMalayChineseIndian

No.964853204

CR2.85.54.3

ASR3.34.94.8

CR740.40.60.6

CumR0.40.60.6

Year20072008200920102011

No.446393414466462

CR3.63.13.23.63.5

ASR4.13.63.74.03.8

CR740.50.40.50.50.4

CumR0.50.40.50.50.4

Page 94: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

72Figure 79: Corpus Uteri: Age-standardised rate (ASR) by state, Malaysia, 2007-2011

Figure 78: Corpus Uteri: Stage

Figure 77: Corpus Uteri: Age-specific incidence rate, Malaysia, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 95: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

73

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Ahmad Zudfadli et al, Pahang Cancer Registry Report, 1999-2003, Pahang State Health Department,Malaysia.

Azizah Ab M, Devaraj T, Bina Rai S, Norbaiyah Y, Nooraihan M, Noorshila S (2010, August), Penang Cancer Registry Report 2004-2008, Penang State Health Department, Malaysia.

Curado M.P., Edwards B., Shin H.R., Storm H., Ferlay J., Heanue M. and Boyle P., eds (2007), CancerIncidence in Five Continents, Vol. X, IARC Scientific Publications No 160, Lyon, France.

D. Forman, F. Bray, D.H. Brewster, C. Gombe Mbalawa, B. Kohler, M. Pineros, E. Steliarova-Foucher, R. Swaminathan and J. Ferlay (2014), Cancer Incidence in Five Continents, Vol. X, IARC Scientific Publications No.164, Lyon, France.

Department of Statistics, Malaysia (2007-2011), Population Distribution and Basic DemographicCharacteristics, Population and Housing Census of Malaysia 2010, Malaysia.

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F, GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: Population Fact Sheets, Malaysia [Internet].

Fritz A., et al., 2000, International Classification of Diseases for Oncology, 3rd Edition, World HealthOrganization.

Health Facts 2009-2013, Health Informatics Center, Planning and Development Division, Ministry of Health Malaysia.

National Cancer Institute (NIH), www.cancer.gov/publication/dictionaries/cancer-terms.

Noor Hashimah A., Fauziah M.N., Norazmi A., Rohaida I., Anees A.H and Wan Mansor H (2011), Kelantan Cancer Registry Report 2004-2008, Kelantan State Health Department, Malaysia.

O.M. Jensen, D.M. Parkin, R. MacLennan, C.S. Muir and R.G. Skeet (1991), Cancer Registration: Principles and Methods, IARC Scientific Publications No. 95, Lyon, France.

Parkin, D.M., Chen, V.W., Ferlay, J., Galceran, J., Storm, H.H. & Whelan, S.L. (1994), Comparability and Quality Control in Cancer Registration, IARC Technical Report No. 19, Lyon, France.

Percy, C., Van Holten, V., Muir, C. (1990), International Classification of Diseases for Oncology, 2nd Edition, World Health Organization.

Segi, M. (1960), Cancer Mortality for Selected Sites in 24 Countries (1950-1957), Sendai, Japan, Tohoku University School of Medicine, Department of Public Health.

Singapore Cancer Registry, Annual Registry Report; Trends in Cancer Incidence in Singapore 2009-2013, National Registry of Disease Office, Singapore.

Sobin LH, Gospodarowicz MK & Wittekind C (eds.). (2009). TNM Classification of Malignant Tumours. (7th Edition). Wiley Blackwell.

Zainal Ariffin Omar, Nor Saleha Ibrahim Tamin (2011, Feb), National Cancer Registry Report 2007, Ministry of Health, Putrajaya, Malaysia.

References

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

17.

Page 96: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

74

APPENDIX 1: PERSON-YEARS AT RISK BY SEX, ETHNIC AND AGE GROUP, MALAYSIAN RESIDENTS, 2007-2011

ETHNIC GROUPSAGE GROUPMale 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total

Total 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+TOTAL

Female 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total

Source: Dept. of Statistics Malaysia, 2007-2011Note: The added total may differ due to rounding

3,727,4003,897,4003,878,0003,770,0003,459,0003,026,9002,403,2002,160,4002,021,7001,872,9001,572,4001,231,200

889,200577,900415,100458,000

35,361,000

7,263,5007,596,1007,569,1007,437,0006,879,5005,993,8004,750,8004,347,7004,090,7003,723,4003,154,0002,463,5001,794,3001,195,600

891,0001,048,900

70,198,600

3,536,1003,698,8003,691,0003,667,1003,420,5002,966,9002,347,4002,187,2002,069,1001,850,5001,581,4001,232,300

905,000617,800476,000590,400

34,837,700

1,137,2001,295,4001,359,6001,396,3001,348,6001,325,2001,244,3001,202,7001,173,7001,148,8001,023,800

855,200690,100490,800357,700352,800

16,401,800

2,202,4002,517,7002,643,9002,719,1002,667,9002,596,0002,389,3002,333,8002,299,1002,174,1001,943,8001,631,8001,317,500

933,900696,300776,000

31,842,400

1,065,2001,222,3001,284,4001,322,8001,319,4001,270,8001,145,0001,131,2001,125,4001,025,300

920,100776,600627,600442,900338,400423,400

15,440,400

387,900437,900450,200459,400466,700434,900374,200335,500320,000314,300266,100199,100136,40077,30055,50060,700

4,776,600

760,100858,800888,800903,300913,600857,800733,900672,500651,800624,800536,300404,200283,300164,200123,000140,200

9,516,700

372,300421,000438,700443,900446,800423,000359,500337,300331,800310,400270,200205,000146,80086,80067,60078,500

4,740,100

1,039,0001,045,6001,020,500

980,200857,800752,300585,000543,300506,900450,900362,900255,200179,400135,70091,400

116,2008,922,800

2,028,8002,042,7002,009,3001,954,1001,738,5001,503,2001,167,7001,085,200

995,800865,000681,600480,100353,000268,200184,900239,700

17,597,600

989,700997,100988,600973,800880,900750,700582,900541,900488,800414,400318,500224,700173,500132,80093,500

123,5008,674,900

6,291,3006,676,3006,708,3006,606,0006,131,7005,539,5004,606,7004,241,7004,022,5003,786,8003,225,2002,540,9001,895,2001,281,500

919,700989,000

65,462,200

12,254,90013,015,70013,111,10013,013,40012,199,50010,950,8009,041,6008,439,1008,037,6007,387,4006,315,4004,979,5003,748,0002,561,9001,895,2002,204,900

129,155,300

5,963,5006,339,3006,402,5006,407,4006,067,8005,411,3004,434,9004,197,5004,015,0003,600,4003,090,3002,438,7001,852,9001,280,300

975,7001,215,700

63,693,100

MALAY CHINESE INDIAN OTHERS TOTAL

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 97: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

75

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

APPENDIX 2: PERSON-YEARS AT RISK BY SEX, STATE AND AGE GROUP, MALAYSIANRESIDENTS, 2007-2011

Source: Dept. of Statistics Malaysia, 2007-2011Note: The added total may differ due to rounding

STATEAGE GROUPMale 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total

Female 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total

Total 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+TOTAL

1,186,6001,170,1001,102,6001,128,8001,348,2001,330,6001,098,300

962,000830,000723,200577,700428,200301,600183,600124,800128,900

12,624,400

1,126,6001,114,7001,057,4001,127,3001,389,8001,311,9001,026,200

894,400769,200648,900520,900400,300304,600177,500130,100160,800

12,160,900

2,313,2002,284,5002,159,9002,256,3002,738,0002,642,6002,124,4001,856,4001,599,0001,371,9001,098,400

828,500606,200361,000255,000290,100

24,785,500

728,400786,400783,600734,700720,100680,800581,200538,600500,800463,000387,500307,900232,000158,700115,600124,700

7,844,200

682,100739,300732,000687,800678,400641,200533,700509,500479,600423,100370,200291,500215,900149,500116,000147,000

7,396,500

1,410,4001,525,4001,515,4001,422,3001,398,4001,322,0001,114,9001,047,900

980,400886,400757,600599,600448,100308,200231,900271,500

15,240,600

690,600702,500692,900673,000581,900524,700387,400350,100332,900306,100250,100169,500109,20083,90056,80065,200

5,976,300

654,500667,700669,200664,300600,500536,000394,900354,900319,200274,100214,900144,200100,10077,80056,70063,500

5,790,700

1,345,3001,370,1001,362,0001,337,4001,182,0001,060,700

782,400704,900652,100580,200465,100313,600209,400161,900113,600128,700

11,769,100

574,400631,400619,400593,600499,200436,900384,500397,200391,200359,600303,400237,900177,300127,50082,900

107,2005,924,100

559,100613,000601,800580,700516,300433,000380,300386,400361,000321,200266,700215,700164,200122,60085,400

125,6005,732,400

1,133,5001,244,5001,221,3001,174,3001,015,500

870,100764,800783,500752,300680,700569,900453,500341,400250,200168,300232,900

11,660,600

482,500573,200597,800587,500500,800376,100333,200330,100349,300353,000330,700281,500224,800160,000122,000129,000

5,730,600

465,000562,500593,100579,400472,300357,500325,300332,000360,700349,800324,800282,400229,300162,800138,200160,600

5,695,400

947,5001,135,6001,190,9001,166,700

973,000733,900658,300662,000710,000702,700655,500563,900454,100322,700260,100288,900

11,426,100

SELANGOR JOHOR SABAH SARAWAK PERAK

Page 98: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

76

APPENDIX 2: PERSON-YEARS AT RISK BY SEX, STATE AND AGE GROUP, MALAYSIAN RESIDENTS, 2007-2011 (CONTINUE)

Source: Dept. of Statistics Malaysia, 2007-2011Note: The added total may differ due to rounding

STATEAGE GROUPMale 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total

Female 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total

Total 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+TOTAL

440,200493,500539,000480,300390,000326,600285,700283,200286,200275,300241,600198,000146,200100,300

80,40083,400

4,650,300

419,400467,600504,200462,200381,900324,000291,000298,900299,700280,100252,400203,300149,400109,300

92,500111,400

4,647,200

859,600961,300

1,043,100942,400772,100650,700576,300582,300585,400555,100493,900401,200295,500209,500173,200195,300

9,297,200

327,200333,600303,100348,500392,100407,500352,500284,200247,300250,000202,400156,000112,50071,80051,80049,400

3,889,300

307,600315,300294,600346,100413,200421,200328,900279,000278,500223,100187,700144,100105,00070,80047,30055,900

3,818,200

634,800649,200597,600694,500805,100828,600681,200563,400525,600473,200390,200300,100217,400142,50099,000

105,2007,707,500

435,400472,000503,600469,500317,600252,200198,700185,400197,100194,600171,700140,600114,20073,60052,00064,000

3,841,200

409,700446,400471,700438,300292,300229,500203,000215,900225,100216,200189,100146,700116,00084,90060,20085,800

3,830,200

845,200918,200975,500907,700609,600481,900401,900401,300422,000410,900360,900287,100230,000158,100112,100148,600

7,671,500

289,900312,400324,600328,400302,700309,600285,800271,300252,900234,000203,200168,500133,80088,80064,80065,800

3,636,200

277,100302,600315,400319,200314,200314,300283,500272,900257,100229,800204,900170,900134,80094,70070,50090,000

3,652,300

567,200615,000640,100647,900616,800623,900569,400544,000510,100463,600408,200339,700268,400183,700135,200155,200

7,288,700

373,500386,500402,600402,300345,200307,300227,600202,000199,100194,400173,200142,300113,50075,00052,20048,500

3,644,700

342,900350,500370,800360,800303,900281,300204,800201,400197,900194,800171,200134,700104,60066,40051,60056,100

3,393,000

716,200736,900773,400763,000649,000588,500432,200403,200397,000389,100344,300277,000218,100141,400103,600104,600

7,037,900

KEDAH WPKL & P KELANTAN PENANG PAHANG

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 99: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

77

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

APPENDIX 2: PERSON-YEARS AT RISK BY SEX, STATE AND AGE GROUP, MALAYSIANRESIDENTS, 2007-2011 (CONTINUE)

Source: Dept. of Statistics Malaysia, 2007-2011Note: The added total may differ due to rounding

STATEAGE GROUPMale 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total

Female 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total

Total 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+TOTAL

290,300302,800307,000304,900253,400192,100150,200137,800137,200133,700115,30089,10066,90045,80031,60035,200

2,593,700

273,500285,200292,600289,800236,500173,000145,400143,700144,200135,600113,40084,30063,30048,90035,40044,800

2,509,700

563,900588,200599,400595,000490,000365,200295,500281,600281,500269,500228,800173,500130,000

94,60067,50079,600

5,103,300

225,200249,100249,900253,400228,000184,200157,900144,200140,800141,200132,500110,00077,30051,90039,30040,400

2,426,300

208,500226,200231,700241,600218,100176,400154,200147,000149,200147,400136,200106,60075,50053,10043,40050,700

2,366,400

433,800475,400481,800494,900446,100360,900311,900291,200290,100288,600268,900216,700152,900105,00082,90091,400

4,792,500

173,900189,200203,500211,300176,600147,500120,700114,800114,200115,60098,20080,40062,70044,50032,60034,700

1,920,900

168,600178,100190,000214,700177,900151,700121,000119,900128,900113,500100,30082,80067,30045,60035,20044,900

1,940,100

342,700367,500393,500426,200354,700299,200241,500234,700243,100229,100198,500163,300130,20089,80067,80080,300

3,861,200

50,10052,70059,80070,80054,60038,40028,20027,80031,90032,20029,50025,40020,40015,10011,10012,300

560,100

48,10050,70059,10076,00051,50037,30029,40029,70033,90033,80031,40026,40020,40015,20012,40017,100

571,300

98,600103,200119,100146,800106,10075,70057,50057,40065,70066,00060,90052,00040,40030,10023,40029,300

1,131,500

22,80021,00018,70018,60022,00024,90015,30012,60011,70011,2008,2005,3003,0002,1001,3001,700

200,000

20,50019,80019,30019,50021,10022,50014,00012,60011,0008,8006,5004,2002,6002,0001,1002,000

186,700

43,40040,80037,80038,30043,10047,20029,00025,10022,70019,80014,6009,6005,8003,6002,4003,100

386,800

TERENGGANU N. SEMBILAN MELAKA PERLIS W. P. LABUAN

Page 100: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

78

AGE GROUPMALAYSIA POPULATION

MALE FEMALEWORLD STANDARD

POPULATION

0-4 5-9

10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+

TOTAL

6,291,3006,676,3006,708,3006,606,0006,131,7005,539,5004,606,7004,241,7004,022,5003,786,8003,225,2002,540,9001,895,2001,281,500919,700989,000

65,462,200

5,963,5006,339,3006,402,5006,407,4006,067,8005,411,3004,434,9004,197,5004,015,0003,600,4003,090,3002,438,7001,852,9001,280,300975,700

1,215,70063,693,100

12,00010,0009,0009,0008,0008,0006,0006,0006,0006,0005,0004,0004,0003,0002,0002,000

100,000

APPENDIX 3: PERSON-YEARS AT RISK, ALL MALAYSIAN, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 101: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

79

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

AGE GROUP MALE FEMALE

0-4 5-9

10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+

TOTAL

3,727,4003,897,4003,878,0003,770,0003,459,0003,026,9002,403,2002,160,4002,021,7001,872,9001,572,4001,231,200889,200577,900415,100458,000

35,361,000

3,536,1003,698,8003,691,0003,667,1003,420,5002,966,9002,347,4002,187,2002,069,1001,850,5001,581,4001,232,300905,000617,800476,000590,400

34,837,700

APPENDIX 4: PERSON-YEARS AT RISK, MALAY RESIDENTS, MALAYSIA, 2007-2011

Page 102: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

80

AGE GROUP MALE FEMALE

0-4 5-9

10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+

TOTAL

1,137,2001,295,4001,359,6001,396,3001,348,6001,325,2001,244,3001,202,7001,173,7001,148,8001,023,800855,200690,100490,800357,700352,800

16,401,800

1,065,2001,222,3001,284,4001,322,8001,319,4001,270,8001,145,0001,131,2001,125,4001,025,300920,100776,600627,600442,900338,400423,400

15,440,400

APPENDIX 5: PERSON-YEARS AT RISK, CHINESE RESIDENTS, MALAYSIA, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 103: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

81

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

AGE GROUP MALE FEMALE

0-4 5-9

10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+

TOTAL

387,900437,900450,200459,400466,700434,900374,200335,500320,000314,300266,100199,100136,40077,30055,50060,700

4,776,600

372,300421,000438,700443,900446,800423,000359,500337,300331,800310,400270,200205,000146,80086,80067,60078,500

4,740,100

APPENDIX 6: PERSON-YEARS AT RISK, INDIAN RESIDENTS, MALAYSIA, 2007-2011

Page 104: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

82

AGE GROUP MALE FEMALE

0-4 5-9

10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+

TOTAL

1,039,0001,045,6001,020,500980,200857,800752,300585,000543,300506,900450,900362,900255,200179,400135,70091,400116,200

8,922,800

989,700997,100988,600973,800880,900750,700582,900541,900488,800414,400318,500224,700173,500132,80093,500123,500

8,674,900

APPENDIX 7: PERSON-YEARS AT RISK, OTHER RESIDENTS, MALAYSIA, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 105: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

83

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

APPENDIX 8: INCIDENCE SUMMARY TABLE, ALL RESIDENTS, MALES, MALAYSIA, 2007-2011

ICD 10C18-C21C33-C34C11C81-C85,C96C61C22C91-C95C16C67C44C70-C72C25C64C32OtherC15C73C62C40-C41C01-C02C47;C49C23-C24C90C03-C06C07-C08C30-C31C12-C13C43C37-C38C17C50C09C60C75C69C10C74C14C63C00C45C66C46C68C65C88All

ColorectalTrachea,Bronchus,LungNasopharynxLymphomaProstateLiverLeukaemiaStomachBladderOther SkinBrain, Nervous systemPancreasKidneyLarynxOther & unspecifiedOesophagusThyroidTestisBoneTongueConnective,Soft tissueGallbladder etc.Multiple MyelomaMouthSalivary glandsNose, sinuses etc.HypopharynxMelanoma of SkinOther Thoracic organsSmall intestineBreastTonsilPenisOther EndocrineEyeOther OropharynxAdrenal glandPharynx unspec.Other male genitalLipMesotheliomaUreterKaposi sarcomaOther Urinary organsRenal PelvisImmunoproliferative dis.All sites Total

(14.2 , 14.9)(14.1 , 14.8)(6.1 , 6.6)(5.3 , 5.7)(6.3 , 6.8)(5.4 , 5.8)(4.0 , 4.4)(3.7 , 4.1)(2.8 , 3.1)(2.5 , 2.8)(1.8 , 2.1)(1.9 , 2.1)(1.6 , 1.8)(1.5 , 1.7)(1.3 , 1.5)(1.3 , 1.5)(0.9 , 1.0)(0.7 , 0.8)(0.7 , 0.8)(0.8 , 0.9)(0.7 , 0.8)(0.7 , 0.9)(0.7 , 0.8)(0.7 , 0.8)(0.4 , 0.5)(0.4 , 0.5)(0.3 , 0.4)(0.3 , 0.4)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.2)(0.1 , 0.2)(0.2 , 0.2)(0.1 , 0.2)(0.1 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)

(86.1 , 87.7)

7,6467,4153,7853,1713,1323,0542,5492,0141,4771,3841,1761,041

901825741737549496493461434413396391273270172167167153137127115109104

814737313022191717135

46,794

16.415.88.16.86.76.55.44.33.23.02.52.21.91.81.61.61.21.11.11.00.90.90.80.80.60.60.40.40.40.30.30.30.20.20.20.20.10.10.10.10.00.00.00.00.00.0

100.0

1.81.80.70.60.90.70.40.50.40.30.20.30.20.20.20.20.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

10.3

11.711.35.84.84.84.73.93.12.32.11.81.61.41.31.11.10.80.80.80.70.70.60.60.60.40.40.30.30.30.20.20.20.20.20.20.10.10.10.00.00.00.00.00.00.00.0

71.4

14.614.46.45.56.65.64.23.92.92.71.92.01.71.61.41.41.00.70.80.80.70.80.70.70.50.50.30.30.30.30.30.20.20.20.20.20.10.10.10.10.00.00.00.00.00.0

86.9

1.81.80.70.60.90.70.40.50.40.30.20.30.20.20.20.20.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.09.8

SITE NO. % CR CR74 ASR (ASR 95%CL) CumR

Page 106: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

84

ICD 10C50C18-C21C53C56C33-C34C81-C85,C96C54C91-C95C73C16C11C22C70-C72C44C25OtherC55C03-C06C64C15C23-C24C01-C02C67C47;C49C40-C41C90C07-C08C43C30-C31C52C37-C38C51C32C17C12-C13C09C69C58C00C75C74C57C10C14C45C66C68C65C88C46All

BreastColorectalCervix UteriOvaryTrachea,Bronchus,LungLymphomaCorpus UteriLeukaemiaThyroidStomachNasopharynxLiverBrain, Nervous systemOther SkinPancreasOther & unspecifiedUterus unspec.MouthKidneyOesophagusGallbladder etc.TongueBladderConnective,Soft tissueBoneMultiple MyelomaSalivary glandsMelanoma of SkinNose, sinuses etc.VaginaOther Thoracic organsVulvaLarynxSmall intestineHypopharynxTonsilEyePlacentaLipOther EndocrineAdrenal glandOther Female GenitalOther OropharynxPharynx unspec.MesotheliomaUreterOther Urinary organsRenal PelvisImmunoproliferative dis.Kaposi sarcomaAll sites Total

(30.7 , 31.6)(10.8 , 11.4)(7.3 , 7.8)(5.7 , 6.1)(5.8 , 6.2)(3.6 , 3.9)(3.7 , 4.0)(3.2 , 3.5)(2.7 , 3.0)(2.5 , 2.8)(2.1 , 2.3)(1.9 , 2.1)(1.7 , 1.9)(1.8 , 2.0)(1.4 , 1.6)(1.1 , 1.2)(0.9 , 1.1)(0.9 , 1.1)(0.7 , 0.9)(0.7 , 0.9)(0.7 , 0.8)(0.6 , 0.8)(0.7 , 0.8)(0.6 , 0.7)(0.5 , 0.7)(0.6 , 0.7)(0.3 , 0.4)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.3)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.1)(0.1 , 0.1)(0.1 , 0.1)(0.1 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)

(98.4 , 100.1)

18,2066,0474,3523,4723,1932,2032,1812,0241,7231,4471,3051,0741,0601,045

7886475805254344294094014003783653482261551381241231231138986686765555145423020191110872

56,713

32.110.77.76.15.63.93.83.53.02.62.31.91.91.81.41.11.00.90.80.80.70.70.70.70.60.60.40.30.20.20.20.20.20.20.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.0

100.0

3.41.40.90.60.70.40.40.30.30.30.20.20.20.20.20.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

11.2

28.69.56.85.45.03.53.43.22.72.32.01.71.71.61.21.00.90.80.70.70.60.60.60.60.60.50.40.20.20.20.20.20.20.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.0

89.0

31.111.17.65.96.03.83.83.42.92.62.22.01.81.91.51.11.01.00.80.80.80.70.70.60.60.70.40.30.20.20.20.20.20.20.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.0

99.3

3.41.30.90.60.70.40.40.30.30.30.20.20.20.20.20.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

10.6

SITE NO. % CR CR74 ASR (ASR 95%CL) CumR

APPENDIX 9: INCIDENCE SUMMARY TABLE, ALL RESIDENTS, FEMALES, MALAYSIA, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 107: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

85

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

APPENDIX 10: INCIDENCE SUMMARY TABLE, MALAY MALES, MALAYSIA, 2007-2011

ICD 10C33-C34C18-C21C81-C85,C96C91-C95C22C61C11C67C70-C72C44C16C25C64C73C40-C41C62OtherC15C32C47;C49C90C01-C02C23-C24C03-C06C30-C31C07-C08C17C43C69C37-C38C75C50C09C12-C13C60C74C10C63C14C45C00C46C66C65C68C88All

Trachea,Bronchus,LungColorectalLymphomaLeukaemiaLiverProstateNasopharynxBladderBrain, Nervous systemOther SkinStomachPancreasKidneyThyroidBoneTestisOther & unspecifiedOesophagusLarynxConnective,Soft tissueMultiple MyelomaTongueGallbladder etc.MouthNose, sinuses etc.Salivary glandsSmall intestineMelanoma of SkinEyeOther Thoracic organsOther EndocrineBreastTonsilHypopharynxPenisAdrenal glandOther OropharynxOther male genitalPharynx unspec.MesotheliomaLipKaposi sarcomaUreterRenal PelvisOther Urinary organsImmunoproliferative dis.All sites Total

(12.1 , 13.0)(10.8 , 11.7)(5.3 , 5.9)(4.2 , 4.7)(4.2 , 4.7)(5.0 , 5.6)(3.1 , 3.5)(3.1 , 3.6)(1.8 , 2.1)(1.8 , 2.2)(1.5 , 1.8)(1.3 , 1.7)(1.1 , 1.3)(1.0 , 1.3)(0.7 , 1.0)(0.7 , 0.8)(0.9 , 1.1)(0.9 , 1.2)(0.9 , 1.2)(0.7 , 0.9)(0.7 , 1.0)(0.5 , 0.7)(0.6 , 0.8)(0.4 , 0.6)(0.4 , 0.5)(0.3 , 0.5)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.3)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)

(69.7 , 71.8)

3,0942,8721,6391,4191,1951,163

9597816125044293793163122822732732582522402201651651301281226962616161504235262222141411844333

18,757

16.515.38.77.66.46.25.14.23.32.72.32.01.71.71.51.51.51.41.31.31.20.90.90.70.70.70.40.30.30.30.30.30.20.20.10.10.10.10.10.10.00.00.00.00.00.0

100.0

1.61.40.60.40.50.70.40.40.20.20.20.20.10.10.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.08.3

8.88.14.64.03.43.32.72.21.71.41.21.10.90.90.80.80.80.70.70.70.60.50.50.40.40.30.20.20.20.20.20.10.10.10.10.10.10.00.00.00.00.00.00.00.00.0

53.1

12.611.35.64.44.55.33.33.31.92.01.71.51.21.10.90.81.01.11.00.80.80.60.70.50.50.40.30.20.20.20.20.20.20.20.10.10.10.00.10.00.00.00.00.00.00.0

70.7

1.61.40.60.40.50.70.40.40.20.20.20.20.10.10.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.08.0

SITE NO. % CR CR74 ASR (ASR 95%CL) CumR

Page 108: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

86

ICD 10C50C18-C21C56C53C33-C34C81-C85,C96C91-C95C73C54C70-C72C22C11C44C16C25C55OtherC47;C49C40-C41C90C64C01-C02C23-C24C67C15C03-C06C07-C08C43C30-C31C51C58C37-C38C32C52C17C69C12-C13C09C75C57C74C00C14C10C45C88C65C66C68C46All

BreastColorectalOvaryCervix UteriTrachea,Bronchus,LungLymphomaLeukaemiaThyroidCorpus UteriBrain, Nervous systemLiverNasopharynxOther SkinStomachPancreasUterus unspec.Other & unspecifiedConnective,Soft tissueBoneMultiple MyelomaKidneyTongueGallbladder etc.BladderOesophagusMouthSalivary glandsMelanoma of SkinNose, sinuses etc.VulvaPlacentaOther Thoracic organsLarynxVaginaSmall intestineEyeHypopharynxTonsilOther EndocrineOther Female GenitalAdrenal glandLipPharynx unspec.Other OropharynxMesotheliomaImmunoproliferative dis.Renal PelvisUreterOther Urinary organsKaposi sarcomaAll sites Total

(26.6 , 27.8)(7.8 , 8.4)(5.5 , 6.1)(4.8 , 5.4)(4.1 , 4.6)(3.5 , 4.0)(3.3 , 3.7)(3.1 , 3.5)(3.1 , 3.5)(1.7 , 2.0)(1.6 , 1.9)(1.2 , 1.4)(1.2 , 1.5)(1.0 , 1.3)(0.9 , 1.1)(0.8 , 1.0)(0.7 , 0.9)(0.6 , 0.7)(0.5 , 0.6)(0.6 , 0.8)(0.5 , 0.7)(0.5 , 0.6)(0.5 , 0.7)(0.5 , 0.6)(0.5 , 0.7)(0.3 , 0.5)(0.3 , 0.4)(0.2 , 0.3)(0.2 , 0.3)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.1)(0.1 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)

(80.8 , 82.9)

8,2252,2311,7541,5021,1871,1421,1191,023

964566477401363312273264236207190178167163155151149112101

69644642403838373128242421211710

8652221

24,188

34.09.37.36.24.94.74.74.24.02.32.01.71.51.31.11.11.00.90.80.70.70.70.60.60.60.50.40.30.30.20.20.20.20.20.20.10.10.10.10.10.10.10.00.00.00.00.00.00.00.0

100.0

2.91.00.60.60.50.40.30.40.40.20.20.10.20.10.10.10.10.10.00.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.09.1

23.66.45.04.33.43.33.22.92.81.61.41.21.00.90.80.80.70.60.50.50.50.50.40.40.40.30.30.20.20.10.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.0

69.5

27.28.15.85.14.43.73.53.33.31.81.71.31.31.11.00.90.80.60.50.70.60.60.60.60.60.40.30.20.20.20.10.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.0

81.9

2.91.00.60.60.50.40.30.40.40.20.20.10.20.10.10.10.10.10.00.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.08.7

SITE NO. % CR CR74 ASR (ASR 95%CL) CumR

APPENDIX 11: INCIDENCE SUMMARY TABLE, MALAY FEMALES, MALAYSIA, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 109: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

87

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

APPENDIX 12: INCIDENCE SUMMARY TABLE,CHINESE MALES, MALAYSIA, 2007-2011

ICD 10C18-C21C33-C34C11C61C22C16C81-C85,C96C44C91-C95C25C67C64C32C70-C72OtherC15C23-C24C01-C02C73C40-C41C62C47;C49C30-C31C03-C06C90C07-C08C12-C13C37-C38C50C17C43C09C60C75C10C69C63C66C68C74C14C00C65C45C46C88All

ColorectalTrachea,Bronchus,LungNasopharynxProstateLiverStomachLymphomaOther SkinLeukaemiaPancreasBladderKidneyLarynxBrain, Nervous systemOther & unspecifiedOesophagusGallbladder etc.TongueThyroidBoneTestisConnective,Soft tissueNose, sinuses etc.MouthMultiple MyelomaSalivary glandsHypopharynxOther Thoracic organsBreastSmall intestineMelanoma of SkinTonsilPenisOther EndocrineOther OropharynxEyeOther male genitalUreterOther Urinary organsAdrenal glandPharynx unspec.LipRenal PelvisMesotheliomaKaposi sarcomaImmunoproliferative dis.All sites Total

(20.4 , 21.7)(18.2 , 19.4)(10.5 , 11.5)(8.6 , 9.5)(7.3 , 8.1)(5.2 , 5.9)(4.7 , 5.3)(3.5 , 4.1)(3.7 , 4.4)(2.6 , 3.1)(2.6 , 3.1)(2.5 , 3.0)(2.2 , 2.6)(1.9 , 2.3)(1.6 , 2.0)(1.5 , 1.9)(0.8 , 1.1)(0.8 , 1.1)(0.6 , 0.9)(0.6 , 0.9)(0.6 , 0.9)(0.6 , 0.8)(0.5 , 0.7)(0.5 , 0.7)(0.4 , 0.7)(0.4 , 0.6)(0.3 , 0.5)(0.3 , 0.5)(0.3 , 0.4)(0.3 , 0.4)(0.2 , 0.4)(0.2 , 0.3)(0.1 , 0.3)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.0)

(111.4 , 114.5)

3,8253,3902,1041,5891,4161,001

908687657516510498431368327305177171142128126126116110102

987473646253463931302315141412111010762

20,424

18.716.610.37.86.94.94.53.43.22.52.52.42.11.81.61.50.90.80.70.60.60.60.60.50.50.50.40.40.30.30.30.20.20.20.10.10.10.10.10.10.10.00.00.00.00.0

100.0

2.62.41.21.20.90.60.60.40.40.40.30.30.30.20.20.20.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

13.4

23.320.612.89.78.66.15.54.24.03.13.13.02.62.22.01.91.11.00.90.80.80.80.70.70.60.60.50.40.40.40.30.30.20.20.20.10.10.10.10.10.10.10.10.00.00.0

124.4

21.118.811.09.07.75.65.03.84.02.82.82.72.42.11.81.71.00.90.80.70.70.70.60.60.60.50.40.40.40.30.30.20.20.20.20.20.10.10.10.10.10.10.10.00.00.0

112.9

2.52.31.21.20.90.60.60.40.30.40.30.30.30.20.20.20.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

12.5

SITE NO. % CR CR74 ASR (ASR 95%CL) CumR

Page 110: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

88

ICD 10C50C18-C21C53C33-C34C56C54C16C81-C85,C96C11C91-C95C44C22C25C73C70-C72OtherC64C55C67C23-C24C40-C41C47;C49C01-C02C90C15C07-C08C03-C06C43C30-C31C51C52C37-C38C32C17C09C75C69C74C57C12-C13C66C10C45C00C58C65C68C14C46C88All

BreastColorectalCervix UteriTrachea,Bronchus,LungOvaryCorpus UteriStomachLymphomaNasopharynxLeukaemiaOther SkinLiverPancreasThyroidBrain, Nervous systemOther & unspecifiedKidneyUterus unspec.BladderGallbladder etc.BoneConnective,Soft tissueTongueMultiple MyelomaOesophagusSalivary glandsMouthMelanoma of SkinNose, sinuses etc.VulvaVaginaOther Thoracic organsLarynxSmall intestineTonsilOther EndocrineEyeAdrenal glandOther Female GenitalHypopharynxUreterOther OropharynxMesotheliomaLipPlacentaRenal PelvisOther Urinary organsPharynx unspec.Kaposi sarcomaImmunoproliferative dis.All sites Total

(40.6 , 42.5)(16.5 , 17.7)(9.4 , 10.3)(8.1 , 8.9)(6.0 , 6.7)(4.5 , 5.2)(3.8 , 4.4)(3.4 , 4.0)(3.2 , 3.7)(3.1 , 3.7)(2.2 , 2.7)(2.1 , 2.6)(2.1 , 2.5)(1.9 , 2.3)(1.7 , 2.2)(1.4 , 1.7)(1.1 , 1.4)(1.0 , 1.3)(0.9 , 1.2)(0.8 , 1.1)(0.5 , 0.7)(0.5 , 0.7)(0.4 , 0.7)(0.4 , 0.7)(0.4 , 0.6)(0.3 , 0.5)(0.3 , 0.5)(0.2 , 0.4)(0.2 , 0.4)(0.2 , 0.4)(0.2 , 0.4)(0.2 , 0.4)(0.2 , 0.3)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.0 , 0.1)(0.0 , 0.2)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)

(124.5 , 127.9)

7,3333,0231,7321,4861,107

8537256396115274464114003713052732141991851711051049998827166555252524941322418161412109887554311

22,114

33.213.77.86.75.03.93.32.92.82.42.01.91.81.71.41.21.00.90.80.80.50.50.40.40.40.30.30.20.20.20.20.20.20.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.0

100.0

4.62.11.21.00.70.60.40.40.40.30.30.30.30.20.20.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

14.2

47.519.611.29.67.25.54.74.14.03.42.92.72.62.42.01.81.41.31.21.10.70.70.60.60.50.50.40.40.30.30.30.30.30.20.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.0

143.2

41.517.19.88.56.34.94.13.73.53.42.52.32.32.11.91.51.21.11.01.00.60.60.60.60.50.40.40.30.30.30.30.30.20.20.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.0

126.2

4.52.01.21.00.70.60.40.40.40.30.30.30.30.20.20.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

13.2

SITE NO. % CR CR74 ASR (ASR 95%CL) CumR

APPENDIX 13: INCIDENCE SUMMARY TABLE,CHINESE FEMALES, MALAYSIA, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 111: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

89

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

APPENDIX 14: INCIDENCE SUMMARY TABLE, INDIAN MALES, MALAYSIA, 2007-2011

ICD 10C18-C21C33-C34C61C16C81-C85,C96C91-C95C22C03-C06C15C32C67C70-C72C01-C02C25OtherC64C44C11C62C12-C13C73C09C40-C41C23-C24C10C90C07-C08C60C47;C49C50C75C00C17C14C43C30-C31C37-C38C69C74C45C46C63C66All

ColorectalTrachea,Bronchus,LungProstateStomachLymphomaLeukaemiaLiverMouthOesophagusLarynxBladderBrain, Nervous systemTonguePancreasOther & unspecifiedKidneyOther SkinNasopharynxTestisHypopharynxThyroidTonsilBoneGallbladder etc.Other OropharynxMultiple MyelomaSalivary glandsPenisConnective,Soft tissueBreastOther EndocrineLipSmall intestinePharynx unspec.Melanoma of SkinNose, sinuses etc.Other Thoracic organsEyeAdrenal glandMesotheliomaKaposi sarcomaOther male genitalUreterAll sites Total

(9.2 , 11.4)(6.6 , 8.5)(5.2 , 7.0)(4.4 , 5.9)(3.6 , 4.8)(3.2 , 4.3)(2.5 , 3.7)(2.3 , 3.4)(2.1 , 3.2)(1.8 , 2.8)(2.0 , 3.1)(1.4 , 2.2)(1.4 , 2.3)(1.3 , 2.2)(1.0 , 1.8)(0.9 , 1.6)(0.9 , 1.6)(0.8 , 1.4)(0.6 , 1.1)(0.7 , 1.4)(0.4 , 1.0)(0.5 , 1.0)(0.4 , 0.8)(0.4 , 1.0)(0.4 , 1.0)(0.5 , 1.1)(0.4 , 0.9)(0.2 , 0.6)(0.1 , 0.5)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.3)(0.0 , 0.3)(0.0 , 0.1)(0.0 , 0.2)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)

(67.6 , 73.2)

3892701881871871711141079890868374705547454443383029282726252416141010998864421111

2,679

14.510.17.07.07.06.44.34.03.73.43.23.12.82.62.11.81.71.61.61.41.11.11.01.01.00.90.90.60.50.40.40.30.30.30.30.20.10.10.10.00.00.00.0

100.0

1.21.00.80.60.40.30.40.30.40.30.30.20.20.20.20.20.20.10.10.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.08.4

8.15.63.93.93.93.62.42.22.01.91.81.71.51.51.21.00.90.90.90.80.60.60.60.60.50.50.50.30.30.20.20.20.20.20.20.10.10.10.00.00.00.00.0

56.0

10.37.66.15.24.23.83.12.92.72.32.51.81.91.81.41.31.31.10.81.00.70.70.60.70.70.80.60.40.30.20.20.20.20.20.20.20.10.10.10.00.00.00.0

70.4

1.21.00.80.60.40.30.40.30.40.30.30.20.20.20.20.20.20.10.10.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.08.1

SITE NO. % CR CR74 ASR (ASR 95%CL) CumR

Page 112: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

90

ICD 10C50C18-C21C53C03-C06C56C54C15C16C91-C95C81-C85,C96C33-C34C73C01-C02C70-C72C55C44C22OtherC25C23-C24C12-C13C64C40-C41C11C67C90C32C07-C08C47;C49C00C52C10C09C30-C31C37-C38C51C75C17C14C43C57C69C45C58C65C74C88All

BreastColorectalCervix UteriMouthOvaryCorpus UteriOesophagusStomachLeukaemiaLymphomaTrachea,Bronchus,LungThyroidTongueBrain, Nervous systemUterus unspec.Other SkinLiverOther & unspecifiedPancreasGallbladder etc.HypopharynxKidneyBoneNasopharynxBladderMultiple MyelomaLarynxSalivary glandsConnective,Soft tissueLipVaginaOther OropharynxTonsilNose, sinuses etc.Other Thoracic organsVulvaOther EndocrineSmall intestinePharynx unspec.Melanoma of SkinOther Female GenitalEyeMesotheliomaPlacentaRenal PelvisAdrenal glandImmunoproliferative dis.All sites Total

(35.3 , 38.9)(7.8 , 9.7)(6.7 , 8.4)(6.6 , 8.4)(5.3 , 6.8)(4.1 , 5.4)(3.0 , 4.2)(2.7 , 3.8)(2.5 , 3.5)(2.5 , 3.5)(2.5 , 3.7)(2.0 , 3.0)(2.0 , 2.9)(1.3 , 2.1)(1.1 , 1.8)(1.1 , 1.8)(1.1 , 1.9)(1.1 , 1.8)(1.0 , 1.7)(0.6 , 1.3)(0.6 , 1.1)(0.4 , 0.8)(0.4 , 0.9)(0.3 , 0.8)(0.4 , 0.9)(0.4 , 0.9)(0.3 , 0.7)(0.2 , 0.5)(0.2 , 0.6)(0.2 , 0.5)(0.1 , 0.5)(0.1 , 0.5)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.3)(0.1 , 0.4)(0.0 , 0.3)(0.0 , 0.2)(0.0 , 0.2)(0.0 , 0.2)(0.0 , 0.2)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)

(106.9 , 113.3)

1,705364327287277204145137137130127119100

786059585857373527262524242018161514111010101086554321111

4,798

35.57.66.86.05.84.33.02.92.92.72.62.52.11.61.31.21.21.21.20.80.70.60.50.50.50.50.40.40.30.30.30.20.20.20.20.20.20.10.10.10.10.10.00.00.00.00.0

100.0

4.21.10.91.00.70.60.50.40.30.40.40.30.30.20.20.20.20.20.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

13.0

36.07.76.96.15.84.33.12.92.92.72.72.52.11.61.31.21.21.21.20.80.70.60.50.50.50.50.40.40.30.30.30.20.20.20.20.20.20.10.10.10.10.10.00.00.00.00.0

101.2

37.18.77.67.56.14.83.63.23.03.03.12.52.51.71.41.51.51.41.30.90.90.60.60.60.60.60.50.40.40.40.30.30.20.20.20.20.20.10.10.10.10.10.00.00.00.00.0

110.1

4.21.10.91.00.70.60.50.40.30.40.40.30.30.20.20.20.20.20.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

12.2

SITE NO. % CR CR74 ASR (ASR 95%CL) CumR

APPENDIX 15: INCIDENCE SUMMARY TABLE, INDIAN FEMALES, MALAYSIA, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 113: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

91

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

APPENDIX 16: INCIDENCE SUMMARY TABLE, OTHERS MALES, MALAYSIA, 2007-2011

ICD 10C11C33-C34C18-C21C81-C85,C96C16C22C91-C95C61C44C70-C72C67OtherC25C15C73C40-C41C62C47;C49C32C01-C02C90C23-C24C43C03-C06C64C60C07-C08C37-C38C12-C13C30-C31C69C17C50C74C09C75C46C14C00C10C45C63All

NasopharynxTrachea,Bronchus,LungColorectalLymphomaStomachLiverLeukaemiaProstateOther SkinBrain, Nervous systemBladderOther & unspecifiedPancreasOesophagusThyroidBoneTestisConnective,Soft tissueLarynxTongueMultiple MyelomaGallbladder etc.Melanoma of SkinMouthKidneyPenisSalivary glandsOther Thoracic organsHypopharynxNose, sinuses etc.EyeSmall intestineBreastAdrenal glandTonsilOther EndocrineKaposi sarcomaPharynx unspec.LipOther OropharynxMesotheliomaOther male genitalAll sites Total

(9.1 , 10.6)(11.0 , 12.8)(8.6 , 10.2)(6.0 , 7.3)(6.4 , 7.8)(5.1 , 6.4)(3.3 , 4.2)(3.2 , 4.3)(2.2 , 3.1)(1.2 , 1.7)(1.4 , 2.2)(1.1 , 1.8)(1.0 , 1.7)(1.1 , 1.7)(0.8 , 1.3)(0.4 , 0.8)(0.4 , 0.8)(0.5 , 1.0)(0.7 , 1.3)(0.6 , 1.1)(0.6 , 1.1)(0.6 , 1.0)(0.5 , 1.0)(0.5 , 1.0)(0.4 , 0.9)(0.3 , 0.7)(0.2 , 0.6)(0.3 , 0.7)(0.3 , 0.7)(0.2 , 0.4)(0.1 , 0.3)(0.1 , 0.3)(0.1 , 0.3)(0.1 , 0.3)(0.1 , 0.3)(0.0 , 0.1)(0.0 , 0.2)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.0)

(78.2 , 82.8)

6786615604373973293021921481131008676766555545452514944444440342929252016131311107643331

4,934

13.713.411.38.98.06.76.13.93.02.32.01.71.51.51.31.11.11.11.11.01.00.90.90.90.80.70.60.60.50.40.30.30.30.20.20.10.10.10.10.10.10.0

100.0

1.11.51.10.80.90.70.30.50.30.10.30.20.20.20.10.10.10.10.10.10.10.10.10.10.10.10.00.10.10.00.00.00.00.00.00.00.00.00.00.00.00.09.7

7.67.46.24.94.43.73.42.11.61.31.11.00.80.80.70.60.60.60.60.60.50.50.50.50.40.40.30.30.30.20.20.10.10.10.10.10.10.00.00.00.00.0

55.0

9.911.99.46.77.15.83.83.82.61.51.81.51.41.41.10.60.60.71.00.90.80.80.80.80.60.50.40.50.50.30.20.20.20.20.20.10.10.10.00.10.00.0

80.5

1.11.51.10.80.90.70.30.50.30.10.30.20.20.20.10.10.10.10.10.10.10.10.10.10.10.10.00.10.10.00.00.00.00.00.00.00.00.00.00.00.00.09.2

SITE NO. % CR CR74 ASR (ASR 95%CL) CumR

Page 114: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

92

ICD 10C50C53C18-C21C33-C34C56C81-C85,C96C16C11C91-C95C73C44C54C22C70-C72OtherC03-C06C25C55C15C47;C49C90C23-C24C40-C41C67C01-C02C07-C08C43C64C37-C38C52C58C69C00C51C17C32C12-C13C30-C31C09C74C57C68C10C45C14C75All

BreastCervix UteriColorectalTrachea,Bronchus,LungOvaryLymphomaStomachNasopharynxLeukaemiaThyroidOther SkinCorpus UteriLiverBrain, Nervous systemOther & unspecifiedMouthPancreasUterus unspec.OesophagusConnective,Soft tissueMultiple MyelomaGallbladder etc.BoneBladderTongueSalivary glandsMelanoma of SkinKidneyOther Thoracic organsVaginaPlacentaEyeLipVulvaSmall intestineLarynxHypopharynxNose, sinuses etc.TonsilAdrenal glandOther Female GenitalOther Urinary organsOther OropharynxMesotheliomaPharynx unspec.Other EndocrineAll sites Total

(13.3 , 15.2)(11.2 , 12.9)(6.6 , 8.1)(6.7 , 8.2)(4.3 , 5.4)(4.0 , 5.1)(4.3 , 5.5)(3.5 , 4.5)(2.8 , 3.6)(2.7 , 3.6)(2.7 , 3.7)(2.1 , 2.9)(1.9 , 2.7)(1.2 , 1.8)(1.0 , 1.6)(0.8 , 1.4)(0.7 , 1.3)(0.6 , 1.1)(0.7 , 1.3)(0.5 , 0.9)(0.6 , 1.1)(0.6 , 1.1)(0.4 , 0.7)(0.5 , 1.0)(0.4 , 0.8)(0.3 , 0.7)(0.3 , 0.6)(0.2 , 0.5)(0.2 , 0.6)(0.2 , 0.5)(0.1 , 0.3)(0.1 , 0.3)(0.2 , 0.5)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.3)(0.1 , 0.3)(0.0 , 0.2)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)

(87.2 , 92.0)

943791429393334292273268241210177160128111806058575351484644403936262624201717161514141312109543321

5,613

16.814.17.67.06.05.24.94.84.33.73.22.92.32.01.41.11.01.00.90.90.90.80.80.70.70.60.50.50.40.40.30.30.30.30.20.20.20.20.20.20.10.10.10.10.00.0

100.0

1.51.30.91.00.50.50.60.40.30.40.40.30.30.20.10.20.10.10.10.10.10.10.00.10.10.10.10.00.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

10.2

10.89.14.94.53.83.33.13.12.82.42.01.81.51.30.90.70.70.70.60.60.60.50.50.50.40.40.30.30.30.20.20.20.20.20.20.20.10.10.10.10.10.00.00.00.00.0

64.4

14.312.07.47.44.94.54.94.03.23.23.22.52.31.51.31.11.00.91.00.70.90.90.50.70.60.50.50.40.40.30.20.20.30.30.20.30.30.20.20.10.10.10.10.10.00.0

89.6

1.51.30.91.00.50.50.60.40.30.40.40.30.30.20.10.20.10.10.10.10.10.10.00.10.10.10.10.00.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.09.7

SITE NO. % CR CR74 ASR (ASR 95%CL) CumR

APPENDIX 17: INCIDENCE SUMMARY TABLE, OTHERS FEMALES, MALAYSIA, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 115: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

93

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

APPENDIX 18: INCIDENCE SUMMARY TABLE OF 15 SELECTED CANCER SITES BY STATE AND SEX, MALAYSIA, 2007-2011

STATE

1. Female BreastSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan2. ColorectalSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan3. Trachea, Bronchus, LungSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan

3,1592,792

8051,1981,8091,2201,453

5941,958

79053488373115117

889920367509532422348266720239175322251473

35348729434729919317514134116411312292271

1,1081,173

519638657545428357810355227400298

6910

7591,289

482619788400383333861444313270343

695

1.82.31.71.51.31.61.91.42.71.51.62.52.11.51.3

1.22.71.81.61.61.21.61.43.22.02.21.62.51.60.7

8.715.0

8.710.711.511.711.29.3

22.39.98.7

16.515.5

7.95.0

6.016.4

8.110.413.7

8.610.0

8.723.712.311.911.117.8

7.92.5

13.518.214.312.310.913.214.511.923.312.312.019.217.412.411.4

9.420.314.012.213.19.8

12.911.225.115.916.712.920.412.46.3

1.82.21.71.51.31.61.91.42.61.51.62.42.11.51.3

1.22.61.81.51.61.21.61.43.12.02.21.62.51.60.7

25.837.713.920.931.826.238.815.553.623.321.437.436.426.48.9

7.3

12.46.38.99.39.19.37.0

19.77.07.0

13.612.58.21.6

2.96.65.16.05.24.24.73.79.34.84.55.24.64.70.5

3.64.32.22.53.22.74.81.85.52.82.64.04.02.91.5

1.41.71.31.21.01.21.51.02.21.01.11.71.50.90.3

0.50.91.21.00.60.50.70.51.00.70.70.70.60.50.3

31.739.819.722.729.325.942.217.050.025.724.837.035.726.412.6

10.614.110.610.28.39.3

11.87.8

18.78.18.9

14.412.27.72.8

4.37.69.27.34.74.26.04.28.95.95.75.44.54.51.5

3.54.22.12.43.12.74.71.85.42.72.63.93.92.91.5

1.41.71.31.21.01.21.51.02.11.01.11.71.50.90.3

0.50.91.21.00.60.50.70.51.00.70.70.70.60.50.2

FEMALENO. CR CR74 ASR CumR

MALENO. CR CR74 ASR CumR

Page 116: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

94

STATE

4. LymphomaSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan5. NasopharynxSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan6. LeukaemiaSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan

1332019525517385

10682

191106609197136

130172152258141487128

1274035385331

35028815319615112875

11618396967683114

24456261359219153135132272160107139145

245

382524369665459182210

77394135

7014311223

9

439392212248147152

91145217116131

8611832

0

2.34.33.44.43.01.82.82.15.23.12.43.84.82.33.1

1.12.32.64.52.51.01.90.73.51.21.41.62.60.50.5

2.93.92.63.42.72.82.03.05.02.83.83.24.11.92.1

2.75.84.46.03.83.33.53.47.54.44.15.77.52.72.5

3.06.76.2

11.28.03.95.52.0

10.83.72.75.95.82.64.5

3.55.03.54.22.63.32.43.86.03.25.03.56.13.70.0

0.20.50.50.50.30.20.40.20.60.40.30.40.50.20.3

0.10.20.40.50.20.10.20.10.40.20.20.10.30.10.1

0.30.30.20.30.20.20.20.30.40.30.40.30.40.10.4

0.60.70.70.70.40.40.50.40.80.60.60.60.90.60.5

0.40.81.01.30.90.50.60.31.10.50.30.70.60.51.0

0.40.40.30.40.20.30.30.30.60.30.40.40.50.50.0

2.14.64.84.92.81.83.22.45.03.52.84.04.62.13.5

1.22.43.74.82.31.02.00.83.31.31.71.52.60.60.7

3.24.13.03.72.62.92.13.25.33.04.23.34.42.13.1

4.36.46.36.63.73.53.93.97.65.34.96.07.94.34.0

3.57.28.5

11.67.74.15.92.4

10.24.43.16.26.14.08.1

4.05.33.94.52.73.42.64.06.43.55.23.86.66.00.0

0.20.50.50.50.30.20.40.20.60.40.30.40.50.20.3

0.10.20.40.50.20.10.20.10.40.20.20.10.30.10.1

0.30.30.20.30.20.20.20.30.40.30.40.30.40.10.4

0.60.70.70.70.40.40.50.40.80.60.60.60.90.60.5

0.40.81.01.20.90.50.60.31.10.50.30.70.60.51.0

0.40.40.30.40.20.30.30.30.60.30.40.40.50.50.0

FEMALENO. CR CR74 ASR CumR

MALENO. CR CR74 ASR CumR

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 117: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

95

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

STATE

7. Cervix UteriSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan8. LiverSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan9. OvarySelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan

537518471640380295222132399193120190162557

185144848873662469

13557494935110

508446259325359233118184332158173168161232

550413236289226128

79166361150157127126

202

0.80.70.80.70.50.40.30.61.20.60.90.70.90.40.0

4.35.33.94.93.92.72.14.39.94.26.05.26.62.31.0

6.46.16.65.53.73.12.55.4

10.25.07.65.87.23.61.9

0.80.70.80.70.50.40.30.61.20.60.90.70.90.40.0

4.47.08.1

11.26.76.35.93.5

10.95.74.88.08.19.63.7

1.51.91.41.51.31.40.61.83.71.72.02.11.71.90.0

4.16.04.55.76.35.03.14.89.14.76.97.18.04.01.0

0.70.91.31.30.70.70.80.41.20.70.71.00.91.00.6

0.30.30.40.20.10.20.10.20.40.20.30.30.20.20.0

0.60.70.60.60.60.50.40.60.90.50.90.80.80.40.2

5.77.6

11.512.16.16.36.83.8

10.16.35.88.27.99.66.3

2.22.22.71.81.11.40.72.03.61.92.52.31.71.80.0

5.16.46.16.15.95.03.55.38.65.08.17.17.83.91.7

0.70.91.31.30.70.70.80.41.20.70.71.00.91.00.6

0.30.30.40.20.10.20.10.20.40.20.30.30.20.20.0

0.20.40.60.50.20.20.30.10.50.20.20.40.30.20.1

FEMALENO. CR CR74 ASR CumR

MALENO. CR CR74 ASR CumR

Page 118: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

96

STATE

10. StomachSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan11. ProstateSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan12. Other SkinSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan

162208183195121776523

1844533755862

7715714890

163483354

1254035343340

237310253337155

808035

2386535986512

3

383548199206325216187170447106

96100101

242

120206125110208

884264

18460585252

51

1.32.83.23.42.11.71.70.65.01.31.33.22.91.01.0

0.62.12.61.62.91.00.91.43.41.21.41.41.60.70.0

1.94.04.25.72.71.72.10.96.51.81.34.03.41.41.5

3.07.03.33.55.74.64.94.4

12.32.93.74.15.32.71.0

0.92.62.11.83.61.91.11.75.11.72.22.12.70.60.5

0.20.40.60.50.20.20.30.10.50.20.20.40.30.20.1

0.10.30.50.20.30.10.10.20.40.20.20.20.20.00.0

0.40.61.00.80.30.20.30.10.80.30.30.60.50.20.6

0.81.20.80.50.70.71.00.81.70.50.80.70.70.60.6

0.10.40.50.20.40.30.20.30.60.30.30.20.30.10.3

1.93.25.44.01.91.72.20.64.71.61.63.42.80.90.9

0.92.44.61.82.51.01.21.63.31.51.71.51.60.50.0

2.84.97.46.62.61.92.71.16.92.31.94.73.82.13.5

5.59.36.44.35.45.57.15.9

13.84.05.65.16.44.22.8

1.53.23.72.13.52.11.62.15.42.22.92.43.10.91.3

0.20.40.60.50.20.20.30.10.50.20.20.40.30.20.1

0.10.30.50.20.30.10.10.20.40.20.20.20.20.00.0

0.40.60.90.80.30.20.30.10.80.30.30.60.40.20.6

0.81.20.80.50.70.71.00.81.70.50.80.70.70.60.6

0.10.40.50.20.40.30.20.30.60.30.30.20.30.10.3

FEMALENO. CR CR74 ASR CumR

MALENO. CR CR74 ASR CumR

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 119: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

97

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

STATE

13. ThyroidSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan14. BrainSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan15. Corpus UteriSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan

21026513516114910170

17012496

1114362200

1311246889

2047451498363413327141

33632611919019012711288

273789796

109202

53795541423823465041261925

70

168172

8096

1925974569051394734

93

0.10.10.20.10.10.10.10.20.10.10.10.10.10.20.0

0.20.20.20.10.30.10.20.10.20.10.10.20.20.10.2

0.41.00.90.70.70.80.61.21.41.11.00.81.30.80.0

1.32.21.31.63.31.31.91.52.51.41.51.91.81.01.5

0.61.11.40.80.70.90.71.51.41.41.20.81.41.30.0

1.62.41.71.63.21.32.01.52.51.61.62.01.91.61.8

0.10.10.20.10.10.10.10.20.10.10.10.10.10.20.0

0.20.20.20.10.30.10.20.10.20.10.10.20.20.10.2

1.73.62.32.82.62.21.94.43.42.84.41.83.13.50.0

1.11.71.21.63.61.61.41.32.31.91.61.41.32.40.5

2.74.42.13.33.32.73.02.37.52.33.94.15.43.51.0

0.20.40.30.30.30.20.20.50.30.30.50.20.30.40.0

0.10.20.20.10.30.10.20.10.20.20.20.20.10.20.1

0.40.60.30.40.40.30.40.30.80.30.50.50.60.40.5

1.93.63.23.02.52.22.04.93.13.05.21.83.03.70.0

1.31.81.61.63.41.61.61.42.31.91.91.51.42.50.7

3.74.83.13.73.12.83.52.57.02.54.64.15.23.42.5

0.20.40.30.30.30.20.20.50.30.30.50.20.30.40.0

0.10.20.20.10.30.10.20.10.20.20.20.20.10.20.1

0.40.60.30.40.40.30.40.30.80.30.50.50.60.40.5

FEMALENO. CR CR74 ASR CumR

MALENO. CR CR74 ASR CumR

Page 120: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

98

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages 30 46

139

127

312

7 8137

85 172 37 737

2014 15

338

2637

31 8930

54 413

1041 27

082

574

15 167

493

167

1384 22 17 43

413

711

531

32 496 31 901 13 19

1477 17 10

411

76 549 47 109

379

2792 5

396

779

1328 44

274

1---

--46

794

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 20 0 0 1 0 0 0 6 1 1 0 0 17 0 2 0 40 1 26 1 0 2 0 52 87 0 14 4 3 32 0 019

9 74 90 6---

--68

2

5-

-

9 0 0 0 2 0 0 4 0 1 0 0 0 1 0 0 3 0 0 2 2 0 0 16 0 4 0 0 8 0 1 0 7 0 4 0 0 1 0 5 61 2 3 1 9 60 0 012

1 42 58 6---

--42

4

10-

-

14 0 0 3 0 0 0 28 0 0 0 1 0 4 0 0 8 0 0 4 2 0 3 62 0 5 0 0 11 0 0 0 13 0 3 0 0 0 0 1 72 6 2 10 16 61 0 0 74 57 37 6---

--48

9

15-

-

19 0 2 3 3 1 1 57 1 0 0 2 0 5 2 0 3 0 0 3 0 3 6 82 4 12 0 0 25 0 0 3 38 3 2 0 0 3 0 0 65 10 1 11 47 90 0 0 54 78 35 10 -----

665

20-

-

24 0 6 3 13 1 1 58 1 0 3 4 3 20 13 1 11 1 1 4 1 30 16 54 5 10 0 2 18 0 2 3 80 0 3 0 0 2 0 0 46 15 0 5 52 113 0 1 44 98 23 10 -----

777

25-

-

29 0 10 11 12 2 1 91 0 0 3 21 3 44 24 0 24 3 6 2 1 38 13 34 3 15 0 1 23 1 0 2 93 2 5 0 0 5 0 0 42 29 2 3 40 95 0 4 39 83 24 13 -----

867

30-

-

34 1 17 4 16 1 018

2 1 0 5 29 6 62 61 2 52 1 13 3 7 67 7 18 3 27 0 1 20 4 4 2 60 1 13 0 0 9 0 4 68 15 0 3 25 110 0 3 26 67 9 9

-----

1038

35-

-

39 0 18 14 21 4 031

3 0 1 7 56 210

9 89 3 82 10 19 17 813

5 14 19 6 27 0 2 23 5 7 1 55 0 22 0 1 21 0 3 72 30 1 8 24 135 0 8 21 85 17 25 -----

1540

40-

-

44 4 32 18 19 7 244

0 3 0 27 79 919

115

0 916

8 17 44 26 16 253 12 29 10 49 1 4 34 11 11 14 25 1 55 0 0 46 1 1 82 46 2 10 27 191 0 19 26 97 13 39 -----

2370

45-

-

49 2 57 34 30 15 857

4 8 2 54 132 20 281

282 5

255 30 92 32 45 483 11 21 10 85 2 1 41 13 9 26 23 2 90 3 0 74 1 4 94 58 1 14 22 229 0 43 20 103 11 56 -----

3508

50-

-

54 5 53 42 25 13 858

5 17 6 71 188 14 400

384 10 438 46 116 43 94 754 18 23 22 92 4 1 42 18 10 100 20 3

116 0 1

116 0 7

117 58 3 12 31 304 1 48 29 115 29 75 -----

4727

55-

-

59 3 64 48 31 16 650

2 18 610

421

9 27 526

499 10 511 69 148 25 114

911 16 29 26 148 2 1 47 18 17 231 9 4

130 2 0

153 3 3

112 74 4 11 25 325 0 75 41 117 18 101

-----

5599

60-

-

64 2 60 59 34 27 15 376 24 8

121

271 22 535

619 15 506 65 186 44 166

1219 15 34 19 181 2 0 37 21 17 474 10 4

143 0 4

215 5 2 86 62 4 7 12 335 0 71 25 93 19 99 -----

6370

65-

-

69 4 49 46 23 11 829

8 31 411

131

0 21 522

620 11 368 60 169 23 148

1267 18 28 28 214 5 2 43 16 16 671 8 4

124 3 8

251 3 4 69 63 4 7 15 314 1 55 24 89 19 99 -----

6309

70-

-

74 4 47 39 25 15 14 170 38 2

103

301 21 515

476 13 322 60 123 16 107

1120 8 16 14 210 3 0 18 13 8

745 7 3

103 2 3

257 1 7 56 46 4 1 17 201 0 34 21 67 18 80 -----

5494

75+

5 46 67 19 14 16 106 29 7

128

401 5

611

512 10 283 51 124 25 114

1135 10 22 16 304 3 2 27 17 11 860 8 3 62 2 2

322 3 11 47 35 2 2 14 197 3 35 15 63 22 107

-----

5935

% of

Total

0.10%

1.00%

0.80%

0.60%

0.30%

0.20%

8.10%

0.40%

0.10%

1.60%

4.30%

0.30%

8.20%

8.00%

0.20%

6.50%

0.90%

2.20%

0.60%

1.80%

15.80

%0.4

0%1.1

0%0.4

0%3.0

0%0.0

0%0.0

0%0.9

0%0.3

0%0.2

0%6.7

0%1.1

0%0.1

0%1.9

0%0.0

0%0.0

0%3.2

0%0.0

0%0.2

0%2.5

0%1.2

0%0.1

0%0.2

0%0.8

0%6.0

0%0.0

0%0.8

0%1.7

0%2.8

0%0.9

0%1.6

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

19:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

AL

L R

ESI

DE

NT

S, M

AL

ES,

MA

LA

YSI

A, 2

007-

2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 121: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

99

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages 55 40

152

522

6 68 3013

05 86 20 429

1447 89

3350

2611 86

1074 40

978

813

811

331

93 123

365

155

1045 19 2

378

1820

612

312

443

5221

81 580

3472 42 65 43

4 8 11 400 10 67

1060

1723 45 51 27

919

24 734

852

411

49 351

647

-----

5671

3

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 2 0 1 0 0 0 0 0 0 16 0 1 3 1 1 0 7 1 2 0 0 17 0 0 1 0 0 0 11 0 0 21 0 0 1 0 28 60 0 11 0 0 23 0 014

8 67 75 10 -----

508

5-

-

9 0 0 1 2 0 0 2 0 0 0 0 0 0 1 0 1 0 0 0 0 0 2 14 0 4 0 0 12 0 0 0 0 0 0 11 0 0 3 0 0 0 0 3 74 2 4 0 1 22 0 0 83 32 33 6---

--31

3

10-

-

14 1 2 3 6 0 1 4 0 1 0 1 0 3 1 0 1 0 0 3 0 0 3 49 0 3 0 0 14 2 0 1 0 0 0 43 0 0 5 0 0 1 0 2 64 15 0 1 4 54 0 0 56 39 28 2---

--41

3

15-

-

19 0 1 4 9 1 0 24 0 0 0 10 0 7 0 0 6 0 0 2 0 1 1 49 1 12 0 0 30 3 0 0 0 0 0 94 0 2 6 0 0 1 0 3 40 55 1 3 40 63 0 0 38 59 22 7---

--59

5

20-

-

24 0 3 2 10 0 1 48 2 0 0 10 3 30 13 1 5 1 6 3 0 10 5 21 4 8 0 0 15 71 0 0 16 2 411

7 0 9 7 1 0 3 0 0 46 101 1 2 59 96 1 0 22 71 12 23 -----

865

25-

-

29 0 12 5 15 0 1 42 2 0 0 23 1 47 24 1 11 1 8 3 0 27 3 16 4 14 0 0 24 251 0 2 64 30 10 127 1 10 6 1 0 1 0 3 44 132 1 1 49 88 0 1 16 62 13 13 -----

1210

30-

-

34 1 17 3 7 2 1 59 1 2 0 29 7 64 46 0 22 10 14 3 3 36 6 21 5 21 0 0 19 714 3 0

136 59 19 133 2 11 10 0 0 6 0 1 41 123 1 1 29 72 0 0 13 71 8 18 -----

1870

35-

-

39 1 13 10 16 1 110

1 0 0 5 41 2 97 72 1 35 9 20 13 4 79 5 12 10 20 1 0 2713

29 3 733

710

5 33 196 4 16 20 0 0 7 0 1 62 166 4 5 10 92 0 9 20 93 18 28 -----

3161

40-

-

44 1 39 19 23 4 015

4 4 1 19 71 514

612

8 6 47 8 38 10 314

7 7 30 16 44 0 0 2823

65 6 749

119

0 60 330 5 6 16 1 0 12 0 2 82 175 4 5 14 108 0 22 18 82 15 37 -----

5051

45-

-

49 2 35 18 24 6 219

3 9 1 22 109 6

248

196 4 73 22 44 5 8

261 8 21 9 53 0 1 43

3286 11 13 683

278 96 527 12 8 45 0 0 26 0 4

108

194 2 6 18 166 0 22 17 108 19 55 -----

7127

50-

-

54 7 59 49 22 8 119

2 7 3 48 145 17 329

285 11 99 30 83 14 10 335 11 18 12 68 2 0 26

3030 16 11 67

638

3 98 557 6 1 55 1 2 32 3 4

112

194 5 11 15 217 1 46 25 112 21 61 -----

7586

55-

-

59 5 40 56 20 13 316

9 13 4 60 172 12 464

363 12 144 70 116 23 14 411 17 24 15 89 5 0 28

2647 18 24 58

841

0 92 449 3 1 50 0 1 50 1 3 89 157 2 8 10 224 1 62 19 116 19 83 -----

7489

60-

-

64 3 52 78 24 7 512

6 13 3 62 180 6

445

339 12 148 54 130 8 17 455 14 24 17 95 3 0 22

1790 12 9

455

309 67 319 1 1 60 1 0 51 4 4 76 125 3 4 10 209 2 66 13 87 16 77 -----

6113

65-

-

69 4 28 79 15 6 4 80 9 1 57 190 9

392

347 10 139 59 99 13 18 500 14 19 23 145 2 0 29

1174 12 15 330

186 36 256 5 0 39 1 5 56 0 3 82 143 2 3 5

178 0 47 14 44 17 56 -----

5000

70-

-

74 11 51 95 21 8 4 66 16 1 63 174 7

455

376 8

144 64 103 14 15 416 13 18 15 160 4 1 20 820 17 16 320

119 42 159 1 0 40 1 1 58 0 2 48 70 2 1 6

156 0 46 8 53 13 72 -----

4414

75+ 19 49 10

3 12 12 6 43 10 2 93 292 14 623

420 20 183 81 126 21 20 514 14 22 23 307 2 0 24 724 25 18 256

110 23 143 2 0 51 1 2 95 2 4 32 71 2 0 9

156 2 27 14 53 22 99 -----

4998

% of

Total

0.10%

0.70%

0.90%

0.40%

0.10%

0.10%

2.30%

0.20%

0.00%

0.80%

2.60%

0.20%

5.90%

4.60%

0.20%

1.90%

0.70%

1.40%

0.20%

0.20%

5.60%

0.20%

0.60%

0.30%

1.80%

0.00%

0.00%

0.70%

32.10

%0.2

0%0.2

0%7.7

0%3.8

0%1.0

0%6.1

0%0.1

0%0.1

0%0.8

0%0.0

0%0.0

0%0.7

0%0.0

0%0.1

0%1.9

0%3.0

0%0.1

0%0.1

0%0.5

0%3.4

0%0.0

0%0.6

0%0.9

0%2.0

0%0.6

0%1.1

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

20:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

MA

LA

YSI

A, 2

007-

2011

Page 122: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

100

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages 30 46

139

127

312

7 8137

85 172 37 737

2014 15

338

2637

31 8930

54 413

1041 27

082

574

15 167

493

167

1384 22 17 43

413

711

531

32 496 31 901 13 19

1477 17 10

411

76 549 47 109

379

2792 5

396

779

1328 44

274

1---

--46

794

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0.1 0 0 0 0 0.3 0 0 0 0.6 0 0.4 0 0 0 0 0.8 1.4 0 0.2 0.1 0 0.5 0 0 3.2 1.2 1.4 0.1 ----- 11

5-

-

9 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0.1 0 0 0.1 0 0 0 0.1 0 0.1 0 0 0 0 0.1 0.9 0 0 0 0.1 0.9 0 0 1.8 0.6 0.9 0.1 ----- 6

10-

-

14 0 0 0 0 0 0 0.4 0 0 0 0 0 0.1 0 0 0.1 0 0 0.1 0 0 0 0.9 0 0.1 0 0 0.2 0 0 0 0.2 0 0 0 0 0 0 0 1.1 0.1 0 0.1 0.2 0.9 0 0 1.1 0.8 0.6 0.1 ----- 7

15-

-

19 0 0 0 0 0 0 0.9 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.1 1.2 0.1 0.2 0 0 0.4 0 0 0 0.6 0 0 0 0 0 0 0 1 0.2 0 0.2 0.7 1.4 0 0 0.8 1.2 0.5 0.2 ----- 10

20-

-

24 0 0.1 0 0.2 0 0 0.9 0 0 0 0.1 0 0.3 0.2 0 0.2 0 0 0.1 0 0.5 0.3 0.9 0.1 0.2 0 0 0.3 0 0 0 1.3 0 0 0 0 0 0 0 0.8 0.2 0 0.1 0.8 1.8 0 0 0.7 1.6 0.4 0.2 ----- 13

25-

-

29 0 0.2 0.2 0.2 0 0 1.6 0 0 0.1 0.4 0.1 0.8 0.4 0 0.4 0.1 0.1 0 0 0.7 0.2 0.6 0.1 0.3 0 0 0.4 0 0 0 1.7 0 0.1 0 0 0.1 0 0 0.8 0.5 0 0.1 0.7 1.7 0 0.1 0.7 1.5 0.4 0.2 ----- 16

30-

-

34 0 0.4 0.1 0.3 0 0 4 0 0 0.1 0.6 0.1 1.4 1.3 0 1.1 0 0.3 0.1 0.2 1.5 0.2 0.4 0.1 0.6 0 0 0.4 0.1 0.1 0 1.3 0 0.3 0 0 0.2 0 0.1 1.5 0.3 0 0.1 0.5 2.4 0 0.1 0.6 1.5 0.2 0.2 ----- 23

35-

-

39 0 0.4 0.3 0.5 0.1 0 7.4 0 0 0.2 1.3 0 2.6 2.1 0.1 1.9 0.2 0.4 0.4 0.2 3.2 0.3 0.4 0.1 0.6 0 0 0.5 0.1 0.2 0 1.3 0 0.5 0 0 0.5 0 0.1 1.7 0.7 0 0.2 0.6 3.2 0 0.2 0.5 2 0.4 0.6 ----- 36

40-

-

44 0.1 0.8 0.4 0.5 0.2 010

.9 0.1 0 0.7 2 0.2 4.7 3.7 0.2 4.2 0.4 1.1 0.6 0.4 6.3 0.3 0.7 0.2 1.2 0 0.1 0.8 0.3 0.3 0.3 0.6 0 1.4 0 0 1.1 0 0 2 1.1 0 0.2 0.7 4.7 0 0.5 0.6 2.4 0.3 1---

-- 59

45-

-

49 0.1 1.5 0.9 0.8 0.4 0.2 15.1 0.2 0.1 1.4 3.5 0.5 7.4 7.4 0.1 6.7 0.8 2.4 0.8 1.2 12.7 0.3 0.6 0.3 2.2 0.1 0 1.1 0.3 0.2 0.7 0.6 0.1 2.4 0.1 0 1.9 0 0.1 2.5 1.5 0 0.4 0.6 6 0 1.1 0.5 2.7 0.3 1.5 ----- 92

50-

-

54 0.2 1.6 1.3 0.8 0.4 0.2 18.2 0.5 0.2 2.2 5.8 0.4 12.4

11.9 0.3 13.6 1.4 3.6 1.3 2.9 23.4 0.6 0.7 0.7 2.9 0.1 0 1.3 0.6 0.3 3.1 0.6 0.1 3.6 0 0 3.6 0 0.2 3.6 1.8 0.1 0.4 1 9.4 0 1.5 0.9 3.6 0.9 2.3 -----

147

55-

-

59 0.1 2.5 1.9 1.2 0.6 0.2 19.8 0.7 0.2 4.1 8.6 1.1 20.7

19.7 0.4 20.1 2.7 5.8 1 4.5 35.9 0.6 1.1 1 5.8 0.1 0 1.9 0.7 0.7 9.1 0.4 0.2 5.1 0.1 0 6 0.1 0.1 4.4 2.9 0.2 0.4 1

12.8 0 3 1.6 4.6 0.7 4

-----

221

60-

-

64 0.1 3.2 3.1 1.8 1.4 0.8 19.8 1.3 0.4 6.4 14.3 1.2 28.1

32.6 0.8 26.6 3.4 9.8 2.3 8.7 64.1 0.8 1.8 1 9.5 0.1 0 1.9 1.1 0.9 24.9 0.5 0.2 7.5 0 0.2 11.3 0.3 0.1 4.5 3.3 0.2 0.4 0.6 17.6 0 3.7 1.3 4.9 1 5.2 -----

335

65-

-

69 0.3 3.9 3.6 1.8 0.9 0.6 23.6 2.5 0.3 8.8 24.6 1.7 41.4

49.1 0.9 29.2 4.8 13.4 1.8 11.7

100.4 1.4 2.2 2.2 17 0.4 0.2 3.4 1.3 1.3 53.2 0.6 0.3 9.8 0.2 0.6 19.9 0.2 0.3 5.5 5 0.3 0.6 1.2 24.9 0.1 4.4 1.9 7.1 1.5 7.8 -----

500

70-

-

74 0.4 5 4.2 2.7 1.6 1.5 18.2 4.1 0.2 11

32.2 2.2 55.2 51 1.4 34.5 6.4 13.2 1.7 11.5 120 0.9 1.7 1.5 22

.5 0.3 0 1.9 1.4 0.9 79.8 0.7 0.3 11 0.2 0.3 27.5 0.1 0.7 6 4.9 0.4 0.1 1.8 21.5 0 3.6 2.2 7.2 1.9 8.6 -----

589

75+ 0.5 4.7 6.9 2 1.4 1.6 10

.9 3 0.7 13.2

41.2 0.5 62.8

52.7 1

29.1 5.2 12.8 2.6 11.7

116.7 1 2.3 1.6 31.3 0.3 0.2 2.8 1.7 1.1 88.4 0.8 0.3 6.4 0.2 0.2 33.1 0.3 1.1 4.8 3.6 0.2 0.2 1.4 20.3 0.3 3.6 1.5 6.5 2.3 11 -----

610

Crud

e Ra

te 0 0.7 0.6 0.4 0.2 0.1 5.8 0.3 0.1 1.1 3.1 0.2 5.8 5.7 0.1 4.7 0.6 1.6 0.4 1.3 11.3 0.3 0.8 0.3 2.1 0 0 0.7 0.2 0.2 4.8 0.8 0 1.4 0 0 2.3 0 0.2 1.8 0.8 0.1 0.2 0.6 4.3 0 0.6 1.2 2 0.7 1.1 -----

71.4

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

21:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, A

LL

RE

SID

EN

TS,

MA

LE

S, M

AL

AY

SIA

, 200

7-20

11

ASR

Wor

ld 0.1 0.8 0.7 0.5 0.2 0.2 6.4 0.3 0.1 1.4 3.9 0.3 7.2 7.2 0.2 5.6 0.8 2 0.5 1.6 14.4 0.3 0.8 0.3 2.7 0 0 0.7 0.3 0.2 6.6 0.7 0.1 1.7 0 0 2.9 0 0.2 1.9 1 0.1 0.2 0.6 4.9 0 0.7 1.3 2.2 0.7 1.4 -----

86.9

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 123: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

101

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages 55 40

152

522

6 68 3013

05 86 20 429

1447 89

3350

2611 86

1074 40

978

813

811

331

93 123

365

155

1045 19 2

378

1820

612

312

443

5221

81 580

3472 42 65 43

4 8 11 400 10 67

1060

1723 45 51 27

919

24 734

852

411

49 351

647

-----

5671

3

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.1 0 0 0 0.1 0 0 0 0 0.3 0 0 0 0 0 0 0.2 0 0 0.4 0 0 0 0 0.5 1 0 0.2 0 0 0.4 0 0 2.5 1.1 1.3 0.2 ----- 8

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0.1 0 0 0.2 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 1.2 0 0.1 0 0 0.3 0 0 1.3 0.5 0.5 0.1 ----- 5

10-

-

14 0 0 0 0.1 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0.2 0 0 0 0 0 0 0.7 0 0 0.1 0 0 0 0 0 1 0.2 0 0 0.1 0.8 0 0 0.9 0.6 0.4 0---

-- 6

15-

-

19 0 0 0.1 0.1 0 0 0.4 0 0 0 0.2 0 0.1 0 0 0.1 0 0 0 0 0 0 0.8 0 0.2 0 0 0.5 0 0 0 0 0 0 1.5 0 0 0.1 0 0 0 0 0 0.6 0.9 0 0 0.6 1 0 0 0.6 0.9 0.3 0.1 ----- 9

20-

-

24 0 0 0 0.2 0 0 0.8 0 0 0 0.2 0 0.5 0.2 0 0.1 0 0.1 0 0 0.2 0.1 0.3 0.1 0.1 0 0 0.2 1.2 0 0 0.3 0 0.1 1.9 0 0.1 0.1 0 0 0 0 0 0.8 1.7 0 0 1 1.6 0 0 0.4 1.2 0.2 0.4 ----- 14

25-

-

29 0 0.2 0.1 0.3 0 0 0.8 0 0 0 0.4 0 0.9 0.4 0 0.2 0 0.1 0.1 0 0.5 0.1 0.3 0.1 0.3 0 0 0.4 4.6 0 0 1.2 0.6 0.2 2.3 0 0.2 0.1 0 0 0 0 0.1 0.8 2.4 0 0 0.9 1.6 0 0 0.3 1.1 0.2 0.2 ----- 22

30-

-

34 0 0.4 0.1 0.2 0 0 1.3 0 0 0 0.7 0.2 1.5 1 0 0.5 0.2 0.3 0.1 0.1 0.8 0.1 0.5 0.1 0.5 0 0 0.4 16.3 0.1 0 3.1 1.3 0.4 3 0 0.3 0.2 0 0 0.1 0 0 0.9 2.8 0 0 0.7 1.6 0 0 0.3 1.6 0.2 0.4 ----- 43

35-

-

39 0 0.3 0.2 0.4 0 0 2.4 0 0 0.1 1 0 2.3 1.7 0 0.8 0.2 0.5 0.3 0.1 1.9 0.1 0.3 0.2 0.5 0 0 0.6 31.7 0.1 0.2 8 2.5 0.8 4.7 0.1 0.4 0.5 0 0 0.2 0 0 1.5 4 0.1 0.1 0.2 2.2 0 0.2 0.5 2.2 0.4 0.7 ----- 75

40-

-

44 0 1 0.5 0.6 0.1 0 3.8 0.1 0 0.5 1.8 0.1 3.6 3.2 0.1 1.2 0.2 0.9 0.2 0.1 3.6 0.2 0.7 0.4 1.1 0 0 0.7 58.7 0.1 0.2 12.2 4.7 1.5 8.2 0.1 0.1 0.4 0 0 0.3 0 0 2 4.3 0.1 0.1 0.3 2.7 0 0.5 0.4 2 0.4 0.9 -----

125

45-

-

49 0.1 1 0.5 0.7 0.2 0.1 5.4 0.3 0 0.6 3 0.2 6.9 5.4 0.1 2 0.6 1.2 0.1 0.2 7.3 0.2 0.6 0.3 1.5 0 0 1.2 91.3 0.3 0.4 19 7.7 2.7 14.6 0.3 0.2 1.3 0 0 0.7 0 0.1 3 5.4 0.1 0.2 0.5 4.6 0 0.6 0.5 3 0.5 1.5 -----

198

50-

-

54 0.2 1.9 1.6 0.7 0.3 0 6.2 0.2 0.1 1.6 4.7 0.5 10.6 9.2 0.4 3.2 1 2.7 0.5 0.3 10.8 0.4 0.6 0.4 2.2 0.1 0 0.8 97.9 0.5 0.4 21.8

12.4 3.2 18 0.2 0 1.8 0 0.1 1 0.1 0.1 3.6 6.3 0.2 0.4 0.5 7 0 1.5 0.8 3.6 0.7 2

-----

245

55-

-

59 0.2 1.6 2.3 0.8 0.5 0.1 6.9 0.5 0.2 2.5 7.1 0.5 19.1

14.9 0.5 5.9 2.9 4.8 0.9 0.6 16.9 0.7 1 0.6 3.7 0.2 0 1.2

108.7 0.7 1

24.2

16.8 3.8 18.4 0.1 0 2.1 0 0 2.1 0 0.1 3.7 6.4 0.1 0.3 0.4 9.2 0 2.5 0.8 4.8 0.8 3.4 -----

308

60-

-

64 0.2 2.8 4.2 1.3 0.4 0.3 6.8 0.7 0.2 3.3 9.7 0.3 23.9

18.2 0.6 8 2.9 7 0.4 0.9 24.4 0.8 1.3 0.9 5.1 0.2 0 1.2 96.2 0.6 0.5 24.4

16.6 3.6 17.1 0.1 0.1 3.2 0.1 0 2.7 0.2 0.2 4.1 6.7 0.2 0.2 0.5 11.2 0.1 3.5 0.7 4.7 0.9 4.1 -----

328

65-

-

69 0.3 2.2 6.3 1.2 0.5 0.3 6.4 0.7 0.1 4.5 15.2 0.7 31.3

27.7 0.8 11.1 4.7 7.9 1 1.4 39.9 1.1 1.5 1.8 11.6 0.2 0 2.3 93.6 1 1.2 26.3

14.8 2.9 20.4 0.4 0 3.1 0.1 0.4 4.5 0 0.2 6.5 11.4 0.2 0.2 0.4 14.2 0 3.7 1.1 3.5 1.4 4.5 -----

399

70-

-

74 1.1 5.2 9.6 2.1 0.8 0.4 6.7 1.6 0.1 6.4 17.6 0.7 46.1

38.1 0.8 14.6 6.5 10.4 1.4 1.5 42.2 1.3 1.8 1.5 16.2 0.4 0.1 2

83.1 1.7 1.6 32.4

12.1 4.3 16.1 0.1 0 4.1 0.1 0.1 5.9 0 0.2 4.9 7.1 0.2 0.1 0.6 15.8 0 4.7 0.8 5.4 1.3 7.3 -----

447

75+ 1.6 4.1 8.6 1 1 0.5 3.6 0.8 0.2 7.8 24

.4 1.2 52 35 1.7 15.3 6.8 10.5 1.8 1.7 42.9 1.2 1.8 1.9 25.6 0.2 0 2

60.4 2.1 1.5 21.4 9.2 1.9 11.9 0.2 0 4.3 0.1 0.2 7.9 0.2 0.3 2.7 5.9 0.2 0 0.8 13 0.2 2.3 1.2 4.4 1.8 8.3 -----

417

Crud

eRa

te 0.1 0.6 0.8 0.4 0.1 0 2 0.1 0 0.7 2.3 0.1 5.3 4.1 0.1 1.7 0.6 1.2 0.2 0.2 5 0.2 0.6 0.2 1.6 0 0 0.6 28.6 0.2 0.2 6.8 3.4 0.9 5.4 0.1 0.1 0.7 0 0 0.6 0 0.1 1.7 2.7 0.1 0.1 0.4 3 0 0.5 0.8 1.8 0.6 1

----- 89

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

22:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, M

AL

AY

SIA

, 200

7-20

11

ASR

Wor

ld 0.1 0.7 1 0.4 0.1 0.1 2.2 0.2 0 0.8 2.6 0.2 6.1 4.8 0.2 2 0.8 1.5 0.2 0.2 6 0.2 0.6 0.3 1.9 0 0 0.6 31

.1 0.2 0.2 7.6 3.9 1 5.9 0.1 0.1 0.8 0 0 0.7 0 0.1 1.8 2.9 0.1 0.1 0.4 3.3 0 0.7 0.9 1.9 0.6 1.1 -----

99.3

Page 124: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

102

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

816

513

012

2 42 22 959 35 14 258

429 69

1291

1536 45

1195 16

537

912

825

230

94 61 282 62 504 11 4

240 50 26

1163 27

3 14 316 3 4

781 3 61 612

312 22 61 226

1413 3

220

381

704

334

273

-----

1875

7

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 10 0 0 1 0 0 0 5 1 1 0 0 12 0 1 0 19 1 14 1 0 2 0 33 62 0 7 1 2 18 0 010

7 55 69 2---

--42

5

5-

-

9 0 0 0 1 0 0 2 0 1 0 0 0 1 0 0 0 0 0 1 1 0 0 12 0 3 0 0 5 0 1 0 4 0 3 0 0 0 0 5 33 1 1 1 4 31 0 0 59 25 53 3---

--25

1

10-

-

14 0 0 3 0 0 0 18 0 0 0 1 0 2 0 0 4 0 0 1 1 0 3 32 0 4 0 0 6 0 0 0 11 0 3 0 0 0 0 0 40 2 1 6 14 40 0 0 41 29 30 4---

--29

6

15-

-

19 0 1 0 1 0 1 25 0 0 0 2 0 5 0 0 2 0 0 2 0 1 4 56 2 9 0 0 16 0 0 2 23 2 2 0 0 1 0 0 34 9 0 8 30 44 0 0 26 48 25 7---

--38

8

20-

-

24 0 2 3 6 1 1 28 0 0 1 1 2 10 6 1 8 0 0 3 0 20 11 25 5 7 0 0 11 0 1 3 52 0 2 0 0 1 0 0 31 10 0 3 37 73 0 1 24 52 18 5---

--46

5

25-

-

29 0 6 5 8 1 1 43 0 0 2 5 1 20 14 0 14 1 5 1 0 21 7 27 1 10 0 0 18 1 0 2 62 1 3 0 0 3 0 0 18 21 1 2 24 55 0 1 20 46 18 8---

--49

7

30-

-

34 1 7 2 11 1 0 38 0 0 0 9 4 31 43 0 30 0 7 2 2 37 4 11 1 12 0 1 12 3 1 1 28 1 5 0 0 4 0 3 42 10 0 2 18 57 0 1 8 32 8 5---

--49

5

35-

-

39 0 4 8 14 1 0 66 0 1 4 21 0 49 51 2 43 5 6 8 2 76 6 12 3 13 0 1 7 1 1 1 25 0 9 0 1 8 0 1 36 17 0 6 19 70 0 7 9 42 12 9---

--67

7

40-

-

44 1 18 10 5 4 1 92 0 0 13 24 3 86 75 7 80 9 28 13 313

7 4 10 5 24 0 1 17 6 2 4 9 1 15 0 0 25 1 1 40 23 1 7 17 109 0 14 13 53 10 20 -----

1041

45-

-

49 1 25 10 12 4 513

6 3 0 21 48 911

412

8 311

5 11 43 17 19 239 3 11 4 43 1 0 28 4 0 10 13 1 34 1 0 49 0 1 50 32 1 8 13 129 0 29 10 55 7 35 -----

1535

50-

-

54 1 23 15 10 3 214

8 1 3 24 54 717

117

6 622

8 27 45 18 30 361 5 13 8 36 1 0 23 5 1 44 6 3 48 0 0 65 0 4 65 29 1 7 20 167 1 32 12 68 22 32 -----

2071

55-

-

59 1 18 13 12 4 011

5 6 2 33 48 15 206

205 3

198 27 51 13 45 397 1 13 10 56 2 0 27 10 5 80 5 1 51 0 0 77 2 2 60 43 2 3 8

163 0 43 13 54 13 32 -----

2188

60-

-

64 0 18 17 15 8 2 96 1 2 54 50 10 181

267 9

168 24 73 22 39 517 5 22 2 70 1 0 18 6 6

171 6 0 42 0 1

124 0 1 36 36 1 5 4

151 0 37 12 46 14 35 -----

2425

65-

-

69 1 12 16 6 2 2 71 6 2 31 64 713

523

0 511

8 22 53 9 35 460 3 14 9 75 1 1 17 3 3

229 5 1 40 0 1

131 0 2 29 31 3 2 6

139 1 27 12 39 10 18 -----

2139

70-

-

74 0 16 11 11 5 1 47 6 0 37 48 813

218

4 5 93 24 35 7 31 435 3 9 6 69 3 0 8 5 1

287 2 1 30 1 0

127 0 3 18 30 2 0 5 85 0 15 10 29 12 26 -----

1923

75+

2 15 17 10 8 5 34 12 3 38 54 314

815

7 4 84 15 33 10 44 393 2 10 5 72 2 0 15 6 3

329 3 1 15 0 1

164 0 5 18 18 1 0 5 82 1 13 5 31 13 32 -----

1941

% of

Total

0.00%

0.90%

0.70%

0.70%

0.20%

0.10%

5.10%

0.20%

0.10%

1.40%

2.30%

0.40%

6.90%

8.20%

0.20%

6.40%

0.90%

2.00%

0.70%

1.30%

16.50

%0.3

0%1.5

0%0.3

0%2.7

0%0.1

0%0.0

0%1.3

0%0.3

0%0.1

0%6.2

0%1.5

0%0.1

0%1.7

0%0.0

0%0.0

0%4.2

0%0.0

0%0.3

0%3.3

0%1.7

0%0.1

0%0.3

0%1.2

0%7.5

0%0.0

0%1.2

0%2.0

0%3.8

0%1.8

0%1.5

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

23:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

MA

LA

Y M

AL

ES,

MA

LA

YSI

A, 2

007-

2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 125: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

103

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages 17 16

311

210

1 24 840

1 28 10 149

312 37

1101

1104 26 47

715

527

3 64 3811

87 40 190 69 363 6 1

207

8225 46 38

1502 96

426

417

54 21 42 167 2 2

151 2 31 566

1023 21 24 16

497

8 517

825

962

623

423

6---

--24

188

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 9 0 1 3 0 1 0 7 0 2 0 0 11 0 0 0 0 0 0 5 0 0 17 0 0 1 0 14 30 0 5 0 0 17 0 0 83 46 58 4---

--31

6

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 2 11 0 2 0 0 9 0 0 0 0 0 0 8 0 0 0 0 0 0 0 3 46 0 3 0 0 10 0 0 33 18 24 4---

--17

4

10-

-

14 1 1 2 1 0 1 2 0 1 0 1 0 2 1 0 1 0 0 2 0 0 2 29 0 2 0 0 8 1 0 1 0 0 0 28 0 0 3 0 0 0 0 2 39 7 0 1 3 28 0 0 29 24 20 1---

--24

4

15-

-

19 0 0 3 6 1 0 12 0 0 0 4 0 5 0 0 6 0 0 1 0 0 1 31 0 9 0 0 20 3 0 0 0 0 0 61 0 1 4 0 0 1 0 1 22 34 1 2 24 29 0 0 24 38 12 2---

--35

8

20-

-

24 0 3 0 4 0 1 19 1 0 0 1 1 17 6 0 3 1 4 2 0 7 2 12 2 4 0 0 9 46 0 0 5 2 0 63 0 5 3 1 0 2 0 0 28 71 1 2 42 68 1 0 18 49 10 14 -----

530

25-

-

29 0 4 3 6 0 1 18 0 0 0 9 1 26 10 0 7 0 2 2 0 12 3 12 2 10 0 0 16 146 0 1 23 18 8 80 0 5 3 1 0 1 0 3 27 82 1 1 24 57 0 1 5 29 11 7

-----

678

30-

-

34 1 10 2 2 2 1 20 1 2 0 8 4 33 29 0 12 6 8 1 1 18 1 11 2 9 0 0 11 415 2 0 45 38 10 74 2 9 3 0 0 1 0 0 19 67 0 1 20 39 0 0 4 44 4 6

-----

998

35-

-

39 0 5 2 7 0 0 30 0 0 1 10 0 38 37 1 16 7 13 7 1 44 1 7 3 5 1 0 14 723 1 3

108 52 21 111 2 9 11 0 0 3 0 0 36 108 2 3 4 38 0 2 9 48 13 16 -----

1573

40-

-

44 0 20 6 7 0 0 34 3 0 6 23 4 65 73 3 24 1 17 2 2 62 2 18 8 23 0 0 2311

78 4 320

110

3 22 163 4 4 8 0 0 8 0 0 41 104 2 4 8 54 0 13 10 42 9 13 -----

2424

45-

-

49 0 22 5 11 2 0 61 2 0 6 29 211

4 99 2 40 11 17 1 211

5 2 11 6 25 0 0 1815

96 4 425

813

0 45 256 6 7 19 0 0 10 0 1 64 112 0 3 14 102 0 11 6 60 14 27 -----

3352

50-

-

54 2 21 10 11 2 1 54 1 1 21 41 714

113

4 2 59 14 26 3 315

3 3 8 5 23 1 0 1613

85 8 725

617

4 46 286 1 1 25 0 0 10 0 2 55 107 2 3 9

110 0 30 12 50 11 20 -----

3373

55-

-

59 2 18 7 7 4 0 59 4 1 20 36 515

616

4 3 72 31 48 14 416

1 4 11 7 30 3 0 1511

23 7 623

317

6 49 226 3 0 18 0 1 27 1 1 47 82 1 4 7

103 1 35 7 66 14 30 -----

3154

60-

-

64 0 13 17 13 1 1 41 5 1 18 41 114

814

2 5 65 23 45 4 615

9 7 6 8 37 0 0 10 708 3 1

163

127 27 135 0 1 22 0 0 17 1 1 40 79 2 0 2

113 2 28 6 43 10 29 -----

2377

65-

-

69 1 11 14 7 0 0 17 3 0 20 38 410

413

9 3 58 17 27 7 716

2 5 3 11 48 0 0 11 411 4 5 87 76 20 124 2 0 16 0 1 20 0 1 36 90 0 0 1 73 0 27 3 27 7 13 -----

1761

70-

-

74 5 13 19 11 5 0 24 4 1 26 34 413

014

8 0 54 18 38 6 613

8 3 8 5 57 0 1 728

5 8 3 72 37 13 84 0 0 10 0 0 20 0 1 23 42 0 0 2 71 0 22 5 19 6 26 -----

1514

75+

5 22 22 8 7 2 9 4 2 31 37 412

212

2 7 50 26 27 9 615

5 2 5 10 77 1 0 920

5 5 4 51 31 3 50 1 0 5 0 0 30 0 1 13 38 1 0 4 66 1 9 5 23 11 24 -----

1362

% of

Total

0.10%

0.70%

0.50%

0.40%

0.10%

0.00%

1.70%

0.10%

0.00%

0.60%

1.30%

0.20%

4.60%

4.60%

0.10%

2.00%

0.60%

1.10%

0.30%

0.20%

4.90%

0.20%

0.80%

0.30%

1.50%

0.00%

0.00%

0.90%

34.00

%0.2

0%0.2

0%6.2

0%4.0

0%1.1

0%7.3

0%0.1

0%0.2

0%0.7

0%0.0

0%0.0

0%0.6

0%0.0

0%0.1

0%2.3

0%4.2

0%0.1

0%0.1

0%0.7

0%4.0

0%0.0

0%0.7

0%1.1

0%2.6

0%1.0

0%1.0

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

24:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

MA

LA

Y F

EM

AL

ES,

MA

LA

YSI

A, 2

007-

2011

Page 126: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

104

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

816

513

012

2 42 22 959 35 14 258

429 69

1291

1536 45

1195 16

537

912

825

230

94 61 282 62 504 11 4

240 50 26

1163 27

3 14 316 3 4

781 3 61 612

312 22 61 226

1413 3

220

381

704

334

273

-----

1875

7

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0.1 0 0 0 0 0.3 0 0 0 0.5 0 0.4 0 0 0.1 0 0.9 1.7 0 0.2 0 0.1 0.5 0 0 2.9 1.5 1.9 0.1 ----- 11

5-

-

9 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0.1 0 0 0.1 0 0 0 0.1 0 0.1 0 0 0 0 0.1 0.8 0 0 0 0.1 0.8 0 0 1.5 0.6 1.4 0.1 ----- 6

10-

-

14 0 0 0.1 0 0 0 0.5 0 0 0 0 0 0.1 0 0 0.1 0 0 0 0 0 0.1 0.8 0 0.1 0 0 0.2 0 0 0 0.3 0 0.1 0 0 0 0 0 1 0.1 0 0.2 0.4 1 0 0 1.1 0.7 0.8 0.1 ----- 8

15-

-

19 0 0 0 0 0 0 0.7 0 0 0 0.1 0 0.1 0 0 0.1 0 0 0.1 0 0 0.1 1.5 0.1 0.2 0 0 0.4 0 0 0.1 0.6 0.1 0.1 0 0 0 0 0 0.9 0.2 0 0.2 0.8 1.2 0 0 0.7 1.3 0.7 0.2 ----- 10

20-

-

24 0 0.1 0.1 0.2 0 0 0.8 0 0 0 0 0.1 0.3 0.2 0 0.2 0 0 0.1 0 0.6 0.3 0.7 0.1 0.2 0 0 0.3 0 0 0.1 1.5 0 0.1 0 0 0 0 0 0.9 0.3 0 0.1 1.1 2.1 0 0 0.7 1.5 0.5 0.1 ----- 13

25-

-

29 0 0.2 0.2 0.3 0 0 1.4 0 0 0.1 0.2 0 0.7 0.5 0 0.5 0 0.2 0 0 0.7 0.2 0.9 0 0.3 0 0 0.6 0 0 0.1 2 0 0.1 0 0 0.1 0 0 0.6 0.7 0 0.1 0.8 1.8 0 0 0.7 1.5 0.6 0.3 ----- 16

30-

-

34 0 0.3 0.1 0.5 0 0 1.6 0 0 0 0.4 0.2 1.3 1.8 0 1.3 0 0.3 0.1 0.1 1.6 0.2 0.5 0 0.5 0 0 0.5 0.1 0 0 1.2 0 0.2 0 0 0.2 0 0.1 1.8 0.4 0 0.1 0.8 2.4 0 0 0.3 1.3 0.3 0.2 ----- 21

35-

-

39 0 0.2 0.4 0.6 0 0 3.1 0 0 0.2 1 0 2.3 2.4 0.1 2 0.2 0.3 0.4 0.1 3.5 0.3 0.6 0.1 0.6 0 0 0.3 0 0 0 1.2 0 0.4 0 0 0.4 0 0 1.7 0.8 0 0.3 0.9 3.2 0 0.3 0.4 1.9 0.6 0.4 ----- 31

40-

-

44 0 0.9 0.5 0.2 0.2 0 4.5 0 0 0.6 1.2 0.1 4.3 3.7 0.3 4 0.4 1.4 0.6 0.1 6.8 0.2 0.5 0.2 1.2 0 0 0.8 0.3 0.1 0.2 0.4 0 0.7 0 0 1.2 0 0 2 1.1 0 0.3 0.8 5.4 0 0.7 0.6 2.6 0.5 1---

-- 51

45-

-

49 0.1 1.3 0.5 0.6 0.2 0.3 7.2 0.2 0 1.1 2.6 0.5 6.1 6.8 0.2 6.1 0.6 2.3 0.9 112

.7 0.2 0.6 0.2 2.3 0.1 0 1.5 0.2 0 0.5 0.7 0.1 1.8 0.1 0 2.6 0 0.1 2.7 1.7 0.1 0.4 0.7 6.9 0 1.5 0.5 2.9 0.4 1.9 ----- 82

50-

-

54 0.1 1.5 1 0.6 0.2 0.1 9.4 0.1 0.2 1.5 3.4 0.4 10.9

11.2 0.4 14.5 1.7 2.9 1.1 1.9 23 0.3 0.8 0.5 2.3 0.1 0 1.5 0.3 0.1 2.8 0.4 0.2 3.1 0 0 4.1 0 0.3 4.1 1.8 0.1 0.4 1.3 10.6 0.1 2 0.8 4.3 1.4 2

-----

132

55-

-

59 0.1 1.5 1.1 1 0.3 0 9.3 0.5 0.2 2.7 3.9 1.2 16.7

16.6 0.2 16.1 2.2 4.1 1.1 3.7 32.2 0.1 1.1 0.8 4.5 0.2 0 2.2 0.8 0.4 6.5 0.4 0.1 4.1 0 0 6.2 0.2 0.2 4.9 3.5 0.2 0.2 0.6 13.2 0 3.5 1.1 4.4 1.1 2.6 -----

178

60-

-

64 0 2 1.9 1.7 0.9 0.2 10.8 0.1 0.2 6.1 5.6 1.1 20.3 30 1

18.9 2.7 8.2 2.5 4.4 58 0.6 2.5 0.2 7.9 0.1 0 2 0.7 0.7 19.2 0.7 0 4.7 0 0.1 13.9 0 0.1 4 4 0.1 0.6 0.4 16.9 0 4.2 1.3 5.2 1.6 3.9 -----

272

65-

-

69 0.2 2.1 2.8 1.1 0.4 0.4 12.5 1.1 0.4 5.5 11.3 1.2 23.8

40.6 0.9 20.8 3.9 9.3 1.6 6.2 81.1 0.5 2.5 1.6 13.2 0.2 0.2 3 0.5 0.5 40.4 0.9 0.2 7.1 0 0.2 23.1 0 0.4 5.1 5.5 0.5 0.4 1.1 24.5 0.2 4.8 2.1 6.9 1.8 3.2 -----

377

70-

-

74 0 3.8 2.6 2.6 1.2 0.2 11.1 1.4 0 8.7 11.3 1.9 31.2

43.5 1.2 22 5.7 8.3 1.7 7.3

102.7 0.7 2.1 1.4 16.3 0.7 0 1.9 1.2 0.2 67.8 0.5 0.2 7.1 0.2 0 30 0 0.7 4.3 7.1 0.5 0 1.2 20.1 0 3.5 2.4 6.8 2.8 6.1 -----

454

75+ 0.4 3.3 3.8 2.2 1.8 1.1 7.6 2.7 0.7 8.5 12 0.7 33 35 0.9 18

.7 3.3 7.4 2.2 9.8 87.5 0.4 2.2 1.1 16 0.4 0 3.3 1.3 0.7 73.3 0.7 0.2 3.3 0 0.2 36.5 0 1.1 4 4 0.2 0 1.1 18.3 0.2 2.9 1.1 6.9 2.9 7.1 -----

432

Crud

eRa

te 0 0.5 0.4 0.3 0.1 0.1 2.7 0.1 0 0.7 1.2 0.2 3.7 4.3 0.1 3.4 0.5 1.1 0.4 0.7 8.8 0.2 0.8 0.2 1.4 0 0 0.7 0.1 0.1 3.3 0.8 0 0.9 0 0 2.2 0 0.2 1.7 0.9 0.1 0.2 0.6 4 0 0.6 1.1 2 0.9 0.8 -----

53.1

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

25:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, M

AL

AY

MA

LE

S, M

AL

AY

SIA

, 200

7-20

11

ASR

Wor

ld 0 0.6 0.5 0.4 0.2 0.1 3.3 0.2 0.1 1.1 1.7 0.3 5 6.1 0.2 4.5 0.7 1.5 0.5 112

.6 0.2 0.9 0.2 2 0 0 0.8 0.2 0.1 5.3 0.8 0 1.2 0 0 3.3 0 0.2 1.9 1.1 0.1 0.2 0.6 5 0 0.8 1.1 2.3 1 1---

--70

.8

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 127: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

105

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages 17 16

311

210

1 24 840

1 28 10 149

312 37

1101

1104 26 47

715

527

3 64 3811

87 40 190 69 363 6 1

207

8225 46 38

1502 96

426

417

54 21 42 167 2 2

151 2 31 566

1023 21 24 16

497

8 517

825

962

623

423

6---

--24

188

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.1 0 0 0 0.2 0 0.1 0 0 0.3 0 0 0 0 0 0 0.1 0 0 0.5 0 0 0 0 0.4 0.9 0 0.1 0 0 0.5 0 0 2.4 1.3 1.6 0.1 ----- 9

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.3 0 0.1 0 0 0.2 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0.1 1.2 0 0.1 0 0 0.3 0 0 0.9 0.5 0.6 0.1 ----- 5

10-

-

14 0 0 0.1 0 0 0 0.1 0 0 0 0 0 0.1 0 0 0 0 0 0.1 0 0 0.1 0.8 0 0.1 0 0 0.2 0 0 0 0 0 0 0.8 0 0 0.1 0 0 0 0 0.1 1.1 0.2 0 0 0.1 0.8 0 0 0.8 0.7 0.5 0---

-- 7

15-

-

19 0 0 0.1 0.2 0 0 0.3 0 0 0 0.1 0 0.1 0 0 0.2 0 0 0 0 0 0 0.8 0 0.2 0 0 0.5 0.1 0 0 0 0 0 1.7 0 0 0.1 0 0 0 0 0 0.6 0.9 0 0.1 0.7 0.8 0 0 0.7 1 0.3 0.1 ----- 10

20-

-

24 0 0.1 0 0.1 0 0 0.6 0 0 0 0 0 0.5 0.2 0 0.1 0 0.1 0.1 0 0.2 0.1 0.4 0.1 0.1 0 0 0.3 1.3 0 0 0.1 0.1 0 1.8 0 0.1 0.1 0 0 0.1 0 0 0.8 2.1 0 0.1 1.2 2 0 0 0.5 1.4 0.3 0.4 ----- 16

25-

-

29 0 0.1 0.1 0.2 0 0 0.6 0 0 0 0.3 0 0.9 0.3 0 0.2 0 0.1 0.1 0 0.4 0.1 0.4 0.1 0.3 0 0 0.5 4.9 0 0 0.8 0.6 0.3 2.7 0 0.2 0.1 0 0 0 0 0.1 0.9 2.7 0 0 0.8 1.9 0 0 0.2 1 0.4 0.2 ----- 23

30-

-

34 0 0.4 0.1 0.1 0.1 0 0.9 0 0.1 0 0.3 0.2 1.4 1.3 0 0.5 0.3 0.3 0 0 0.8 0 0.5 0.1 0.4 0 0 0.5 17.9 0.1 0 1.9 1.6 0.4 3.2 0.1 0.4 0.1 0 0 0 0 0 0.8 2.9 0 0 0.9 1.7 0 0 0.2 1.9 0.2 0.3 ----- 43

35-

-

39 0 0.2 0.1 0.3 0 0 1.4 0 0 0 0.5 0 1.7 1.7 0 0.7 0.3 0.6 0.3 0 2 0 0.3 0.1 0.2 0 0 0.6 33.1 0 0.1 4.9 2.4 1 5.1 0.1 0.4 0.5 0 0 0.1 0 0 1.6 4.9 0.1 0.1 0.2 1.7 0 0.1 0.4 2.2 0.6 0.7 ----- 72

40-

-

44 0 1 0.3 0.3 0 0 1.6 0.1 0 0.3 1.1 0.2 3.1 3.5 0.1 1.2 0 0.8 0.1 0.1 3 0.1 0.9 0.4 1.1 0 0 1.1 56.8 0.2 0.1 9.7 5 1.1 7.9 0.2 0.2 0.4 0 0 0.4 0 0 2 5 0.1 0.2 0.4 2.6 0 0.6 0.5 2 0.4 0.6 -----

117

45-

-

49 0 1.2 0.3 0.6 0.1 0 3.3 0.1 0 0.3 1.6 0.1 6.2 5.3 0.1 2.2 0.6 0.9 0.1 0.1 6.2 0.1 0.6 0.3 1.4 0 0 186

.2 0.2 0.2 13.9 7 2.4 13.8 0.3 0.4 1 0 0 0.5 0 0.1 3.5 6.1 0 0.2 0.8 5.5 0 0.6 0.3 3.2 0.8 1.5 -----

181

50-

-

54 0.1 1.3 0.6 0.7 0.1 0.1 3.4 0.1 0.1 1.3 2.6 0.4 8.9 8.5 0.1 3.7 0.9 1.6 0.2 0.2 9.7 0.2 0.5 0.3 1.5 0.1 0 187

.4 0.5 0.4 16.1 11 2.9 18 0.1 0.1 1.6 0 0 0.6 0 0.1 3.5 6.7 0.1 0.2 0.6 6.9 0 1.9 0.8 3.2 0.7 1.3 -----

213

55-

-

59 0.2 1.5 0.6 0.6 0.3 0 4.8 0.3 0.1 1.6 2.9 0.4 12.7

13.3 0.2 5.8 2.5 3.9 1.1 0.3 13.1 0.3 0.9 0.6 2.4 0.2 0 1.2 91.1 0.6 0.5 18.9

14.3 4

18.3 0.2 0 1.5 0 0.1 2.2 0.1 0.1 3.8 6.7 0.1 0.3 0.6 8.4 0.1 2.8 0.6 5.4 1.1 2.4 -----

256

60-

-

64 0 1.4 1.9 1.4 0.1 0.1 4.5 0.6 0.1 2 4.5 0.1 16.3

15.6 0.6 7.2 2.5 5 0.4 0.7 17.5 0.8 0.7 0.9 4.1 0 0 1.1 78 0.3 0.1 18 14 3

14.9 0 0.1 2.4 0 0 1.9 0.1 0.1 4.4 8.7 0.2 0 0.2 12.5 0.2 3.1 0.7 4.7 1.1 3.2 -----

262

65-

-

69 0.2 1.8 2.3 1.2 0 0 2.8 0.5 0 3.3 6.3 0.7 17.2 23 0.5 9.6 2.8 4.5 1.2 1.2 26.8 0.8 0.5 1.8 7.9 0 0 1.8 68.1 0.7 0.8 14.4

12.6 3.3 20.5 0.3 0 2.6 0 0.2 3.3 0 0.2 6

14.9 0 0 0.2 12.1 0 4.5 0.5 4.5 1.2 2.2 -----

292

70-

-

74 1 2.7 3.9 2.3 1 0 5 0.8 0.2 5.4 7 0.8 26.9

30.6 0

11.2 3.7 7.9 1.2 1.2 28.5 0.6 1.7 1

11.8 0 0.2 1.4 58.9 1.7 0.6 14.9 7.6 2.7 17.4 0 0 2.1 0 0 4.1 0 0.2 4.8 8.7 0 0 0.4 14.7 0 4.5 1 3.9 1.2 5.4 -----

313

75+ 0.9 3.8 3.8 1.4 1.2 0.3 1.5 0.7 0.3 5.3 6.4 0.7 21 21 1.2 8.6 4.5 4.6 1.5 1

26.7 0.3 0.9 1.7 13.2 0.2 0 1.5 35.3 0.9 0.7 8.8 5.3 0.5 8.6 0.2 0 0.9 0 0 5.2 0 0.2 2.2 6.5 0.2 0 0.7 11.4 0.2 1.5 0.9 4 1.9 4.1 -----

234

Crud

eRa

te

0 0.5 0.3 0.3 0.1 0 1.2 0.1 0 0.4 0.9 0.1 3.2 3.2 0.1 1.4 0.4 0.8 0.2 0.1 3.4 0.1 0.5 0.2 1 0 0 0.6 23.6 0.1 0.1 4.3 2.8 0.8 5 0.1 0.1 0.5 0 0 0.4 0 0.1 1.6 2.9 0.1 0.1 0.5 2.8 0 0.5 0.7 1.8 0.7 0.7 -----

69.5

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

26:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, M

AL

AY

FE

MA

LE

S, M

AL

AY

SIA

, 200

7-20

11

ASR

Wor

ld 0.1 0.6 0.4 0.3 0.1 0 1.3 0.1 0 0.6 1.1 0.1 4 4.1 0.1 1.7 0.6 1 0.2 0.1 4.4 0.1 0.5 0.2 1.3 0 0 0.6 27.2 0.2 0.1 5.1 3.3 0.9 5.8 0.1 0.1 0.6 0 0 0.6 0 0.1 1.8 3.3 0.1 0.1 0.4 3.3 0 0.7 0.8 2 0.7 0.8 -----

81.9

Page 128: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

106

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages 10 17

111

0 98 46 3021

04 74 11 305

1001 62

2033

1764 28

1416 17

751

611

643

133

90 73 128 53 687 7 6

126 64 39

1589 12

6 15 498 10 14 510 14 23 368

142 12 31 78 830 2

102

204

383 70 327

-----

2042

4

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 6 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 8 0 6 0 0 0 0 8 12 0 2 0 0 4 0 0 42 8 15 1---

--11

6

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 1 1 0 0 2 0 1 0 0 2 0 0 0 3 0 1 0 0 0 0 0 12 1 1 0 1 2 0 0 20 8 4 1---

-- 64

10-

-

14 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 3 0 0 2 0 0 0 17 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 18 0 0 0 0 9 0 0 19 13 4 1---

-- 90

15-

-

19 0 0 1 0 1 0 13 0 0 0 0 0 0 1 0 1 0 0 0 0 1 2 13 1 1 0 0 4 0 0 0 8 1 0 0 0 2 0 0 18 0 1 1 8 13 0 0 13 15 5 3---

--12

7

20-

-

24 0 2 0 7 0 0 9 0 0 2 0 0 6 2 0 2 0 0 1 1 6 4 11 0 2 0 1 2 0 1 0 11 0 0 0 0 1 0 0 9 5 0 2 8 24 0 0 11 25 2 3---

--16

0

25-

-

29 0 2 1 1 1 0 25 0 0 0 10 2 6 5 0 3 1 0 0 1 11 5 5 0 5 0 1 3 0 0 0 14 1 2 0 0 1 0 0 14 4 0 0 8 17 0 3 11 22 3 4---

--19

2

30-

-

34 0 7 1 2 0 011

1 0 0 3 9 1 13 12 1 13 1 2 0 2 22 2 4 0 9 0 0 5 1 0 0 18 0 8 0 0 5 0 0 19 3 0 1 3 23 0 0 11 20 1 2---

--33

5

35-

-

39 0 8 3 4 3 018

5 0 0 1 15 1 44 20 0 25 3 11 6 4 33 2 7 0 7 0 1 10 2 3 0 21 0 12 0 0 8 0 2 22 9 0 1 3 44 0 1 4 25 1 14 -----

565

40-

-

44 1 10 5 7 3 026

4 2 0 7 27 2 68 48 1 67 5 12 10 10 81 5 11 3 19 1 2 12 3 1 8 11 0 33 0 0 15 0 0 21 13 0 2 5 46 0 2 8 32 3 10 -----

896

45-

-

49 1 16 8 12 3 232

5 2 1 20 43 911

211

2 110

9 11 33 12 21 161 6 5 4 29 0 1 9 6 0 11 7 0 46 2 0 12 1 0 25 19 0 3 6 65 0 8 6 28 2 14 -----

1329

50-

-

54 1 18 11 10 4 233

9 6 1 22 73 417

515

8 215

6 14 51 23 42 280 8 7 6 38 2 0 12 9 3 38 11 0 51 0 0 28 0 1 33 15 2 5 6 67 0 5 8 28 3 25 -----

1803

55-

-

59 1 29 12 11 7 129

9 8 2 43 98 11 260

241 5

238 29 75 10 47 403 14 12 10 70 0 0 14 3 6

118 2 3 69 2 0 50 1 1 37 18 2 8 8

108 0 21 19 40 2 42 -----

2510

60-

-

64 0 23 20 12 8 521

5 15 4 45 141 9

293

300 5

259 30 92 20 92 537 7 8 9 95 1 0 14 13 7

240 3 3 89 0 3 73 5 0 41 15 1 1 3

121 0 20 11 30 3 46 -----

2987

65-

-

69 2 20 15 13 4 317

6 15 0 51 153 11 327

330 4

195 29 99 8 97 645 9 9 13 113 2 0 17 10 7

368 3 3 75 3 7 84 3 2 32 19 1 4 6

130 0 14 9 39 9 65 -----

3253

70-

-

74 2 19 11 12 9 9 95 17 1 44 178 10 334

248 5

177 25 68 8 57 583 3 6 2

107 0 0 10 7 4

376 1 2 65 1 3 99 1 4 29 9 1 1 9 76 0 15 7 26 5 40 -----

2821

75+

2 17 22 7 3 8 46 9 2 67 254 2

394

287 4

159 29 73 15 56 627 6 10 5

191 1 0 9 10 7

430 4 2 41 2 1

132 3 5 26 12 1 2 4 81 2 13 5 24 8 56 -----

3176

% of

Total 0.0

0%0.8

0%0.5

0%0.5

0%0.2

0%0.1

0%10

.30%

0.40%

0.10%

1.50%

4.90%

0.30%

10.00

%8.6

0%0.1

0%6.9

0%0.9

0%2.5

0%0.6

0%2.1

0%16

.60%

0.40%

0.60%

0.30%

3.40%

0.00%

0.00%

0.60%

0.30%

0.20%

7.80%

0.60%

0.10%

2.40%

0.00%

0.10%

2.50%

0.10%

0.10%

1.80%

0.70%

0.10%

0.20%

0.40%

4.10%

0.00%

0.50%

1.00%

1.90%

0.30%

1.60% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

27:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

CH

INE

SE M

AL

ES,

MA

LA

YSI

A, 2

007-

2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 129: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

107

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

7 99 66 71 24 861

1 10 3 82 725 32

1837

1151 35 41

117

140

0 52 4114

86 49 105 55 446 8 1

104

7333 52 52

1732 85

319

911

07 12 521

4 5 918

5 4 16 305

371 14 18 70 569 1 98 133

314 80 273

-----

2211

4

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 4 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 0 0 2 0 0 0 0 1 21 0 3 0 0 3 0 0 25 9 10 2---

-- 85

5-

-

9 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 2 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 14 1 1 0 1 6 0 0 23 4 5 1---

-- 63

10-

-

14 0 0 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 8 0 1 0 0 3 0 0 0 0 0 0 5 0 0 1 0 0 1 0 0 11 5 0 0 1 11 0 0 12 11 7 0---

-- 82

15-

-

19 0 0 1 3 0 0 5 0 0 0 2 0 0 0 0 0 0 0 1 0 0 0 5 1 1 0 0 6 0 0 0 0 0 0 17 0 0 0 0 0 0 0 0 10 12 0 1 11 19 0 0 8 12 6 1---

--12

2

20-

-

24 0 0 1 2 0 0 14 0 0 0 4 0 6 3 0 1 0 1 0 0 1 2 4 2 2 0 0 6 13 0 0 5 0 2 23 0 1 2 0 0 0 0 0 10 12 0 0 7 15 0 0 4 9 1 4---

--15

7

25-

-

29 0 4 0 5 0 0 13 0 0 0 6 0 10 6 0 3 1 4 1 0 8 0 1 1 1 0 0 4 61 0 0 18 7 0 28 0 1 0 0 0 0 0 0 5 29 0 0 13 20 0 0 3 25 2 3---

--28

3

30-

-

34 0 5 0 2 0 0 21 0 0 0 12 2 17 9 0 2 2 4 2 1 11 3 7 3 9 0 0 420

0 0 0 45 9 7 37 0 0 3 0 0 2 0 0 12 30 0 0 7 18 0 0 6 14 2 8---

--51

6

35-

-

39 0 6 2 5 1 1 42 0 0 0 16 0 47 19 0 11 1 5 4 3 23 2 3 6 10 0 0 842

5 0 011

1 27 9 52 0 2 7 0 0 4 0 1 19 26 0 2 3 37 0 3 5 30 3 4---

--98

5

40-

-

44 0 7 2 10 3 0 87 0 0 1 29 1 57 33 2 14 4 13 5 0 62 1 7 5 12 0 0 282

6 2 113

5 53 17 99 0 1 7 0 0 2 0 2 25 40 2 0 4 32 0 6 6 20 3 13 -----

1653

45-

-

49 1 5 2 7 2 1 90 0 0 5 47 2 93 68 0 19 8 16 4 310

3 5 6 2 12 0 1 1612

24 3 524

310

0 33 170 5 0 17 0 0 11 0 2 27 42 0 2 3 31 0 4 8 34 3 16 -----

2501

50-

-

54 1 15 5 4 3 0 92 2 2 2 52 713

710

4 5 26 11 38 9 312

7 4 7 4 25 1 0 811

83 7 223

814

7 42 171 2 0 23 1 2 13 2 2 31 46 3 4 4 58 1 6 6 36 6 27 -----

2757

55-

-

59 0 10 5 9 4 1 88 0 0 8 80 525

314

2 2 47 27 48 5 417

7 5 10 4 34 0 0 911

38 6 823

417

6 25 162 0 0 26 0 0 17 0 0 26 42 1 2 2 76 0 17 8 23 3 35 -----

3004

60-

-

64 0 15 11 4 3 1 63 1 1 9 93 324

215

4 5 55 20 70 4 621

5 6 15 5 40 2 0 884

2 6 719

512

9 23 128 0 0 33 1 0 26 2 3 24 25 0 3 4 48 0 19 6 27 6 34 -----

2642

65-

-

69 0 8 10 5 3 0 42 0 0 14 97 224

717

2 5 59 22 63 5 824

5 7 11 7 61 2 0 12 608 5 7

169 84 11 88 3 0 19 1 4 26 0 2 37 24 2 3 3 68 0 9 6 11 8 27 -----

2332

70-

-

74 1 9 10 8 2 2 26 2 0 9 90 127

418

8 6 63 36 52 2 420

6 5 7 7 67 2 0 840

5 7 11 188 61 18 59 1 0 29 1 1 29 0 1 18 13 1 1 3 62 0 21 2 26 6 32 -----

2083

75+

4 15 15 4 3 2 27 5 0 34 197 9

454

252 10 107 39 86 10 8

308 8 13 8

169 1 0 10 408 16 10 151 60 12 65 1 0 44 1 2 54 0 2 15 24 1 0 4 65 0 13 5 23 9 66 -----

2849

% of

Total

0.00%

0.40%

0.30%

0.30%

0.10%

0.00%

2.80%

0.00%

0.00%

0.40%

3.30%

0.10%

8.30%

5.20%

0.20%

1.90%

0.80%

1.80%

0.20%

0.20%

6.70%

0.20%

0.50%

0.20%

2.00%

0.00%

0.00%

0.50%

33.20

%0.2

0%0.2

0%7.8

0%3.9

0%0.9

0%5.0

0%0.1

0%0.0

0%1.0

0%0.0

0%0.0

0%0.8

0%0.0

0%0.1

0%1.4

0%1.7

0%0.1

0%0.1

0%0.3

0%2.6

0%0.0

0%0.4

0%0.6

0%1.4

0%0.4

0%1.2

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

28:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

CH

INE

SE F

EM

AL

ES,

MA

LA

YSI

A, 2

007-

2011

Page 130: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

108

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages 10 17

111

0 98 46 3021

04 74 11 305

1001 62

2033

1764 28

1416 17

751

611

643

133

90 73 128 53 687 7 6

126 64 39

1589 12

6 15 498 10 14 510 14 23 368

142 12 31 78 830 2

102

204

383 70 327

-----

2042

4

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0.1 0 0 0 0 0.2 0 0 0 0.7 0 0.5 0 0 0 0 0.7 1.1 0 0.2 0 0 0.4 0 0 3.7 0.7 1.3 0.1 ----- 10

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.1 0.1 0 0 0.2 0 0.1 0 0 0.2 0 0 0 0.2 0 0.1 0 0 0 0 0 0.9 0.1 0.1 0 0.1 0.2 0 0 1.5 0.6 0.3 0.1 ----- 5

10-

-

14 0 0 0 0 0 0 0.1 0 0 0 0 0 0.1 0 0 0.2 0 0 0.1 0 0 0 1.2 0 0 0 0 0.1 0 0 0 0.1 0 0 0 0 0 0 0 1.3 0 0 0 0 0.7 0 0 1.4 1 0.3 0.1 ----- 7

15-

-

19 0 0 0.1 0 0.1 0 0.9 0 0 0 0 0 0 0.1 0 0.1 0 0 0 0 0.1 0.1 0.9 0.1 0.1 0 0 0.3 0 0 0 0.6 0.1 0 0 0 0.1 0 0 1.3 0 0.1 0.1 0.6 0.9 0 0 0.9 1.1 0.4 0.2 ----- 9

20-

-

24 0 0.1 0 0.5 0 0 0.7 0 0 0.1 0 0 0.4 0.1 0 0.1 0 0 0.1 0.1 0.4 0.3 0.8 0 0.1 0 0.1 0.1 0 0.1 0 0.8 0 0 0 0 0.1 0 0 0.7 0.4 0 0.1 0.6 1.8 0 0 0.8 1.9 0.1 0.2 ----- 12

25-

-

29 0 0.2 0.1 0.1 0.1 0 1.9 0 0 0 0.8 0.2 0.5 0.4 0 0.2 0.1 0 0 0.1 0.8 0.4 0.4 0 0.4 0 0.1 0.2 0 0 0 1.1 0.1 0.2 0 0 0.1 0 0 1.1 0.3 0 0 0.6 1.3 0 0.2 0.8 1.7 0.2 0.3 ----- 14

30-

-

34 0 0.6 0.1 0.2 0 0 8.9 0 0 0.2 0.7 0.1 1 1 0.1 1 0.1 0.2 0 0.2 1.8 0.2 0.3 0 0.7 0 0 0.4 0.1 0 0 1.4 0 0.6 0 0 0.4 0 0 1.5 0.2 0 0.1 0.2 1.9 0 0 0.9 1.6 0.1 0.2 ----- 27

35-

-

39 0 0.7 0.2 0.3 0.2 015

.4 0 0 0.1 1.2 0.1 3.7 1.7 0 2.1 0.2 0.9 0.5 0.3 2.7 0.2 0.6 0 0.6 0 0.1 0.8 0.2 0.2 0 1.7 0 1 0 0 0.7 0 0.2 1.8 0.7 0 0.1 0.2 3.7 0 0.1 0.3 2.1 0.1 1.2 ----- 47

40-

-

44 0.1 0.9 0.4 0.6 0.3 022

.5 0.2 0 0.6 2.3 0.2 5.8 4.1 0.1 5.7 0.4 1 0.9 0.9 6.9 0.4 0.9 0.3 1.6 0.1 0.2 1 0.3 0.1 0.7 0.9 0 2.8 0 0 1.3 0 0 1.8 1.1 0 0.2 0.4 3.9 0 0.2 0.7 2.7 0.3 0.9 ----- 76

45-

-

49 0.1 1.4 0.7 1 0.3 0.2 28.2 0.2 0.1 1.7 3.7 0.8 9.7 9.7 0.1 9.5 1 2.9 1 1.8 14 0.5 0.4 0.3 2.5 0 0.1 0.8 0.5 0 1 0.6 0 4 0.2 0 1 0.1 0 2.2 1.6 0 0.3 0.5 5.6 0 0.7 0.5 2.4 0.2 1.2 -----

115

50-

-

54 0.1 1.8 1.1 1 0.4 0.2 33.1 0.6 0.1 2.2 7.1 0.4 17.1

15.4 0.2 15.3 1.4 5 2.2 4.1 27.4 0.8 0.7 0.6 3.7 0.2 0 1.2 0.9 0.3 3.7 1.1 0 5 0 0 2.7 0 0.1 3.2 1.5 0.2 0.5 0.6 6.6 0 0.5 0.8 2.7 0.3 2.4 -----

176

55-

-

59 0.1 3.4 1.4 1.3 0.8 0.1 35 0.9 0.2 511

.5 1.3 30.4

28.2 0.6 27.9 3.4 8.8 1.2 5.5 47.2 1.6 1.4 1.2 8.2 0 0 1.6 0.4 0.7 13.8 0.2 0.4 8.1 0.2 0 5.9 0.1 0.1 4.3 2.1 0.2 0.9 0.9 12.6 0 2.5 2.2 4.7 0.2 4.9 -----

294

60-

-

64 0 3.3 2.9 1.7 1.2 0.7 31 2.2 0.6 6.5 20.3 1.3 42.2

43.2 0.7 37.3 4.3 13.3 2.9 13.3

77.4 1 1.2 1.3 13.7 0.1 0 2 1.9 1

34.6 0.4 0.4 12.8 0 0.4 10.5 0.7 0 5.9 2.2 0.1 0.1 0.4 17.4 0 2.9 1.6 4.3 0.4 6.6 -----

430

65-

-

69 0.4 4.1 3.1 2.7 0.8 0.6 36.3 3.1 0

10.5

31.6 2.3 67.5

68.1 0.8 40.3 6

20.4 1.7 20

133.1 1.9 1.9 2.7 23.3 0.4 0 3.5 2.1 1.4 76 0.6 0.6 15.5 0.6 1.4 17.3 0.6 0.4 6.6 3.9 0.2 0.8 1.2 26.8 0 2.9 1.9 8.1 1.9 13.4 -----

672

70-

-

74 0.6 5.2 3 3.3 2.5 2.5 26.2 4.7 0.3 12.1 49 2.8 92 68.3 1.4 48.8 6.9 18.7 2.2 15.7

160.6 0.8 1.7 0.6 29.5 0 0 2.8 1.9 1.1

103.6 0.3 0.6 17.9 0.3 0.8 27.3 0.3 1.1 8 2.5 0.3 0.3 2.5 20.9 0 4.1 1.9 7.2 1.4 11 -----

777

75+ 0.6 4.9 6.3 2 0.9 2.3 13

.3 2.6 0.6 19.3

73.2 0.6

113.6 82.7 1.2 45.8 8.4 21 4.3 16.1

180.7 1.7 2.9 1.4 55.1 0.3 0 2.6 2.9 2

123.9 1.2 0.6 11

.8 0.6 0.3 38 0.9 1.4 7.5 3.5 0.3 0.6 1.2 23.3 0.6 3.7 1.4 6.9 2.3 16.1 -----

915

Crud

eRa

te 0.1 1 0.7 0.6 0.3 0.2 12.8 0.5 0.1 1.9 6.1 0.4 12.4

10.7 0.2 8.6 1.1 3.1 0.7 2.6 20.7 0.4 0.8 0.3 4.2 0 0 0.8 0.4 0.2 9.7 0.8 0.1 3 0.1 0.1 3.1 0.1 0.1 2.2 0.9 0.1 0.2 0.5 5.1 0 0.6 1.2 2.3 0.4 2

-----

124.4

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

29:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, C

HIN

ESE

MA

LE

S, M

AL

AY

SIA

, 200

7-20

11

ASR

Wor

ld 0.1 0.9 0.6 0.5 0.2 0.2 11 0.4 0.1 1.7 5.6 0.3 11.2 9.7 0.2 7.7 1 2.8 0.6 2.4 18.8 0.4 0.7 0.3 3.8 0 0 0.7 0.4 0.2 9 0.7 0.1 2.7 0.1 0.1 2.8 0.1 0.2 2.1 0.8 0.1 0.2 0.4 4.6 0 0.6 1.4 2.2 0.5 1.8 -----

113

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 131: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

109

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

7 99 66 71 24 861

1 10 3 82 725 32

1837

1151 35 41

117

140

0 52 4114

86 49 105 55 446 8 1

104

7333 52 52

1732 85

319

911

07 12 521

4 5 918

5 4 16 305

371 14 18 70 569 1 98 133

314 80 273

-----

2211

4

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.4 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0.2 0 0 0.2 0 0 0 0 0.1 2 0 0.3 0 0 0.3 0 0 2.3 0.8 0.9 0.2 ----- 8

5-

-

9 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.1 0 0.2 0 0 0 0 0 0 0 0 0 0.1 0 0 0.1 0 0 0 0 0 1.1 0.1 0.1 0 0.1 0.5 0 0 1.9 0.3 0.4 0.1 ----- 5

10-

-

14 0 0 0.1 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.6 0 0.1 0 0 0.2 0 0 0 0 0 0 0.4 0 0 0.1 0 0 0.1 0 0 0.9 0.4 0 0 0.1 0.9 0 0 0.9 0.9 0.5 0---

-- 6

15-

-

19 0 0 0.1 0.2 0 0 0.4 0 0 0 0.2 0 0 0 0 0 0 0 0.1 0 0 0 0.4 0.1 0.1 0 0 0.5 0 0 0 0 0 0 1.3 0 0 0 0 0 0 0 0 0.8 0.9 0 0.1 0.8 1.4 0 0 0.6 0.9 0.5 0.1 ----- 9

20-

-

24 0 0 0.1 0.2 0 0 1.1 0 0 0 0.3 0 0.5 0.2 0 0.1 0 0.1 0 0 0.1 0.2 0.3 0.2 0.2 0 0 0.5 1 0 0 0.4 0 0.2 1.7 0 0.1 0.2 0 0 0 0 0 0.8 0.9 0 0 0.5 1.1 0 0 0.3 0.7 0.1 0.3 ----- 12

25-

-

29 0 0.3 0 0.4 0 0 1 0 0 0 0.5 0 0.8 0.5 0 0.2 0.1 0.3 0.1 0 0.6 0 0.1 0.1 0.1 0 0 0.3 4.8 0 0 1.4 0.5 0 2.2 0 0.1 0 0 0 0 0 0 0.4 2.3 0 0 1 1.6 0 0 0.2 2 0.2 0.2 ----- 22

30-

-

34 0 0.4 0 0.2 0 0 1.8 0 0 0 1.1 0.2 1.5 0.8 0 0.2 0.2 0.4 0.2 0.1 1 0.3 0.6 0.3 0.8 0 0 0.4 17.6 0 0 4 0.8 0.6 3.3 0 0 0.3 0 0 0.2 0 0 1.1 2.6 0 0 0.6 1.6 0 0 0.5 1.2 0.2 0.7 ----- 45

35-

-

39 0 0.5 0.2 0.4 0.1 0.1 3.7 0 0 0 1.4 0 4.2 1.7 0 1 0.1 0.4 0.4 0.3 2 0.2 0.3 0.5 0.9 0 0 0.7 37.6 0 0 9.8 2.4 0.8 4.6 0 0.2 0.6 0 0 0.4 0 0.1 1.7 2.3 0 0.2 0.3 3.3 0 0.3 0.4 2.7 0.3 0.4 ----- 87

40-

-

44 0 0.6 0.2 0.9 0.3 0 7.7 0 0 0.1 2.6 0.1 5 2.9 0.2 1.2 0.4 1.2 0.4 0 5.5 0.1 0.6 0.4 1.1 0 0 0.2 73.1 0.2 0.1 11.9 4.7 1.5 8.8 0 0.1 0.6 0 0 0.2 0 0.2 2.2 3.5 0.2 0 0.4 2.8 0 0.5 0.5 1.8 0.3 1.2 -----

146

45-

-

49 0.1 0.5 0.2 0.7 0.2 0.1 8.8 0 0 0.5 4.6 0.2 9.1 6.7 0 1.9 0.8 1.6 0.4 0.3 10.1 0.5 0.6 0.2 1.2 0 0.1 1.6 120 0.3 0.5 23.8 9.8 3.2 16.7 0.5 0 1.7 0 0 1.1 0 0.2 2.6 4.1 0 0.2 0.3 3 0 0.4 0.8 3.3 0.3 1.6 -----

245

50-

-

54 0.1 1.6 0.5 0.4 0.3 0 10 0.2 0.2 0.2 5.7 0.8 14.9

11.3 0.5 2.8 1.2 4.1 1 0.3 13.8 0.4 0.8 0.4 2.7 0.1 0 0.9

128.6 0.8 0.2 25

.9 16 4.6 18.6 0.2 0 2.5 0.1 0.2 1.4 0.2 0.2 3.4 5 0.3 0.4 0.4 6.3 0.1 0.7 0.7 3.9 0.7 2.9 -----

300

55-

-

59 0 1.3 0.6 1.2 0.5 0.1 11.3 0 0 1

10.3 0.6 32.6

18.3 0.3 6.1 3.5 6.2 0.6 0.5 22.8 0.6 1.3 0.5 4.4 0 0 1.2

146.7 0.8 1

30.2

22.7 3.2 20.9 0 0 3.4 0 0 2.2 0 0 3.4 5.4 0.1 0.3 0.3 9.8 0 2.2 1 3 0.4 4.5 -----

387

60-

-

64 0 2.4 1.7 0.6 0.5 0.2 10 0.2 0.2 1.4 14.7 0.5 38.3

24.4 0.8 8.7 3.2 11.1 0.6 1

34.1 1 2.4 0.8 6.3 0.3 0 1.3

133.4 1 1.1 30.9

20.4 3.6 20.3 0 0 5.2 0.2 0 4.1 0.3 0.5 3.8 4 0 0.5 0.6 7.6 0 3 1 4.3 1 5.4 -----

418

65-

-

69 0 1.8 2.3 1.2 0.7 0 9.7 0 0 3.2 22.4 0.5 56.9

39.6 1.2 13.6 5.1 14.5 1.2 1.8 56.5 1.6 2.5 1.6 14.1 0.5 0 2.8

140.1 1.2 1.6 38.9

19.4 2.5 20.3 0.7 0 4.4 0.2 0.9 6 0 0.5 8.5 5.5 0.5 0.7 0.7 15.7 0 2.1 1.4 2.5 1.8 6.2 -----

537

70-

-

74 0.3 2.6 2.9 2.3 0.6 0.6 7.6 0.6 0 2.6 26.4 0.3 80.2

55.1 1.8 18.5

10.5

15.2 0.6 1.2 60.3 1.5 2.1 2.1 19.6 0.6 0 2.3

118.6 2.1 3.2 55.1

17.9 5.3 17.3 0.3 0 8.5 0.3 0.3 8.5 0 0.3 5.3 3.8 0.3 0.3 0.9 18.2 0 6.2 0.6 7.6 1.8 9.4 -----

610

75+

1 3.6 3.6 1 0.7 0.5 6.5 1.2 0 8.1 47.2 2.2

108.8 60

.4 2.4 25.6 9.3 20.6 2.4 1.9 73.8 1.9 3.1 1.9 40.5 0.2 0 2.4 97.7 3.8 2.4 36.2

14.4 2.9 15.6 0.2 0

10.5 0.2 0.5 12.9 0 0.5 3.6 5.7 0.2 0 1

15.6 0 3.1 1.2 5.5 2.2 15.8 -----

682

Crud

eRa

te

0 0.6 0.4 0.5 0.2 0.1 4 0.1 0 0.5 4.7 0.2 11.9 7.5 0.2 2.7 1.1 2.6 0.3 0.3 9.6 0.3 0.7 0.4 2.9 0.1 0 0.7 47.5 0.3 0.3 11.2 5.5 1.3 7.2 0.1 0 1.4 0 0.1 1.2 0 0.1 2 2.4 0.1 0.1 0.5 3.7 0 0.6 0.9 2 0.5 1.8 -----

143.2

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

30:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, C

HIN

ESE

FE

MA

LE

S, M

AL

AY

SIA

, 200

7-20

11

ASR

Wor

ld 0 0.6 0.4 0.4 0.1 0 3.5 0.1 0 0.5 4.1 0.2 10.4 6.6 0.2 2.3 1 2.3 0.3 0.2 8.5 0.3 0.6 0.3 2.5 0 0 0.6 41.5 0.3 0.3 9.8 4.9 1.1 6.3 0.1 0 1.2 0 0.1 1 0 0.1 1.9 2.1 0.1 0.1 0.4 3.3 0 0.6 1 1.9 0.5 1.5 -----

126.2

Page 132: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

110

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

9 74 107 24 29 26 44 38 8 98 187 9

197

183 9

114 27 70 6 90 270 4 28 8 45 1 1 14 10 16 188 43 1 47 0 1 86 0 4 83 30 2 10 31 156 0 25 67 89 15 55 -----

2679

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 2 3 0 1 0 0 0 0 0 10 1 3 0---

-- 24

5-

-

9 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 9 0 0 14 1 0 0---

-- 30

10-

-

14 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 6 1 1 1 1 4 0 0 3 7 2 0---

-- 31

15-

-

19 0 0 2 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 2 0 0 1 0 0 0 3 0 0 0 0 0 0 0 5 0 0 1 6 12 0 0 6 5 3 0---

-- 50

20-

-

24 0 1 0 0 0 0 1 1 0 0 2 1 1 1 0 1 0 0 0 0 2 0 8 0 0 0 0 2 0 0 0 9 0 1 0 0 0 0 0 2 0 0 0 3 7 0 0 6 3 1 0---

-- 53

25-

-

29 0 0 2 0 0 0 1 0 0 1 3 0 3 2 0 3 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 10 0 0 0 0 1 0 0 3 3 0 1 5 7 0 0 3 8 1 0---

-- 60

30-

-

34 0 2 0 0 0 0 3 1 0 0 8 0 5 1 0 1 0 2 0 3 1 1 0 1 1 0 0 0 0 0 1 7 0 0 0 0 0 0 0 3 2 0 0 0 11 0 0 5 7 0 1---

-- 67

35-

-

39 0 3 0 1 0 0 3 0 0 2 4 1 6 5 1 0 0 1 1 1 4 0 0 1 0 0 0 0 1 1 0 4 0 0 0 0 2 0 0 9 0 0 1 1 5 0 0 3 4 0 0---

-- 65

40-

-

44 0 0 2 4 0 1 2 0 0 4 7 1 10 8 1 2 2 4 1 2 9 1 4 0 2 0 0 1 1 0 2 3 0 5 0 0 2 0 0 7 3 0 1 2 13 0 1 4 4 0 4---

--12

0

45-

-

49 0 12 14 2 6 1 2 2 0 7 11 1 27 20 0 12 4 7 0 4 26 0 2 0 3 0 0 3 0 3 4 2 0 5 0 0 5 0 0 10 3 0 3 0 6 0 1 3 11 2 2---

--22

6

50-

-

54 3 8 13 1 4 4 6 10 2 19 22 0 20 29 1 13 2 14 0 17 37 1 2 1 5 0 0 0 3 3 8 1 0 8 0 1 11 0 0 10 5 0 0 3 25 0 2 3 10 1 9---

--33

7

55-

-

59 1 13 18 5 4 5 6 3 1 16 28 0 27 27 2 19 5 10 2 15 30 0 2 1 6 0 0 2 2 3 14 1 0 5 0 0 12 0 0 8 5 0 0 5 19 0 1 4 10 0 13 -----

350

60-

-

64 2 17 15 5 9 7 8 5 1 11 22 1 28 23 1 17 6 14 0 23 50 0 2 1 1 0 0 1 1 1 30 1 1 6 0 0 9 0 1 5 2 0 1 1 14 0 9 0 7 2 7---

--36

8

65-

-

69 1 5 10 3 2 3 5 3 2 19 31 1 22 24 1 11 1 4 1 5 40 0 2 0 4 1 0 2 1 3 40 0 0 8 0 0 20 0 0 1 3 0 1 1 10 0 6 1 4 0 6---

--30

8

70-

-

74 2 5 11 1 1 3 2 9 1 10 22 3 21 18 1 19 3 10 1 10 36 0 0 2 10 0 0 0 0 1 42 1 0 4 0 0 11 0 0 4 2 0 0 2 7 0 1 0 4 0 4---

--28

4

75+

0 8 20 1 3 2 4 3 1 9 27 0 27 25 1 14 4 3 0 9 35 0 2 0 10 0 1 1 1 1 47 1 0 3 0 0 13 0 1 2 1 0 0 1 7 0 4 2 3 0 9---

--30

6

% of

Total 0.3

0%2.8

0%4.0

0%0.9

0%1.1

0%1.0

0%1.6

0%1.4

0%0.3

0%3.7

0%7.0

0%0.3

0%7.4

0%6.8

0%0.3

0%4.3

0%1.0

0%2.6

0%0.2

0%3.4

0%10

.10%

0.10%

1.00%

0.30%

1.70%

0.00%

0.00%

0.50%

0.40%

0.60%

7.00%

1.60%

0.00%

1.80%

0.00%

0.00%

3.20%

0.00%

0.10%

3.10%

1.10%

0.10%

0.40%

1.20%

5.80%

0.00%

0.90%

2.50%

3.30%

0.60%

2.10% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

31:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

IN

DIA

N M

AL

ES,

MA

LA

YSI

A, 2

007-

2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 133: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

111

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages 15 10

028

7 18 10 11 25 35 514

513

7 618

217

0 12 58 37 57 10 20 127 10 26 5 59 2 0 16

1705 10 14 32

720

4 60 277 4 1 27 1 0 24 0 3 78 119 1 8 25 105 1 24 45 72 20 58 -----

4798

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 1 0 0 7 1 6 1---

-- 20

5-

-

9 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 5 0 0 0 0 0 0 0 9 2 3 0---

-- 25

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 4 0 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0 0 0 0 0 4 1 0 0 0 5 0 0 4 1 0 0---

-- 24

15-

-

19 0 0 0 0 0 0 1 0 0 0 2 0 1 0 0 0 0 0 0 0 0 0 3 0 1 0 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 2 2 0 0 2 3 0 0 1 2 2 1---

-- 28

20-

-

24 0 0 0 0 0 0 1 0 0 0 2 0 2 2 0 0 0 0 1 0 0 0 0 0 0 0 0 0 3 0 0 3 0 0 9 0 0 0 0 0 0 0 0 2 9 0 0 4 3 0 0 0 0 0 1---

-- 42

25-

-

29 0 1 0 2 0 0 0 2 0 0 4 0 3 0 1 0 0 1 0 0 0 0 1 0 0 0 0 1 20 0 0 4 1 0 4 0 0 1 0 0 0 0 0 7 9 0 0 8 2 0 0 6 4 0 1---

-- 83

30-

-

34 0 1 0 0 0 0 0 0 0 0 3 1 5 5 0 2 0 1 0 1 2 1 1 0 1 0 0 1 57 0 0 6 3 1 4 0 0 2 0 0 0 0 0 4 8 0 0 1 3 0 0 3 6 1 3---

--12

7

35-

-

39 1 1 3 1 0 0 0 0 0 3 6 0 3 8 0 1 1 2 2 0 2 1 0 0 2 0 0 1 87 1 2 15 12 0 11 1 0 0 0 0 0 0 0 3 15 0 0 2 5 0 0 4 6 2 2---

--20

6

40-

-

44 0 7 7 3 1 0 2 1 0 9 8 0 12 11 0 4 2 1 0 1 8 2 2 0 4 0 0 119

2 0 0 21 14 7 29 0 0 1 1 0 1 0 0 7 9 0 1 2 4 0 0 0 4 2 6---

--38

7

45-

-

49 1 6 10 3 1 0 1 6 1 8 13 2 12 9 1 3 1 4 0 1 11 0 1 1 2 0 0 226

4 1 2 40 22 5 49 1 0 5 0 0 1 0 0 6 14 1 1 0 7 0 3 1 7 1 1---

--53

2

50-

-

54 2 16 31 4 2 0 5 3 0 21 19 2 18 26 0 4 2 13 0 3 18 0 2 0 5 0 0 031

4 1 2 58 32 4 52 1 0 6 0 0 3 0 0 13 17 0 4 2 12 0 2 4 13 2 5---

--74

3

55-

-

59 1 9 37 1 2 2 6 7 2 21 19 0 25 25 4 7 9 10 2 5 21 4 2 1 9 1 0 028

1 3 4 45 33 11 33 0 1 3 0 0 2 0 2 8 10 0 1 1 14 0 5 4 10 0 8---

--71

1

60-

-

64 0 22 46 3 2 1 2 5 1 26 15 0 31 24 2 8 5 8 0 2 16 0 0 1 6 0 0 217

6 1 0 44 38 14 33 1 0 3 0 0 3 0 0 7 10 0 1 3 16 0 6 1 8 0 6---

--59

9

65-

-

69 0 6 41 0 2 4 2 5 1 17 14 1 16 13 1 9 6 4 1 0 17 0 4 1 7 0 0 311

5 1 2 30 21 4 25 0 0 2 0 0 1 0 0 4 8 0 0 0 15 0 5 1 1 0 10 -----

420

70-

-

74 2 22 55 0 0 2 3 5 0 20 14 0 30 25 1 8 5 6 3 5 16 1 3 0 7 1 0 210

2 1 0 31 16 7 7 0 0 0 0 0 6 0 0 1 6 0 0 0 9 0 0 0 5 0 9---

--43

6

75+

8 9 57 0 0 2 1 1 0 20 18 0 23 22 2 12 6 7 0 2 16 1 2 1 15 0 0 2 93 1 2 30 12 7 14 0 0 2 0 0 7 0 1 1 1 0 0 0 6 1 3 0 2 1 4---

--41

5

% of

Total

0.30%

2.10%

6.00%

0.40%

0.20%

0.20%

0.50%

0.70%

0.10%

3.00%

2.90%

0.10%

3.80%

3.50%

0.30%

1.20%

0.80%

1.20%

0.20%

0.40%

2.60%

0.20%

0.50%

0.10%

1.20%

0.00%

0.00%

0.30%

35.50

%0.2

0%0.3

0%6.8

0%4.3

0%1.3

0%5.8

0%0.1

0%0.0

0%0.6

0%0.0

0%0.0

0%0.5

0%0.0

0%0.1

0%1.6

0%2.5

0%0.0

0%0.2

0%0.5

0%2.2

0%0.0

0%0.5

0%0.9

0%1.5

0%0.4

0%1.2

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

32:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

IN

DIA

N F

EM

AL

ES,

MA

LA

YSI

A, 2

007-

2011

Page 134: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

112

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

9 74 107 24 29 26 44 38 8 98 187 9

197

183 9

114 27 70 6 90 270 4 28 8 45 1 1 14 10 16 188 43 1 47 0 1 86 0 4 83 30 2 10 31 156 0 25 67 89 15 55 -----

2679

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0.5 0.8 0 0.3 0 0 0 0 0 2.6 0.3 0.8 0---

-- 6

5-

-

9 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.1 0 0 0 0 2.1 0 0 3.2 0.2 0 0---

-- 7

10-

-

14 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.2 0 0.2 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 1.3 0.2 0.2 0.2 0.2 0.9 0 0 0.7 1.6 0.4 0---

-- 7

15-

-

19 0 0 0.4 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0.4 0 0 0.2 0 0 0 0.7 0 0 0 0 0 0 0 1.1 0 0 0.2 1.3 2.6 0 0 1.3 1.1 0.7 0---

-- 11

20-

-

24 0 0.2 0 0 0 0 0.2 0.2 0 0 0.4 0.2 0.2 0.2 0 0.2 0 0 0 0 0.4 0 1.7 0 0 0 0 0.4 0 0 0 1.9 0 0.2 0 0 0 0 0 0.4 0 0 0 0.6 1.5 0 0 1.3 0.6 0.2 0---

-- 11

25-

-

29 0 0 0.5 0 0 0 0.2 0 0 0.2 0.7 0 0.7 0.5 0 0.7 0 0.2 0 0 0 0.2 0 0.2 0 0 0 0 0 0 0 2.3 0 0 0 0 0.2 0 0 0.7 0.7 0 0.2 1.1 1.6 0 0 0.7 1.8 0.2 0---

-- 14

30-

-

34 0 0.5 0 0 0 0 0.8 0.3 0 0 2.2 0 1.3 0.3 0 0.3 0 0.5 0 0.8 0.3 0.3 0 0.3 0.3 0 0 0 0 0 0.3 1.9 0 0 0 0 0 0 0 0.8 0.5 0 0 0 3 0 0 1.3 1.9 0 0.3 ----- 18

35-

-

39 0 0.9 0 0.3 0 0 0.9 0 0 0.6 1.2 0.3 1.8 1.5 0.3 0 0 0.3 0.3 0.3 1.2 0 0 0.3 0 0 0 0 0.3 0.3 0 1.2 0 0 0 0 0.6 0 0 2.7 0 0 0.3 0.3 1.5 0 0 0.9 1.2 0 0---

-- 19

40-

-

44 0 0 0.6 1.3 0 0.3 0.6 0 0 1.3 2.2 0.3 3.1 2.5 0.3 0.6 0.6 1.3 0.3 0.6 2.8 0.3 1.3 0 0.6 0 0 0.3 0.3 0 0.6 0.9 0 1.6 0 0 0.6 0 0 2.2 0.9 0 0.3 0.6 4.1 0 0.3 1.3 1.3 0 1.3 ----- 38

45-

-

49 0 3.8 4.4 0.6 1.9 0.3 0.6 0.6 0 2.2 3.5 0.3 8.5 6.3 0 3.8 1.3 2.2 0 1.3 8.2 0 0.6 0 0.9 0 0 0.9 0 0.9 1.3 0.6 0 1.6 0 0 1.6 0 0 3.2 0.9 0 0.9 0 1.9 0 0.3 0.9 3.5 0.6 0.6 ----- 71

50-

-

54 1.1 3 4.9 0.4 1.5 1.5 2.3 3.8 0.8 7.1 8.3 0 7.5 10.9 0.4 4.9 0.8 5.3 0 6.4 13.9 0.4 0.8 0.4 1.9 0 0 0 1.1 1.1 3 0.4 0 3 0 0.4 4.1 0 0 3.8 1.9 0 0 1.1 9.4 0 0.8 1.1 3.8 0.4 3.4 -----

127

55-

-

59 0.5 6.5 9 2.5 2 2.5 3 1.5 0.5 814

.1 013

.613

.6 1 9.5 2.5 5 1 7.5 15.1 0 1 0.5 3 0 0 1 1 1.5 7 0.5 0 2.5 0 0 6 0 0 4 2.5 0 0 2.5 9.5 0 0.5 2 5 0 6.5 -----

176

60-

-

64 1.5 12.4

10.9 3.6 6.5 5.1 5.8 3.6 0.7 8 16 0.7 20.4

16.7 0.7 12.4 4.4 10.2 0

16.7

36.4 0 1.5 0.7 0.7 0 0 0.7 0.7 0.7 21.8 0.7 0.7 4.4 0 0 6.5 0 0.7 3.6 1.5 0 0.7 0.7 10.2 0 6.5 0 5.1 1.5 5.1 -----

268

65-

-

69 1.3 6.7 13.4 4 2.7 4 6.7 4 2.7 25.5

41.6 1.3 29.5

32.2 1.3 14.8 1.3 5.4 1.3 6.7 53.7 0 2.7 0 5.4 1.3 0 2.7 1.3 4

53.7 0 0

10.7 0 0

26.8 0 0 1.3 4 0 1.3 1.3 13.4 0 8.1 1.3 5.4 0 8.1 -----

413

70-

-

74 3.5 8.9 19.5 1.8 1.8 5.3 3.5 15.9 1.8 17.7

38.9 5.3 37.2

31.9 1.8 33.6 5.3 17.7 1.8 17.7

63.7 0 0 3.5 17.7 0 0 0 0 1.8 74.3 1.8 0 7.1 0 0

19.5 0 0 7.1 3.5 0 0 3.5 12.4 0 1.8 0 7.1 0 7.1 -----

503

75+

013

.132

.8 1.6 4.9 3.3 6.6 4.9 1.6 14.8

44.3 0

44.3 41 1.6 23 6.6 4.9 0

14.8

57.4 0 3.3 0

16.4 0 1.6 1.6 1.6 1.6 77.1 1.6 0 4.9 0 0

21.3 0 1.6 3.3 1.6 0 0 1.6 11.5 0 6.6 3.3 4.9 0

14.8 -----

502

Crud

eRa

te 0.2 1.5 2.2 0.5 0.6 0.5 0.9 0.8 0.2 2 3.9 0.2 4.1 3.8 0.2 2.4 0.6 1.5 0.1 1.9 5.6 0.1 0.6 0.2 0.9 0 0 0.3 0.2 0.3 3.9 0.9 0 1 0 0 1.8 0 0.1 1.7 0.6 0 0.2 0.6 3.3 0 0.5 1.4 1.9 0.3 1.2 ----- 56

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

33:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, I

ND

IAN

MA

LE

S, M

AL

AY

SIA

, 200

7-20

11

ASR

Wor

ld 0.2 1.9 2.9 0.6 0.7 0.7 1.1 1 0.2 2.7 5.2 0.2 5.2 4.9 0.2 3.1 0.7 1.8 0.2 2.3 7.6 0.1 0.6 0.2 1.3 0 0 0.3 0.2 0.4 6.1 0.8 0 1.3 0 0 2.5 0 0.1 1.8 0.7 0.1 0.2 0.7 3.5 0 0.8 1.5 2 0.3 1.4 -----

70.4

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 135: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

113

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages 15 10

028

7 18 10 11 25 35 514

513

7 618

217

0 12 58 37 57 10 20 127 10 26 5 59 2 0 16

1705 10 14 32

720

4 60 277 4 1 27 1 0 24 0 3 78 119 1 8 25 105 1 24 45 72 20 58 -----

4798

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.1 0 0 0 0 0.3 0 0 1.9 0.3 1.6 0.3 ----- 5

5-

-

9 0 0 0 0.2 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 1.2 0 0 0 0 0 0 0 2.1 0.5 0.7 0---

-- 6

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0.2 0 0 0 0.9 0 0 0 0 0 0.2 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0 0.9 0.2 0 0 0 1.1 0 0 0.9 0.2 0 0---

-- 5

15-

-

19 0 0 0 0 0 0 0.2 0 0 0 0.5 0 0.2 0 0 0 0 0 0 0 0 0 0.7 0 0.2 0 0 0 0 0 0 0 0 0 1.1 0 0 0 0 0 0 0 0 0.5 0.5 0 0 0.5 0.7 0 0 0.2 0.5 0.5 0.2 ----- 6

20-

-

24 0 0 0 0 0 0 0.2 0 0 0 0.4 0 0.4 0.4 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0.7 0 0 0.7 0 0 2 0 0 0 0 0 0 0 0 0.4 2 0 0 0.9 0.7 0 0 0 0 0 0.2 ----- 9

25-

-

29 0 0.2 0 0.5 0 0 0 0.5 0 0 0.9 0 0.7 0 0.2 0 0 0.2 0 0 0 0 0.2 0 0 0 0 0.2 4.7 0 0 0.9 0.2 0 0.9 0 0 0.2 0 0 0 0 0 1.6 2.1 0 0 1.9 0.5 0 0 1.4 0.9 0 0.2 ----- 20

30-

-

34 0 0.3 0 0 0 0 0 0 0 0 0.8 0.3 1.4 1.4 0 0.6 0 0.3 0 0.3 0.6 0.3 0.3 0 0.3 0 0 0.3 16 0 0 1.7 0.8 0.3 1.1 0 0 0.6 0 0 0 0 0 1.1 2.3 0 0 0.3 0.8 0 0 0.8 1.7 0.3 0.8 ----- 36

35-

-

39 0.3 0.3 0.9 0.3 0 0 0 0 0 0.9 1.8 0 0.9 2.4 0 0.3 0.3 0.6 0.6 0 0.6 0.3 0 0 0.6 0 0 0.3 25.9 0.3 0.6 4.5 3.6 0 3.3 0.3 0 0 0 0 0 0 0 0.9 4.5 0 0 0.6 1.5 0 0 1.2 1.8 0.6 0.6 ----- 61

40-

-

44 0 2.1 2.1 0.9 0.3 0 0.6 0.3 0 2.7 2.4 0 3.6 3.3 0 1.2 0.6 0.3 0 0.3 2.4 0.6 0.6 0 1.2 0 0 0.3 57.7 0 0 6.3 4.2 2.1 8.7 0 0 0.3 0.3 0 0.3 0 0 2.1 2.7 0 0.3 0.6 1.2 0 0 0 1.2 0.6 1.8 -----

116

45-

-

49 0.3 1.9 3.2 1 0.3 0 0.3 1.9 0.3 2.6 4.2 0.6 3.9 2.9 0.3 1 0.3 1.3 0 0.3 3.5 0 0.3 0.3 0.6 0 0 0.6 85 0.3 0.6 12.9 7.1 1.6 15.8 0.3 0 1.6 0 0 0.3 0 0 1.9 4.5 0.3 0.3 0 2.3 0 1 0.3 2.3 0.3 0.3 -----

171

50-

-

54 0.7 5.9 11.4 1.5 0.7 0 1.8 1.1 0 7.8 7 0.7 6.6 9.6 0 1.5 0.7 4.8 0 1.1 6.6 0 0.7 0 1.8 0 0 0

115.9 0.4 0.7 21

.411

.8 1.5 19.2 0.4 0 2.2 0 0 1.1 0 0 4.8 6.3 0 1.5 0.7 4.4 0 0.7 1.5 4.8 0.7 1.8 -----

274

55-

-

59 0.5 4.4 18.1 0.5 1 1 2.9 3.4 1

10.3 9.3 0

12.2

12.2 2 3.4 4.4 4.9 1 2.4 10.3 2 1 0.5 4.4 0.5 0 0

137.4 1.5 2 22 16

.1 5.4 16.1 0 0.5 1.5 0 0 1 0 1 3.9 4.9 0 0.5 0.5 6.8 0 2.4 2 4.9 0 3.9 -----

348

60-

-

64 014

.931

.1 2 1.4 0.7 1.4 3.4 0.7 17.6

10.1 0

20.9

16.2 1.4 5.4 3.4 5.4 0 1.4 10.8 0 0 0.7 4.1 0 0 1.4

118.9 0.7 0

29.7

25.7 9.5 22.3 0.7 0 2 0 0 2 0 0 4.7 6.8 0 0.7 2

10.8 0 4.1 0.7 5.4 0 4.1 -----

405

65-

-

69 0 7.2 49.4 0 2.4 4.8 2.4 6 1.2 20.5

16.9 1.2 19.3

15.7 1.2 10.8 7.2 4.8 1.2 0

20.5 0 4.8 1.2 8.4 0 0 3.6

138.6 1.2 2.4 36.1

25.3 4.8 30.1 0 0 2.4 0 0 1.2 0 0 4.8 9.6 0 0 0

18.1 0 6 1.2 1.2 0 12 -----

506

70-

-

74 2.9 32.1

80.3 0 0 2.9 4.4 7.3 0

29.2

20.4 0

43.8

36.5 1.5 11.7 7.3 8.8 4.4 7.3 23.4 1.5 4.4 0

10.2 1.5 0 2.9

148.9 1.5 0

45.3

23.4

10.2

10.2 0 0 0 0 0 8.8 0 0 1.5 8.8 0 0 0

13.1 0 0 0 7.3 0

13.1 -----

637

75+ 10

.311

.673

.6 0 0 2.6 1.3 1.3 025

.823

.2 029

.728

.4 2.6 15.5 7.7 9 0 2.6 20.6 1.3 2.6 1.3 19.4 0 0 2.6 120 1.3 2.6 38

.715

.5 918

.1 0 0 2.6 0 0 9 0 1.3 1.3 1.3 0 0 0 7.7 1.3 3.9 0 2.6 1.3 5.2 -----

536

Crud

eRa

te 0.3 2.1 6.1 0.4 0.2 0.2 0.5 0.7 0.1 3.1 2.9 0.1 3.8 3.6 0.3 1.2 0.8 1.2 0.2 0.4 2.7 0.2 0.5 0.1 1.2 0 0 0.3 36 0.2 0.3 6.9 4.3 1.3 5.8 0.1 0 0.6 0 0 0.5 0 0.1 1.6 2.5 0 0.2 0.5 2.2 0 0.5 0.9 1.5 0.4 1.2 -----

101.2

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

34:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, I

ND

IAN

FE

MA

LE

S, M

AL

AY

SIA

, 200

7-20

11

ASR

Wor

ld 0.4 2.5 7.5 0.4 0.2 0.3 0.6 0.9 0.1 3.6 3.2 0.1 4.4 4 0.3 1.5 0.9 1.3 0.2 0.5 3.1 0.2 0.6 0.1 1.5 0 0 0.4 37.1 0.2 0.3 7.6 4.8 1.4 6.1 0.1 0 0.6 0 0 0.6 0 0.1 1.7 2.5 0 0.2 0.5 2.5 0 0.6 1 1.5 0.5 1.4 -----

110.1

Page 136: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

114

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

3 51 44 29 10 367

8 25 4 76 397 13 305

248 7

329 44 76 20 52 661 29 55 44 148 3 6 54 13 34 192 54 1 40 0 0

100 0 16 113 65 11 7 44 393 0 49 127

152 23 86 -----

4934

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 3 0 1 0 13 0 4 0 0 0 0 9 10 0 4 3 1 10 0 0 40 10 3 3---

--11

7

5-

-

9 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 11 0 1 0 4 18 0 0 28 8 1 2---

-- 79

10-

-

14 0 0 0 0 0 0 8 0 0 0 0 0 1 0 0 1 0 0 1 0 0 0 12 0 0 0 0 3 0 0 0 1 0 0 0 0 0 0 1 8 3 0 3 1 8 0 0 11 8 1 1---

-- 72

15-

-

19 0 1 0 2 0 0 19 0 0 0 0 0 0 1 0 0 0 0 1 0 1 0 10 1 0 0 0 4 0 0 1 4 0 0 0 0 0 0 0 8 1 0 1 3 21 0 0 9 10 2 0---

--10

0

20-

-

24 0 1 0 0 0 0 20 0 0 0 1 0 3 4 0 0 1 1 0 0 2 1 10 0 1 0 1 3 0 0 0 8 0 0 0 0 0 0 0 4 0 0 0 4 9 0 0 3 18 2 2---

-- 99

25-

-

29 0 2 3 3 0 0 22 0 0 0 3 0 15 3 0 4 1 0 1 0 6 0 2 1 0 0 0 2 0 0 0 7 0 0 0 0 0 0 0 7 1 1 0 3 16 0 0 5 7 2 1---

--11

8

30-

-

34 0 1 1 3 0 0 30 0 0 2 3 1 13 5 1 8 0 2 1 0 7 0 3 1 5 0 0 3 0 3 0 7 0 0 0 0 0 0 1 4 0 0 0 4 19 0 2 2 8 0 1---

--14

1

35-

-

39 0 3 3 2 0 0 59 0 0 0 16 0 10 13 0 14 2 1 2 1 22 6 0 2 7 0 0 6 1 2 0 5 0 1 0 0 3 0 0 5 4 1 0 1 16 0 0 5 14 4 2---

--23

3

40-

-

44 2 4 1 3 0 0 82 1 0 3 21 3 27 19 0 19 1 0 2 1 26 2 4 2 4 0 1 4 1 8 0 2 0 2 0 0 4 0 0 14 7 1 0 3 23 0 2 1 8 0 5---

--31

3

45-

-

49 0 4 2 4 2 011

1 1 1 6 30 1 28 22 1 19 4 9 3 1 57 2 3 2 10 1 0 1 3 6 1 1 1 5 0 0 8 0 3 9 4 0 0 3 29 0 5 1 9 0 5---

--41

8

50-

-

54 0 4 3 4 2 0 92 0 0 6 39 3 34 21 1 41 3 6 2 5 76 4 1 7 13 1 1 7 1 3 10 2 0 9 0 0 12 0 2 9 9 0 0 2 45 0 9 6 9 3 9---

--51

6

55-

-

59 0 4 5 3 1 0 82 1 1 12 45 1 33 26 0 56 8 12 0 7 81 1 2 5 16 0 1 4 3 3 19 1 0 5 0 0 14 0 0 7 8 0 0 4 35 0 10 5 13 3 14 -----

551

60-

-

64 0 2 7 2 2 1 57 3 1 11 58 2 33 29 0 62 5 7 2 12 115 3 2 7 15 0 0 4 1 3 33 0 0 6 0 0 9 0 0 4 9 2 0 4 49 0 5 2 10 0 11 -----

590

65-

-

69 0 12 5 1 3 0 46 7 0 10 62 2 38 36 1 44 8 13 5 11 122 6 3 6 22 1 1 7 2 3 34 0 0 1 0 0 16 0 0 7 10 0 0 2 35 0 8 2 7 0 10 -----

609

70-

-

74 0 7 6 1 0 1 26 6 0 12 53 0 28 26 2 33 8 10 0 9 66 2 1 4 24 0 0 0 1 2 40 3 0 4 0 0 20 0 0 5 5 1 0 1 33 0 3 4 8 1 10 -----

466

75+

1 6 8 1 0 1 22 5 1 14 66 0 42 43 1 26 3 15 0 5 80 2 0 6 31 0 1 2 0 0 54 0 0 3 0 0 13 0 0 1 4 0 0 4 27 0 5 3 5 1 10 -----

512

% of

Total 0.1

0%1.0

0%0.9

0%0.6

0%0.2

0%0.1

0%13

.70%

0.50%

0.10%

1.50%

8.00%

0.30%

6.20%

5.00%

0.10%

6.70%

0.90%

1.50%

0.40%

1.10%

13.40

%0.6

0%1.1

0%0.9

0%3.0

0%0.1

0%0.1

0%1.1

0%0.3

0%0.7

0%3.9

0%1.1

0%0.0

0%0.8

0%0.0

0%0.0

0%2.0

0%0.0

0%0.3

0%2.3

0%1.3

0%0.2

0%0.1

0%0.9

0%8.0

0%0.0

0%1.0

0%2.6

0%3.1

0%0.5

0%1.7

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

35:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

OT

HE

RS

MA

LE

S, M

AL

AY

SIA

, 200

7-20

11

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 137: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

115

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages 16 39 60 36 10 326

8 13 2 53 273 14 230

186 13 128 46 58 12 14 393 24 44 26 177 3 0 51 943 15 20 791

160 57 334 5 17 26 0 0 40 4 17 111

210 9 1 20 272 0 48 87 137 17 80 -----

5613

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 1 0 0 0 6 0 0 0 0 0 0 4 0 0 2 0 0 0 0 13 5 0 3 0 0 2 0 0 33 11 1 3---

-- 87

5-

-

9 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 9 1 0 0 0 6 0 0 18 8 1 1---

-- 51

10-

-

14 0 1 0 2 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 0 3 0 0 0 0 0 0 8 0 0 1 0 0 0 0 0 10 2 0 0 0 10 0 0 11 3 1 1---

-- 63

15-

-

19 0 1 0 0 0 0 6 0 0 0 2 0 1 0 0 0 0 0 0 0 1 0 10 0 1 0 0 4 0 0 0 0 0 0 11 0 1 2 0 0 0 0 2 6 7 0 0 3 12 0 0 5 7 2 3---

-- 87

20-

-

24 0 0 1 4 0 0 14 1 0 0 3 2 5 2 1 1 0 1 0 0 2 1 5 0 2 0 0 0 9 0 0 3 0 2 22 0 3 2 0 0 1 0 0 6 9 0 0 6 10 0 0 0 13 1 4---

--13

6

25-

-

29 0 3 2 2 0 0 11 0 0 0 4 0 8 8 0 1 0 1 0 0 7 0 2 1 3 0 0 3 24 0 1 19 4 2 15 1 4 2 0 0 0 0 0 5 12 0 0 4 9 0 0 2 4 0 2---

--16

6

30-

-

34 0 1 1 3 0 0 18 0 0 0 6 0 9 3 0 6 2 1 0 0 5 1 2 0 2 0 0 3 42 1 0 40 9 1 18 0 2 2 0 0 3 0 1 6 18 1 0 1 12 0 0 0 7 1 1---

--22

9

35-

-

39 0 1 3 3 0 0 29 0 0 1 9 2 9 8 0 7 0 0 0 0 10 1 2 1 3 0 0 4 94 1 210

3 14 3 22 1 5 2 0 0 0 0 0 4 17 2 0 1 12 0 4 2 9 0 6---

--39

7

40-

-

44 1 5 4 3 0 0 31 0 1 3 11 0 12 11 1 5 1 7 3 0 15 2 3 3 5 0 0 216

9 0 313

4 20 14 39 1 1 0 0 0 1 0 0 9 22 0 0 0 18 0 3 2 16 1 5---

--58

7

45-

-

49 0 2 1 3 1 1 41 1 0 3 20 0 29 20 1 11 2 7 0 2 32 1 3 0 14 0 0 720

2 3 214

2 26 13 52 0 1 4 0 0 4 0 1 11 26 1 0 1 26 0 4 2 7 1 11 -----

742

50-

-

54 2 7 3 3 1 0 41 1 0 4 33 1 33 21 4 10 3 6 2 1 37 4 1 3 15 0 0 214

8 0 012

4 30 6 48 2 0 1 0 0 6 1 0 13 24 0 0 0 37 0 8 3 13 2 9---

--71

3

55-

-

59 2 3 7 3 3 0 16 2 1 11 37 2 30 32 3 18 3 10 2 1 52 4 1 3 16 1 0 410

5 2 6 76 25 7 28 0 0 3 0 0 4 0 0 8 23 0 1 0 31 0 5 0 17 2 10 -----

620

60-

-

64 3 2 4 4 1 2 20 2 0 9 31 2 24 19 0 20 6 7 0 3 65 1 3 3 12 1 0 2 64 2 1 53 15 3 23 0 0 2 0 0 5 1 0 5 11 1 0 1 32 0 13 0 9 0 8---

--49

5

65-

-

69 3 3 14 3 1 0 19 1 0 6 41 2 25 23 1 13 14 5 0 3 76 2 1 4 29 0 0 3 40 2 1 44 5 1 19 0 0 2 0 0 9 0 0 5 21 0 0 1 22 0 6 4 5 2 6---

--48

7

70-

-

74 3 7 11 2 1 0 13 5 0 8 36 2 21 15 1 19 5 7 3 0 56 4 0 3 29 1 0 3 28 1 2 29 5 4 9 0 0 1 0 0 3 0 0 6 9 1 0 1 14 0 3 1 3 1 5---

--38

1

75+

2 3 9 0 2 0 6 0 0 8 40 1 24 24 1 14 10 6 2 4 35 3 2 4 46 0 0 3 18 3 2 24 7 1 14 0 0 0 0 0 4 2 0 3 8 0 0 1 19 0 2 4 5 1 5---

--37

2

% of

Total

0.30%

0.70%

1.10%

0.60%

0.20%

0.10%

4.80%

0.20%

0.00%

0.90%

4.90%

0.20%

4.10%

3.30%

0.20%

2.30%

0.80%

1.00%

0.20%

0.20%

7.00%

0.40%

0.80%

0.50%

3.20%

0.10%

0.00%

0.90%

16.80

%0.3

0%0.4

0%14

.10%

2.90%

1.00%

6.00%

0.10%

0.30%

0.50%

0.00%

0.00%

0.70%

0.10%

0.30%

2.00%

3.70%

0.20%

0.00%

0.40%

4.80%

0.00%

0.90%

1.50%

2.40%

0.30%

1.40% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

36:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

OT

HE

RS

FE

MA

LE

S, M

AL

AY

SIA

, 200

7-20

11

Page 138: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

116

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

3 51 44 29 10 367

8 25 4 76 397 13 305

248 7

329 44 76 20 52 661 29 55 44 148 3 6 54 13 34 192 54 1 40 0 0

100 0 16 113 65 11 7 44 393 0 49 127

152 23 86 -----

4934

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0.1 0 1.2 0 0.4 0 0 0 0 0.8 0.9 0 0.4 0.3 0.1 0.9 0 0 3.8 0.9 0.3 0.3 ----- 11

5-

-

9 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.1 0 0 1 0 0.1 0 0.4 1.7 0 0 2.7 0.8 0.1 0.2 ----- 8

10-

-

14 0 0 0 0 0 0 0.8 0 0 0 0 0 0.1 0 0 0.1 0 0 0.1 0 0 0 1.2 0 0 0 0 0.3 0 0 0 0.1 0 0 0 0 0 0 0.1 0.8 0.3 0 0.3 0.1 0.8 0 0 1.1 0.8 0.1 0.1 ----- 7

15-

-

19 0 0.1 0 0.2 0 0 1.9 0 0 0 0 0 0 0.1 0 0 0 0 0.1 0 0.1 0 1 0.1 0 0 0 0.4 0 0 0.1 0.4 0 0 0 0 0 0 0 0.8 0.1 0 0.1 0.3 2.1 0 0 0.9 1 0.2 0---

-- 10

20-

-

24 0 0.1 0 0 0 0 2.3 0 0 0 0.1 0 0.3 0.5 0 0 0.1 0.1 0 0 0.2 0.1 1.2 0 0.1 0 0.1 0.3 0 0 0 0.9 0 0 0 0 0 0 0 0.5 0 0 0 0.5 1 0 0 0.3 2.1 0.2 0.2 ----- 12

25-

-

29 0 0.3 0.4 0.4 0 0 2.9 0 0 0 0.4 0 2 0.4 0 0.5 0.1 0 0.1 0 0.8 0 0.3 0.1 0 0 0 0.3 0 0 0 0.9 0 0 0 0 0 0 0 0.9 0.1 0.1 0 0.4 2.1 0 0 0.7 0.9 0.3 0.1 ----- 15

30-

-

34 0 0.2 0.2 0.5 0 0 5.2 0 0 0.3 0.5 0.2 2.2 0.9 0.2 1.4 0 0.3 0.2 0 1.2 0 0.5 0.2 0.9 0 0 0.5 0 0.5 0 1.2 0 0 0 0 0 0 0.2 0.7 0 0 0 0.7 3.3 0 0.3 0.3 1.4 0 0.2 ----- 24

35-

-

39 0 0.5 0.5 0.4 0 010

.8 0 0 0 2.9 0 1.8 2.4 0 2.6 0.4 0.2 0.4 0.2 4 1.1 0 0.4 1.3 0 0 1.1 0.2 0.4 0 0.9 0 0.2 0 0 0.5 0 0 0.9 0.7 0.2 0 0.2 2.9 0 0 0.9 2.6 0.7 0.4 ----- 43

40-

-

44 0.4 0.8 0.2 0.6 0 016

.1 0.2 0 0.6 4.1 0.6 5.3 3.7 0 3.7 0.2 0 0.4 0.2 5.1 0.4 0.8 0.4 0.8 0 0.2 0.8 0.2 1.6 0 0.4 0 0.4 0 0 0.8 0 0 2.8 1.4 0.2 0 0.6 4.5 0 0.4 0.2 1.6 0 1---

-- 62

45-

-

49 0 0.9 0.4 0.9 0.4 024

.4 0.2 0.2 1.3 6.6 0.2 6.2 4.8 0.2 4.2 0.9 2 0.7 0.2 12.5 0.4 0.7 0.4 2.2 0.2 0 0.2 0.7 1.3 0.2 0.2 0.2 1.1 0 0 1.8 0 0.7 2 0.9 0 0 0.7 6.4 0 1.1 0.2 2 0 1.1 ----- 92

50-

-

54 0 1.1 0.8 1.1 0.5 025

.2 0 0 1.6 10.7 0.8 9.3 5.8 0.3 11.2 0.8 1.6 0.5 1.4 20.8 1.1 0.3 1.9 3.6 0.3 0.3 1.9 0.3 0.8 2.7 0.5 0 2.5 0 0 3.3 0 0.5 2.5 2.5 0 0 0.5 12.3 0 2.5 1.6 2.5 0.8 2.5 -----

141

55-

-

59 0 1.6 2 1.2 0.4 032

.4 0.4 0.4 4.7 17.8 0.4 13 10.3 0

22.1 3.2 4.7 0 2.8 32 0.4 0.8 2 6.3 0 0.4 1.6 1.2 1.2 7.5 0.4 0 2 0 0 5.5 0 0 2.8 3.2 0 0 1.6 13.8 0 3.9 2 5.1 1.2 5.5 -----

217

60-

-

64 0 1.1 3.9 1.1 1.1 0.6 31.9 1.7 0.6 6.2 32.5 1.1 18.5

16.2 0

34.7 2.8 3.9 1.1 6.7 64.4 1.7 1.1 3.9 8.4 0 0 2.2 0.6 1.7 18.5 0 0 3.4 0 0 5 0 0 2.2 5 1.1 0 2.2 27.5 0 2.8 1.1 5.6 0 6.2 -----

331

65-

-

69 0 8.8 3.7 0.7 2.2 033

.7 5.1 0 7.3 45.4 1.5 27.8

26.4 0.7 32.2 5.9 9.5 3.7 8.1 89.4 4.4 2.2 4.4 16.1 0.7 0.7 5.1 1.5 2.2 24.9 0 0 0.7 0 0

11.7 0 0 5.1 7.3 0 0 1.5 25.6 0 5.9 1.5 5.1 0 7.3 -----

446

70-

-

74 0 7.7 6.6 1.1 0 1.1 28.7 6.6 0

13.3

58.6 0

30.9

28.7 2.2 36.5 8.8 11.1 0 9.9 72.9 2.2 1.1 4.4 26.5 0 0 0 1.1 2.2 44.2 3.3 0 4.4 0 0

22.1 0 0 5.5 5.5 1.1 0 1.1 36.5 0 3.3 4.4 8.8 1.1 11.1 -----

515

75+ 0.9 5.2 6.9 0.9 0 0.9 19 4.3 0.9 12

.156

.9 036

.237

.1 0.9 22.4 2.6 12.9 0 4.3 69 1.7 0 5.2 26.7 0 0.9 1.7 0 0

46.6 0 0 2.6 0 0

11.2 0 0 0.9 3.4 0 0 3.4 23.3 0 4.3 2.6 4.3 0.9 8.6 -----

441

Crud

eRa

te 0 0.6 0.5 0.3 0.1 0 7.6 0.3 0 0.8 4.4 0.1 3.4 2.8 0.1 3.7 0.5 0.8 0.2 0.6 7.4 0.3 0.6 0.5 1.6 0 0.1 0.6 0.1 0.4 2.1 0.6 0 0.4 0 0 1.1 0 0.2 1.3 0.7 0.1 0.1 0.5 4.4 0 0.5 1.4 1.7 0.3 1---

-- 55

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

37:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, O

TH

ER

S M

AL

ES,

MA

LA

YSI

A, 2

007-

2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

ASR

Wor

ld 0 0.9 0.8 0.4 0.2 0.1 9.9 0.5 0.1 1.4 7.1 0.2 5 4.2 0.1 5.8 0.8 1.4 0.3 111

.9 0.5 0.6 0.8 2.6 0 0.1 0.7 0.2 0.5 3.8 0.6 0 0.6 0 0 1.8 0 0.2 1.5 1.1 0.2 0.1 0.6 6.1 0 0.8 1.5 2 0.3 1.5 -----

80.5

Page 139: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

117

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages 16 39 60 36 10 326

8 13 2 53 273 14 230

186 13 128 46 58 12 14 393 24 44 26 177 3 0 51 943 15 20 791

160 57 334 5 17 26 0 0 40 4 17 111

210 9 1 20 272 0 48 87 137 17 80 -----

5613

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0.1 0 0 0 0.6 0 0 0 0 0 0 0.4 0 0 0.2 0 0 0 0 1.3 0.5 0 0.3 0 0 0.2 0 0 3.3 1.1 0.1 0.3 ----- 9

5-

-

9 0 0 0 0.1 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0.2 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0.9 0.1 0 0 0 0.6 0 0 1.8 0.8 0.1 0.1 ----- 5

10-

-

14 0 0.1 0 0.2 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0.3 0 0 0 0 0 0 0.8 0 0 0.1 0 0 0 0 0 1 0.2 0 0 0 1 0 0 1.1 0.3 0.1 0.1 ----- 6

15-

-

19 0 0.1 0 0 0 0 0.6 0 0 0 0.2 0 0.1 0 0 0 0 0 0 0 0.1 0 1 0 0.1 0 0 0.4 0 0 0 0 0 0 1.1 0 0.1 0.2 0 0 0 0 0.2 0.6 0.7 0 0 0.3 1.2 0 0 0.5 0.7 0.2 0.3 ----- 9

20-

-

24 0 0 0.1 0.5 0 0 1.6 0.1 0 0 0.3 0.2 0.6 0.2 0.1 0.1 0 0.1 0 0 0.2 0.1 0.6 0 0.2 0 0 0 1 0 0 0.3 0 0.2 2.5 0 0.3 0.2 0 0 0.1 0 0 0.7 1 0 0 0.7 1.1 0 0 0 1.5 0.1 0.5 ----- 15

25-

-

29 0 0.4 0.3 0.3 0 0 1.5 0 0 0 0.5 0 1.1 1.1 0 0.1 0 0.1 0 0 0.9 0 0.3 0.1 0.4 0 0 0.4 3.2 0 0.1 2.5 0.5 0.3 2 0.1 0.5 0.3 0 0 0 0 0 0.7 1.6 0 0 0.5 1.2 0 0 0.3 0.5 0 0.3 ----- 22

30-

-

34 0 0.2 0.2 0.5 0 0 3.1 0 0 0 1 0 1.6 0.5 0 1 0.3 0.2 0 0 0.9 0.2 0.3 0 0.3 0 0 0.5 7.3 0.2 0 6.9 1.6 0.2 3.1 0 0.3 0.3 0 0 0.5 0 0.2 1 3.1 0.2 0 0.2 2.1 0 0 0 1.2 0.2 0.2 ----- 40

35-

-

39 0 0.2 0.6 0.6 0 0 5.3 0 0 0.2 1.7 0.4 1.7 1.5 0 1.3 0 0 0 0 1.8 0.2 0.4 0.2 0.6 0 0 0.7 17.3 0.2 0.4 18.9 2.6 0.6 4 0.2 0.9 0.4 0 0 0 0 0 0.7 3.1 0.4 0 0.2 2.2 0 0.7 0.4 1.7 0 1.1 ----- 73

40-

-

44 0.2 1 0.8 0.6 0 0 6.3 0 0.2 0.6 2.2 0 2.4 2.2 0.2 1 0.2 1.4 0.6 0 3.1 0.4 0.6 0.6 1 0 0 0.4 34.4 0 0.6 27.3 4.1 2.9 7.9 0.2 0.2 0 0 0 0.2 0 0 1.8 4.5 0 0 0 3.7 0 0.6 0.4 3.3 0.2 1

-----

120

45-

-

49 0 0.5 0.2 0.7 0.2 0.2 9.8 0.2 0 0.7 4.8 0 7 4.8 0.2 2.6 0.5 1.7 0 0.5 7.7 0.2 0.7 0 3.4 0 0 1.7 48.4 0.7 0.5 34.1 6.2 3.1 12.5 0 0.2 1 0 0 1 0 0.2 2.6 6.2 0.2 0 0.2 6.2 0 1 0.5 1.7 0.2 2.6 -----

178

50-

-

54 0.6 2.2 0.9 0.9 0.3 0 13 0.3 0 1.3 10.4 0.3 10.4 6.6 1.3 3.2 0.9 1.9 0.6 0.3 11.7 1.3 0.3 0.9 4.7 0 0 0.6 46.8 0 0

39.2 9.5 1.9 15.2 0.6 0 0.3 0 0 1.9 0.3 0 4.1 7.6 0 0 0

11.7 0 2.5 0.9 4.1 0.6 2.8 -----

226

55-

-

59 0.9 1.4 3.2 1.4 1.4 0 7.2 0.9 0.5 516

.7 0.9 13.5

14.4 1.4 8.1 1.4 4.5 0.9 0.5 23.5 1.8 0.5 1.4 7.2 0.5 0 1.8 47.4 0.9 2.7 34.3

11.3 3.2 12.6 0 0 1.4 0 0 1.8 0 0 3.6 10.4 0 0.5 0 14 0 2.3 0 7.7 0.9 4.5 -----

280

60-

-

64 1.7 1.1 2.3 2.3 0.6 1.1 11.5 1.1 0 5.2 17.8 1.1 13.8

10.9 0

11.5 3.4 4 0 1.7 37.3 0.6 1.7 1.7 6.9 0.6 0 1.1 36.7 1.1 0.6 30.4 8.6 1.7 13.2 0 0 1.1 0 0 2.9 0.6 0 2.9 6.3 0.6 0 0.6 18.3 0 7.5 0 5.2 0 4.6 -----

284

65-

-

69 2.2 2.2 10.5 2.2 0.7 0

14.2 0.7 0 4.5 30.7 1.5 18.7

17.2 0.7 9.7 10.5 3.7 0 2.2 56.9 1.5 0.7 3

21.7 0 0 2.2 30 1.5 0.7 33 3.7 0.7 14.2 0 0 1.5 0 0 6.7 0 0 3.7 15.7 0 0 0.7 16.5 0 4.5 3 3.7 1.5 4.5 -----

365

70-

-

74 3.2 7.6 11.9 2.2 1.1 0

14.1 5.4 0 8.6 38.9 2.2 22.7

16.2 1.1 20.5 5.4 7.6 3.2 0

60.5 4.3 0 3.2 31.4 1.1 0 3.2 30.3 1.1 2.2 31.4 5.4 4.3 9.7 0 0 1.1 0 0 3.2 0 0 6.5 9.7 1.1 0 1.1 15.1 0 3.2 1.1 3.2 1.1 5.4 -----

412

75+ 1.6 2.4 7.3 0 1.6 0 4.9 0 0 6.5 32

.7 0.8 19.6

19.6 0.8 11.4 8.2 4.9 1.6 3.3 28.6 2.4 1.6 3.3 37.6 0 0 2.4 14.7 2.4 1.6 19.6 5.7 0.8 11.4 0 0 0 0 0 3.3 1.6 0 2.4 6.5 0 0 0.8 15.5 0 1.6 3.3 4.1 0.8 4.1 -----

304

Crud

eRa

te 0.2 0.4 0.7 0.4 0.1 0 3.1 0.1 0 0.6 3.1 0.2 2.6 2.1 0.1 1.5 0.5 0.7 0.1 0.2 4.5 0.3 0.5 0.3 2 0 0 0.6 10.8 0.2 0.2 9.1 1.8 0.7 3.8 0.1 0.2 0.3 0 0 0.5 0 0.2 1.3 2.4 0.1 0 0.2 3.1 0 0.6 1 1.6 0.2 0.9 -----

64.4

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

38:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, O

TH

ER

S F

EM

AL

ES,

MA

LA

YSI

A, 2

007-

2011

ASR

Wor

ld 0.3 0.6 1.1 0.5 0.2 0.1 4 0.3 0 1 4.9 0.2 3.9 3.2 0.2 2.3 0.9 1 0.2 0.3 7.4 0.4 0.5 0.5 3.2 0.1 0 0.7 14.3 0.3 0.3 12 2.5 0.9 4.9 0.1 0.2 0.4 0 0 0.7 0.1 0.2 1.5 3.2 0.1 0 0.2 4.3 0 0.9 1 1.9 0.2 1.3 -----

89.6

Page 140: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

118

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

7 55 71 33 22 24 382 15 4

106

237 24 487

605 16 550 90 159 30 134

759 14 44 16 120 5 3 40 16 14 383 71 5

118 3 2

183 2 10 168 53 2 17 83 492 0 68 138

286 15 80 -----

6261

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 4 8 0 0 0 1 1 0 0 21 4 2 0---

-- 43

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 7 0 0 0 1 2 0 0 12 4 1 0---

-- 30

10-

-

14 0 0 1 0 0 0 2 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9 0 0 2 2 6 0 0 9 9 1 0---

-- 46

15-

-

19 0 1 0 0 0 1 3 0 0 0 0 0 0 0 0 1 0 0 0 0 0 2 7 0 1 0 0 2 0 0 0 7 0 0 0 0 1 0 0 4 1 0 3 10 15 0 0 9 23 2 1---

-- 94

20-

-

24 0 1 0 2 0 0 6 0 0 1 1 1 5 1 0 2 0 0 1 0 2 3 8 2 0 0 1 1 0 0 1 14 0 1 0 0 0 0 0 8 2 0 0 17 20 0 0 15 22 2 1---

--14

1

25-

-

29 0 2 1 1 0 0 11 0 0 0 6 1 6 5 0 5 1 1 0 0 4 1 3 1 1 0 0 1 1 0 0 19 2 0 0 0 0 0 0 6 4 0 0 9 25 0 0 8 19 1 2---

--14

7

30-

-

34 0 3 0 3 0 0 27 0 0 0 7 1 5 16 0 9 0 2 0 0 11 1 0 0 4 0 0 5 1 0 1 12 0 1 0 0 0 0 1 10 1 0 1 6 24 0 2 8 16 0 3---

--18

1

35-

-

39 0 1 0 2 2 0 32 0 0 0 7 1 13 17 1 14 1 3 3 3 24 1 4 0 1 0 1 1 0 3 0 8 0 6 0 0 2 0 2 19 2 0 2 6 20 0 3 8 21 0 5---

--23

9

40-

-

44 0 2 2 1 0 2 54 0 0 5 12 0 30 25 2 31 7 7 3 3 38 0 5 1 6 1 0 2 0 1 2 2 0 8 0 0 8 0 0 11 4 0 2 8 29 0 2 9 32 1 4---

--36

2

45-

-

49 0 9 12 9 3 1 64 0 0 10 16 1 35 50 1 49 8 12 2 7 50 1 1 1 14 0 0 3 2 0 5 1 0 12 1 0 4 0 0 13 7 0 2 6 50 0 7 6 27 0 7---

--50

9

50-

-

54 3 5 13 3 3 3 55 5 0 11 36 0 52 67 1 85 12 22 4 23 83 1 2 2 6 1 0 4 4 2 9 3 0 14 0 0 15 0 1 19 7 0 0 4 56 0 9 5 17 0 14 -----

681

55-

-

59 1 9 11 3 2 2 55 3 1 17 24 7 81 73 4 89 14 31 6 16 102 0 2 2 18 0 0 9 3 1 38 0 0 25 0 0 24 0 0 15 5 0 1 5 67 0 17 12 25 1 12 -----

833

60-

-

64 1 10 6 3 6 4 32 2 2 24 28 4 73 91 1 87 15 30 4 30 129 1 5 1 19 0 0 4 3 2 63 3 1 18 0 1 28 1 0 12 8 1 2 2 71 0 9 7 14 1 9

-----

868

65-

-

69 1 5 7 4 3 2 23 1 0 14 38 2 62 94 3 74 16 22 2 24 122 2 3 2 13 2 0 3 0 1 85 0 1 9 1 0 35 0 1 12 8 0 1 1 50 0 7 4 22 1 7

-----

790

70-

-

74 1 5 6 0 3 4 10 4 0 11 31 5 71 91 2 63 11 16 2 17 107 1 1 3 8 1 0 1 1 1 91 0 1 16 1 1 27 0 0 8 2 1 0 3 32 0 7 3 15 2 10 -----

697

75+

0 2 12 2 0 5 8 0 1 13 31 1 54 75 1 40 5 13 2 11 87 0 0 1 28 0 1 1 1 3 88 2 0 7 0 0 39 1 1 7 2 0 1 2 24 0 5 2 16 0 5---

--60

0

% of

Total 0.1

0%0.9

0%1.1

0%0.5

0%0.4

0%0.4

0%6.1

0%0.2

0%0.1

0%1.7

0%3.8

0%0.4

0%7.8

0%9.7

0%0.3

0%8.8

0%1.4

0%2.5

0%0.5

0%2.1

0%12

.10%

0.20%

0.70%

0.30%

1.90%

0.10%

0.00%

0.60%

0.30%

0.20%

6.10%

1.10%

0.10%

1.90%

0.00%

0.00%

2.90%

0.00%

0.20%

2.70%

0.80%

0.00%

0.30%

1.30%

7.90%

0.00%

1.10%

2.20%

4.60%

0.20%

1.30% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

39:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

SE

LA

NG

OR

, AL

L R

ESI

DE

NT

S, M

AL

ES,

200

7-20

11

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 141: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

119

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

11 68 115 12 6 8

130 14 1 66 162 13 424

456 9

185 77 128 31 16 353 10 28 18 77 2 0 30

3159 18 12 53

733

6 68 508 9 1 62 2 2 58 1 6

131

210 7 14 74 338 0 59 101

227 22 72 -----

8484

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 1 0 0 2 0 0 0 0 1 7 0 0 0 0 2 0 0 13 8 0 0---

-- 37

5-

-

9 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 6 0 0 0 0 2 0 0 10 1 1 0---

-- 26

10-

-

14 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 7 0 0 1 0 0 0 0 1 2 2 0 1 0 7 0 0 4 6 2 0---

-- 38

15-

-

19 0 0 1 0 0 0 3 0 0 0 2 0 0 0 0 0 0 0 1 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 16 0 0 2 0 0 0 0 0 5 7 0 2 9 9 0 0 15 11 1 1---

-- 88

20-

-

24 0 0 1 1 0 0 6 0 0 0 1 0 4 2 0 0 1 0 1 0 0 1 2 1 0 0 0 2 9 0 0 3 0 0 13 0 0 0 0 0 0 0 0 5 16 0 0 16 19 0 0 9 16 0 3---

--13

2

25-

-

29 0 1 0 1 0 1 6 0 0 0 2 1 6 4 0 2 1 3 0 0 5 0 2 0 1 0 0 1 54 0 0 7 1 1 20 0 0 2 1 0 0 0 1 7 18 0 1 15 18 0 1 3 14 0 0---

--20

1

30-

-

34 0 3 0 0 0 0 4 0 0 0 5 1 11 7 0 5 1 1 0 1 4 1 3 1 2 0 0 414

9 0 0 14 15 4 13 0 0 3 0 0 0 0 0 9 16 0 0 12 17 0 0 5 18 2 1---

--33

2

35-

-

39 1 2 1 0 0 1 14 0 0 1 5 0 11 12 0 7 2 5 4 1 6 0 1 4 5 0 0 325

3 1 1 41 14 2 31 1 1 1 0 0 2 0 0 13 23 1 3 4 19 0 1 6 23 3 2---

--53

2

40-

-

44 0 5 5 2 0 0 18 0 0 5 7 1 23 19 2 10 3 5 1 0 20 1 7 1 6 0 0 143

2 0 0 55 31 4 58 2 0 4 0 0 2 0 1 9 27 3 1 5 20 0 7 4 13 2 5---

--82

7

45-

-

49 2 8 4 3 0 1 21 1 0 4 13 1 35 39 0 13 4 10 1 0 22 0 1 2 5 0 0 153

7 2 2 87 33 6 75 2 0 5 0 0 2 0 0 12 17 0 0 3 27 0 2 6 25 1 8---

--10

43

50-

-

54 2 10 15 3 0 1 16 1 0 4 17 3 37 58 0 23 4 18 2 1 44 2 2 1 7 0 0 153

0 1 0 82 51 15 88 2 0 10 0 0 4 0 0 12 18 1 1 4 49 0 3 9 19 6 5---

--11

82

55-

-

59 1 7 13 0 2 2 21 3 0 8 21 3 56 69 1 26 22 24 7 2 56 3 3 1 4 1 0 443

1 2 4 67 72 17 61 1 0 9 0 0 12 0 0 9 17 0 1 0 45 0 12 6 25 1 17 -----

1169

60-

-

64 0 12 22 0 1 0 6 2 0 11 23 1 73 63 2 20 9 24 2 2 46 1 0 3 7 0 0 228

5 2 0 63 60 5 43 0 0 8 0 0 8 1 2 11 14 1 2 2 28 0 12 7 22 1 8---

--91

7

65-

-

69 0 5 14 1 2 1 5 3 0 12 21 1 53 62 1 28 9 10 3 3 51 0 1 1 10 0 0 119

9 3 3 50 36 8 36 1 0 4 0 2 5 0 0 11 14 0 1 2 30 0 7 1 5 0 7---

--72

3

70-

-

74 2 11 23 1 1 1 8 2 0 10 17 0 57 60 0 20 11 17 1 3 42 1 1 2 11 1 0 315

6 3 1 40 12 2 22 0 0 4 0 0 8 0 0 9 10 1 1 0 21 0 9 1 12 0 7---

--62

5

75+

3 4 16 0 0 0 1 2 0 11 28 1 58 61 3 30 10 11 7 3 57 0 1 1 19 0 0 112

4 4 1 28 11 4 23 0 0 5 1 0 15 0 0 4 11 0 0 2 25 0 5 2 9 2 8---

--61

2

% of

Total

0.10%

0.80%

1.40%

0.10%

0.10%

0.10%

1.50%

0.20%

0.00%

0.80%

1.90%

0.20%

5.00%

5.40%

0.10%

2.20%

0.90%

1.50%

0.40%

0.20%

4.20%

0.10%

0.30%

0.20%

0.90%

0.00%

0.00%

0.40%

37.20

%0.2

0%0.1

0%6.3

0%4.0

0%0.8

0%6.0

0%0.1

0%0.0

0%0.7

0%0.0

0%0.0

0%0.7

0%0.0

0%0.1

0%1.5

0%2.5

0%0.1

0%0.2

0%0.9

0%4.0

0%0.0

0%0.7

0%1.2

0%2.7

0%0.3

0%0.8

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

40:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

SE

LA

NG

OR

, AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

200

7-20

11

Page 142: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

120

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

7 55 71 33 22 24 382 15 4

106

237 24 487

605 16 550 90 159 30 134

759 14 44 16 120 5 3 40 16 14 383 71 5

118 3 2

183 2 10 168 53 2 17 83 492 0 68 138

286 15 80 -----

6261

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0.1 0 0 0 0 0.3 0.7 0 0 0 0.1 0.1 0 0 1.8 0.3 0.2 0---

-- 4

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0.1 0.2 0 0 1 0.3 0.1 0---

-- 3

10-

-

14 0 0 0.1 0 0 0 0.2 0 0 0 0 0 0 0 0 0.1 0 0 0.1 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0.2 0.2 0.5 0 0 0.8 0.8 0.1 0---

-- 4

15-

-

19 0 0.1 0 0 0 0.1 0.3 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0.2 0.6 0 0.1 0 0 0.2 0 0 0 0.6 0 0 0 0 0.1 0 0 0.4 0.1 0 0.3 0.9 1.3 0 0 0.8 2 0.2 0.1 ----- 8

20-

-

24 0 0.1 0 0.1 0 0 0.4 0 0 0.1 0.1 0.1 0.4 0.1 0 0.1 0 0 0.1 0 0.1 0.2 0.6 0.1 0 0 0.1 0.1 0 0 0.1 1 0 0.1 0 0 0 0 0 0.6 0.1 0 0 1.2 1.4 0 0 1.1 1.6 0.1 0.1 ----- 10

25-

-

29 0 0.1 0.1 0.1 0 0 0.8 0 0 0 0.4 0.1 0.4 0.4 0 0.4 0.1 0.1 0 0 0.3 0.1 0.2 0.1 0.1 0 0 0.1 0.1 0 0 1.4 0.1 0 0 0 0 0 0 0.4 0.3 0 0 0.7 1.8 0 0 0.6 1.4 0.1 0.1 ----- 11

30-

-

34 0 0.3 0 0.3 0 0 2.5 0 0 0 0.6 0.1 0.5 1.5 0 0.8 0 0.2 0 0 1 0.1 0 0 0.4 0 0 0.5 0.1 0 0.1 1.1 0 0.1 0 0 0 0 0.1 0.9 0.1 0 0.1 0.5 2.2 0 0.2 0.7 1.5 0 0.3 ----- 17

35-

-

39 0 0.1 0 0.2 0.2 0 3.3 0 0 0 0.7 0.1 1.3 1.8 0.1 1.4 0.1 0.3 0.3 0.3 2.5 0.1 0.4 0 0.1 0 0.1 0.1 0 0.3 0 0.8 0 0.6 0 0 0.2 0 0.2 2 0.2 0 0.2 0.6 2.1 0 0.3 0.8 2.2 0 0.5 ----- 25

40-

-

44 0 0.2 0.2 0.1 0 0.2 6.5 0 0 0.6 1.4 0 3.6 3 0.2 3.7 0.8 0.8 0.4 0.4 4.6 0 0.6 0.1 0.7 0.1 0 0.2 0 0.1 0.2 0.2 0 1 0 0 1 0 0 1.3 0.5 0 0.2 1 3.5 0 0.2 1.1 3.9 0.1 0.5 ----- 44

45-

-

49 0 1.2 1.6 1.2 0.4 0.1 8.8 0 0 1.4 2.2 0.1 4.8 6.9 0.1 6.7 1.1 1.6 0.3 1 6.9 0.1 0.1 0.1 1.9 0 0 0.4 0.3 0 0.7 0.1 0 1.6 0.1 0 0.5 0 0 1.8 1 0 0.3 0.8 6.9 0 1 0.8 3.7 0 1---

-- 70

50-

-

54 0.5 0.9 2.2 0.5 0.5 0.5 9.5 0.9 0 1.9 6.2 0 911

.6 0.2 14.7 2.1 3.8 0.7 4

14.3 0.2 0.3 0.3 1 0.2 0 0.7 0.7 0.3 1.6 0.5 0 2.4 0 0 2.6 0 0.2 3.3 1.2 0 0 0.7 9.7 0 1.6 0.9 2.9 0 2.4 -----

118

55-

-

59 0.2 2.1 2.6 0.7 0.5 0.5 12.8 0.7 0.2 4 5.6 1.6 18.9 17 0.9 20.7 3.3 7.2 1.4 3.7 23.8 0 0.5 0.5 4.2 0 0 2.1 0.7 0.2 8.9 0 0 5.8 0 0 5.6 0 0 3.5 1.2 0 0.2 1.2 15.6 0 4 2.8 5.8 0.2 2.8 -----

194

60-

-

64 0.3 3.3 2 1 2 1.3 10.5 0.7 0.7 7.9 9.2 1.3 24 29.9 0.3 28.6 4.9 9.9 1.3 9.9 42.4 0.3 1.6 0.3 6.3 0 0 1.3 1 0.7 20.7 1 0.3 5.9 0 0.3 9.2 0.3 0 3.9 2.6 0.3 0.7 0.7 23.4 0 3 2.3 4.6 0.3 3

-----

286

65-

-

69 0.6 2.8 3.9 2.2 1.7 1.1 12.8 0.6 0 7.8 21.2 1.1 34.5

52.4 1.7 41.2 8.9 12.3 1.1 13.4 68 1.1 1.7 1.1 7.2 1.1 0 1.7 0 0.6 47.4 0 0.6 5 0.6 0

19.5 0 0.6 6.7 4.5 0 0.6 0.6 27.9 0 3.9 2.2 12.3 0.6 3.9 -----

440

70-

-

74 0.8 3.9 4.7 0 2.3 3.1 7.8 3.1 0 8.6 24.2 3.9 55.5

71.1 1.6 49.2 8.6 12.5 1.6 13.3

83.6 0.8 0.8 2.3 6.3 0.8 0 0.8 0.8 0.8 71.1 0 0.8 12.5 0.8 0.8 21.1 0 0 6.3 1.6 0.8 0 2.3 25 0 5.5 2.3 11.7 1.6 7.8 -----

545

75+

0 1.6 9.3 1.6 0 3.9 6.2 0 0.8 10.1

24.1 0.8 42 58.4 0.8 31.1 3.9 10.1 1.6 8.6 67.7 0 0 0.8 21.8 0 0.8 0.8 0.8 2.3 68.5 1.6 0 5.4 0 0

30.4 0.8 0.8 5.4 1.6 0 0.8 1.6 18.7 0 3.9 1.6 12.5 0 3.9 -----

467

Crud

eRa

te 0.1 0.4 0.6 0.3 0.2 0.2 3 0.1 0 0.8 1.9 0.2 3.8 4.8 0.1 4.3 0.7 1.3 0.2 1.1 6 0.1 0.3 0.1 0.9 0 0 0.3 0.1 0.1 3 0.6 0 0.9 0 0 1.4 0 0.1 1.3 0.4 0 0.1 0.7 3.9 0 0.5 1.1 2.3 0.1 0.6 -----

49.3

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

41:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, S

EL

AN

GO

R, A

LL

RE

SID

EN

TS,

MA

LE

S, 2

007-

2011

ASR

Wor

ld 0.1 0.6 0.8 0.3 0.3 0.3 3.5 0.2 0.1 1.3 2.8 0.3 5.8 7.4 0.2 6.4 1.1 1.9 0.3 1.7 9.4 0.1 0.4 0.2 1.5 0.1 0 0.4 0.2 0.2 5.5 0.5 0.1 1.3 0 0 2.4 0 0.1 1.6 0.6 0 0.2 0.6 5.1 0 0.8 1.2 2.7 0.1 0.9 -----

71.3

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 143: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

121

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

11 68 115 12 6 8

130 14 1 66 162 13 424

456 9

185 77 128 31 16 353 10 28 18 77 2 0 30

3159 18 12 53

733

6 68 508 9 1 62 2 2 58 1 6

131

210 7 14 74 338 0 59 101

227 22 72 -----

8484

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.1 0 0 0.2 0 0 0 0 0.1 0.6 0 0 0 0 0.2 0 0 1.1 0.7 0 0---

-- 3

5-

-

9 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.1 0 0 0.2 0 0 0 0 0 0.5 0 0 0 0 0.2 0 0 0.9 0.1 0.1 0---

-- 2

10-

-

14 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0.2 0 0 0 0 0.1 0 0 0 0 0 0 0.7 0 0 0.1 0 0 0 0 0.1 0.2 0.2 0 0.1 0 0.7 0 0 0.4 0.6 0.2 0---

-- 4

15-

-

19 0 0 0.1 0 0 0 0.3 0 0 0 0.2 0 0 0 0 0 0 0 0.1 0 0 0 0.2 0 0 0 0 0.1 0 0 0 0 0 0 1.4 0 0 0.2 0 0 0 0 0 0.4 0.6 0 0.2 0.8 0.8 0 0 1.3 1 0.1 0.1 ----- 8

20-

-

24 0 0 0.1 0.1 0 0 0.4 0 0 0 0.1 0 0.3 0.1 0 0 0.1 0 0.1 0 0 0.1 0.1 0.1 0 0 0 0.1 0.6 0 0 0.2 0 0 0.9 0 0 0 0 0 0 0 0 0.3 1.1 0 0 1.1 1.3 0 0 0.6 1.1 0 0.2 ----- 9

25-

-

29 0 0.1 0 0.1 0 0.1 0.4 0 0 0 0.1 0.1 0.4 0.3 0 0.1 0.1 0.2 0 0 0.4 0 0.1 0 0.1 0 0 0.1 4 0 0 0.5 0.1 0.1 1.5 0 0 0.1 0.1 0 0 0 0.1 0.5 1.3 0 0.1 1.1 1.3 0 0.1 0.2 1 0 0---

-- 15

30-

-

34 0 0.3 0 0 0 0 0.4 0 0 0 0.5 0.1 1.1 0.7 0 0.5 0.1 0.1 0 0.1 0.4 0.1 0.3 0.1 0.2 0 0 0.4 14.7 0 0 1.4 1.5 0.4 1.3 0 0 0.3 0 0 0 0 0 0.9 1.6 0 0 1.2 1.7 0 0 0.5 1.8 0.2 0.1 ----- 33

35-

-

39 0.1 0.2 0.1 0 0 0.1 1.6 0 0 0.1 0.6 0 1.2 1.3 0 0.8 0.2 0.6 0.4 0.1 0.7 0 0.1 0.4 0.6 0 0 0.3 28.2 0.1 0.1 4.6 1.6 0.2 3.5 0.1 0.1 0.1 0 0 0.2 0 0 1.4 2.6 0.1 0.3 0.4 2.1 0 0.1 0.7 2.6 0.3 0.2 ----- 59

40-

-

44 0 0.6 0.6 0.3 0 0 2.3 0 0 0.6 0.9 0.1 3 2.5 0.3 1.3 0.4 0.6 0.1 0 2.6 0.1 0.9 0.1 0.8 0 0 0.1 56.1 0 0 7.1 4 0.5 7.5 0.3 0 0.5 0 0 0.3 0 0.1 1.2 3.5 0.4 0.1 0.6 2.6 0 0.9 0.5 1.7 0.3 0.6 -----

107

45-

-

49 0.3 1.2 0.6 0.5 0 0.2 3.2 0.2 0 0.6 2 0.2 5.4 6 0 2 0.6 1.5 0.2 0 3.4 0 0.2 0.3 0.8 0 0 0.2 82.6 0.3 0.3 13.4 5.1 0.9 11.5 0.3 0 0.8 0 0 0.3 0 0 1.8 2.6 0 0 0.5 4.2 0 0.3 0.9 3.8 0.2 1.2 -----

160

50-

-

54 0.4 1.9 2.9 0.6 0 0.2 3.1 0.2 0 0.8 3.2 0.6 7.1 11.1 0 4.4 0.8 3.4 0.4 0.2 8.4 0.4 0.4 0.2 1.3 0 0 0.2

101.3 0.2 0

15.7 9.7 2.9 16.8 0.4 0 1.9 0 0 0.8 0 0 2.3 3.4 0.2 0.2 0.8 9.4 0 0.6 1.7 3.6 1.1 1

-----

226

55-

-

59 0.2 1.7 3.2 0 0.5 0.5 5.2 0.7 0 2 5.2 0.7 14 17.2 0.2 6.5 5.5 6 1.7 0.5 14 0.7 0.7 0.2 1 0.2 0 1

107.5 0.5 1

16.7 18 4.2 15.2 0.2 0 2.2 0 0 3 0 0 2.2 4.2 0 0.2 0

11.2 0 3 1.5 6.2 0.2 4.2 -----

292

60-

-

64 0 3.9 7.1 0 0.3 0 1.9 0.6 0 3.5 7.4 0.3 23.5

20.3 0.6 6.4 2.9 7.7 0.6 0.6 14.8 0.3 0 1 2.3 0 0 0.6 91.8 0.6 0

20.3

19.3 1.6 13.9 0 0 2.6 0 0 2.6 0.3 0.6 3.5 4.5 0.3 0.6 0.6 9 0 3.9 2.3 7.1 0.3 2.6 -----

295

65-

-

69 0 2.9 8.2 0.6 1.2 0.6 2.9 1.8 0 712

.3 0.6 31.1

36.4 0.6 16.4 5.3 5.9 1.8 1.8 29.9 0 0.6 0.6 5.9 0 0 0.6

116.7 1.8 1.8 29.3

21.1 4.7 21.1 0.6 0 2.3 0 1.2 2.9 0 0 6.5 8.2 0 0.6 1.2 17.6 0 4.1 0.6 2.9 0 4.1 -----

424

70-

-

74 1.5 8.3 17.3 0.8 0.8 0.8 6 1.5 0 7.5 12.8 0

42.9

45.1 0 15 8.3 12.8 0.8 2.3 31.6 0.8 0.8 1.5 8.3 0.8 0 2.3

117.3 2.3 0.8 30.1 9 1.5 16.5 0 0 3 0 0 6 0 0 6.8 7.5 0.8 0.8 0

15.8 0 6.8 0.8 9 0 5.3 -----

470

75+ 1.9 2.5 10 0 0 0 0.6 1.2 0 6.9 17

.4 0.6 36.1 38 1.9 18.7 6.2 6.9 4.4 1.9 35.5 0 0.6 0.6 11.8 0 0 0.6 77.3 2.5 0.6 17.4 6.9 2.5 14.3 0 0 3.1 0.6 0 9.3 0 0 2.5 6.9 0 0 1.2 15.6 0 3.1 1.2 5.6 1.2 5

-----

381

Crud

eRa

te 0.1 0.6 0.9 0.1 0 0.1 1.1 0.1 0 0.5 1.3 0.1 3.5 3.7 0.1 1.5 0.6 1 0.3 0.1 2.9 0.1 0.2 0.1 0.6 0 0 0.2 25.8 0.1 0.1 4.4 2.7 0.6 4.1 0.1 0 0.5 0 0 0.5 0 0 1.1 1.7 0.1 0.1 0.6 2.8 0 0.5 0.8 1.9 0.2 0.6 -----

69.3

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

42:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, S

EL

AN

GO

R, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, 2

007-

2011

ASR

Wor

ld 0.1 0.8 1.4 0.1 0.1 0.1 1.2 0.2 0 0.8 1.9 0.1 5.1 5.5 0.1 2.2 0.9 1.5 0.3 0.2 4.3 0.1 0.2 0.2 0.9 0 0 0.3 31.7 0.2 0.1 5.7 3.7 0.7 5.1 0.1 0 0.7 0 0 0.7 0 0.1 1.3 1.9 0.1 0.1 0.5 3.4 0 0.7 0.9 2.1 0.2 0.8 -----

89.7

Page 144: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

122

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

3 59 51 35 16 10 524 21 0

105

310 27 571

584 18 413 48 157 33 116

1289 28 59 18 20

6 2 2 84 21 17 548 82 7

144 1 6

250 4 9

172 79 6 9 49 407 0 82 103

191 98 128

-----

7202

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 1 1 0 0 0 3 0 0 0 5 1 2 0 0 0 0 6 17 0 2 0 0 5 0 0 23 18 24 2---

--11

7

5-

-

9 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 3 0 1 0 0 3 0 0 0 1 0 0 0 0 0 0 0 6 0 0 1 1 6 0 0 18 8 14 0---

-- 65

10-

-

14 0 0 1 0 0 0 4 0 0 0 0 0 0 0 0 2 0 0 0 0 0 3 9 0 1 0 0 0 0 0 0 4 0 3 0 0 0 0 0 5 0 1 1 0 5 0 0 12 4 12 1---

-- 68

15-

-

19 0 0 0 0 0 0 6 0 0 0 0 0 1 1 0 2 0 0 1 0 1 1 16 1 0 0 0 7 0 0 0 5 3 0 0 0 0 0 0 9 1 0 0 7 16 0 0 4 11 10 3---

--10

6

20-

-

24 0 1 0 4 0 0 3 0 0 0 0 1 1 3 0 0 0 0 0 0 6 2 3 1 1 0 0 0 0 1 0 9 0 0 0 0 0 0 0 6 4 0 1 9 23 0 0 6 13 5 2---

--10

5

25-

-

29 0 2 0 2 0 0 9 0 0 0 0 1 2 1 0 2 0 1 0 0 9 3 6 0 4 0 0 3 0 0 0 18 0 0 0 0 2 0 0 8 7 0 0 6 7 0 0 4 18 6 3---

--12

4

30-

-

34 0 2 0 3 0 0 30 0 0 1 6 1 10 8 0 9 0 4 0 0 12 2 1 0 5 0 0 2 0 0 0 8 1 5 0 0 0 0 0 8 3 0 0 4 14 0 0 4 11 1 2---

--15

7

35-

-

39 0 3 1 3 0 0 45 0 0 1 5 1 17 9 1 10 0 3 5 0 18 2 2 2 4 0 1 4 1 2 0 11 0 3 0 0 2 0 0 6 3 0 1 3 30 0 2 2 10 4 6---

--22

3

40-

-

44 1 8 6 0 1 0 66 1 0 5 10 1 28 15 2 28 4 7 1 3 45 3 2 0 4 0 0 6 2 1 4 9 0 7 0 0 9 0 0 13 5 0 1 3 27 0 7 6 15 3 4---

--36

3

45-

-

49 0 7 3 3 3 0 71 0 0 8 20 6 41 44 2 36 1 9 6 9 80 3 2 0 15 0 0 12 0 2 6 5 0 14 1 0 14 0 0 18 9 1 1 3 29 0 12 4 17 3 9---

--52

9

50-

-

54 0 9 4 1 3 0 99 0 0 13 22 1 60 63 6 66 6 17 4 10 138 1 2 1 18 0 0 10 2 2 13 2 1 17 0 0 14 0 1 11 10 0 2 4 52 0 10 5 21 1 19 -----

741

55-

-

59 1 4 4 5 4 2 62 3 0 16 30 4 84 66 1 71 7 18 3 19 166 2 6 2 18 0 0 7 2 1 40 1 0 23 0 0 26 2 0 27 14 1 1 1 48 0 13 6 12 3 14 -----

840

60-

-

64 0 6 10 6 3 1 52 5 0 20 49 4 77 116 3 69 9 36 5 26 205 2 2 3 31 1 0 12 4 0 88 0 0 32 0 2 39 1 0 11 6 0 0 1 45 0 16 2 11 2 19 -----

1032

65-

-

69 0 7 6 1 0 1 45 4 0 14 50 3 73 105 1 42 6 28 3 17 212 1 2 3 33 0 1 6 3 6

125 2 1 19 0 4 36 1 1 10 10 0 0 2 45 0 11 3 9 3 20 -----

975

70-

-

74 0 5 5 4 1 2 20 5 0 17 53 3 88 69 1 38 6 19 2 13 216 2 2 2 34 1 0 3 2 1

128 1 0 16 0 0 46 0 0 9 2 0 0 1 32 0 6 1 6 5 10 -----

877

75+

1 5 11 2 1 3 10 3 0 10 65 1 89 84 1 33 9 15 2 19 181 1 0 2 37 0 0 6 5 1

144 1 0 3 0 0 62 0 1 8 5 1 0 4 23 0 5 3 7 2 14 -----

880

% of

Total 0.0

0%0.8

0%0.7

0%0.5

0%0.2

0%0.1

0%7.3

0%0.3

0%0.0

0%1.5

0%4.3

0%0.4

0%7.9

0%8.1

0%0.2

0%5.7

0%0.7

0%2.2

0%0.5

0%1.6

0%17

.90%

0.40%

0.80%

0.20%

2.90%

0.00%

0.00%

1.20%

0.30%

0.20%

7.60%

1.10%

0.10%

2.00%

0.00%

0.10%

3.50%

0.10%

0.10%

2.40%

1.10%

0.10%

0.10%

0.70%

5.70%

0.00%

1.10%

1.40%

2.70%

1.40%

1.80% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

43:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

JO

HO

R, A

LL

RE

SID

EN

TS,

MA

LE

S, 2

007-

2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 145: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

123

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

1 40 40 35 6 217

2 10 3 47 208 12 490

420 10 144 55 119 14 10 487 12 41 18 157 2 0 69

2792 18 19 51

832

6 52 446 7 8 62 0 1 58 1 9

124

265 7 5 35 285 1 55 66 148 74 104

-----

8110

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 2 0 0 0 1 0 0 2 0 1 0 0 1 0 0 0 0 0 0 2 0 0 1 0 0 0 0 3 7 0 1 0 0 8 0 0 14 8 20 2---

-- 74

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 1 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 9 1 1 0 0 3 0 0 13 3 12 1---

-- 49

10-

-

14 0 0 0 0 0 0 2 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 7 0 1 0 0 3 0 0 0 0 0 0 5 0 0 1 0 0 0 0 0 12 3 0 0 1 6 0 0 7 5 5 0---

-- 61

15-

-

19 0 0 0 3 0 0 0 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 5 0 1 0 0 6 0 0 0 0 0 0 11 0 0 0 0 0 0 0 0 5 5 1 0 4 19 0 0 3 5 7 0---

-- 78

20-

-

24 0 0 0 1 0 0 2 1 0 0 3 0 3 1 0 2 0 2 0 0 0 1 4 0 2 0 0 2 9 0 0 0 0 0 16 0 1 2 0 0 0 0 0 2 18 1 0 8 15 0 0 4 11 0 6---

--11

7

25-

-

29 0 1 0 2 0 0 5 1 0 0 3 0 6 2 0 1 0 1 0 0 2 2 3 1 2 0 0 8 34 0 1 10 5 1 13 0 0 0 0 0 0 0 0 7 25 1 0 6 15 0 0 4 8 3 5---

--17

8

30-

-

34 0 0 0 0 0 0 13 0 0 0 4 0 10 7 0 3 1 4 1 0 5 0 1 0 5 0 0 111

3 1 0 17 7 3 18 2 2 1 0 0 1 0 0 4 25 0 1 2 9 0 0 1 11 1 5---

--27

9

35-

-

39 0 2 0 1 0 0 17 0 0 0 5 0 21 20 0 8 1 2 1 0 12 1 1 2 2 0 0 422

1 1 0 29 20 4 24 0 2 2 0 0 0 0 0 6 30 1 0 0 15 0 2 1 14 0 5---

--47

7

40-

-

44 0 4 2 7 0 0 23 0 1 3 12 0 21 23 2 11 2 8 3 0 26 0 4 0 5 0 0 837

1 0 0 47 32 8 44 1 1 4 0 0 4 0 0 9 24 0 1 2 17 0 2 2 9 0 6---

--74

9

45-

-

49 0 4 1 3 2 0 28 0 0 2 16 0 23 36 1 9 2 4 1 0 51 3 1 1 4 0 0 850

3 0 2 85 36 10 68 1 2 9 0 0 6 0 2 13 23 0 2 4 29 0 5 4 14 5 8---

--10

31

50-

-

54 0 8 4 2 2 0 30 1 0 7 21 1 41 52 1 13 4 5 2 0 42 0 1 3 12 0 0 347

4 3 1 79 52 2 72 0 0 7 0 1 7 0 1 17 33 0 0 1 31 0 7 4 15 2 13 -----

1077

55-

-

59 0 4 5 5 0 0 20 1 1 4 22 2 69 51 1 14 8 23 0 0 63 1 2 3 16 1 0 643

2 4 2 86 62 7 65 2 0 11 0 0 7 0 1 7 25 0 1 3 19 0 8 4 17 4 11 -----

1100

60-

-

64 0 5 5 3 1 0 20 2 1 11 23 1 69 49 0 19 7 18 1 2 73 1 1 1 16 0 0 728

1 2 1 59 44 11 41 0 0 10 0 0 8 1 1 8 19 0 0 0 31 1 10 2 11 5 11 -----

893

65-

-

69 0 2 7 3 1 0 5 0 0 7 25 3 56 48 1 19 6 20 2 1 67 0 2 3 13 0 0 416

0 2 3 31 27 2 28 1 0 4 0 0 4 0 0 12 18 0 0 0 27 0 6 1 3 4 7---

--63

5

70-

-

74 1 5 5 4 0 1 2 4 0 3 28 1 68 59 2 16 9 11 2 4 65 1 2 1 25 1 0 310

4 3 5 40 24 2 25 0 0 3 0 0 10 0 0 4 8 0 0 1 21 0 7 1 4 2 13 -----

600

75+

0 5 11 1 0 1 4 0 0 10 44 410

1 71 2 26 15 21 1 2 81 0 4 3 52 0 0 3 90 2 4 35 17 2 14 0 0 7 0 0 11 0 0 2 8 1 0 3 20 0 8 1 10 4 11 -----

712

% of

Total

0.00%

0.50%

0.50%

0.40%

0.10%

0.00%

2.10%

0.10%

0.00%

0.60%

2.60%

0.10%

6.00%

5.20%

0.10%

1.80%

0.70%

1.50%

0.20%

0.10%

6.00%

0.10%

0.50%

0.20%

1.90%

0.00%

0.00%

0.90%

34.40

%0.2

0%0.2

0%6.4

0%4.0

0%0.6

0%5.5

0%0.1

0%0.1

0%0.8

0%0.0

0%0.0

0%0.7

0%0.0

0%0.1

0%1.5

0%3.3

0%0.1

0%0.1

0%0.4

0%3.5

0%0.0

0%0.7

0%0.8

0%1.8

0%0.9

0%1.3

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

44:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

JO

HO

R, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, 2

007-

2011

Page 146: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

124

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

3 59 51 35 16 10 524 21 0

105

310 27 571

584 18 413 48 157 33 116

1289 28 59 18 20

6 2 2 84 21 17 548 82 7

144 1 6

250 4 9

172 79 6 9 49 407 0 82 103

191 98 128

-----

7202

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0.1 0.1 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0.1 0.1 0 0 0 0.4 0 0 0 0.7 0.1 0.3 0 0 0 0 0.8 2.3 0 0.3 0 0 0.7 0 0 3.2 2.5 3.3 0.3 ----- 16

5-

-

9 0 0 0 0.1 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0.4 0 0.1 0 0 0.4 0 0 0 0.1 0 0 0 0 0 0 0 0.8 0 0 0.1 0.1 0.8 0 0 2.3 1 1.8 0---

-- 8

10-

-

14 0 0 0.1 0 0 0 0.5 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0.4 1.1 0 0.1 0 0 0 0 0 0 0.5 0 0.4 0 0 0 0 0 0.6 0 0.1 0.1 0 0.6 0 0 1.5 0.5 1.5 0.1 ----- 9

15-

-

19 0 0 0 0 0 0 0.8 0 0 0 0 0 0.1 0.1 0 0.3 0 0 0.1 0 0.1 0.1 2.2 0.1 0 0 0 1 0 0 0 0.7 0.4 0 0 0 0 0 0 1.2 0.1 0 0 1 2.2 0 0 0.5 1.5 1.4 0.4 ----- 14

20-

-

24 0 0.1 0 0.6 0 0 0.4 0 0 0 0 0.1 0.1 0.4 0 0 0 0 0 0 0.8 0.3 0.4 0.1 0.1 0 0 0 0 0.1 0 1.2 0 0 0 0 0 0 0 0.8 0.6 0 0.1 1.2 3.2 0 0 0.8 1.8 0.7 0.3 ----- 15

25-

-

29 0 0.3 0 0.3 0 0 1.3 0 0 0 0 0.1 0.3 0.1 0 0.3 0 0.1 0 0 1.3 0.4 0.9 0 0.6 0 0 0.4 0 0 0 2.6 0 0 0 0 0.3 0 0 1.2 1 0 0 0.9 1 0 0 0.6 2.6 0.9 0.4 ----- 18

30-

-

34 0 0.3 0 0.5 0 0 5.2 0 0 0.2 1 0.2 1.7 1.4 0 1.6 0 0.7 0 0 2.1 0.3 0.2 0 0.9 0 0 0.3 0 0 0 1.4 0.2 0.9 0 0 0 0 0 1.4 0.5 0 0 0.7 2.4 0 0 0.7 1.9 0.2 0.3 ----- 27

35-

-

39 0 0.6 0.2 0.6 0 0 8.3 0 0 0.2 0.9 0.2 3.2 1.7 0.2 1.9 0 0.6 0.9 0 3.3 0.4 0.4 0.4 0.7 0 0.2 0.7 0.2 0.4 0 2 0 0.6 0 0 0.4 0 0 1.1 0.6 0 0.2 0.6 5.6 0 0.4 0.4 1.9 0.7 1.1 ----- 41

40-

-

44 0.2 1.6 1.2 0 0.2 013

.2 0.2 0 1 2 0.2 5.6 3 0.4 5.6 0.8 1.4 0.2 0.6 9 0.6 0.4 0 0.8 0 0 1.2 0.4 0.2 0.8 1.8 0 1.4 0 0 1.8 0 0 2.6 1 0 0.2 0.6 5.4 0 1.4 1.2 3 0.6 0.8 ----- 72

45-

-

49 0 1.5 0.7 0.7 0.7 015

.6 0 0 1.8 4.4 1.3 9 9.6 0.4 7.9 0.2 2 1.3 217

.5 0.7 0.4 0 3.3 0 0 2.6 0 0.4 1.3 1.1 0 3.1 0.2 0 3.1 0 0 3.9 2 0.2 0.2 0.7 6.4 0 2.6 0.9 3.7 0.7 2---

--11

6

50-

-

54 0 2.3 1 0.3 0.8 025

.6 0 0 3.4 5.7 0.3 15.5

16.3 1.6 17.1 1.6 4.4 1 2.6 35.7 0.3 0.5 0.3 4.7 0 0 2.6 0.5 0.5 3.4 0.5 0.3 4.4 0 0 3.6 0 0.3 2.8 2.6 0 0.5 1

13.4 0 2.6 1.3 5.4 0.3 4.9 -----

191

55-

-

59 0.3 1.3 1.3 1.6 1.3 0.6 20.1 1 0 5.2 9.7 1.3 27.3

21.4 0.3 23.1 2.3 5.8 1 6.2 53.9 0.6 1.9 0.6 5.8 0 0 2.3 0.6 0.3 13 0.3 0 7.5 0 0 8.4 0.6 0 8.8 4.5 0.3 0.3 0.3 15.6 0 4.2 1.9 3.9 1 4.5 -----

273

60-

-

64 0 2.6 4.3 2.6 1.3 0.4 22.3 2.1 0 8.6 21 1.7 33.1

49.8 1.3 29.6 3.9 15.5 2.1 11.2 88 0.9 0.9 1.3 13.3 0.4 0 5.2 1.7 0

37.8 0 0

13.7 0 0.9 16.7 0.4 0 4.7 2.6 0 0 0.4 19.3 0 6.9 0.9 4.7 0.9 8.2 -----

443

65-

-

69 0 4.5 3.8 0.6 0 0.6 28.8 2.6 0 8.9 32 1.9 46.7

67.1 0.6 26.8 3.8 17.9 1.9 10.9

135.5 0.6 1.3 1.9 21.1 0 0.6 3.8 1.9 3.8 79.9 1.3 0.6 12.1 0 2.6 23 0.6 0.6 6.4 6.4 0 0 1.3 28.8 0 7 1.9 5.8 1.9 12.8 -----

623

70-

-

74 0 4.3 4.3 3.4 0.9 1.7 17 4.3 014

.545

.1 2.6 74.9

58.7 0.9 32.3 5.1 16.2 1.7 11.1

183.9 1.7 1.7 1.7 28.9 0.9 0 2.6 1.7 0.9 109 0.9 0

13.6 0 0

39.2 0 0 7.7 1.7 0 0 0.9 27.2 0 5.1 0.9 5.1 4.3 8.5 -----

746

75+ 0.8 4.1 9 1.6 0.8 2.4 8.2 2.4 0 8.2 53

.1 0.8 72.7

68.6 0.8 26.9 7.3 12.2 1.6 15.5

147.8 0.8 0 1.6 30.2 0 0 4.9 4.1 0.8

117.6 0.8 0 2.4 0 0

50.6 0 0.8 6.5 4.1 0.8 0 3.3 18.8 0 4.1 2.4 5.7 1.6 11.4 -----

718

Crud

eRa

te 0 0.8 0.7 0.4 0.2 0.1 6.7 0.3 0 1.3 4 0.3 7.3 7.4 0.2 5.3 0.6 2 0.4 1.5 16.4 0.4 0.8 0.2 2.6 0 0 1.1 0.3 0.2 7 1 0.1 1.8 0 0.1 3.2 0.1 0.1 2.2 1 0.1 0.1 0.6 5.2 0 1 1.3 2.4 1.2 1.6 -----

91.8

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

45:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, J

OH

OR

, AL

L R

ESI

DE

NT

S, M

AL

ES,

200

7-20

11

ASR

Wor

ld 0 0.8 0.8 0.5 0.2 0.2 7.2 0.3 0 1.6 4.9 0.4 8.8 9.2 0.3 6.1 0.7 2.5 0.5 1.8 20.3 0.4 0.8 0.3 3.2 0 0 1.2 0.3 0.3 9.3 1 0.1 2.2 0 0.1 4 0.1 0.1 2.4 1.1 0.1 0.1 0.6 5.8 0 1.2 1.4 2.6 1.3 1.9 -----

109

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 147: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

125

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

1 40 40 35 6 217

2 10 3 47 208 12 490

420 10 144 55 119 14 10 487 12 41 18 157 2 0 69

2792 18 19 51

832

6 52 446 7 8 62 0 1 58 1 9

124

265 7 5 35 285 1 55 66 148 74 104

-----

8110

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.3 0 0 0 0.1 0 0 0.3 0 0.1 0 0 0.1 0 0 0 0 0 0 0.3 0 0 0.1 0 0 0 0 0.4 1 0 0.1 0 0 1.2 0 0 2.1 1.2 2.9 0.3 ----- 11

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0.1 0.1 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 1.2 0.1 0.1 0 0 0.4 0 0 1.8 0.4 1.6 0.1 ----- 7

10-

-

14 0 0 0 0 0 0 0.3 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.1 1 0 0.1 0 0 0.4 0 0 0 0 0 0 0.7 0 0 0.1 0 0 0 0 0 1.6 0.4 0 0 0.1 0.8 0 0 1 0.7 0.7 0---

-- 8

15-

-

19 0 0 0 0.4 0 0 0 0 0 0 0.3 0 0 0 0 0.1 0 0 0 0 0 0 0.7 0 0.1 0 0 0.9 0 0 0 0 0 0 1.6 0 0 0 0 0 0 0 0 0.7 0.7 0.1 0 0.6 2.8 0 0 0.4 0.7 1 0---

-- 11

20-

-

24 0 0 0 0.1 0 0 0.3 0.1 0 0 0.4 0 0.4 0.1 0 0.3 0 0.3 0 0 0 0.1 0.6 0 0.3 0 0 0.3 1.3 0 0 0 0 0 2.4 0 0.1 0.3 0 0 0 0 0 0.3 2.6 0.1 0 1.2 2.2 0 0 0.6 1.6 0 0.9 ----- 17

25-

-

29 0 0.2 0 0.3 0 0 0.8 0.2 0 0 0.5 0 0.9 0.3 0 0.2 0 0.2 0 0 0.3 0.3 0.5 0.2 0.3 0 0 1.2 5.2 0 0.2 1.5 0.8 0.2 2 0 0 0 0 0 0 0 0 1.1 3.9 0.2 0 0.9 2.3 0 0 0.6 1.2 0.5 0.8 ----- 27

30-

-

34 0 0 0 0 0 0 2.5 0 0 0 0.8 0 1.9 1.3 0 0.6 0.2 0.8 0.2 0 0.9 0 0.2 0 0.9 0 0 0.2 21.4 0.2 0 3.2 1.3 0.6 3.4 0.4 0.4 0.2 0 0 0.2 0 0 0.8 4.7 0 0.2 0.4 1.7 0 0 0.2 2.1 0.2 0.9 ----- 53

35-

-

39 0 0.4 0 0.2 0 0 3.3 0 0 0 1 0 4.1 3.9 0 1.6 0.2 0.4 0.2 0 2.4 0.2 0.2 0.4 0.4 0 0 0.8 43.3 0.2 0 5.7 3.9 0.8 4.7 0 0.4 0.4 0 0 0 0 0 1.2 5.9 0.2 0 0 2.9 0 0.4 0.2 2.7 0 1

----- 93

40-

-

44 0 0.8 0.4 1.5 0 0 4.8 0 0.2 0.6 2.5 0 4.4 4.8 0.4 2.3 0.4 1.7 0.6 0 5.4 0 0.8 0 1 0 0 1.7 77.1 0 0 9.8 6.6 1.7 9.1 0.2 0.2 0.8 0 0 0.8 0 0 1.9 5 0 0.2 0.4 3.5 0 0.4 0.4 1.9 0 1.2 -----

156

45-

-

49 0 0.9 0.2 0.7 0.5 0 6.6 0 0 0.5 3.8 0 5.5 8.5 0.2 2.1 0.5 0.9 0.2 012

.1 0.7 0.2 0.2 0.9 0 0 1.911

9.2 0 0.5 20.1 8.5 2.4 16.1 0.2 0.5 2.1 0 0 1.4 0 0.5 3.1 5.5 0 0.5 0.9 6.9 0 1.2 0.9 3.3 1.2 1.9 -----

244

50-

-

54 0 2.2 1.1 0.5 0.5 0 8.1 0.3 0 1.9 5.7 0.3 11 14 0.3 3.5 1.1 1.3 0.5 011

.3 0 0.3 0.8 3.2 0 0 0.812

7.6 0.8 0.3 21.3 14 0.5 19.4 0 0 1.9 0 0.3 1.9 0 0.3 4.6 8.9 0 0 0.3 8.3 0 1.9 1.1 4 0.5 3.5 -----

290

55-

-

59 0 1.4 1.7 1.7 0 0 6.9 0.3 0.3 1.4 7.6 0.7 23.7

17.5 0.3 4.8 2.7 7.9 0 0

21.7 0.3 0.7 1 5.5 0.3 0 2.1

148.5 1.4 0.7 29

.621

.3 2.4 22.3 0.7 0 3.8 0 0 2.4 0 0.3 2.4 8.6 0 0.3 1 6.5 0 2.7 1.4 5.8 1.4 3.8 -----

378

60-

-

64 0 2.2 2.2 1.3 0.4 0 8.9 0.9 0.4 4.9 10.2 0.4 30.7

21.8 0 8.5 3.1 8 0.4 0.9 32.5 0.4 0.4 0.4 7.1 0 0 3.1

125.2 0.9 0.4 26.3

19.6 4.9 18.3 0 0 4.5 0 0 3.6 0.4 0.4 3.6 8.5 0 0 0

13.8 0.4 4.5 0.9 4.9 2.2 4.9 -----

398

65-

-

69 0 1.4 4.8 2.1 0.7 0 3.4 0 0 4.8 17.1 2.1 38.4

32.9 0.7 13 4.1 13.7 1.4 0.7 45.9 0 1.4 2.1 8.9 0 0 2.7

109.6 1.4 2.1 21.2

18.5 1.4 19.2 0.7 0 2.7 0 0 2.7 0 0 8.2 12.3 0 0 0

18.5 0 4.1 0.7 2.1 2.7 4.8 -----

435

70-

-

74 0.9 4.3 4.3 3.4 0 0.9 1.7 3.4 0 2.6 23.8 0.9 57.9

50.2 1.7 13.6 7.7 9.4 1.7 3.4 55.3 0.9 1.7 0.9 21.3 0.9 0 2.6 88.5 2.6 4.3 34 20.4 1.7 21.3 0 0 2.6 0 0 8.5 0 0 3.4 6.8 0 0 0.9 17.9 0 6 0.9 3.4 1.7 11.1 -----

511

75+

0 3.5 7.6 0.7 0 0.7 2.8 0 0 6.9 30.5 2.8 69.9

49.1 1.4 18 10.4

14.5 0.7 1.4 56.1 0 2.8 2.1 36 0 0 2.1 62.3 1.4 2.8 24.2

11.8 1.4 9.7 0 0 4.8 0 0 7.6 0 0 1.4 5.5 0.7 0 2.1 13.8 0 5.5 0.7 6.9 2.8 7.6 -----

493

Crud

eRa

te

0 0.5 0.5 0.5 0.1 0 2.3 0.1 0 0.6 2.8 0.2 6.6 5.7 0.1 1.9 0.7 1.6 0.2 0.1 6.6 0.2 0.6 0.2 2.1 0 0 0.9 37.7 0.2 0.3 7 4.4 0.7 6 0.1 0.1 0.8 0 0 0.8 0 0.1 1.7 3.6 0.1 0.1 0.5 3.8 0 0.7 0.9 2 1 1.4 -----

109.5

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

46:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, J

OH

OR

, AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

200

7-20

11

ASR

Wor

ld 0 0.6 0.6 0.5 0.1 0 2.4 0.2 0 0.7 3.2 0.2 7.5 6.4 0.1 2.2 0.8 1.9 0.2 0.2 7.6 0.2 0.6 0.3 2.4 0 0 139

.8 0.3 0.3 7.6 4.8 0.8 6.4 0.1 0.1 0.9 0 0 0.9 0 0.1 1.8 3.6 0.1 0.1 0.5 4.2 0 0.9 0.9 2 1.1 1.5 -----

118.7

Page 148: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

126

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

2 32 32 17 9 536

9 24 3 48 253 17 336

174 9

236 24 49 18 35 482 29 33 33 125 4 5 31 14 14 199 32 1 32 0 1 73 1 14 80 55 6 1 20 241 0 32 95 112 5 60 -----

3522

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 2 0 1 0 8 0 3 0 0 0 0 9 8 0 0 0 0 3 0 0 32 10 0 4---

-- 82

5-

-

9 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 3 0 0 0 0 8 0 0 24 6 1 2---

-- 49

10-

-

14 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 2 0 0 1 6 0 0 7 7 0 2---

-- 39

15-

-

19 0 1 0 1 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 7 1 0 0 0 1 0 0 1 2 0 0 0 0 1 0 0 5 0 0 0 2 12 0 0 8 6 0 0---

-- 57

20-

-

24 0 0 0 2 0 0 11 0 0 0 1 0 4 1 0 0 1 1 0 0 0 0 6 0 0 0 1 1 0 0 0 5 0 0 0 0 0 0 0 3 0 0 0 3 3 0 0 3 13 0 1---

-- 60

25-

-

29 0 1 3 1 0 0 12 0 0 0 4 0 11 2 0 2 1 0 1 0 5 0 1 1 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 6 2 1 0 0 9 0 1 5 5 0 0---

-- 77

30-

-

34 0 0 2 1 0 0 18 0 0 1 3 1 9 5 1 4 0 1 1 0 3 0 1 1 4 0 1 2 0 1 0 3 0 1 0 0 1 0 0 4 0 0 0 2 13 0 0 2 6 0 0---

-- 92

35-

-

39 0 0 3 2 0 0 23 0 0 0 7 0 13 6 0 7 0 1 0 1 12 4 0 2 6 0 0 3 0 1 0 5 0 1 0 0 1 0 0 3 2 0 0 1 11 0 0 4 7 1 2---

--12

9

40-

-

44 2 1 0 0 0 0 35 1 0 1 11 3 20 14 1 15 1 2 3 0 18 1 2 1 4 0 1 2 2 3 0 2 0 2 0 0 2 0 0 7 5 1 0 0 13 0 1 1 4 1 1---

--18

4

45-

-

49 0 2 3 0 1 0 64 0 0 3 20 1 18 20 1 19 2 5 1 3 42 2 2 1 6 1 0 2 3 2 0 0 1 1 0 0 6 0 3 4 5 0 0 3 23 0 4 1 6 0 1---

--28

2

50-

-

54 0 3 3 1 2 0 55 0 1 5 19 3 35 24 0 31 2 3 3 3 50 4 0 6 9 1 1 2 1 2 10 2 0 7 0 0 8 0 2 8 9 2 0 1 31 0 5 4 9 0 5---

--37

2

55-

-

59 0 4 3 2 0 0 48 1 1 8 32 2 41 19 0 33 4 7 0 5 68 2 3 3 12 0 1 3 3 3 19 1 0 5 0 0 8 0 0 8 8 0 1 2 22 0 6 2 11 1 16 -----

418

60-

-

64 0 3 4 2 2 1 31 3 0 1 29 3 44 15 1 40 3 6 2 7 78 3 1 6 13 0 0 2 0 0 26 0 0 5 0 0 3 0 0 4 3 1 0 2 27 0 3 1 3 0 7---

--38

5

65-

-

69 0 8 2 2 3 0 27 7 0 9 44 3 40 31 1 35 3 9 4 5 86 8 3 4 20 1 0 7 2 1 41 0 0 3 0 0 16 0 0 4 10 0 0 1 21 0 6 0 8 1 9---

--48

5

70-

-

74 0 5 3 2 1 3 19 6 0 10 40 1 40 13 3 25 4 5 2 7 56 2 2 3 25 0 0 0 3 0 42 1 0 3 0 1 13 0 0 6 6 1 0 0 21 0 3 0 7 0 4---

--38

8

75+

0 4 6 1 0 1 11 5 1 10 43 0 61 24 1 23 3 9 0 4 63 3 0 4 26 1 0 3 0 0 60 0 0 1 0 0 13 1 0 4 3 0 0 2 18 0 3 1 4 0 6---

--42

3

% of

Total 0.1

0%0.9

0%0.9

0%0.5

0%0.3

0%0.1

0%10

.50%

0.70%

0.10%

1.40%

7.20%

0.50%

9.50%

4.90%

0.30%

6.70%

0.70%

1.40%

0.50%

1.00%

13.70

%0.8

0%0.9

0%0.9

0%3.5

0%0.1

0%0.1

0%0.9

0%0.4

0%0.4

0%5.7

0%0.9

0%0.0

0%0.9

0%0.0

0%0.0

0%2.1

0%0.0

0%0.4

0%2.3

0%1.6

0%0.2

0%0.0

0%0.6

0%6.8

0%0.0

0%0.9

0%2.7

0%3.2

0%0.1

0%1.7

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

47:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

SA

BA

H, A

LL

RE

SID

EN

TS,

MA

LE

S, 2

007-

2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 149: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

127

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages 17 22 41 18 3 415

2 10 0 28 183 14 253

104 10 84 16 40 7 6

294 27 27 16 148 1 0 35 805 7 18 471

119 81 259 4 9 17 0 0 30 4 10 68 135 9 1 18 177 0 31 64 87 2 59 -----

4045

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 1 0 0 2 0 0 0 0 7 4 0 1 0 0 1 0 0 19 9 0 3---

-- 53

5-

-

9 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 4 1 1 0 0 5 0 0 18 4 0 2---

-- 40

10-

-

14 0 1 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 0 0 0 0 3 0 0 0 0 0 0 4 0 0 1 0 0 0 0 0 5 0 0 0 0 6 0 0 9 2 0 1---

-- 41

15-

-

19 0 1 0 0 0 0 2 0 0 0 1 0 1 0 0 1 0 0 0 0 0 0 8 0 1 0 0 2 0 0 0 0 0 0 13 0 1 0 0 0 0 0 2 1 2 0 0 5 7 0 0 4 5 0 4---

-- 61

20-

-

24 0 0 1 3 0 0 6 1 0 0 4 1 4 1 1 1 0 1 0 0 1 0 1 0 1 0 0 2 6 0 0 2 0 2 18 0 2 2 0 0 0 0 0 5 9 0 0 4 10 0 0 0 8 0 3---

--10

0

25-

-

29 0 1 2 1 0 0 4 0 0 0 4 0 10 3 0 1 0 1 0 0 5 0 1 1 3 0 0 3 13 0 1 13 3 2 8 0 1 1 0 0 0 0 0 4 7 0 0 3 6 0 0 2 2 0 1---

--10

7

30-

-

34 0 1 1 1 0 0 4 0 0 0 3 0 5 1 0 1 2 1 0 0 4 1 1 0 3 0 0 1 35 1 0 21 5 1 9 0 2 0 0 0 3 0 0 3 8 1 0 1 7 0 0 0 5 0 2---

--13

4

35-

-

39 0 1 2 1 0 0 15 0 0 0 9 2 10 3 0 3 0 0 0 0 9 0 0 1 1 0 0 3 77 0 2 44 10 7 19 1 3 1 0 0 0 0 0 1 16 1 0 0 8 0 2 3 8 0 2---

--26

5

40-

-

44 1 2 2 1 0 0 15 0 0 1 8 0 13 7 0 1 1 6 1 0 9 2 1 1 4 0 0 012

6 0 3 75 10 14 28 1 0 1 0 0 1 0 0 5 15 0 0 0 12 0 3 3 10 0 5---

--38

8

45-

-

49 0 2 0 2 0 1 27 1 0 3 12 1 24 10 1 5 0 5 1 0 26 1 2 0 15 0 0 317

0 2 1 86 19 14 45 0 0 1 0 0 4 0 1 7 19 1 0 1 17 0 2 1 5 1 5---

--54

4

50-

-

54 2 6 4 1 0 0 28 2 0 2 21 2 33 14 3 4 2 3 1 1 30 4 1 2 12 0 0 212

8 1 0 83 22 15 36 1 0 2 0 0 3 1 0 8 17 1 0 0 24 0 6 1 10 1 8---

--54

8

55-

-

59 2 1 3 3 2 0 15 2 0 6 24 1 30 15 1 14 1 4 1 0 34 5 1 2 15 1 0 2 96 1 4 52 22 12 28 0 0 2 0 0 4 0 0 4 13 0 1 0 16 0 3 0 9 0 6---

--45

8

60-

-

64 3 1 2 1 0 1 8 2 0 3 13 1 28 9 0 16 1 4 1 2 37 2 2 2 12 0 0 0 55 1 1 32 9 5 19 0 0 1 0 0 6 1 0 3 5 0 0 1 17 0 6 0 6 0 5---

--32

4

65-

-

69 3 1 12 0 1 0 10 0 0 2 27 2 30 12 1 9 5 7 0 0 58 3 1 2 26 0 0 2 42 0 3 27 6 1 16 1 0 0 0 0 4 0 0 5 12 2 0 1 10 0 4 1 0 0 3---

--35

2

70-

-

74 4 2 7 2 0 1 10 2 0 6 22 2 30 11 2 18 0 4 0 1 43 5 0 2 18 0 0 4 33 0 2 21 6 5 6 0 0 2 0 0 1 0 0 6 4 1 0 1 14 0 4 0 3 0 3---

--30

8

75+

2 2 5 0 0 1 5 0 0 5 35 2 35 18 1 9 4 4 2 2 38 4 1 3 37 0 0 2 24 1 1 15 7 3 8 0 0 1 0 0 4 2 0 3 7 0 0 1 17 0 1 3 1 0 6---

--32

2

% of

Total

0.40%

0.50%

1.00%

0.40%

0.10%

0.10%

3.80%

0.20%

0.00%

0.70%

4.50%

0.30%

6.30%

2.60%

0.20%

2.10%

0.40%

1.00%

0.20%

0.10%

7.30%

0.70%

0.70%

0.40%

3.70%

0.00%

0.00%

0.90%

19.90

%0.2

0%0.4

0%11

.60%

2.90%

2.00%

6.40%

0.10%

0.20%

0.40%

0.00%

0.00%

0.70%

0.10%

0.20%

1.70%

3.30%

0.20%

0.00%

0.40%

4.40%

0.00%

0.80%

1.60%

2.20%

0.00%

1.50% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

48:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

SA

BA

H, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, 2

007-

2011

Page 150: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

128

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

2 32 32 17 9 536

9 24 3 48 253 17 336

174 9

236 24 49 18 35 482 29 33 33 125 4 5 31 14 14 199 32 1 32 0 1 73 1 14 80 55 6 1 20 241 0 32 95 112 5 60 -----

3522

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0.1 0 1.1 0 0.4 0 0 0 0 1.3 1.1 0 0 0 0 0.4 0 0 4.6 1.4 0 0.6 ----- 12

5-

-

9 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.1 0 0 0.4 0 0 0 0 1.1 0 0 3.4 0.9 0.1 0.3 ----- 7

10-

-

14 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0 0 0.1 0 0 0.1 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0.3 0 0 0.1 0.9 0 0 1 1 0 0.3 ----- 6

15-

-

19 0 0.1 0 0.1 0 0 1.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 1 0.1 0 0 0 0.1 0 0 0.1 0.3 0 0 0 0 0.1 0 0 0.7 0 0 0 0.3 1.8 0 0 1.2 0.9 0 0---

-- 8

20-

-

24 0 0 0 0.3 0 0 1.9 0 0 0 0.2 0 0.7 0.2 0 0 0.2 0.2 0 0 0 0 1 0 0 0 0.2 0.2 0 0 0 0.9 0 0 0 0 0 0 0 0.5 0 0 0 0.5 0.5 0 0 0.5 2.3 0 0.2 ----- 10

25-

-

29 0 0.2 0.6 0.2 0 0 2.2 0 0 0 0.7 0 2.1 0.4 0 0.4 0.2 0 0.2 0 0.9 0 0.2 0.2 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 1.1 0.4 0.2 0 0 1.7 0 0.2 0.9 0.9 0 0---

-- 14

30-

-

34 0 0 0.5 0.3 0 0 4.7 0 0 0.3 0.8 0.3 2.4 1.3 0.3 1 0 0.3 0.3 0 0.8 0 0.3 0.3 1 0 0.3 0.5 0 0.3 0 0.8 0 0.3 0 0 0.3 0 0 1 0 0 0 0.5 3.4 0 0 0.5 1.6 0 0---

-- 24

35-

-

39 0 0 0.9 0.6 0 0 6.6 0 0 0 2 0 3.7 1.7 0 2 0 0.3 0 0.3 3.4 1.1 0 0.6 1.7 0 0 0.9 0 0.3 0 1.4 0 0.3 0 0 0.3 0 0 0.9 0.6 0 0 0.3 3.2 0 0 1.1 2 0.3 0.6 ----- 37

40-

-

44 0.6 0.3 0 0 0 010

.5 0.3 0 0.3 3.3 0.9 6 4.2 0.3 4.5 0.3 0.6 0.9 0 5.4 0.3 0.6 0.3 1.2 0 0.3 0.6 0.6 0.9 0 0.6 0 0.6 0 0 0.6 0 0 2.1 1.5 0.3 0 0 3.9 0 0.3 0.3 1.2 0.3 0.3 ----- 55

45-

-

49 0 0.7 1 0 0.3 020

.8 0 0 1 6.5 0.3 5.9 6.5 0.3 6.2 0.7 1.6 0.3 113

.7 0.7 0.7 0.3 2 0.3 0 0.7 1 0.7 0 0 0.3 0.3 0 0 2 0 1 1.3 1.6 0 0 1 7.5 0 1.3 0.3 2 0 0.3 ----- 92

50-

-

54 0 1.2 1.2 0.4 0.8 0 22 0 0.4 2 7.6 1.2 14 9.6 012

.4 0.8 1.2 1.2 1.2 20 1.6 0 2.4 3.6 0.4 0.4 0.8 0.4 0.8 4 0.8 0 2.8 0 0 3.2 0 0.8 3.2 3.6 0.8 0 0.4 12.4 0 2 1.6 3.6 0 2

-----

149

55-

-

59 0 2.4 1.8 1.2 0 028

.5 0.6 0.6 4.7 19 1.2 24.3

11.3 0

19.6 2.4 4.2 0 3

40.4 1.2 1.8 1.8 7.1 0 0.6 1.8 1.8 1.8 11.3 0.6 0 3 0 0 4.7 0 0 4.7 4.7 0 0.6 1.2 13.1 0 3.6 1.2 6.5 0.6 9.5 -----

248

60-

-

64 0 2.8 3.7 1.9 1.9 0.9 29 2.8 0 0.9 27.1 2.8 41.1 14 0.9 37.4 2.8 5.6 1.9 6.5 72.9 2.8 0.9 5.6 12.2 0 0 1.9 0 0

24.3 0 0 4.7 0 0 2.8 0 0 3.7 2.8 0.9 0 1.9 25.2 0 2.8 0.9 2.8 0 6.5 -----

360

65-

-

69 0 9.5 2.4 2.4 3.6 0 32 8.3 010

.752

.1 3.6 47.3

36.7 1.2 41.4 3.6 10.7 4.7 5.9

101.8 9.5 3.6 4.7 23.7 1.2 0 8.3 2.4 1.2 48.5 0 0 3.6 0 0

18.9 0 0 4.7 11.8 0 0 1.2 24.9 0 7.1 0 9.5 1.2 10.7 -----

574

70-

-

74 0 8.9 5.3 3.5 1.8 5.3 33.6

10.6 0

17.7

70.8 1.8 70.8 23 5.3 44.3 7.1 8.9 3.5 12.4

99.1 3.5 3.5 5.3 44.3 0 0 0 5.3 0

74.3 1.8 0 5.3 0 1.8 23 0 0

10.6

10.6 1.8 0 0

37.2 0 5.3 0

12.4 0 7.1 -----

687

75+

0 6.2 9.2 1.5 0 1.5 16.9 7.7 1.5 15.4

66.2 0

93.9

36.9 1.5 35.4 4.6 13.8 0 6.2 96.9 4.6 0 6.2 40 1.5 0 4.6 0 0

92.3 0 0 1.5 0 0 20 1.5 0 6.2 4.6 0 0 3.1 27.7 0 4.6 1.5 6.2 0 9.2 -----

651

Crud

eRa

te 0 0.5 0.5 0.3 0.2 0.1 6.2 0.4 0.1 0.8 4.2 0.3 5.6 2.9 0.2 3.9 0.4 0.8 0.3 0.6 8.1 0.5 0.6 0.6 2.1 0.1 0.1 0.5 0.2 0.2 3.3 0.5 0 0.5 0 0 1.2 0 0.2 1.3 0.9 0.1 0 0.3 4 0 0.5 1.6 1.9 0.1 1---

--58

.9

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

49:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, S

AB

AH

, AL

L R

ESI

DE

NT

S, M

AL

ES,

200

7-20

11

ASR

Wor

ld 0 0.9 0.8 0.4 0.3 0.2 8.5 0.8 0.1 1.4 7.4 0.5 9.3 4.7 0.3 6.6 0.7 1.4 0.5 1.1 14 0.8 0.6 0.9 3.7 0.1 0.1 0.8 0.4 0.3 6.4 0.5 0 0.8 0 0 2.1 0 0.3 1.7 1.4 0.1 0 0.4 5.9 0 0.9 1.5 2.3 0.1 1.6 -----

93.6

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 151: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

129

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages 17 22 41 18 3 415

2 10 0 28 183 14 253

104 10 84 16 40 7 6

294 27 27 16 148 1 0 35 805 7 18 471

119 81 259 4 9 17 0 0 30 4 10 68 135 9 1 18 177 0 31 64 87 2 59 -----

4045

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0 0 0.2 0 0 0.3 0 0 0 0 1.1 0.6 0 0.2 0 0 0.2 0 0 2.9 1.4 0 0.5 ----- 8

5-

-

9 0 0 0 0.1 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.6 0.1 0.1 0 0 0.7 0 0 2.7 0.6 0 0.3 ----- 6

10-

-

14 0 0.2 0 0.2 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0.5 0 0 0 0 0 0 0.6 0 0 0.2 0 0 0 0 0 0.8 0 0 0 0 0.9 0 0 1.4 0.3 0 0.2 ----- 6

15-

-

19 0 0.1 0 0 0 0 0.3 0 0 0 0.1 0 0.1 0 0 0.1 0 0 0 0 0 0 1.2 0 0.1 0 0 0.3 0 0 0 0 0 0 1.9 0 0.1 0 0 0 0 0 0.3 0.1 0.3 0 0 0.7 1 0 0 0.6 0.7 0 0.6 ----- 9

20-

-

24 0 0 0.2 0.5 0 0 1 0.2 0 0 0.7 0.2 0.7 0.2 0.2 0.2 0 0.2 0 0 0.2 0 0.2 0 0.2 0 0 0.3 1 0 0 0.3 0 0.3 3 0 0.3 0.3 0 0 0 0 0 0.8 1.5 0 0 0.7 1.7 0 0 0 1.3 0 0.5 ----- 17

25-

-

29 0 0.2 0.4 0.2 0 0 0.7 0 0 0 0.7 0 1.8 0.6 0 0.2 0 0.2 0 0 0.9 0 0.2 0.2 0.6 0 0 0.6 2.4 0 0.2 2.4 0.6 0.4 1.5 0 0.2 0.2 0 0 0 0 0 0.7 1.3 0 0 0.6 1.1 0 0 0.4 0.4 0 0.2 ----- 20

30-

-

34 0 0.3 0.3 0.3 0 0 1 0 0 0 0.8 0 1.3 0.3 0 0.3 0.5 0.3 0 0 1 0.3 0.3 0 0.8 0 0 0.3 9 0.3 0 5.4 1.3 0.3 2.3 0 0.5 0 0 0 0.8 0 0 0.8 2.1 0.3 0 0.3 1.8 0 0 0 1.3 0 0.5 ----- 35

35-

-

39 0 0.3 0.6 0.3 0 0 4.2 0 0 0 2.5 0.6 2.8 0.8 0 0.8 0 0 0 0 2.5 0 0 0.3 0.3 0 0 0.8 21.7 0 0.6 12.4 2.8 2 5.4 0.3 0.8 0.3 0 0 0 0 0 0.3 4.5 0.3 0 0 2.3 0 0.6 0.8 2.3 0 0.6 ----- 75

40-

-

44 0.3 0.6 0.6 0.3 0 0 4.7 0 0 0.3 2.5 0 4.1 2.2 0 0.3 0.3 1.9 0.3 0 2.8 0.6 0.3 0.3 1.3 0 0 039

.6 0 0.9 23.6 3.1 4.4 8.8 0.3 0 0.3 0 0 0.3 0 0 1.6 4.7 0 0 0 3.8 0 0.9 0.9 3.1 0 1.6 -----

122

45-

-

49 0 0.7 0 0.7 0 0.4 9.8 0.4 0 1.1 4.4 0.4 8.7 3.6 0.4 1.8 0 1.8 0.4 0 9.5 0.4 0.7 0 5.5 0 0 1.1 61.9 0.7 0.4 31.3 6.9 5.1 16.4 0 0 0.4 0 0 1.5 0 0.4 2.6 6.9 0.4 0 0.4 6.2 0 0.7 0.4 1.8 0.4 1.8 -----

198

50-

-

54 0.9 2.8 1.9 0.5 0 0 13 0.9 0 0.9 9.8 0.9 15.4 6.5 1.4 1.9 0.9 1.4 0.5 0.5 14 1.9 0.5 0.9 5.6 0 0 0.9 59.5 0.5 0

38.6

10.2 7

16.7 0.5 0 0.9 0 0 1.4 0.5 0 3.7 7.9 0.5 0 0

11.2 0 2.8 0.5 4.7 0.5 3.7 -----

255

55-

-

59 1.4 0.7 2.1 2.1 1.4 010

.5 1.4 0 4.2 16.8 0.7 21.1

10.5 0.7 9.8 0.7 2.8 0.7 0

23.9 3.5 0.7 1.4 10.5 0.7 0 1.4 67.4 0.7 2.8 36.5

15.4 8.4 19.7 0 0 1.4 0 0 2.8 0 0 2.8 9.1 0 0.7 0

11.2 0 2.1 0 6.3 0 4.2 -----

321

60-

-

64 3 1 2 1 0 1 8 2 0 313

.1 128

.1 9 016

.1 1 4 1 237

.2 2 2 212

.1 0 0 055

.3 1 132

.2 9 519

.1 0 0 1 0 0 6 1 0 3 5 0 0 117

.1 0 6 0 6 0 5---

--32

6

65-

-

69 4 1.3 16 0 1.3 013

.3 0 0 2.7 36 2.7 40 16 1.3 12 6.7 9.3 0 077

.3 4 1.3 2.7 34.7 0 0 2.7 56 0 4 36 8 1.3 21.3 1.3 0 0 0 0 5.3 0 0 6.7 16 2.7 0 1.3 13.3 0 5.3 1.3 0 0 4

-----

469

70-

-

74 7 3.5 12.3 3.5 0 1.8 17.5 3.5 0

10.5

38.6 3.5 52.6

19.3 3.5 31.6 0 7 0 1.8 75.4 8.8 0 3.5 31.6 0 0 7

57.9 0 3.5 36.8

10.5 8.8 10.5 0 0 3.5 0 0 1.8 0 0

10.5 7 1.8 0 1.8 24.6 0 7 0 5.3 0 5.3 -----

540

75+ 3.2 3.2 7.9 0 0 1.6 7.9 0 0 7.9 55

.6 3.2 55.6

28.6 1.6 14.3 6.4 6.4 3.2 3.2 60.3 6.4 1.6 4.8 58.7 0 0 3.2 38.1 1.6 1.6 23.8

11.1 4.8 12.7 0 0 1.6 0 0 6.4 3.2 0 4.8 11.1 0 0 1.6 27 0 1.6 4.8 1.6 0 9.5 -----

511

Crud

eRa

te 0.3 0.4 0.7 0.3 0.1 0.1 2.6 0.2 0 0.5 3.2 0.2 4.4 1.8 0.2 1.4 0.3 0.7 0.1 0.1 5.1 0.5 0.5 0.3 2.6 0 0 0.6 13.9 0.1 0.3 8.1 2.1 1.4 4.5 0.1 0.2 0.3 0 0 0.5 0.1 0.2 1.2 2.3 0.2 0 0.3 3.1 0 0.5 1.1 1.5 0 1

-----

69.8

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

50:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, S

AB

AH

, AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

200

7-20

11

ASR

Wor

ld 0.6 0.5 1.3 0.4 0.1 0.1 3.7 0.3 0 0.9 5.4 0.4 7.3 3 0.3 2.7 0.5 1.2 0.2 0.2 9.2 0.8 0.5 0.5 4.6 0 0 0.8 19.7 0.2 0.5 11.6 3.1 2 6.1 0.1 0.1 0.4 0 0 0.9 0.1 0.2 1.6 3.2 0.2 0 0.3 4.5 0 0.9 1.1 1.8 0 1.4 -----

105.4

Page 152: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

130

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

1 32 23 28 7 166

5 9 2 57 337 6

349

288 1

289 54 88 18 75 619 8 48 30 110 1 2 57 11 26 206 54 1 67 0 0 95 0 9 96 41 9 11 49 310 0 38 96 121 31 73 -----

4549

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 11 0 5 0 0 0 0 7 5 0 5 3 1 4 0 0 28 7 6 0---

-- 83

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 1 14 0 2 0 5 10 0 0 10 3 0 0---

-- 50

10-

-

14 0 0 0 0 0 0 3 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 14 0 0 0 0 3 0 0 0 2 0 0 0 0 0 0 1 9 1 0 3 1 6 0 0 15 5 1 0---

-- 65

15-

-

19 0 0 0 1 0 0 14 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 7 0 0 0 0 4 0 0 0 5 0 0 0 0 0 0 0 4 1 0 3 2 12 0 0 3 4 1 0---

-- 63

20-

-

24 0 1 0 1 0 0 13 0 0 0 0 0 1 3 0 1 0 0 0 0 3 1 4 1 1 0 0 4 0 0 0 8 0 0 0 0 0 0 0 6 0 0 0 6 12 0 0 4 8 2 1---

-- 81

25-

-

29 0 1 0 2 0 0 20 0 0 0 2 0 5 2 0 2 1 0 0 0 2 1 2 0 1 0 0 1 0 0 0 7 0 0 0 0 0 0 0 2 3 0 0 6 9 0 0 2 6 1 1---

-- 79

30-

-

34 0 2 0 2 0 0 28 0 0 2 1 0 12 2 0 7 0 1 0 1 7 0 3 2 2 0 0 2 0 3 0 7 0 1 0 0 0 0 0 4 0 0 0 4 11 0 1 3 4 0 2---

--11

4

35-

-

39 0 4 0 4 1 0 69 0 0 0 14 0 9 12 0 10 4 0 0 0 11 2 2 1 1 0 0 6 2 1 0 3 0 1 0 0 2 0 0 8 3 1 1 1 8 0 0 4 11 2 3---

--20

1

40-

-

44 0 2 2 3 1 0 79 0 0 3 23 0 16 10 0 14 0 1 3 2 26 2 6 4 3 0 0 6 0 5 0 1 0 5 0 0 2 0 0 9 3 0 0 7 22 0 2 0 7 0 5---

--27

4

45-

-

49 0 6 2 5 1 0 99 1 1 6 19 2 28 22 0 11 3 11 5 3 44 0 3 2 9 0 0 2 1 4 4 2 0 5 0 0 7 0 0 7 3 0 1 2 20 0 5 1 9 2 7---

--36

5

50-

-

54 0 1 1 3 0 010

0 0 0 2 28 2 42 23 1 35 4 9 2 12 66 1 2 3 13 1 0 10 2 3 10 3 0 10 0 0 9 0 0 8 4 0 0 2 38 0 5 6 13 4 12 -----

490

55-

-

59 0 3 2 2 1 0 82 1 0 12 33 2 43 39 0 58 8 12 1 10 77 1 1 4 13 0 0 4 1 2 12 1 0 7 0 0 13 0 0 3 8 0 0 2 30 0 8 5 10 3 8---

--52

2

60-

-

64 0 3 4 0 0 0 67 1 1 9 59 0 47 43 0 63 7 11 1 12 123 0 1 2 14 0 0 5 2 3 45 0 0 9 0 0 16 0 0 7 6 1 0 2 46 0 5 3 14 2 8

-----

642

65-

-

69 0 4 4 1 0 0 46 3 0 5 50 0 44 39 0 31 14 22 3 13 114 0 1 7 14 0 1 7 2 2 43 0 0 10 0 0 11 0 0 6 4 0 0 2 34 0 5 3 12 2 10 -----

569

70-

-

74 0 2 3 1 2 0 25 3 0 5 43 0 42 42 0 26 7 14 0 8 67 0 0 1 11 0 0 0 0 2 35 1 0 11 0 0 18 0 0 3 3 0 0 3 24 0 2 6 3 2 7---

--42

2

75+

1 3 5 3 1 1 20 0 0 13 65 0 59 50 0 31 6 7 2 14 79 0 0 3 28 0 1 2 1 1 57 0 1 3 0 0 17 0 0 1 2 0 0 3 24 0 5 3 5 3 9---

--52

9

% of

Total 0.0

0%0.7

0%0.5

0%0.6

0%0.2

0%0.0

0%14

.60%

0.20%

0.00%

1.30%

7.40%

0.10%

7.70%

6.30%

0.00%

6.40%

1.20%

1.90%

0.40%

1.60%

13.60

%0.2

0%1.1

0%0.7

0%2.4

0%0.0

0%0.0

0%1.3

0%0.2

0%0.6

0%4.5

0%1.2

0%0.0

0%1.5

0%0.0

0%0.0

0%2.1

0%0.0

0%0.2

0%2.1

0%0.9

0%0.2

0%0.2

0%1.1

0%6.8

0%0.0

0%0.8

0%2.1

0%2.7

0%0.7

0%1.6

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

51:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

SA

RA

WA

K, A

LL

RE

SID

EN

TS,

MA

LE

S, 2

007-

2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 153: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

131

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

0 30 30 44 8 025

8 4 1 34 195 2

275

229 5 88 52 51 12 19 347 12 31 24 90 4 1 40

1198 20 10 64

019

0 21 325 0 13 31 0 0 29 0 11 89 161 8 1 33 222 0 37 72 103 21 64 -----

5185

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 7 0 0 2 0 0 0 0 8 5 0 3 0 0 2 0 0 36 6 1 1---

-- 77

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 1 9 0 2 0 1 4 0 0 9 6 1 0---

-- 36

10-

-

14 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 1 0 0 0 0 0 0 9 0 0 0 0 0 0 0 0 7 2 0 0 1 6 0 0 5 6 3 0---

-- 45

15-

-

19 0 0 0 2 0 0 6 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 6 1 1 0 0 2 1 0 0 0 0 0 6 0 0 1 0 0 0 0 0 6 7 0 0 4 10 0 0 2 2 1 0---

-- 61

20-

-

24 0 0 0 1 0 0 12 0 0 0 1 0 1 1 0 1 0 0 1 0 2 1 4 0 0 0 0 1 5 0 0 4 1 0 16 0 1 1 0 0 0 0 0 3 5 0 0 7 7 0 0 0 7 1 1---

-- 85

25-

-

29 0 2 1 2 0 0 9 0 0 0 0 0 1 5 0 0 0 0 0 0 1 0 2 1 1 0 0 1 21 0 0 6 2 0 15 0 4 1 0 0 0 0 0 2 11 0 0 4 5 0 0 0 7 0 1---

--10

5

30-

-

34 0 1 1 2 1 0 20 0 0 0 3 1 9 3 0 4 2 0 0 0 4 0 4 1 0 0 0 2 36 0 0 27 8 1 16 0 1 1 0 0 1 0 1 3 11 0 0 4 7 0 0 0 3 0 2---

--18

0

35-

-

39 0 3 1 4 1 0 27 0 0 1 3 0 8 5 1 3 1 0 0 0 8 2 2 1 2 0 0 310

0 1 0 76 8 1 19 0 4 2 0 0 0 0 0 7 10 1 0 4 7 0 3 1 7 1 4---

--33

2

40-

-

44 0 2 1 5 0 0 33 0 0 1 7 0 13 10 1 7 0 5 3 0 14 0 2 4 3 0 0 119

8 2 0 86 18 2 31 0 1 0 0 0 0 0 1 8 18 1 0 1 19 0 1 2 4 1 1---

--50

7

45-

-

49 0 1 3 4 1 0 38 0 0 1 15 0 22 19 0 8 3 2 0 3 22 0 1 0 4 0 1 621

6 0 111

2 33 4 47 0 2 4 0 0 1 0 0 5 18 0 1 1 15 0 3 2 12 0 10 -----

641

50-

-

54 0 4 1 4 1 0 37 1 0 5 19 0 21 13 1 6 5 12 2 1 38 2 3 1 8 0 0 317

8 2 1 96 36 6 44 0 0 5 0 0 4 0 0 10 24 0 0 2 25 0 6 4 12 2 4---

--64

9

55-

-

59 0 3 6 4 0 0 22 1 1 5 25 0 54 34 1 10 6 8 2 1 45 0 0 3 6 0 0 517

6 3 2 68 33 4 44 0 0 3 0 0 2 0 0 10 19 0 0 0 34 0 5 2 11 1 7---

--66

6

60-

-

64 0 3 1 4 0 0 23 0 0 6 36 1 29 34 1 16 5 9 0 4 70 3 2 2 9 2 0 412

0 4 0 55 23 2 32 0 0 5 0 0 2 0 0 6 8 1 0 1 22 0 12 0 6 1 8---

--57

2

65-

-

69 0 2 4 3 0 0 17 1 0 4 26 0 33 34 0 13 12 3 0 6 66 2 0 3 12 1 0 5 68 3 2 37 14 0 14 0 0 4 0 0 10 0 0 5 19 0 0 0 26 0 5 4 7 2 5---

--47

2

70-

-

74 0 4 4 5 1 0 6 1 0 4 24 0 33 26 0 6 5 3 3 2 38 0 1 2 13 1 0 1 43 0 1 40 8 1 9 0 0 1 0 0 3 0 0 1 6 0 0 2 16 0 1 1 2 4 8---

--33

0

75+

0 5 7 2 3 0 8 0 0 7 35 0 51 45 0 10 13 9 1 2 38 1 1 4 31 0 0 3 36 5 3 33 6 0 14 0 0 1 0 0 6 0 0 2 3 0 0 1 17 0 1 4 5 2 12 -----

427

% of

Total

0.00%

0.60%

0.60%

0.80%

0.20%

0.00%

5.00%

0.10%

0.00%

0.70%

3.80%

0.00%

5.30%

4.40%

0.10%

1.70%

1.00%

1.00%

0.20%

0.40%

6.70%

0.20%

0.60%

0.50%

1.70%

0.10%

0.00%

0.80%

23.10

%0.4

0%0.2

0%12

.30%

3.70%

0.40%

6.30%

0.00%

0.30%

0.60%

0.00%

0.00%

0.60%

0.00%

0.20%

1.70%

3.10%

0.20%

0.00%

0.60%

4.30%

0.00%

0.70%

1.40%

2.00%

0.40%

1.20% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

52:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

SA

RA

WA

K, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, 2

007-

2011

Page 154: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

132

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

1 32 23 28 7 166

5 9 2 57 337 6

349

288 1

289 54 88 18 75 619 8 48 30 110 1 2 57 11 26 206 54 1 67 0 0 95 0 9 96 41 9 11 49 310 0 38 96 121 31 73 -----

4549

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 1.9 0 0.9 0 0 0 0 1.2 0.9 0 0.9 0.5 0.2 0.7 0 0 4.8 1.2 1 0---

-- 14

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0.2 2.2 0 0.3 0 0.8 1.6 0 0 1.6 0.5 0 0---

-- 8

10-

-

14 0 0 0 0 0 0 0.5 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 2.3 0 0 0 0 0.5 0 0 0 0.3 0 0 0 0 0 0 0.2 1.5 0.2 0 0.5 0.2 1 0 0 2.4 0.8 0.2 0---

-- 11

15-

-

19 0 0 0 0.2 0 0 2.3 0 0 0 0 0 0 0.2 0 0 0 0 0.2 0 0 0 1.2 0 0 0 0 0.7 0 0 0 0.8 0 0 0 0 0 0 0 0.7 0.2 0 0.5 0.3 2 0 0 0.5 0.7 0.2 0---

-- 11

20-

-

24 0 0.2 0 0.2 0 0 2.6 0 0 0 0 0 0.2 0.6 0 0.2 0 0 0 0 0.6 0.2 0.8 0.2 0.2 0 0 0.8 0 0 0 1.6 0 0 0 0 0 0 0 1.2 0 0 0 1.2 2.4 0 0 0.8 1.6 0.4 0.2 ----- 16

25-

-

29 0 0.2 0 0.5 0 0 4.6 0 0 0 0.5 0 1.1 0.5 0 0.5 0.2 0 0 0 0.5 0.2 0.5 0 0.2 0 0 0.2 0 0 0 1.6 0 0 0 0 0 0 0 0.5 0.7 0 0 1.4 2.1 0 0 0.5 1.4 0.2 0.2 ----- 18

30-

-

34 0 0.5 0 0.5 0 0 7.3 0 0 0.5 0.3 0 3.1 0.5 0 1.8 0 0.3 0 0.3 1.8 0 0.8 0.5 0.5 0 0 0.5 0 0.8 0 1.8 0 0.3 0 0 0 0 0 1 0 0 0 1 2.9 0 0.3 0.8 1 0 0.5 ----- 30

35-

-

39 0 1 0 1 0.3 017

.3 0 0 0 3.5 0 2.3 3 0 2.5 1 0 0 0 2.8 0.5 0.5 0.3 0.3 0 0 1.5 0.5 0.3 0 0.8 0 0.3 0 0 0.5 0 0 2 0.8 0.3 0.3 0.3 2 0 0 1 2.8 0.5 0.8 ----- 50

40-

-

44 0 0.5 0.5 0.8 0.3 020

.2 0 0 0.8 5.9 0 4.1 2.6 0 3.6 0 0.3 0.8 0.5 6.6 0.5 1.5 1 0.8 0 0 1.5 0 1.3 0 0.3 0 1.3 0 0 0.5 0 0 2.3 0.8 0 0 1.8 5.6 0 0.5 0 1.8 0 1.3 ----- 70

45-

-

49 0 1.7 0.6 1.4 0.3 027

.4 0.3 0.3 1.7 5.3 0.6 7.7 6.1 0 3 0.8 3 1.4 0.8 12.2 0 0.8 0.6 2.5 0 0 0.6 0.3 1.1 1.1 0.6 0 1.4 0 0 1.9 0 0 1.9 0.8 0 0.3 0.6 5.5 0 1.4 0.3 2.5 0.6 1.9 -----

101

50-

-

54 0 0.3 0.3 1 0 0 33 0 0 0.7 9.2 0.7 13.8 7.6 0.3 11.5 1.3 3 0.7 4

21.7 0.3 0.7 1 4.3 0.3 0 3.3 0.7 1 3.3 1 0 3.3 0 0 3 0 0 2.6 1.3 0 0 0.7 12.5 0 1.6 2 4.3 1.3 4

-----

161

55-

-

59 0 1.3 0.8 0.8 0.4 034

.5 0.4 0 5.1 13.9 0.8 18.1

16.4 0

24.4 3.4 5.1 0.4 4.2 32.4 0.4 0.4 1.7 5.5 0 0 1.7 0.4 0.8 5.1 0.4 0 2.9 0 0 5.5 0 0 1.3 3.4 0 0 0.8 12.6 0 3.4 2.1 4.2 1.3 3.4 -----

220

60-

-

64 0 1.5 2 0 0 0 34 0.5 0.5 4.6 30 023

.921

.8 0 32 3.6 5.6 0.5 6.1 62.4 0 0.5 1 7.1 0 0 2.5 1 1.5 22.8 0 0 4.6 0 0 8.1 0 0 3.6 3 0.5 0 1

23.4 0 2.5 1.5 7.1 1 4.1 -----

326

65-

-

69 0 3.1 3.1 0.8 0 036

.1 2.4 0 3.9 39.2 0

34.5

30.6 0

24.3 11

17.3 2.4 10.2

89.4 0 0.8 5.5 11 0 0.8 5.5 1.6 1.6 33.7 0 0 7.8 0 0 8.6 0 0 4.7 3.1 0 0 1.6 26.7 0 3.9 2.4 9.4 1.6 7.8 -----

446

70-

-

74 0 2.4 3.7 1.2 2.4 030

.5 3.7 0 6.1 52.4 0

51.2

51.2 0

31.7 8.5 17.1 0 9.8 81.7 0 0 1.2 13.4 0 0 0 0 2.4 42.7 1.2 0

13.4 0 0 22 0 0 3.7 3.7 0 0 3.7 29.3 0 2.4 7.3 3.7 2.4 8.5 -----

515

75+ 0.9 2.8 4.7 2.8 0.9 0.9 18

.8 0 012

.2 61 055

.4 47 029

.1 5.6 6.6 1.9 13.1

74.2 0 0 2.8 26.3 0 0.9 1.9 0.9 0.9 53.5 0 0.9 2.8 0 0 16 0 0 0.9 1.9 0 0 2.8 22.5 0 4.7 2.8 4.7 2.8 8.5 -----

497

Crud

eRa

te 0 0.5 0.4 0.5 0.1 011

.2 0.2 0 1 5.7 0.1 5.9 4.8 0 4.9 0.9 1.5 0.3 1.3 10.4 0.1 0.8 0.5 1.8 0 0 1 0.2 0.4 3.5 0.9 0 1.1 0 0 1.6 0 0.2 1.6 0.7 0.2 0.2 0.8 5.2 0 0.6 1.6 2 0.5 1.2 -----

76.4

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

53:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, S

AR

AW

AK

, AL

L R

ESI

DE

NT

S, M

AL

ES,

200

7-20

11

ASR

Wor

ld 0 0.6 0.5 0.5 0.1 011

.6 0.2 0 1.1 6.6 0.1 6.7 5.6 0 5.5 1.1 1.8 0.3 1.5 12.2 0.1 0.8 0.6 2.1 0 0 1 0.2 0.5 4.3 0.9 0 1.3 0 0 1.9 0 0.2 1.6 0.8 0.2 0.2 0.9 5.7 0 0.7 1.7 2.2 0.6 1.4 -----

85.7

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 155: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

133

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

0 30 30 44 8 025

8 4 1 34 195 2

275

229 5 88 52 51 12 19 347 12 31 24 90 4 1 40

1198 20 10 64

019

0 21 325 0 13 31 0 0 29 0 11 89 161 8 1 33 222 0 37 72 103 21 64 -----

5185

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0 0.2 0 0 0 0.2 0 0 0 0 0 0 1.2 0 0 0.4 0 0 0 0 1.4 0.9 0 0.5 0 0 0.4 0 0 6.3 1.1 0.2 0.2 ----- 14

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0.2 1.5 0 0.3 0 0.2 0.6 0 0 1.5 1 0.2 0---

-- 6

10-

-

14 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0.2 0 0 0 0 0 0 1.5 0 0 0 0 0 0 0 0 1.2 0.3 0 0 0.2 1 0 0 0.8 1 0.5 0---

-- 7

15-

-

19 0 0 0 0.3 0 0 1 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0.2 0.2 1 0.2 0.2 0 0 0.3 0.2 0 0 0 0 0 1 0 0 0.2 0 0 0 0 0 1 1.2 0 0 0.7 1.7 0 0 0.3 0.3 0.2 0---

-- 10

20-

-

24 0 0 0 0.2 0 0 2.3 0 0 0 0.2 0 0.2 0.2 0 0.2 0 0 0.2 0 0.4 0.2 0.8 0 0 0 0 0.2 1 0 0 0.8 0.2 0 3.1 0 0.2 0.2 0 0 0 0 0 0.6 1 0 0 1.4 1.4 0 0 0 1.4 0.2 0.2 ----- 16

25-

-

29 0 0.5 0.2 0.5 0 0 2.1 0 0 0 0 0 0.2 1.2 0 0 0 0 0 0 0.2 0 0.5 0.2 0.2 0 0 0.2 4.9 0 0 1.4 0.5 0 3.5 0 0.9 0.2 0 0 0 0 0 0.5 2.6 0 0 0.9 1.2 0 0 0 1.6 0 0.2 ----- 24

30-

-

34 0 0.3 0.3 0.5 0.3 0 5.3 0 0 0 0.8 0.3 2.4 0.8 0 1.1 0.5 0 0 0 1.1 0 1.1 0.3 0 0 0 0.5 9.5 0 0 7.2 2.1 0.3 4.2 0 0.3 0.3 0 0 0.3 0 0.3 0.8 2.9 0 0 1.1 1.9 0 0 0 0.8 0 0.5 ----- 48

35-

-

39 0 0.8 0.3 1 0.3 0 7 0 0 0.3 0.8 0 2.1 1.3 0.3 0.8 0.3 0 0 0 2.1 0.5 0.5 0.3 0.5 0 0 0.8 25.8 0.3 0

19.6 2.1 0.3 4.9 0 1 0.5 0 0 0 0 0 1.8 2.6 0.3 0 1 1.8 0 0.8 0.3 1.8 0.3 1

----- 86

40-

-

44 0 0.6 0.3 1.4 0 0 9.1 0 0 0.3 1.9 0 3.6 2.8 0.3 1.9 0 1.4 0.8 0 3.9 0 0.6 1.1 0.8 0 0 0.3 54.9 0.6 0

23.8 5 0.6 8.6 0 0.3 0 0 0 0 0 0.3 2.2 5 0.3 0 0.3 5.3 0 0.3 0.6 1.1 0.3 0.3 -----

140

45-

-

49 0 0.3 0.9 1.2 0.3 011

.8 0 0 0.3 4.7 0 6.8 5.9 0 2.5 0.9 0.6 0 0.9 6.8 0 0.3 0 1.2 0 0.3 1.9 67.2 0 0.3 34.8

10.3 1.2 14.6 0 0.6 1.2 0 0 0.3 0 0 1.6 5.6 0 0.3 0.3 4.7 0 0.9 0.6 3.7 0 3.1 -----

199

50-

-

54 0 1.5 0.4 1.5 0.4 013

.9 0.4 0 1.9 7.2 0 7.9 4.9 0.4 2.3 1.9 4.5 0.8 0.4 14.3 0.8 1.1 0.4 3 0 0 1.1 67.1 0.8 0.4 36.2

13.6 2.3 16.6 0 0 1.9 0 0 1.5 0 0 3.8 9 0 0 0.8 9.4 0 2.3 1.5 4.5 0.8 1.5 -----

244

55-

-

59 0 1.4 2.8 1.9 0 010

.2 0.5 0.5 2.3 11.6 0

25.1

15.8 0.5 4.6 2.8 3.7 0.9 0.5 20.9 0 0 1.4 2.8 0 0 2.3 81.7 1.4 0.9 31.6

15.3 1.9 20.4 0 0 1.4 0 0 0.9 0 0 4.6 8.8 0 0 0

15.8 0 2.3 0.9 5.1 0.5 3.2 -----

309

60-

-

64 0 1.8 0.6 2.4 0 014

.1 0 0 3.7 22 0.6 17.7

20.8 0.6 9.8 3.1 5.5 0 2.4 42.8 1.8 1.2 1.2 5.5 1.2 0 2.4 73.4 2.4 0

33.6

14.1 1.2 19.6 0 0 3.1 0 0 1.2 0 0 3.7 4.9 0.6 0 0.6 13.5 0 7.3 0 3.7 0.6 4.9 -----

350

65-

-

69 0 1.6 3.3 2.4 0 013

.8 0.8 0 3.3 21.1 0

26.8

27.6 0

10.6 9.8 2.4 0 4.9 53.7 1.6 0 2.4 9.8 0.8 0 4.1 55.3 2.4 1.6 30.1

11.4 0

11.4 0 0 3.3 0 0 8.1 0 0 4.1 15.4 0 0 0

21.1 0 4.1 3.3 5.7 1.6 4.1 -----

384

70-

-

74 0 4.7 4.7 5.9 1.2 0 7.1 1.2 0 4.7 28.4 0

39.1

30.8 0 7.1 5.9 3.6 3.6 2.4 45 0 1.2 2.4 15.4 1.2 0 1.2 50.9 0 1.2 47.3 9.5 1.2 10.7 0 0 1.2 0 0 3.6 0 0 1.2 7.1 0 0 2.4 18.9 0 1.2 1.2 2.4 4.7 9.5 -----

391

75+

0 4 5.6 1.6 2.4 0 6.4 0 0 5.6 28 040

.8 36 0 810

.4 7.2 0.8 1.6 30.4 0.8 0.8 3.2 24.8 0 0 2.4 28.8 4 2.4 26.4 4.8 0

11.2 0 0 0.8 0 0 4.8 0 0 1.6 2.4 0 0 0.8 13.6 0 0.8 3.2 4 1.6 9.6 -----

342

Crud

eRa

te

0 0.5 0.5 0.8 0.1 0 4.5 0.1 0 0.6 3.4 0 4.8 4 0.1 1.5 0.9 0.9 0.2 0.3 6 0.2 0.5 0.4 1.6 0.1 0 0.7 20.9 0.3 0.2 11.2 3.3 0.4 5.7 0 0.2 0.5 0 0 0.5 0 0.2 1.6 2.8 0.1 0 0.6 3.9 0 0.6 1.3 1.8 0.4 1.1 -----

90.4

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

54:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, S

AR

AW

AK

, AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

200

7-20

11

ASR

Wor

ld 0 0.6 0.6 0.8 0.1 0 4.8 0.1 0 0.7 4 0 5.4 4.6 0.1 1.8 1.1 1 0.2 0.4 7.3 0.2 0.5 0.5 1.8 0.1 0 0.8 22.7 0.4 0.2 12.1 3.7 0.4 6.1 0 0.2 0.6 0 0 0.6 0 0.2 1.6 3 0.2 0 0.6 4.3 0 0.8 1.4 1.9 0.4 1.3 -----

100.2

Page 156: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

134

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

5 62 43 30 13 10 459 19 5 80 155 8

338

310 9

226 42 98 32 87 788 25 53 17 208 5 1 15 15 12 325 36 6 94 2 3

116 5 6

192 42 1 31 23 196 1 18 64 58 25 51 -----

4465

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 4 0 0 0 0 1 0 0 21 3 3 0---

-- 37

5-

-

9 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 2 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 2 0 0 0 0 6 0 0 12 6 1 0---

-- 34

10-

-

14 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18 0 0 0 2 3 0 0 8 5 1 0---

-- 42

15-

-

19 0 0 0 0 0 0 3 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 8 0 2 0 0 2 0 0 0 2 0 0 0 0 0 0 0 13 0 0 2 3 4 0 0 8 5 1 1---

-- 56

20-

-

24 0 0 0 1 0 0 3 1 0 0 0 0 1 1 0 1 0 0 0 0 4 3 8 1 2 0 0 1 0 0 0 4 0 0 0 0 0 0 0 6 4 0 2 1 10 0 0 2 3 2 0---

-- 61

25-

-

29 0 0 1 3 1 0 8 0 0 1 1 0 4 3 0 0 0 1 0 1 2 3 6 0 1 0 0 2 0 0 0 6 0 1 0 0 0 0 0 3 0 0 1 2 10 0 0 3 3 2 0---

-- 69

30-

-

34 0 1 1 1 0 0 19 0 0 0 2 0 2 2 1 2 0 0 0 1 4 1 1 0 1 0 0 1 0 0 0 8 0 0 0 0 0 0 0 13 2 0 0 1 2 0 0 0 2 0 0---

-- 68

35-

-

39 0 2 6 2 0 0 40 0 0 0 2 0 7 5 0 3 1 0 0 0 7 0 2 1 4 0 0 1 0 0 0 5 0 0 0 0 3 0 1 9 4 0 2 1 9 0 0 1 1 0 2---

--12

1

40-

-

44 0 5 1 3 1 0 61 0 0 5 3 0 15 13 1 8 0 3 3 2 17 3 3 0 10 0 0 0 1 0 2 2 1 10 0 0 3 0 0 12 2 0 2 2 15 0 0 2 3 1 2---

--21

7

45-

-

49 1 14 3 3 2 3 65 2 0 4 7 0 27 21 0 18 4 10 3 3 45 2 1 0 9 0 1 1 1 1 1 2 1 6 0 0 1 1 0 19 1 0 4 2 16 0 3 0 4 1 3---

--31

6

50-

-

54 1 3 2 1 1 2 62 4 1 12 16 1 26 20 0 28 1 12 3 9 64 4 3 3 7 0 0 1 3 1 15 3 1 11 0 0 6 0 0 18 5 0 7 3 13 0 2 0 1 4 3---

--38

3

55-

-

59 0 8 6 5 2 0 68 0 0 13 23 1 50 54 1 41 7 9 5 9 83 1 4 5 22 2 0 2 1 1 20 1 0 11 1 0 7 0 0 21 9 0 5 3 23 0 4 0 6 2 6---

--54

2

60-

-

64 1 11 10 4 2 1 54 3 1 8 20 3 49 59 2 30 6 17 6 18 129 4 4 2 25 0 0 0 3 5 39 0 0 15 0 0 20 2 0 24 5 0 2 0 26 0 4 0 6 2 6

-----

628

65-

-

69 0 5 4 2 1 0 34 1 0 11 24 1 61 44 2 40 5 13 1 21 142 1 2 2 34 2 0 2 3 1 58 0 2 18 0 3 25 1 0 13 1 1 3 1 28 0 3 2 7 0 11 -----

636

70-

-

74 2 5 5 2 1 2 32 4 0 11 21 2 40 35 1 29 9 17 2 11 137 2 2 1 39 0 0 1 1 1 87 1 1 11 1 0 22 0 1 11 3 0 1 1 17 0 0 4 2 2 8

-----

588

75+

0 8 4 2 2 2 9 3 3 15 36 0 55 53 1 23 9 16 9 10 154 1 3 2 52 1 0 1 2 1

103 0 0 11 0 0 29 1 3 6 6 0 0 1 13 1 2 1 1 3 9

-----

667

% of

Total 0.1

0%1.4

0%1.0

0%0.7

0%0.3

0%0.2

0%10

.30%

0.40%

0.10%

1.80%

3.50%

0.20%

7.60%

6.90%

0.20%

5.10%

0.90%

2.20%

0.70%

1.90%

17.60

%0.6

0%1.2

0%0.4

0%4.7

0%0.1

0%0.0

0%0.3

0%0.3

0%0.3

0%7.3

0%0.8

0%0.1

0%2.1

0%0.0

0%0.1

0%2.6

0%0.1

0%0.1

0%4.3

0%0.9

0%0.0

0%0.7

0%0.5

0%4.4

0%0.0

0%0.4

0%1.4

0%1.3

0%0.6

0%1.1

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

55:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

PE

RA

K, A

LL

RE

SID

EN

TS,

MA

LE

S, 2

007-

2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 157: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

135

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

3 46 70 18 3 614

1 9 2 47 121 6

287

240 5 73 49 98 15 8

299 7 50 13 163 4 0 11

1809 14 14 38

019

0 90 359 4 9 44 1 0 28 0 5

204

149 0 16 23 150 0 22 43 91 17 48 -----

5504

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 4 0 0 0 0 1 7 0 0 0 0 0 0 0 11 2 3 0---

-- 29

5-

-

9 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12 0 0 0 0 1 0 0 9 6 0 1---

-- 32

10-

-

14 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 6 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 13 3 0 0 0 3 0 0 6 2 0 0---

-- 39

15-

-

19 0 0 0 1 0 0 3 0 0 0 0 0 1 0 0 2 0 0 0 0 0 0 3 0 0 0 0 1 0 0 0 0 0 0 9 0 0 0 0 0 0 0 0 5 3 0 1 3 0 0 0 6 7 1 0---

-- 46

20-

-

24 0 0 0 0 0 0 4 0 0 0 0 0 2 1 0 0 0 0 0 0 1 1 3 0 2 0 0 0 4 0 0 0 0 2 11 0 2 0 0 0 0 0 0 7 9 0 0 6 6 0 0 2 1 0 1---

-- 65

25-

-

29 0 1 0 0 0 0 0 0 0 0 2 0 6 1 0 2 0 1 0 0 3 0 0 0 1 0 0 0 15 0 0 3 1 2 15 0 3 0 0 0 0 0 0 5 8 0 0 3 6 0 0 2 5 1 1---

-- 87

30-

-

34 0 1 0 0 0 1 4 0 0 0 3 1 6 6 0 1 0 0 0 1 2 0 0 0 2 0 0 0 50 0 0 9 3 4 13 0 1 0 0 0 0 0 0 8 10 0 0 2 3 0 0 1 4 1 2---

--13

9

35-

-

39 0 2 2 2 0 0 5 0 0 1 2 0 7 10 0 2 1 3 0 0 8 1 2 1 1 1 0 111

3 0 0 17 8 0 13 1 0 2 0 0 0 0 0 17 8 0 1 0 10 0 0 0 10 2 2---

--25

6

40-

-

44 0 7 1 2 1 0 16 0 0 1 8 0 9 6 0 1 1 3 0 0 18 0 1 2 5 0 0 319

4 0 0 31 11 5 26 0 1 0 1 0 0 0 0 14 11 0 1 2 6 0 2 0 8 0 4---

--40

2

45-

-

49 0 3 4 3 0 0 17 1 0 2 10 0 22 7 0 4 2 5 1 1 27 1 1 0 6 0 0 030

6 1 0 51 19 9 56 1 1 5 0 0 0 0 0 25 22 0 2 3 16 0 0 1 8 1 2---

--64

6

50-

-

54 0 4 3 1 0 0 21 1 1 4 7 2 26 23 1 4 4 8 1 3 27 0 4 1 10 1 0 231

7 5 0 65 37 20 58 1 0 4 0 0 0 0 0 26 17 0 7 4 23 0 4 0 8 1 2---

--75

8

55-

-

59 0 6 6 2 1 0 20 1 1 5 15 0 36 33 1 9 9 15 3 1 31 1 3 2 15 2 0 031

4 1 2 47 28 12 56 0 0 6 0 0 3 0 0 24 18 0 2 0 17 0 5 1 11 3 8---

--77

6

60-

-

64 0 8 14 3 0 2 24 1 0 9 17 0 39 35 0 10 9 17 1 0 37 0 9 2 14 0 0 019

1 1 6 44 33 11 34 0 1 6 0 0 5 0 0 15 18 0 1 0 20 0 3 1 6 0 8---

--65

5

65-

-

69 0 5 8 1 0 1 11 2 0 4 13 1 29 31 0 11 4 13 2 1 43 0 6 2 25 0 0 113

5 2 1 44 24 7 28 0 0 4 0 0 3 0 1 13 13 0 1 0 13 0 5 1 2 1 5---

--51

7

70-

-

74 0 5 16 2 1 0 8 0 0 5 9 0 42 40 1 11 9 16 3 0 48 1 7 0 24 0 0 1 87 0 2 36 14 13 20 0 0 3 0 0 9 0 1 5 4 0 0 0 12 0 1 1 7 1 3---

--46

8

75+

3 4 15 0 0 2 8 3 0 16 35 2 62 47 2 16 10 17 3 1 54 0 4 3 57 0 0 1 83 4 2 33 12 5 19 1 0 10 0 0 8 0 2 8 5 0 0 0 14 0 2 1 4 2 9---

--58

9

% of

Total

0.10%

0.80%

1.30%

0.30%

0.10%

0.10%

2.60%

0.20%

0.00%

0.90%

2.20%

0.10%

5.20%

4.40%

0.10%

1.30%

0.90%

1.80%

0.30%

0.10%

5.40%

0.10%

0.90%

0.20%

3.00%

0.10%

0.00%

0.20%

32.90

%0.3

0%0.3

0%6.9

0%3.5

0%1.6

0%6.5

0%0.1

0%0.2

0%0.8

0%0.0

0%0.0

0%0.5

0%0.0

0%0.1

0%3.7

0%2.7

0%0.0

0%0.3

0%0.4

0%2.7

0%0.0

0%0.4

0%0.8

0%1.7

0%0.3

0%0.9

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

56:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

PE

RA

K, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, 2

007-

2011

Page 158: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

136

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

5 62 43 30 13 10 459 19 5 80 155 8

338

310 9

226 42 98 32 87 788 25 53 17 208 5 1 15 15 12 325 36 6 94 2 3

116 5 6

192 42 1 31 23 196 1 18 64 58 25 51 -----

4465

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.2 0.8 0 0 0 0 0.2 0 0 4.4 0.6 0.6 0---

-- 8

5-

-

9 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0.2 0 0 0.3 0 0 0 0 0 0 0.2 0 0.2 0 0 0 0 0 0 0 0.3 0 0 0 0 1 0 0 2.1 1 0.2 0---

-- 6

10-

-

14 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0.3 0.5 0 0 1.3 0.8 0.2 0---

-- 7

15-

-

19 0 0 0 0 0 0 0.5 0.2 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 1.4 0 0.3 0 0 0.3 0 0 0 0.3 0 0 0 0 0 0 0 2.2 0 0 0.3 0.5 0.7 0 0 1.4 0.9 0.2 0.2 ----- 10

20-

-

24 0 0 0 0.2 0 0 0.6 0.2 0 0 0 0 0.2 0.2 0 0.2 0 0 0 0 0.8 0.6 1.6 0.2 0.4 0 0 0.2 0 0 0 0.8 0 0 0 0 0 0 0 1.2 0.8 0 0.4 0.2 2 0 0 0.4 0.6 0.4 0---

-- 12

25-

-

29 0 0 0.3 0.8 0.3 0 2.1 0 0 0.3 0.3 0 1.1 0.8 0 0 0 0.3 0 0.3 0.5 0.8 1.6 0 0.3 0 0 0.5 0 0 0 1.6 0 0.3 0 0 0 0 0 0.8 0 0 0.3 0.5 2.7 0 0 0.8 0.8 0.5 0---

-- 19

30-

-

34 0 0.3 0.3 0.3 0 0 5.7 0 0 0 0.6 0 0.6 0.6 0.3 0.6 0 0 0 0.3 1.2 0.3 0.3 0 0.3 0 0 0.3 0 0 0 2.4 0 0 0 0 0 0 0 3.9 0.6 0 0 0.3 0.6 0 0 0 0.6 0 0---

-- 20

35-

-

39 0 0.6 1.8 0.6 0 012

.2 0 0 0 0.6 0 2.1 1.5 0 0.9 0.3 0 0 0 2.1 0 0.6 0.3 1.2 0 0 0.3 0 0 0 1.5 0 0 0 0 0.9 0 0.3 2.7 1.2 0 0.6 0.3 2.7 0 0 0.3 0.3 0 0.6 ----- 37

40-

-

44 0 1.4 0.3 0.9 0.3 017

.4 0 0 1.4 0.9 0 4.3 3.7 0.3 2.3 0 0.9 0.9 0.6 4.8 0.9 0.9 0 2.8 0 0 0 0.3 0 0.6 0.6 0.3 2.8 0 0 0.9 0 0 3.4 0.6 0 0.6 0.6 4.3 0 0 0.6 0.9 0.3 0.6 ----- 62

45-

-

49 0.3 3.9 0.8 0.8 0.6 0.8 18.3 0.6 0 1.1 2 0 7.6 5.9 0 5.1 1.1 2.8 0.8 0.8 12.7 0.6 0.3 0 2.5 0 0.3 0.3 0.3 0.3 0.3 0.6 0.3 1.7 0 0 0.3 0.3 0 5.4 0.3 0 1.1 0.6 4.5 0 0.8 0 1.1 0.3 0.8 ----- 89

50-

-

54 0.3 0.9 0.6 0.3 0.3 0.6 18.7 1.2 0.3 3.6 4.8 0.3 7.8 6 0 8.4 0.3 3.6 0.9 2.7 19.3 1.2 0.9 0.9 2.1 0 0 0.3 0.9 0.3 4.5 0.9 0.3 3.3 0 0 1.8 0 0 5.4 1.5 0 2.1 0.9 3.9 0 0.6 0 0.3 1.2 0.9 -----

115

55-

-

59 0 2.8 2.1 1.8 0.7 024

.2 0 0 4.6 8.2 0.4 17.8

19.2 0.4 14.6 2.5 3.2 1.8 3.2 29.5 0.4 1.4 1.8 7.8 0.7 0 0.7 0.4 0.4 7.1 0.4 0 3.9 0.4 0 2.5 0 0 7.5 3.2 0 1.8 1.1 8.2 0 1.4 0 2.1 0.7 2.1 -----

193

60-

-

64 0.4 4.9 4.4 1.8 0.9 0.4 24 1.3 0.4 3.5 8.9 1.3 21.7

26.2 0.9 13.3 2.7 7.5 2.7 8

57.2 1.8 1.8 0.9 11.1 0 0 0 1.3 2.2 17.3 0 0 6.7 0 0 8.9 0.9 0

10.6 2.2 0 0.9 0

11.5 0 1.8 0 2.7 0.9 2.7 -----

279

65-

-

69 0 3.2 2.5 1.3 0.6 021

.6 0.6 0 715

.2 0.6 38.7

27.9 1.3 25.4 3.2 8.3 0.6 13.3

90.2 0.6 1.3 1.3 21.6 1.3 0 1.3 1.9 0.6 36.8 0 1.3 11.4 0 1.9 15.9 0.6 0 8.3 0.6 0.6 1.9 0.6 17.8 0 1.9 1.3 4.4 0 7

-----

404

70-

-

74 1.6 4 4 1.6 0.8 1.6 25.9 3.2 0 8.9 17 1.6 32.4

28.3 0.8 23.5 7.3 13.8 1.6 8.9

110.9 1.6 1.6 0.8 31.6 0 0 0.8 0.8 0.8 70.5 0.8 0.8 8.9 0.8 0

17.8 0 0.8 8.9 2.4 0 0.8 0.8 13.8 0 0 3.2 1.6 1.6 6.5 -----

476

75+

0 6.3 3.2 1.6 1.6 1.6 7.1 2.4 2.4 11.8

28.4 0

43.3

41.7 0.8 18.1 7.1 12.6 7.1 7.9

121.3 0.8 2.4 1.6 41 0.8 0 0.8 1.6 0.8 81.1 0 0 8.7 0 0

22.8 0.8 2.4 4.7 4.7 0 0 0.8 10.2 0.8 1.6 0.8 0.8 2.4 7.1 -----

525

Crud

eRa

te 0.1 1.1 0.8 0.5 0.2 0.2 8 0.3 0.1 1.4 2.7 0.1 5.9 5.4 0.2 3.9 0.7 1.7 0.6 1.5 13.7 0.4 0.9 0.3 3.6 0.1 0 0.3 0.3 0.2 5.7 0.6 0.1 1.6 0 0.1 2 0.1 0.1 3.3 0.7 0 0.5 0.4 3.4 0 0.3 1.1 1 0.4 0.9 -----

77.9

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

57:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, P

ER

AK

, AL

L R

ESI

DE

NT

S, M

AL

ES,

200

7-20

11

ASR

Wor

ld 0.1 1 0.7 0.5 0.2 0.2 7.7 0.3 0.1 1.3 2.6 0.1 5.6 5.1 0.2 3.7 0.7 1.6 0.5 1.5 13.1 0.4 0.9 0.3 3.5 0.1 0 0.3 0.3 0.2 5.4 0.6 0.1 1.6 0 0.1 2 0.1 0.1 3.2 0.7 0 0.5 0.4 3.3 0 0.3 1.2 1 0.4 0.9 -----

74.7

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 159: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

137

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

3 46 70 18 3 614

1 9 2 47 121 6

287

240 5 73 49 98 15 8

299 7 50 13 163 4 0 11

1809 14 14 38

019

0 90 359 4 9 44 1 0 28 0 5

204

149 0 16 23 150 0 22 43 91 17 48 -----

5504

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0.2 1.5 0 0 0 0 0 0 0 2.4 0.4 0.6 0---

-- 6

5-

-

9 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.1 0 0 0 0 0.2 0 0 1.6 1.1 0 0.2 ----- 6

10-

-

14 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.3 1 0 0 0 0 0 0 0 0.2 0 0 0 0.2 0 0 0 0 0 0 0 0 2.2 0.5 0 0 0 0.5 0 0 1 0.3 0 0---

-- 7

15-

-

19 0 0 0 0.2 0 0 0.5 0 0 0 0 0 0.2 0 0 0.3 0 0 0 0 0 0 0.5 0 0 0 0 0.2 0 0 0 0 0 0 1.5 0 0 0 0 0 0 0 0 0.9 0.5 0 0.2 0.5 0 0 0 1 1.2 0.2 0---

-- 8

20-

-

24 0 0 0 0 0 0 0.9 0 0 0 0 0 0.4 0.2 0 0 0 0 0 0 0.2 0.2 0.6 0 0.4 0 0 0 0.9 0 0 0 0 0.4 2.4 0 0.4 0 0 0 0 0 0 1.5 1.9 0 0 1.3 1.3 0 0 0.4 0.2 0 0.2 ----- 14

25-

-

29 0 0.3 0 0 0 0 0 0 0 0 0.6 0 1.7 0.3 0 0.6 0 0.3 0 0 0.8 0 0 0 0.3 0 0 0 4.2 0 0 0.8 0.3 0.6 4.2 0 0.8 0 0 0 0 0 0 1.4 2.3 0 0 0.8 1.7 0 0 0.6 1.4 0.3 0.3 ----- 25

30-

-

34 0 0.3 0 0 0 0.3 1.2 0 0 0 0.9 0.3 1.8 1.8 0 0.3 0 0 0 0.3 0.6 0 0 0 0.6 0 0 015

.3 0 0 2.7 0.9 1.2 4 0 0.3 0 0 0 0 0 0 2.4 3.1 0 0 0.6 0.9 0 0 0.3 1.2 0.3 0.6 ----- 42

35-

-

39 0 0.6 0.6 0.6 0 0 1.5 0 0 0.3 0.6 0 2.1 3 0 0.6 0.3 0.9 0 0 2.4 0.3 0.6 0.3 0.3 0.3 0 0.3 34.2 0 0 5.2 2.4 0 3.9 0.3 0 0.6 0 0 0 0 0 5.2 2.4 0 0.3 0 3 0 0 0 3 0.6 0.6 ----- 78

40-

-

44 0 1.9 0.3 0.6 0.3 0 4.4 0 0 0.3 2.2 0 2.5 1.7 0 0.3 0.3 0.8 0 0 5 0 0.3 0.6 1.4 0 0 0.8 53.4 0 0 8.5 3 1.4 7.2 0 0.3 0 0.3 0 0 0 0 3.9 3 0 0.3 0.6 1.7 0 0.6 0 2.2 0 1.1 -----

111

45-

-

49 0 0.9 1.1 0.9 0 0 4.9 0.3 0 0.6 2.9 0 6.3 2 0 1.1 0.6 1.4 0.3 0.3 7.7 0.3 0.3 0 1.7 0 0 087

.4 0.3 014

.6 5.4 2.6 16 0.3 0.3 1.4 0 0 0 0 0 7.1 6.3 0 0.6 0.9 4.6 0 0 0.3 2.3 0.3 0.6 -----

185

50-

-

54 0 1.2 0.9 0.3 0 0 6.5 0.3 0.3 1.2 2.2 0.6 8 7.1 0.3 1.2 1.2 2.5 0.3 0.9 8.3 0 1.2 0.3 3.1 0.3 0 0.6 97.4 1.5 0 20 11.4 6.1 17.8 0.3 0 1.2 0 0 0 0 0 8 5.2 0 2.2 1.2 7.1 0 1.2 0 2.5 0.3 0.6 -----

233

55-

-

59 0 2.1 2.1 0.7 0.4 0 7.1 0.4 0.4 1.8 5.3 012

.711

.7 0.4 3.2 3.2 5.3 1.1 0.4 11 0.4 1.1 0.7 5.3 0.7 0 011

1 0.4 0.7 16.6 9.9 4.2 19.8 0 0 2.1 0 0 1.1 0 0 8.5 6.4 0 0.7 0 6 0 1.8 0.4 3.9 1.1 2.8 -----

274

60-

-

64 0 3.5 6.1 1.3 0 0.9 10.4 0.4 0 3.9 7.4 0

16.9

15.2 0 4.3 3.9 7.4 0.4 0 16 0 3.9 0.9 6.1 0 0 0

82.7 0.4 2.6 19.1

14.3 4.8 14.7 0 0.4 2.6 0 0 2.2 0 0 6.5 7.8 0 0.4 0 8.7 0 1.3 0.4 2.6 0 3.5 -----

284

65-

-

69 0 3.2 5 0.6 0 0.6 6.9 1.3 0 2.5 8.2 0.6 18.3

19.6 0 6.9 2.5 8.2 1.3 0.6 27.1 0 3.8 1.3 15.8 0 0 0.6 85.2 1.3 0.6 27.8

15.1 4.4 17.7 0 0 2.5 0 0 1.9 0 0.6 8.2 8.2 0 0.6 0 8.2 0 3.2 0.6 1.3 0.6 3.2 -----

326

70-

-

74 0 3.6 11.4 1.4 0.7 0 5.7 0 0 3.6 6.4 0

29.9

28.5 0.7 7.8 6.4 11.4 2.1 0

34.2 0.7 5 0

17.1 0 0 0.7 61.9 0 1.4 25.6 10 9.3 14.2 0 0 2.1 0 0 6.4 0 0.7 3.6 2.8 0 0 0 8.5 0 0.7 0.7 5 0.7 2.1 -----

333

75+ 1.9 2.5 9.5 0 0 1.3 5 1.9 0

10.1

22.1 1.3 39.1

29.7 1.3 10.1 6.3 10.7 1.9 0.6 34.1 0 2.5 1.9 36 0 0 0.6 52.4 2.5 1.3 20.8 7.6 3.2 12 0.6 0 6.3 0 0 5 0 1.3 5 3.2 0 0 0 8.8 0 1.3 0.6 2.5 1.3 5.7 -----

372

Crud

eRa

te 0.1 0.8 1.2 0.3 0.1 0.1 2.5 0.2 0 0.8 2.1 0.1 5 4.2 0.1 1.3 0.9 1.7 0.3 0.1 5.2 0.1 0.9 0.2 2.9 0.1 0 0.2 31.8 0.2 0.2 6.7 3.3 1.6 6.3 0.1 0.2 0.8 0 0 0.5 0 0.1 3.6 2.6 0 0.3 0.4 2.6 0 0.4 0.8 1.6 0.3 0.8 -----

96.6

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

58:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, P

ER

AK

, AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

200

7-20

11

ASR

Wor

ld 0 0.7 1.1 0.3 0 0.1 2.3 0.1 0 0.7 1.9 0.1 4.5 3.7 0.1 1.1 0.7 1.5 0.2 0.1 4.7 0.1 0.8 0.2 2.5 0.1 0 0.2 29.3 0.2 0.2 6.1 3.1 1.4 5.9 0.1 0.2 0.7 0 0 0.4 0 0.1 3.4 2.5 0 0.3 0.4 2.4 0 0.4 0.8 1.5 0.3 0.8 -----

88.5

Page 160: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

138

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

2 41 39 24 17 918

2 18 10 61 80 334

120

1 312

8 14 61 25 53 400 6 39 4 88 0 0 22 6 0

216 40 2 69 0 0

130 0 7 59 38 4 2 8

145 1 14 19 72 61 10 -----

2774

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 3 0 5 0 0 0 0 3 9 0 2 0 0 3 0 0 7 6 12 0---

-- 56

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 6 0 0 0 0 2 0 0 3 3 12 0---

-- 29

10-

-

14 0 0 1 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 3 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 2 4 0 0 0 4 11 0---

-- 33

15-

-

19 0 0 0 0 0 0 3 0 0 0 2 0 1 0 0 0 0 0 0 0 0 1 5 0 2 0 0 2 0 0 1 5 0 0 0 0 0 0 0 5 2 0 0 2 5 0 0 1 1 3 0---

-- 41

20-

-

24 0 0 1 0 1 0 5 0 0 0 0 0 4 0 0 0 0 0 0 0 4 1 1 0 1 0 0 1 0 0 0 8 0 0 0 0 2 0 0 1 0 0 0 1 6 0 0 0 4 3 0---

-- 44

25-

-

29 0 0 2 0 0 1 3 0 0 0 0 0 8 2 0 1 0 2 0 0 2 0 2 0 0 0 0 1 0 0 1 8 0 0 0 0 2 0 0 1 1 0 0 0 2 0 1 0 6 2 0---

-- 48

30-

-

34 0 2 1 2 0 0 4 0 0 0 2 0 5 1 0 3 0 1 0 0 6 0 4 0 1 0 0 0 0 0 0 5 0 1 0 0 3 0 0 4 1 0 0 0 10 0 0 0 4 3 0---

-- 63

35-

-

39 0 2 1 0 0 0 14 0 0 1 3 0 12 7 0 3 0 3 3 0 10 1 2 0 2 0 0 1 0 0 0 2 0 2 0 0 1 0 0 4 1 0 0 0 3 0 0 0 5 2 1---

-- 86

40-

-

44 0 7 4 1 2 0 15 1 0 1 3 0 17 7 1 4 1 3 5 0 15 0 1 1 4 0 0 1 1 0 3 2 0 2 0 0 3 0 0 5 5 0 1 1 12 0 1 0 4 1 1---

--13

6

45-

-

49 0 2 2 1 2 1 31 1 0 4 5 2 29 15 0 11 1 4 3 2 18 0 3 1 6 0 0 0 0 0 2 2 0 7 0 0 2 0 0 5 8 0 0 0 11 0 0 1 3 2 4---

--19

1

50-

-

54 0 5 3 4 1 0 27 1 2 8 3 0 45 13 0 16 4 9 0 5 41 0 2 0 5 0 0 3 1 0 5 2 0 14 0 0 9 0 0 4 1 0 1 1 16 0 0 2 14 3 0---

--27

0

55-

-

59 0 5 3 1 1 0 26 1 2 3 13 1 43 34 1 21 3 10 1 8 45 1 1 0 16 0 0 4 3 0 11 0 0 8 0 0 14 0 0 4 5 1 0 1 11 0 3 2 3 0 1---

--31

1

60-

-

64 0 6 7 5 3 2 18 3 2 9 7 0 41 39 0 18 2 7 4 10 52 0 3 1 8 0 0 1 1 0 26 0 1 13 0 0 18 0 0 4 6 0 0 0 9 0 4 1 7 1 0---

--33

9

65-

-

69 2 2 4 2 1 1 15 3 3 9 8 0 43 33 0 16 0 7 3 12 70 2 5 0 13 0 0 2 0 0 39 1 0 9 0 0 22 0 0 3 2 0 0 0 20 0 2 1 5 3 1---

--36

4

70-

-

74 0 7 3 4 3 1 10 4 1 10 12 0 37 31 0 21 1 3 2 7 62 0 1 1 13 0 0 1 0 0 65 0 0 3 0 0 31 0 2 1 4 1 0 0 12 0 1 0 3 0 0---

--35

8

75+

0 3 7 4 3 3 7 4 0 16 22 0 56 19 1 11 2 12 4 8 75 0 5 0 16 0 0 2 0 0 63 1 1 4 0 0 23 0 2 1 2 0 0 0 19 1 2 1 0 3 2---

--40

5

% of

Total 0.1

0%1.5

0%1.4

0%0.9

0%0.6

0%0.3

0%6.6

0%0.6

0%0.4

0%2.2

0%2.9

0%0.1

0%12

.30%

7.20%

0.10%

4.60%

0.50%

2.20%

0.90%

1.90%

14.40

%0.2

0%1.4

0%0.1

0%3.2

0%0.0

0%0.0

0%0.8

0%0.2

0%0.0

0%7.8

0%1.4

0%0.1

0%2.5

0%0.0

0%0.0

0%4.7

0%0.0

0%0.3

0%2.1

0%1.4

0%0.1

0%0.1

0%0.3

0%5.2

0%0.0

0%0.5

0%0.7

0%2.6

0%2.2

0%0.4

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

59:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

KE

DA

H, A

LL

RE

SID

EN

TS,

MA

LE

S, 2

007-

2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 161: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

139

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

5 40 46 28 9 1 48 8 1 43 77 429

112

9 2 66 18 31 8 619

3 3 29 3 48 0 1 1612

20 5 929

512

7 19 233 4 4 28 1 1 37 0 4 74 101 1 0 6 79 1 23 14 50 64 11 -----

3565

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 2 0 0 0 0 1 0 0 5 4 22 0---

-- 38

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 8 0 0 0 0 1 0 0 3 0 2 1---

-- 20

10-

-

14 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 3 0 0 0 0 1 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 9 0 0 0 0 5 0 0 1 4 7 0---

-- 37

15-

-

19 0 0 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 3 0 3 0 0 1 0 0 0 0 0 0 9 0 1 0 0 0 0 0 0 3 3 0 0 2 2 0 0 1 1 5 0---

-- 37

20-

-

24 0 1 0 0 0 0 3 0 0 0 0 0 4 0 0 0 0 2 0 0 1 0 2 0 0 0 0 1 8 0 0 1 1 0 5 0 0 0 0 0 0 0 0 6 3 0 0 0 6 0 0 1 1 4 1---

-- 51

25-

-

29 0 1 1 0 0 0 1 0 0 0 1 0 3 2 0 0 0 0 0 0 2 0 2 0 0 0 0 2 19 0 0 8 3 0 6 1 0 0 0 0 0 0 1 1 7 0 0 1 1 0 0 0 3 2 0---

-- 68

30-

-

34 0 2 0 1 0 0 4 0 0 0 1 0 3 3 0 1 1 1 1 0 2 0 0 0 0 0 0 1 57 0 0 4 2 0 3 0 0 1 0 0 0 0 0 3 11 0 0 1 7 0 0 1 2 0 0---

--11

3

35-

-

39 0 1 2 2 0 0 1 0 0 0 1 0 11 2 0 3 1 0 1 0 5 0 1 0 1 0 0 2 94 0 1 23 3 1 21 0 0 0 0 0 0 0 0 1 11 0 0 0 5 0 0 0 4 3 0---

--20

1

40-

-

44 0 6 3 1 0 0 7 2 0 1 2 0 16 5 0 4 0 3 0 1 10 0 2 0 4 0 0 017

0 3 0 39 14 2 18 1 2 2 0 0 2 0 0 8 13 0 0 0 3 0 1 0 4 6 0---

--35

5

45-

-

49 0 2 2 2 1 0 7 1 0 3 9 0 15 9 0 4 1 1 0 0 25 0 3 0 1 0 0 124

3 1 1 47 19 3 30 1 1 2 0 0 2 0 0 8 10 0 0 1 6 0 2 0 7 3 2---

--47

6

50-

-

54 0 2 3 5 0 0 4 0 0 6 13 0 35 12 0 8 0 3 1 1 20 0 1 0 3 0 0 219

8 0 1 42 19 2 44 0 0 4 1 0 3 0 1 9 13 0 0 0 4 0 4 0 4 2 0---

--47

0

55-

-

59 0 7 3 3 1 0 7 0 0 9 7 1 39 11 1 11 4 5 2 0 15 0 2 0 4 0 0 117

2 0 5 43 24 4 21 0 0 4 0 0 3 0 1 3 12 1 0 0 9 0 5 1 5 1 2---

--44

9

60-

-

64 0 5 6 5 1 1 4 0 0 6 9 0 40 11 0 11 1 3 0 1 30 1 3 1 0 0 0 0 95 0 0 24 17 5 24 1 0 4 0 0 6 0 0 7 3 0 0 1 4 1 2 0 5 2 1---

--34

1

65-

-

69 0 4 5 2 0 0 3 0 0 6 8 0 38 28 0 3 1 4 1 1 21 1 2 2 5 0 0 2 71 0 1 25 13 2 16 0 0 1 0 1 6 0 1 2 10 0 0 0 9 0 5 0 1 0 1---

--30

2

70-

-

74 2 2 8 3 3 0 6 4 1 7 14 1 46 23 0 11 4 5 2 1 30 1 1 0 14 0 1 0 50 0 0 25 9 0 15 0 0 4 0 0 6 0 0 3 4 0 0 0 11 0 3 1 3 1 2---

--32

7

75+

3 7 11 3 3 0 1 1 0 5 12 2 40 23 1 8 5 4 0 1 32 0 2 0 13 0 0 1 43 1 0 14 3 0 14 0 0 3 0 0 9 0 0 1 1 0 0 0 5 0 1 0 2 4 1---

--28

0

% of

Total

0.10%

1.10%

1.30%

0.80%

0.30%

0.00%

1.30%

0.20%

0.00%

1.20%

2.20%

0.10%

8.20%

3.60%

0.10%

1.90%

0.50%

0.90%

0.20%

0.20%

5.40%

0.10%

0.80%

0.10%

1.30%

0.00%

0.00%

0.40%

34.20

%0.1

0%0.3

0%8.3

0%3.6

0%0.5

0%6.5

0%0.1

0%0.1

0%0.8

0%0.0

0%0.0

0%1.0

0%0.0

0%0.1

0%2.1

0%2.8

0%0.0

0%0.0

0%0.2

0%2.2

0%0.0

0%0.6

0%0.4

0%1.4

0%1.8

0%0.3

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

60:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

KE

DA

H, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, 2

007-

2011

Page 162: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

140

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

2 41 39 24 17 918

2 18 10 61 80 334

120

1 312

8 14 61 25 53 400 6 39 4 88 0 0 22 6 0

216 40 2 69 0 0

130 0 7 59 38 4 2 8

145 1 14 19 72 61 10 -----

2774

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0.2 0 0 0 0 0.5 0 0 0 0.7 0 1.1 0 0 0 0 0.7 2.1 0 0.5 0 0 0.7 0 0 1.6 1.4 2.7 0---

-- 13

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0.2 0 0.2 0 0 0 0 0 1.2 0 0 0 0 0.4 0 0 0.6 0.6 2.4 0---

-- 6

10-

-

14 0 0 0.2 0 0 0 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.5 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0.4 0.7 0 0 0 0.7 2 0---

-- 6

15-

-

19 0 0 0 0 0 0 0.6 0 0 0 0.4 0 0.2 0 0 0 0 0 0 0 0 0.2 1 0 0.4 0 0 0.4 0 0 0.2 1 0 0 0 0 0 0 0 1 0.4 0 0 0.4 1 0 0 0.2 0.2 0.6 0---

-- 9

20-

-

24 0 0 0.3 0 0.3 0 1.3 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0.3 0.3 0 0.3 0 0 0.3 0 0 0 2.1 0 0 0 0 0.5 0 0 0.3 0 0 0 0.3 1.6 0 0 0 1 0.8 0---

-- 11

25-

-

29 0 0 0.6 0 0 0.3 0.9 0 0 0 0 0 2.4 0.6 0 0.3 0 0.6 0 0 0.6 0 0.6 0 0 0 0 0.3 0 0 0.3 2.4 0 0 0 0 0.6 0 0 0.3 0.3 0 0 0 0.6 0 0.3 0 1.8 0.6 0---

-- 15

30-

-

34 0 0.7 0.3 0.7 0 0 1.4 0 0 0 0.7 0 1.7 0.3 0 1 0 0.3 0 0 2.1 0 1.4 0 0.3 0 0 0 0 0 0 1.7 0 0.3 0 0 1 0 0 1.4 0.3 0 0 0 3.5 0 0 0 1.4 1 0---

-- 22

35-

-

39 0 0.7 0.4 0 0 0 4.9 0 0 0.4 1.1 0 4.2 2.5 0 1.1 0 1.1 1.1 0 3.5 0.4 0.7 0 0.7 0 0 0.4 0 0 0 0.7 0 0.7 0 0 0.4 0 0 1.4 0.4 0 0 0 1.1 0 0 0 1.8 0.7 0.4 ----- 30

40-

-

44 0 2.4 1.4 0.3 0.7 0 5.2 0.3 0 0.3 1 0 5.9 2.4 0.3 1.4 0.3 1 1.7 0 5.2 0 0.3 0.3 1.4 0 0 0.3 0.3 0 1 0.7 0 0.7 0 0 1 0 0 1.7 1.7 0 0.3 0.3 4.2 0 0.3 0 1.4 0.3 0.3 ----- 47

45-

-

49 0 0.7 0.7 0.4 0.7 0.4 11.2 0.4 0 1.4 1.8 0.7 10.5 5.4 0 4 0.4 1.4 1.1 0.7 6.5 0 1.1 0.4 2.2 0 0 0 0 0 0.7 0.7 0 2.5 0 0 0.7 0 0 1.8 2.9 0 0 0 4 0 0 0.4 1.1 0.7 1.4 ----- 69

50-

-

54 0 2.1 1.2 1.7 0.4 011

.2 0.4 0.8 3.3 1.2 018

.6 5.4 0 6.6 1.7 3.7 0 2.1 17 0 0.8 0 2.1 0 0 1.2 0.4 0 2.1 0.8 0 5.8 0 0 3.7 0 0 1.7 0.4 0 0.4 0.4 6.6 0 0 0.8 5.8 1.2 0---

--11

2

55-

-

59 0 2.5 1.5 0.5 0.5 013

.1 0.5 1 1.5 6.5 0.5 21.6

17.1 0.5 10.6 1.5 5 0.5 4

22.6 0.5 0.5 0 8 0 0 2 1.5 0 5.5 0 0 4 0 0 7 0 0 2 2.5 0.5 0 0.5 5.5 0 1.5 1 1.5 0 0.5 -----

156

60-

-

64 0 4.1 4.8 3.4 2 1.4 12.3 2 1.4 6.1 4.8 0 28 26.6 0

12.3 1.4 4.8 2.7 6.8 35.5 0 2 0.7 5.5 0 0 0.7 0.7 0

17.7 0 0.7 8.9 0 0

12.3 0 0 2.7 4.1 0 0 0 6.1 0 2.7 0.7 4.8 0.7 0

-----

231

65-

-

69 2.1 2.1 4.1 2.1 1 115

.4 3.1 3.1 9.2 8.2 044

.133

.9 016

.4 0 7.2 3.1 12.3

71.8 2.1 5.1 0

13.3 0 0 2.1 0 0 40 1 0 9.2 0 0

22.6 0 0 3.1 2.1 0 0 0

20.5 0 2.1 1 5.1 3.1 1

-----

373

70-

-

74 0 8.5 3.6 4.8 3.6 1.2 12.1 4.8 1.2 12.1

14.5 0

44.9

37.6 0

25.5 1.2 3.6 2.4 8.5 75.2 0 1.2 1.2 15.8 0 0 1.2 0 0

78.8 0 0 3.6 0 0

37.6 0 2.4 1.2 4.8 1.2 0 0

14.5 0 1.2 0 3.6 0 0

-----

434

75+

0 3.7 8.6 4.9 3.7 3.7 8.6 4.9 019

.6 27 068

.723

.3 1.2 13.5 2.5 14.7 4.9 9.8 92 0 6.1 0

19.6 0 0 2.5 0 0

77.3 1.2 1.2 4.9 0 0

28.2 0 2.5 1.2 2.5 0 0 0

23.3 1.2 2.5 1.2 0 3.7 2.5 -----

497

Crud

eRa

te 0 0.9 0.8 0.5 0.4 0.2 3.9 0.4 0.2 1.3 1.7 0.1 7.3 4.3 0.1 2.8 0.3 1.3 0.5 1.1 8.6 0.1 0.8 0.1 1.9 0 0 0.5 0.1 0 4.6 0.9 0 1.5 0 0 2.8 0 0.2 1.3 0.8 0.1 0 0.2 3.1 0 0.3 0.4 1.5 1.3 0.2 -----

59.6

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

61:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, K

ED

AH

, AL

L R

ESI

DE

NT

S, M

AL

ES,

200

7-20

11

ASR

Wor

ld 0.1 0.9 0.9 0.6 0.4 0.2 4.1 0.5 0.3 1.5 1.9 0.1 8.1 4.9 0.1 3.1 0.3 1.4 0.6 1.3 9.8 0.1 0.9 0.1 2.1 0 0 0.5 0.1 0 5.5 0.9 0.1 1.7 0 0 3.2 0 0.2 1.3 0.9 0.1 0 0.2 3.4 0 0.3 0.5 1.6 1.3 0.2 -----

66.6

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 163: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

141

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

5 40 46 28 9 1 48 8 1 43 77 429

112

9 2 66 18 31 8 619

3 3 29 3 48 0 1 1612

20 5 929

512

7 19 233 4 4 28 1 1 37 0 4 74 101 1 0 6 79 1 23 14 50 64 11 -----

3565

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0.5 0 0 0 0 0.2 0 0 1.2 1 5.3 0---

-- 9

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.2 0 0 0 0 0.2 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 1.7 0 0 0 0 0.2 0 0 0.6 0 0.4 0.2 ----- 4

10-

-

14 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.6 0 0 0 0 0.2 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1.8 0 0 0 0 1 0 0 0.2 0.8 1.4 0---

-- 7

15-

-

19 0 0 0.2 0.2 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0.6 0 0.6 0 0 0.2 0 0 0 0 0 0 1.9 0 0.2 0 0 0 0 0 0 0.6 0.6 0 0 0.4 0.4 0 0 0.2 0.2 1.1 0---

-- 8

20-

-

24 0 0.3 0 0 0 0 0.8 0 0 0 0 0 1.1 0 0 0 0 0.5 0 0 0.3 0 0.5 0 0 0 0 0.3 2.1 0 0 0.3 0.3 0 1.3 0 0 0 0 0 0 0 0 1.6 0.8 0 0 0 1.6 0 0 0.3 0.3 1.1 0.3 ----- 13

25-

-

29 0 0.3 0.3 0 0 0 0.3 0 0 0 0.3 0 0.9 0.6 0 0 0 0 0 0 0.6 0 0.6 0 0 0 0 0.6 5.8 0 0 2.5 0.9 0 1.8 0.3 0 0 0 0 0 0 0.3 0.3 2.2 0 0 0.3 0.3 0 0 0 0.9 0.6 0---

-- 21

30-

-

34 0 0.7 0 0.3 0 0 1.4 0 0 0 0.3 0 1 1 0 0.3 0.3 0.3 0.3 0 0.7 0 0 0 0 0 0 0.3 19.6 0 0 1.4 0.7 0 1 0 0 0.3 0 0 0 0 0 1 3.8 0 0 0.3 2.4 0 0 0.3 0.7 0 0

----- 39

35-

-

39 0 0.3 0.7 0.7 0 0 0.3 0 0 0 0.3 0 3.7 0.7 0 1 0.3 0 0.3 0 1.7 0 0.3 0 0.3 0 0 0.7 31.3 0 0.3 7.7 1 0.3 7 0 0 0 0 0 0 0 0 0.3 3.7 0 0 0 1.7 0 0 0 1.3 1 0

----- 67

40-

-

44 0 2 1 0.3 0 0 2.3 0.7 0 0.3 0.7 0 5.3 1.7 0 1.3 0 1 0 0.3 3.3 0 0.7 0 1.3 0 0 056

.4 1 012

.9 4.6 0.7 6 0.3 0.7 0.7 0 0 0.7 0 0 2.7 4.3 0 0 0 1 0 0.3 0 1.3 2 0---

--11

8

45-

-

49 0 0.7 0.7 0.7 0.4 0 2.5 0.4 0 1.1 3.2 0 5.4 3.2 0 1.4 0.4 0.4 0 0 8.9 0 1.1 0 0.4 0 0 0.4 86.8 0.4 0.4 16.8 6.8 1.1 10.7 0.4 0.4 0.7 0 0 0.7 0 0 2.9 3.6 0 0 0.4 2.1 0 0.7 0 2.5 1.1 0.7 -----

170

50-

-

54 0 0.8 1.2 2 0 0 1.6 0 0 2.4 5.1 013

.8 4.7 0 3.2 0 1.2 0.4 0.4 7.9 0 0.4 0 1.2 0 0 0.8 78.1 0 0.4 16.6 7.5 0.8 17.4 0 0 1.6 0.4 0 1.2 0 0.4 3.6 5.1 0 0 0 1.6 0 1.6 0 1.6 0.8 0

-----

185

55-

-

59 0 3.4 1.5 1.5 0.5 0 3.4 0 0 4.4 3.4 0.5 19.1 5.4 0.5 5.4 2 2.5 1 0 7.4 0 1 0 2 0 0 0.5 84.3 0 2.5 21.1

11.8 2

10.3 0 0 2 0 0 1.5 0 0.5 1.5 5.9 0.5 0 0 4.4 0 2.5 0.5 2.5 0.5 1

-----

220

60-

-

64 0 3.3 4 3.3 0.7 0.7 2.7 0 0 4 6 026

.8 7.4 0 7.4 0.7 2 0 0.7 20.1 0.7 2 0.7 0 0 0 0

63.6 0 0

16.1

11.4 3.3 16.1 0.7 0 2.7 0 0 4 0 0 4.7 2 0 0 0.7 2.7 0.7 1.3 0 3.3 1.3 0.7 -----

228

65-

-

69 0 3.7 4.7 1.9 0 0 2.8 0 0 5.6 7.5 035

.526

.2 0 2.8 0.9 3.7 0.9 0.9 19.6 0.9 1.9 1.9 4.7 0 0 1.9 66.4 0 0.9 23.4

12.2 1.9 15 0 0 0.9 0 0.9 5.6 0 0.9 1.9 9.3 0 0 0 8.4 0 4.7 0 0.9 0 0.9 -----

282

70-

-

74 2.1 2.1 8.5 3.2 3.2 0 6.4 4.2 1.1 7.4 14.8 1.1 48.7

24.3 0

11.6 4.2 5.3 2.1 1.1 31.8 1.1 1.1 0

14.8 0 1.1 0

52.9 0 0

26.5 9.5 0

15.9 0 0 4.2 0 0 6.4 0 0 3.2 4.2 0 0 0

11.6 0 3.2 1.1 3.2 1.1 2.1 -----

346

75+ 2.7 6.4 10 2.7 2.7 0 0.9 0.9 0 4.6 11 1.8 36

.5 21 0.9 7.3 4.6 3.7 0 0.9 29.2 0 1.8 0

11.9 0 0 0.9 39.3 0.9 0

12.8 2.7 0

12.8 0 0 2.7 0 0 8.2 0 0 0.9 0.9 0 0 0 4.6 0 0.9 0 1.8 3.7 0.9 -----

256

Crud

eRa

te 0.1 0.9 1 0.6 0.2 0 1 0.2 0 0.9 1.7 0.1 6.3 2.8 0 1.4 0.4 0.7 0.2 0.1 4.2 0.1 0.6 0.1 1 0 0 0.3 26.2 0.1 0.2 6.3 2.7 0.4 5 0.1 0.1 0.6 0 0 0.8 0 0.1 1.6 2.2 0 0 0.1 1.7 0 0.5 0.3 1.1 1.4 0.2 -----

76.7

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

62:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, K

ED

AH

, AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

200

7-20

11

ASR

Wor

ld 0.1 0.9 1 0.6 0.2 0 1 0.2 0 0.9 1.7 0.1 6.4 2.9 0 1.4 0.4 0.7 0.2 0.1 4.2 0.1 0.6 0.1 1 0 0 0.3 25.9 0.1 0.2 6.3 2.8 0.4 5 0.1 0.1 0.6 0 0 0.8 0 0.1 1.6 2.2 0 0 0.1 1.7 0 0.5 0.3 1.1 1.5 0.2 ----- 77

Page 164: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

142

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

2 37 28 12 7 521

0 7 5 32 80 10 166

260 2 79 16 53 11 49 383 14 28 0 42 0 1 18 7 3

187 37 0 39 0 1 39 0 6 74 23 1 8 23 112 2 24 15 67 9 43 -----

2277

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 3 0 1 0 0 1 0 0 3 0 0 0---

-- 10

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 4 0 0 0 0 1 0 0 4 0 2 0---

-- 14

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 5 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0 0 1 3 0 0---

-- 14

15-

-

19 0 0 1 0 1 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 1 0 0 0 2 0 0 0 0 0 0 0 5 0 0 2 5 3 0 0 1 6 1 0---

-- 34

20-

-

24 0 1 0 0 0 0 2 0 0 0 0 0 2 0 0 0 0 0 0 0 2 2 1 0 0 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 0 0 0 2 4 0 0 2 7 0 0---

-- 31

25-

-

29 0 1 1 0 0 0 4 0 0 1 2 1 1 0 0 1 0 0 0 0 1 4 3 0 1 0 0 2 0 0 0 11 0 0 0 0 0 0 0 6 1 0 1 5 9 0 0 0 1 2 2---

-- 61

30-

-

34 0 3 0 1 1 0 18 1 0 0 3 0 1 3 0 1 1 1 2 1 2 2 1 0 0 0 0 3 0 0 0 6 0 1 0 0 2 0 1 8 2 0 0 1 3 0 0 1 4 1 0---

-- 75

35-

-

39 0 1 2 1 1 0 21 0 1 2 2 0 4 5 0 1 0 1 0 0 9 0 1 0 0 0 0 0 0 0 0 2 0 0 0 0 1 0 0 7 0 0 0 3 3 0 0 0 4 1 1---

-- 74

40-

-

44 0 0 1 1 0 0 18 0 0 3 1 1 4 17 1 5 0 1 1 0 10 0 0 0 0 0 1 4 1 0 0 1 0 2 0 0 1 0 0 3 2 0 0 1 9 0 1 0 3 0 7---

--10

0

45-

-

49 0 4 2 1 1 1 25 0 0 3 6 2 6 11 0 8 1 6 0 4 33 1 2 0 1 0 0 1 2 0 0 3 0 6 0 0 0 0 0 4 1 0 2 0 8 0 2 1 5 1 6---

--16

0

50-

-

54 1 5 4 1 1 0 30 2 0 2 7 1 20 28 0 14 1 4 3 6 51 2 1 0 0 0 0 2 0 0 8 2 0 10 0 0 5 0 2 8 5 0 0 2 12 1 6 0 2 0 3---

--25

2

55-

-

59 1 8 4 0 0 1 26 0 1 1 8 1 22 36 0 10 3 8 1 10 45 1 3 0 6 0 0 1 2 0 19 0 0 4 0 0 4 0 1 10 4 0 1 1 16 0 3 1 12 0 4---

--27

9

60-

-

64 0 4 5 3 1 1 26 2 1 4 7 2 28 48 0 17 3 11 2 2 60 0 2 0 4 0 0 0 2 0 31 1 0 6 0 0 5 0 0 6 2 0 1 0 14 0 6 0 5 1 8---

--32

1

65-

-

69 0 3 4 3 0 2 21 0 1 8 17 0 25 49 0 8 1 6 1 11 61 1 1 0 12 0 0 1 0 1 50 1 0 2 0 0 6 0 0 1 3 0 1 1 15 0 3 0 5 0 6---

--33

1

70-

-

74 0 4 3 1 1 0 5 1 0 4 12 2 23 38 1 10 2 10 0 8 55 0 2 0 5 0 0 0 0 1 47 0 0 4 0 0 6 0 1 6 3 0 0 2 8 0 1 1 5 0 3---

--27

5

75+

0 3 1 0 0 0 11 1 1 4 15 0 30 25 0 3 4 5 1 7 54 1 1 0 13 0 0 2 0 1 32 0 0 4 0 1 9 0 0 2 0 0 0 0 4 1 2 0 5 0 3---

--24

6

% of

Total 0.1

0%1.6

0%1.2

0%0.5

0%0.3

0%0.2

0%9.2

0%0.3

0%0.2

0%1.4

0%3.5

0%0.4

0%7.3

0%11

.40%

0.10%

3.50%

0.70%

2.30%

0.50%

2.20%

16.80

%0.6

0%1.2

0%0.0

0%1.8

0%0.0

0%0.0

0%0.8

0%0.3

0%0.1

0%8.2

0%1.6

0%0.0

0%1.7

0%0.0

0%0.0

0%1.7

0%0.0

0%0.3

0%3.2

0%1.0

0%0.0

0%0.4

0%1.0

0%4.9

0%0.1

0%1.1

0%0.7

0%2.9

0%0.4

0%1.9

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

63:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

WPK

L &

PU

TR

AJA

YA

, A

LL

RE

SID

EN

TS,

M

AL

ES,

200

7-20

11

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 165: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

143

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

1 42 40 10 4 0 71 1 1 14 65 515

918

4 5 24 10 35 13 917

5 3 21 4 33 1 0 1714

53 4 10 222

112 44 118 2 0 20 0 0 18 1 3 51 70 2 3 14 92 3 15 12 54 9 28 -----

3307

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 1 0 0 5 0 0 0---

-- 11

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 1 2 0---

-- 7

10-

-

14 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 2 0 0 1 2 1 0---

-- 11

15-

-

19 0 0 2 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 1 5 3 0 0 3 2 0 0 0 1 1 1---

-- 24

20-

-

24 0 1 0 1 0 0 2 0 0 0 0 0 1 1 0 0 0 0 0 0 1 0 0 1 0 0 0 0 3 0 0 2 0 0 1 0 0 0 0 0 0 0 0 0 7 0 0 4 5 1 0 0 4 1 0---

-- 36

25-

-

29 0 1 1 0 0 0 4 0 0 0 2 0 1 1 0 1 0 0 1 0 2 0 2 0 1 0 0 2 14 0 0 2 0 0 2 0 0 0 0 0 0 0 0 5 8 0 0 4 9 0 0 0 9 1 0---

-- 73

30-

-

34 0 2 1 0 0 0 4 0 0 0 2 1 0 2 0 1 1 2 0 0 3 0 1 0 0 0 0 2 64 0 0 10 4 1 7 0 0 0 0 0 0 0 0 0 3 0 0 0 1 0 0 0 3 0 2---

--11

7

35-

-

39 0 1 0 2 0 0 6 0 0 0 1 0 4 5 0 0 0 1 2 0 4 0 2 0 2 0 0 2 95 0 1 12 5 0 4 0 0 1 0 0 0 0 1 5 8 0 0 0 3 0 0 1 4 0 4---

--17

6

40-

-

44 0 2 3 2 0 0 6 0 0 1 8 0 8 9 0 2 1 0 0 1 9 0 1 1 0 0 0 219

0 0 1 23 6 3 12 0 0 0 0 0 0 0 0 3 3 0 0 0 3 0 1 1 5 0 3---

--31

0

45-

-

49 0 3 0 1 1 0 10 0 1 2 5 0 17 10 0 4 0 1 1 2 12 0 2 0 1 0 0 427

2 0 3 39 12 10 21 2 0 4 0 0 1 0 0 3 6 0 0 1 9 0 1 0 5 0 1---

--46

7

50-

-

54 1 8 1 0 0 0 11 0 0 1 1 2 12 17 0 3 0 1 2 1 19 0 0 0 2 0 0 024

2 0 1 33 27 6 22 0 0 1 0 0 3 1 0 5 8 1 1 1 8 1 2 0 6 1 5---

--45

7

55-

-

59 0 4 6 1 2 0 7 1 0 2 8 0 26 35 2 5 2 7 0 1 24 0 3 0 3 0 0 120

7 1 3 23 19 5 15 0 0 1 0 0 2 0 0 4 4 0 0 1 13 0 2 2 5 1 2---

--45

0

60-

-

64 0 6 6 1 0 0 6 0 0 1 8 1 23 30 1 4 2 9 2 1 29 0 2 0 4 0 0 015

3 0 0 18 17 3 9 0 0 3 0 0 4 0 1 3 3 0 1 0 10 0 3 1 2 1 1---

--36

9

65-

-

69 0 3 5 0 1 0 8 0 0 1 14 1 24 26 1 0 1 5 1 2 28 0 3 1 3 0 0 2 90 1 0 24 9 8 14 0 0 0 0 0 2 0 0 5 7 0 1 0 12 0 2 1 3 0 2---

--31

1

70-

-

74 0 5 6 1 0 0 1 0 0 3 6 0 19 23 0 2 1 3 1 0 20 1 1 0 4 0 0 0 71 1 1 15 8 6 5 0 0 7 0 0 0 0 0 6 5 0 0 0 10 0 3 0 4 0 2---

--24

1

75+

0 6 9 0 0 0 4 0 0 3 10 0 24 25 1 2 2 6 2 1 24 2 1 1 13 1 0 1 52 1 0 21 5 2 4 0 0 3 0 0 5 0 0 0 4 1 0 0 4 1 1 0 0 0 5---

--24

7

% of

Total

0.00%

1.30%

1.20%

0.30%

0.10%

0.00%

2.10%

0.00%

0.00%

0.40%

2.00%

0.20%

4.80%

5.60%

0.20%

0.70%

0.30%

1.10%

0.40%

0.30%

5.30%

0.10%

0.60%

0.10%

1.00%

0.00%

0.00%

0.50%

43.90

%0.1

0%0.3

0%6.7

0%3.4

0%1.3

0%3.6

0%0.1

0%0.0

0%0.6

0%0.0

0%0.0

0%0.5

0%0.0

0%0.1

0%1.5

0%2.1

0%0.1

0%0.1

0%0.4

0%2.8

0%0.1

0%0.5

0%0.4

0%1.6

0%0.3

0%0.8

0% -----

100.0

0%

IDC

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

64:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

WPK

L &

PU

TR

AJA

YA

, AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

20

07-2

011

Page 166: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

144

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

2 37 28 12 7 521

0 7 5 32 80 10 166

260 2 79 16 53 11 49 383 14 28 0 42 0 1 18 7 3

187 37 0 39 0 1 39 0 6 74 23 1 8 23 112 2 24 15 67 9 43 -----

2277

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0.3 0.9 0 0.3 0 0 0.3 0 0 0.9 0 0 0---

-- 3

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 1.2 0 0 0 0 0.3 0 0 1.2 0 0.6 0---

-- 4

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 1.7 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0.7 0 0 0.3 1 0 0---

-- 5

15-

-

19 0 0 0.3 0 0.3 0 0.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0.3 0 0 0 0.6 0 0 0 0 0 0 0 1.4 0 0 0.6 1.4 0.9 0 0 0.3 1.7 0.3 0---

-- 10

20-

-

24 0 0.3 0 0 0 0 0.5 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0.5 0.5 0.3 0 0 0 0 0 0 0 0 1.5 0 0 0 0 0 0 0 0 0 0 0 0.5 1 0 0 0.5 1.8 0 0---

-- 8

25-

-

29 0 0.3 0.3 0 0 0 1 0 0 0.3 0.5 0.3 0.3 0 0 0.3 0 0 0 0 0.3 1 0.8 0 0.3 0 0 0.5 0 0 0 2.8 0 0 0 0 0 0 0 1.5 0.3 0 0.3 1.3 2.3 0 0 0 0.3 0.5 0.5 ----- 15

30-

-

34 0 0.9 0 0.3 0.3 0 5.3 0.3 0 0 0.9 0 0.3 0.9 0 0.3 0.3 0.3 0.6 0.3 0.6 0.6 0.3 0 0 0 0 0.9 0 0 0 1.8 0 0.3 0 0 0.6 0 0.3 2.3 0.6 0 0 0.3 0.9 0 0 0.3 1.2 0.3 0---

-- 22

35-

-

39 0 0.4 0.7 0.4 0.4 0 7.5 0 0.4 0.7 0.7 0 1.4 1.8 0 0.4 0 0.4 0 0 3.2 0 0.4 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0.4 0 0 2.5 0 0 0 1.1 1.1 0 0 0 1.4 0.4 0.4 ----- 27

40-

-

44 0 0 0.4 0.4 0 0 7.4 0 0 1.2 0.4 0.4 1.6 7 0.4 2.1 0 0.4 0.4 0 4.1 0 0 0 0 0 0.4 1.6 0.4 0 0 0.4 0 0.8 0 0 0.4 0 0 1.2 0.8 0 0 0.4 3.7 0 0.4 0 1.2 0 2.9 ----- 41

45-

-

49 0 1.6 0.8 0.4 0.4 0.4 10 0 0 1.2 2.4 0.8 2.4 4.4 0 3.2 0.4 2.4 0 1.6 13.2 0.4 0.8 0 0.4 0 0 0.4 0.8 0 0 1.2 0 2.4 0 0 0 0 0 1.6 0.4 0 0.8 0 3.2 0 0.8 0.4 2 0.4 2.4 ----- 64

50-

-

54 0.5 2.5 2 0.5 0.5 015

.1 1 0 1 3.5 0.5 10.1

14.1 0 7.1 0.5 2 1.5 3

25.7 1 0.5 0 0 0 0 1 0 0 4 1 0 5 0 0 2.5 0 1 4 2.5 0 0 1 6 0.5 3 0 1 0 1.5 -----

127

55-

-

59 0.6 5.2 2.6 0 0 0.6 16.8 0 0.6 0.6 5.2 0.6 14.2

23.3 0 6.5 1.9 5.2 0.6 6.5 29.1 0.6 1.9 0 3.9 0 0 0.6 1.3 0

12.3 0 0 2.6 0 0 2.6 0 0.6 6.5 2.6 0 0.6 0.6 10.4 0 1.9 0.6 7.8 0 2.6 -----

181

60-

-

64 0 3.6 4.4 2.7 0.9 0.9 23.1 1.8 0.9 3.6 6.2 1.8 24.9

42.7 0

15.1 2.7 9.8 1.8 1.8 53.3 0 1.8 0 3.6 0 0 0 1.8 0

27.6 0.9 0 5.3 0 0 4.4 0 0 5.3 1.8 0 0.9 0

12.4 0 5.3 0 4.4 0.9 7.1 -----

285

65-

-

69 0 4.3 5.7 4.3 0 2.9 30 0 1.4 11.4

24.3 0

35.7 70 0

11.4 1.4 8.6 1.4 15.7

87.2 1.4 1.4 0

17.1 0 0 1.4 0 1.4 71.4 1.4 0 2.9 0 0 8.6 0 0 1.4 4.3 0 1.4 1.4 21.4 0 4.3 0 7.1 0 8.6 -----

473

70-

-

74 0 7.6 5.7 1.9 1.9 0 9.5 1.9 0 7.6 22.9 3.8 43.8

72.4 1.9 19.1 3.8 19.1 0

15.2

104.8 0 3.8 0 9.5 0 0 0 0 1.9 89.5 0 0 7.6 0 0

11.4 0 1.9 11.4 5.7 0 0 3.8 15.2 0 1.9 1.9 9.5 0 5.7 -----

524

75+

0 6.3 2.1 0 0 022

.9 2.1 2.1 8.3 31.3 0

62.5

52.1 0 6.3 8.3 10.4 2.1 14.6

112.5 2.1 2.1 0

27.1 0 0 4.2 0 2.1 66.7 0 0 8.3 0 2.1 18.8 0 0 4.2 0 0 0 0 8.3 2.1 4.2 0

10.4 0 6.3 -----

513

Crud

eRa

te 0.1 1 0.7 0.3 0.2 0.1 5.5 0.2 0.1 0.8 2.1 0.3 4.3 6.8 0.1 2.1 0.4 1.4 0.3 1.3 10 0.4 0.7 0 1.1 0 0 0.5 0.2 0.1 4.9 1 0 1 0 0 1 0 0.2 1.9 0.6 0 0.2 0.6 2.9 0.1 0.6 0.4 1.8 0.2 1.1 -----

59.5

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

65:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, W

PKL

& P

UT

RA

JAY

A, A

LL

RE

SID

EN

TS,

MA

LE

S, 2

007-

2011

ASR

Wor

ld 0.1 1.1 0.9 0.4 0.2 0.2 5.9 0.2 0.2 1.1 2.7 0.3 5.7 8.8 0.1 2.5 0.5 1.8 0.3 1.7 12.9 0.3 0.8 0 1.6 0 0 0.5 0.2 0.1 7.1 0.8 0 1.2 0 0 1.3 0 0.2 2 0.7 0 0.2 0.6 3.3 0.1 0.8 0.4 1.9 0.2 1.3 -----

73.1

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 167: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

145

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

1 42 40 10 4 0 71 1 1 14 65 515

918

4 5 24 10 35 13 917

5 3 21 4 33 1 0 1714

53 4 10 222

112 44 118 2 0 20 0 0 18 1 3 51 70 2 3 14 92 3 15 12 54 9 28 -----

3307

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.3 0 0 0 0 0.3 0 0 1.7 0 0 0---

-- 4

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0.3 0.7 0---

-- 2

10-

-

14 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0.3 0 0 0 0.7 0 0 0.3 0.7 0.3 0---

-- 4

15-

-

19 0 0 0.6 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0.3 1.4 0.9 0 0 0.9 0.6 0 0 0 0.3 0.3 0.3 ----- 7

20-

-

24 0 0.2 0 0.2 0 0 0.5 0 0 0 0 0 0.2 0.2 0 0 0 0 0 0 0.2 0 0 0.2 0 0 0 0 0.7 0 0 0.5 0 0 0.2 0 0 0 0 0 0 0 0 0 1.7 0 0 1 1.2 0.2 0 0 1 0.2 0---

-- 9

25-

-

29 0 0.2 0.2 0 0 0 1 0 0 0 0.5 0 0.2 0.2 0 0.2 0 0 0.2 0 0.5 0 0.5 0 0.2 0 0 0.5 3.4 0 0 0.5 0 0 0.5 0 0 0 0 0 0 0 0 1.2 2 0 0 1 2.2 0 0 0 2.2 0.2 0---

-- 18

30-

-

34 0 0.6 0.3 0 0 0 1.3 0 0 0 0.6 0.3 0 0.6 0 0.3 0.3 0.6 0 0 1 0 0.3 0 0 0 0 0.6 20.4 0 0 3.2 1.3 0.3 2.2 0 0 0 0 0 0 0 0 0 1 0 0 0 0.3 0 0 0 1 0 0.6 ----- 37

35-

-

39 0 0.4 0 0.7 0 0 2.2 0 0 0 0.4 0 1.5 1.8 0 0 0 0.4 0.7 0 1.5 0 0.7 0 0.7 0 0 0.7 34.9 0 0.4 4.4 1.8 0 1.5 0 0 0.4 0 0 0 0 0.4 1.8 2.9 0 0 0 1.1 0 0 0.4 1.5 0 1.5 ----- 65

40-

-

44 0 0.7 1.1 0.7 0 0 2.1 0 0 0.4 2.9 0 2.9 3.2 0 0.7 0.4 0 0 0.4 3.2 0 0.4 0.4 0 0 0 0.7 67.7 0 0.4 8.2 2.1 1.1 4.3 0 0 0 0 0 0 0 0 1.1 1.1 0 0 0 1.1 0 0.4 0.4 1.8 0 1.1 -----

111

45-

-

49 0 1.4 0 0.5 0.5 0 4.6 0 0.5 0.9 2.3 0 7.8 4.6 0 1.8 0 0.5 0.5 0.9 5.5 0 0.9 0 0.5 0 0 1.812

5.1 0 1.4 17.9 5.5 4.6 9.7 0.9 0 1.8 0 0 0.5 0 0 1.4 2.8 0 0 0.5 4.1 0 0.5 0 2.3 0 0.5 -----

215

50-

-

54 0.5 4.3 0.5 0 0 0 5.9 0 0 0.5 0.5 1.1 6.5 9.2 0 1.6 0 0.5 1.1 0.5 10.3 0 0 0 1.1 0 0 0

130.8 0 0.5 17

.814

.6 3.2 11.9 0 0 0.5 0 0 1.6 0.5 0 2.7 4.3 0.5 0.5 0.5 4.3 0.5 1.1 0 3.2 0.5 2.7 -----

247

55-

-

59 0 2.8 4.2 0.7 1.4 0 4.9 0.7 0 1.4 5.6 018

.224

.6 1.4 3.5 1.4 4.9 0 0.7 16.8 0 2.1 0 2.1 0 0 0.7

145.3 0.7 2.1 16

.113

.3 3.5 10.5 0 0 0.7 0 0 1.4 0 0 2.8 2.8 0 0 0.7 9.1 0 1.4 1.4 3.5 0.7 1.4 -----

316

60-

-

64 0 5.7 5.7 1 0 0 5.7 0 0 1 7.7 1 22 28.7 1 3.8 1.9 8.6 1.9 1

27.8 0 1.9 0 3.8 0 0 0

146.4 0 0

17.2

16.3 2.9 8.6 0 0 2.9 0 0 3.8 0 1 2.9 2.9 0 1 0 9.6 0 2.9 1 1.9 1 1

-----

353

65-

-

69 0 4.3 7.2 0 1.4 011

.5 0 0 1.4 20.1 1.4 34.5

37.4 1.4 0 1.4 7.2 1.4 2.9 40.3 0 4.3 1.4 4.3 0 0 2.9

129.5 1.4 0

34.5 13 11.5

20.1 0 0 0 0 0 2.9 0 0 7.2 10.1 0 1.4 0

17.3 0 2.9 1.4 4.3 0 2.9 -----

448

70-

-

74 010

.612

.8 2.1 0 0 2.1 0 0 6.4 12.8 0

40.4

48.9 0 4.3 2.1 6.4 2.1 0

42.6 2.1 2.1 0 8.5 0 0 0

151.1 2.1 2.1 31.9 17 12.8

10.6 0 0

14.9 0 0 0 0 0

12.8

10.6 0 0 0

21.3 0 6.4 0 8.5 0 4.3 -----

513

75+

010

.916

.4 0 0 0 7.3 0 0 5.5 18.2 0

43.6

45.5 1.8 3.6 3.6 10.9 3.6 1.8 43.6 3.6 1.8 1.8 23.6 1.8 0 1.8 94.6 1.8 0

38.2 9.1 3.6 7.3 0 0 5.5 0 0 9.1 0 0 0 7.3 1.8 0 0 7.3 1.8 1.8 0 0 0 9.1 -----

449

Crud

eRa

te

0 1.1 1.1 0.3 0.1 0 1.9 0 0 0.4 1.7 0.1 4.2 4.9 0.1 0.6 0.3 0.9 0.3 0.2 4.7 0.1 0.6 0.1 0.9 0 0 0.5 38.8 0.1 0.3 5.9 3 1.2 3.2 0.1 0 0.5 0 0 0.5 0 0.1 1.4 1.9 0.1 0.1 0.4 2.5 0.1 0.4 0.3 1.4 0.2 0.7 -----

88.3

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

66:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, W

PKL

& P

UT

RA

JAY

A, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, 2

007-

2011

ASR

Wor

ld 0 1.3 1.4 0.3 0.1 0 2 0 0 0.5 2.2 0.2 5.4 6.3 0.2 0.7 0.3 1.2 0.4 0.3 6 0.1 0.6 0.1 1.2 0 0 0.5 42.2 0.2 0.3 6.8 3.5 1.5 3.5 0.1 0 0.7 0 0 0.6 0 0.1 1.6 2 0.1 0.1 0.3 2.9 0.1 0.5 0.4 1.4 0.3 0.8 -----

101.2

Page 168: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

146

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

0 21 7 15 4 0 77 4 0 33 35 815

220

4 116

6 18 43 14 35 333 9 38 12 64 0 0 12 4 5

170 27 3 30 0 1

124 0 12 56 46 4 7 1

131 0 31 26 73 46 3

-----

2105

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 1 0 0 0 0 0 0 0 0 2 0 1 0 2 0 0 0 0 1 0 8 10 0 0 0 0 2 0 0 11 5 11 0---

-- 57

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 2 5 1 0 0 0 4 0 0 9 3 10 0---

-- 36

10-

-

14 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 1 0 0 0 2 0 0 0 0 0 0 0 5 1 0 1 0 11 0 0 3 2 4 0---

-- 36

15-

-

19 0 0 0 0 0 0 3 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 9 0 1 0 0 0 0 0 0 2 0 2 0 0 0 0 0 5 1 0 0 0 4 0 0 1 4 4 1---

-- 39

20-

-

24 0 1 1 0 0 0 2 0 0 0 0 0 0 0 0 2 0 0 1 0 1 0 6 0 1 0 0 0 0 0 2 3 0 1 0 0 0 0 0 4 0 0 0 0 8 0 0 1 6 2 1---

-- 43

25-

-

29 0 1 1 1 0 0 6 0 0 0 1 0 4 2 0 3 0 0 0 0 2 1 2 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 2 0 0 0 6 0 0 0 2 2 0---

-- 40

30-

-

34 0 1 0 1 0 0 4 0 0 0 1 0 4 6 0 4 0 0 0 2 4 0 1 0 2 0 0 1 1 0 0 1 0 0 0 0 0 0 0 3 1 0 0 0 4 0 0 1 5 2 0---

-- 49

35-

-

39 0 0 0 0 0 0 1 0 0 0 3 0 7 6 0 8 2 4 0 1 6 1 1 0 4 0 0 1 0 0 1 3 0 0 0 0 1 0 0 2 3 0 0 0 8 0 1 0 4 1 0---

-- 69

40-

-

44 0 1 1 0 1 0 8 0 0 1 1 0 7 9 0 7 1 2 1 1 14 1 1 0 2 0 0 2 0 0 1 0 0 3 0 0 2 0 0 3 3 1 1 0 14 0 3 0 3 1 0---

-- 96

45-

-

49 0 2 1 2 0 0 11 0 0 3 4 0 18 17 0 20 2 5 0 0 27 0 0 2 6 0 0 0 0 0 4 1 0 1 0 0 11 0 0 2 5 0 2 0 10 0 2 0 7 0 0---

--16

5

50-

-

54 0 2 0 0 0 0 11 1 0 2 6 1 18 19 0 28 3 5 5 8 35 1 3 3 4 0 0 2 0 0 10 1 0 4 0 0 9 0 0 5 3 0 0 0 11 0 3 0 7 4 0---

--21

4

55-

-

59 0 3 0 1 0 0 6 0 0 5 4 2 22 30 0 23 2 3 0 4 46 1 0 3 4 0 0 1 0 3 12 4 2 4 0 0 10 0 1 4 3 1 1 1 15 0 9 0 9 1 0---

--24

0

60-

-

64 0 3 0 4 1 0 8 0 0 7 4 2 16 33 1 28 1 7 3 9 65 1 5 0 6 0 0 0 3 0 26 1 0 5 0 0 26 0 0 2 6 1 2 0 16 0 5 0 5 3 0---

--30

5

65-

-

69 0 2 0 1 0 0 6 0 0 2 2 1 22 29 0 21 3 11 0 2 46 1 2 3 10 0 0 1 0 1 31 3 0 6 0 0 21 0 0 1 7 1 0 0 10 0 4 0 3 0 0---

--25

3

70-

-

74 0 3 0 3 1 0 6 0 0 3 2 2 14 22 0 7 3 3 1 5 38 1 2 0 10 0 0 1 0 0 36 3 1 1 0 1 14 0 0 2 9 0 0 0 4 0 3 0 2 0 0---

--20

3

75+

0 2 3 2 1 0 3 3 0 10 7 0 19 31 0 12 1 3 0 3 49 1 2 1 12 0 0 0 0 0 47 0 0 3 0 0 29 0 1 1 1 0 0 0 4 0 1 0 6 1 1---

--26

0

% of

Total 0.0

0%1.0

0%0.3

0%0.7

0%0.2

0%0.0

0%3.7

0%0.2

0%0.0

0%1.6

0%1.7

0%0.4

0%7.2

0%9.7

0%0.0

0%7.9

0%0.9

0%2.0

0%0.7

0%1.7

0%15

.80%

0.40%

1.80%

0.60%

3.00%

0.00%

0.00%

0.60%

0.20%

0.20%

8.10%

1.30%

0.10%

1.40%

0.00%

0.00%

5.90%

0.00%

0.60%

2.70%

2.20%

0.20%

0.30%

0.00%

6.20%

0.00%

1.50%

1.20%

3.50%

2.20%

0.10% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

67:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

KE

LA

NTA

N, A

LL

RE

SID

EN

TS,

MA

LE

S, 2

007-

2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 169: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

147

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

0 17 5 9 2 2 28 3 0 27 23 512

414

0 2 69 12 29 7 814

1 9 22 10 54 0 0 14 594 7 4

132 88 24 184 1 1 21 1 0 22 1 4 49 170 0 3 2 80 0 14 11 65 40 1

-----

2281

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 3 0 0 1 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 4 0 0 0 0 3 0 0 6 7 9 0---

-- 39

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 3 0 0 2 0 7 0---

-- 15

10-

-

14 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 1 0 0 0 8 0 2 0 0 1 0 0 0 0 0 0 3 0 0 1 0 0 0 0 0 3 0 0 0 0 4 0 0 2 3 6 0---

-- 36

15-

-

19 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 3 0 1 0 0 2 0 0 0 0 0 0 6 0 0 2 0 0 1 0 0 1 8 0 0 0 3 0 0 1 3 1 0---

-- 35

20-

-

24 0 0 0 1 0 0 1 0 0 0 0 0 2 3 0 1 0 0 0 0 0 0 1 0 1 0 0 1 1 0 0 1 0 0 4 0 0 0 1 0 1 0 0 4 4 0 1 0 4 0 0 0 8 1 1---

-- 42

25-

-

29 0 1 0 1 0 0 1 0 0 0 1 0 3 0 0 1 0 0 0 0 0 0 1 0 2 0 0 1 13 0 0 2 0 0 10 0 0 0 0 0 0 0 0 0 9 0 0 0 4 0 0 0 3 2 0---

-- 55

30-

-

34 0 1 0 0 0 0 1 0 0 0 1 1 3 3 0 1 0 1 0 0 4 0 2 0 1 0 0 1 24 0 0 4 2 0 12 0 0 1 0 0 0 0 0 2 7 0 0 0 3 0 0 0 3 0 0---

-- 78

35-

-

39 0 0 1 1 0 0 0 0 0 0 1 0 5 4 0 0 0 2 1 0 2 0 0 0 1 0 0 0 51 0 1 8 10 2 8 0 1 0 0 0 0 0 0 1 19 0 0 0 3 0 0 0 2 3 0---

--12

7

40-

-

44 0 1 0 0 0 0 0 1 0 0 0 0 2 6 0 1 0 1 0 1 9 1 0 0 4 0 0 1 90 0 0 19 10 2 23 0 0 2 0 0 1 0 0 3 23 0 1 0 2 0 1 0 4 1 0---

--21

0

45-

-

49 0 2 0 0 0 0 3 1 0 1 2 0 16 9 0 7 0 3 0 1 10 1 2 1 5 0 0 212

2 2 0 19 8 4 16 0 0 5 0 0 2 0 1 12 19 0 0 1 6 0 1 0 6 3 0---

--29

3

50-

-

54 0 3 1 2 0 0 5 0 0 3 4 2 16 10 1 8 2 4 0 0 16 1 1 1 1 0 0 0 91 1 0 19 14 5 33 0 0 2 0 0 2 0 1 4 24 0 0 0 2 0 2 0 5 0 0---

--28

6

55-

-

59 0 0 1 0 1 0 3 1 0 4 2 0 14 27 0 12 3 2 1 1 25 0 0 0 3 0 0 1 75 1 1 23 16 4 19 0 0 2 0 0 4 0 0 3 17 0 1 1 10 0 5 0 5 2 0---

--29

0

60-

-

64 0 2 1 2 1 1 2 0 0 1 1 0 15 15 0 8 3 6 0 1 15 2 2 2 8 0 0 0 45 0 0 16 11 3 13 0 0 2 0 0 1 1 0 1 16 0 0 0 14 0 2 0 6 1 0---

--22

0

65-

-

69 0 2 0 1 0 0 4 0 0 3 4 1 11 17 1 10 3 2 0 1 26 1 0 3 5 0 0 1 41 0 0 9 9 2 17 1 0 1 0 0 4 0 0 7 15 0 0 0 9 0 1 0 4 1 0---

--21

7

70-

-

74 0 3 1 0 0 0 5 0 0 5 0 1 16 26 0 7 0 6 0 1 12 1 0 1 10 0 0 1 26 1 1 7 2 2 12 0 0 2 0 0 2 0 0 1 5 0 0 0 2 0 1 0 4 2 0---

--16

6

75+

0 2 0 1 0 1 1 0 0 10 5 0 20 20 0 9 1 2 3 2 22 2 1 2 9 0 0 1 15 2 1 5 6 0 8 0 0 0 0 0 4 0 0 1 4 0 0 0 8 0 1 0 2 1 0---

--17

2

% of

Total

0.00%

0.70%

0.20%

0.40%

0.10%

0.10%

1.20%

0.10%

0.00%

1.20%

1.00%

0.20%

5.40%

6.10%

0.10%

3.00%

0.50%

1.30%

0.30%

0.40%

6.20%

0.40%

1.00%

0.40%

2.40%

0.00%

0.00%

0.60%

26.00

%0.3

0%0.2

0%5.8

0%3.9

0%1.1

0%8.1

0%0.0

0%0.0

0%0.9

0%0.0

0%0.0

0%1.0

0%0.0

0%0.2

0%2.1

0%7.5

0%0.0

0%0.1

0%0.1

0%3.5

0%0.0

0%0.6

0%0.5

0%2.8

0%1.8

0%0.0

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

68:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

KE

LA

NTA

N, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, 2

007-

2011

Page 170: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

148

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

0 21 7 15 4 0 77 4 0 33 35 815

220

4 116

6 18 43 14 35 333 9 38 12 64 0 0 12 4 5

170 27 3 30 0 1

124 0 12 56 46 4 7 1

131 0 31 26 73 46 3

-----

2105

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0.2 0 0 0 0 0 0 0 0 0.5 0 0.2 0 0.5 0 0 0 0 0.2 0 1.8 2.3 0 0 0 0 0.5 0 0 2.5 1.2 2.5 0---

-- 13

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 1.1 0.2 0 0 0 0.9 0 0 1.9 0.6 2.1 0---

-- 8

10-

-

14 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0.2 0 0 0 0.4 0 0 0 0 0 0 0 1 0.2 0 0.2 0 2.2 0 0 0.6 0.4 0.8 0---

-- 7

15-

-

19 0 0 0 0 0 0 0.6 0 0 0 0 0 0.2 0 0 0 0 0 0.2 0 0 0 1.9 0 0.2 0 0 0 0 0 0 0.4 0 0.4 0 0 0 0 0 1.1 0.2 0 0 0 0.8 0 0 0.2 0.8 0.8 0.2 ----- 8

20-

-

24 0 0.3 0.3 0 0 0 0.7 0 0 0 0 0 0 0 0 0.7 0 0 0.3 0 0.3 0 2 0 0.3 0 0 0 0 0 0.7 1 0 0.3 0 0 0 0 0 1.3 0 0 0 0 2.6 0 0 0.3 2 0.7 0.3 ----- 14

25-

-

29 0 0.4 0.4 0.4 0 0 2.3 0 0 0 0.4 0 1.6 0.8 0 1.2 0 0 0 0 0.8 0.4 0.8 0 0.4 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0.8 0.8 0 0 0 2.3 0 0 0 0.8 0.8 0---

-- 16

30-

-

34 0 0.5 0 0.5 0 0 2 0 0 0 0.5 0 2 3 0 2 0 0 0 1 2 0 0.5 0 1 0 0 0.5 0.5 0 0 0.5 0 0 0 0 0 0 0 1.5 0.5 0 0 0 2 0 0 0.5 2.5 1 0---

-- 25

35-

-

39 0 0 0 0 0 0 0.5 0 0 0 1.6 0 3.8 3.3 0 4.4 1.1 2.2 0 0.5 3.3 0.5 0.5 0 2.2 0 0 0.5 0 0 0.5 1.6 0 0 0 0 0.5 0 0 1.1 1.6 0 0 0 4.4 0 0.5 0 2.2 0.5 0---

-- 38

40-

-

44 0 0.5 0.5 0 0.5 0 4 0 0 0.5 0.5 0 3.5 4.5 0 3.5 0.5 1 0.5 0.5 7.1 0.5 0.5 0 1 0 0 1 0 0 0.5 0 0 1.5 0 0 1 0 0 1.5 1.5 0.5 0.5 0 7.1 0 1.5 0 1.5 0.5 0---

-- 48

45-

-

49 0 1 0.5 1 0 0 5.6 0 0 1.5 2 0 9.2 8.7 010

.2 1 2.6 0 013

.8 0 0 1 3.1 0 0 0 0 0 2 0.5 0 0.5 0 0 5.6 0 0 1 2.6 0 1 0 5.1 0 1 0 3.6 0 0---

-- 84

50-

-

54 0 1.2 0 0 0 0 6.4 0.6 0 1.2 3.5 0.6 10.5 11 0

16.3 1.7 2.9 2.9 4.7 20.4 0.6 1.7 1.7 2.3 0 0 1.2 0 0 5.8 0.6 0 2.3 0 0 5.2 0 0 2.9 1.7 0 0 0 6.4 0 1.7 0 4.1 2.3 0

-----

124

55-

-

59 0 2.2 0 0.7 0 0 4.3 0 0 3.6 2.9 1.4 15.8

21.5 0

16.5 1.4 2.2 0 2.9 33 0.7 0 2.2 2.9 0 0 0.7 0 2.2 8.6 2.9 1.4 2.9 0 0 7.2 0 0.7 2.9 2.2 0.7 0.7 0.7 10.8 0 6.5 0 6.5 0.7 0

-----

172

60-

-

64 0 2.6 0 3.5 0.9 0 6.9 0 0 6.1 3.5 1.7 13.9

28.6 0.9 24.2 0.9 6.1 2.6 7.8 56.3 0.9 4.3 0 5.2 0 0 0 2.6 0

22.5 0.9 0 4.3 0 0

22.5 0 0 1.7 5.2 0.9 1.7 0

13.9 0 4.3 0 4.3 2.6 0

-----

264

65-

-

69 0 2.8 0 1.4 0 0 8.3 0 0 2.8 2.8 1.4 30.6

40.3 0

29.2 4.2 15.3 0 2.8 63.9 1.4 2.8 4.2 13.9 0 0 1.4 0 1.4 43.1 4.2 0 8.3 0 0

29.2 0 0 1.4 9.7 1.4 0 0

13.9 0 5.6 0 4.2 0 0

-----

351

70-

-

74 0 5.7 0 5.7 1.9 011

.4 0 0 5.7 3.8 3.8 26.7

41.9 0

13.3 5.7 5.7 1.9 9.5 72.4 1.9 3.8 0

19.1 0 0 1.9 0 0

68.6 5.7 1.9 1.9 0 1.9 26.7 0 0 3.8 17.1 0 0 0 7.6 0 5.7 0 3.8 0 0

-----

387

75+

0 3.2 4.8 3.2 1.6 0 4.8 4.8 015

.911

.1 030

.249

.2 019

.1 1.6 4.8 0 4.8 77.8 1.6 3.2 1.6 19.1 0 0 0 0 0

74.6 0 0 4.8 0 0 46 0 1.6 1.6 1.6 0 0 0 6.4 0 1.6 0 9.5 1.6 1.6 -----

413

Crud

eRa

te 0 0.5 0.2 0.4 0.1 0 2 0.1 0 0.9 0.9 0.2 4 5.3 0 4.3 0.5 1.1 0.4 0.9 8.7 0.2 1 0.3 1.7 0 0 0.3 0.1 0.1 4.4 0.7 0.1 0.8 0 0 3.2 0 0.3 1.5 1.2 0.1 0.2 0 3.4 0 0.8 0.7 1.9 1.2 0.1 -----

54.8

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

69:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, K

EL

AN

TAN

, AL

L R

ESI

DE

NT

S, M

AL

ES,

200

7-20

11

ASR

Wor

ld 0 0.7 0.2 0.5 0.1 0 2.4 0.1 0 1.1 1.1 0.3 5 6.8 0 5.4 0.6 1.5 0.4 1.2 11.2 0.3 1 0.4 2.2 0 0 0.4 0.1 0.2 5.9 0.8 0.1 1 0 0 4.2 0 0.3 1.5 1.5 0.1 0.2 0 3.9 0 1 0.6 2.1 1.2 0.1 ----- 68

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 171: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

149

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

0 17 5 9 2 2 28 3 0 27 23 512

414

0 2 69 12 29 7 814

1 9 22 10 54 0 0 14 594 7 4

132 88 24 184 1 1 21 1 0 22 1 4 49 170 0 3 2 80 0 14 11 65 40 1

-----

2281

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0.7 0 0 0.2 0 0 0 0 0 0.2 0 0 0.2 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0.5 1 0 0 0 0 0.7 0 0 1.5 1.7 2.2 0---

-- 10

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0.7 0 0 0.4 0 1.6 0---

-- 3

10-

-

14 0 0 0 0 0 0 0 0 0 0 0.2 0 0.2 0 0 0 0 0 0.2 0 0 0 1.7 0 0.4 0 0 0.2 0 0 0 0 0 0 0.6 0 0 0.2 0 0 0 0 0 0.6 0 0 0 0 0.8 0 0 0.4 0.6 1.3 0---

-- 8

15-

-

19 0 0 0 0 0 0 0.2 0 0 0 0.2 0 0 0 0 0.2 0 0 0 0 0 0 0.7 0 0.2 0 0 0.5 0 0 0 0 0 0 1.4 0 0 0.5 0 0 0.2 0 0 0.2 1.8 0 0 0 0.7 0 0 0.2 0.7 0.2 0---

-- 8

20-

-

24 0 0 0 0.4 0 0 0.4 0 0 0 0 0 0.7 1.1 0 0.4 0 0 0 0 0 0 0.4 0 0.4 0 0 0.4 0.4 0 0 0.4 0 0 1.4 0 0 0 0.4 0 0.4 0 0 1.4 1.4 0 0.4 0 1.4 0 0 0 2.8 0.4 0.4 ----- 15

25-

-

29 0 0.4 0 0.4 0 0 0.4 0 0 0 0.4 0 1.3 0 0 0.4 0 0 0 0 0 0 0.4 0 0.9 0 0 0.4 5.6 0 0 0.9 0 0 4.3 0 0 0 0 0 0 0 0 0 3.9 0 0 0 1.7 0 0 0 1.3 0.9 0---

-- 24

30-

-

34 0 0.5 0 0 0 0 0.5 0 0 0 0.5 0.5 1.5 1.5 0 0.5 0 0.5 0 0 2 0 1 0 0.5 0 0 0.5 11.7 0 0 2 1 0 5.9 0 0 0.5 0 0 0 0 0 1 3.4 0 0 0 1.5 0 0 0 1.5 0 0

----- 38

35-

-

39 0 0 0.5 0.5 0 0 0 0 0 0 0.5 0 2.3 1.9 0 0 0 0.9 0.5 0 0.9 0 0 0 0.5 0 0 023

.6 0 0.5 3.7 4.6 0.9 3.7 0 0.5 0 0 0 0 0 0 0.5 8.8 0 0 0 1.4 0 0 0 0.9 1.4 0---

-- 59

40-

-

44 0 0.4 0 0 0 0 0 0.4 0 0 0 0 0.9 2.6 0 0.4 0 0.4 0 0.4 4 0.4 0 0 1.8 0 0 0.4 39.7 0 0 8.4 4.4 0.9 10.2 0 0 0.9 0 0 0.4 0 0 1.3 10.2 0 0.4 0 0.9 0 0.4 0 1.8 0.4 0

----- 93

45-

-

49 0 0.9 0 0 0 0 1.4 0.5 0 0.5 0.9 0 7.4 4.1 0 3.2 0 1.4 0 0.5 4.6 0.5 0.9 0.5 2.3 0 0 0.9 56.1 0.9 0 8.7 3.7 1.8 7.4 0 0 2.3 0 0 0.9 0 0.5 5.5 8.7 0 0 0.5 2.8 0 0.5 0 2.8 1.4 0

-----

135

50-

-

54 0 1.6 0.5 1.1 0 0 2.6 0 0 1.6 2.1 1.1 8.4 5.3 0.5 4.2 1.1 2.1 0 0 8.4 0.5 0.5 0.5 0.5 0 0 047

.9 0.5 0 10 7.4 2.6 17.4 0 0 1.1 0 0 1.1 0 0.5 2.1 12.6 0 0 0 1.1 0 1.1 0 2.6 0 0

-----

151

55-

-

59 0 0 0.7 0 0.7 0 2.1 0.7 0 2.7 1.4 0 9.6 18.6 0 8.2 2.1 1.4 0.7 0.7 17.2 0 0 0 2.1 0 0 0.7 51.6 0.7 0.7 15.8 11 2.7 13.1 0 0 1.4 0 0 2.7 0 0 2.1 11.7 0 0.7 0.7 6.9 0 3.4 0 3.4 1.4 0

-----

199

60-

-

64 0 1.7 0.9 1.7 0.9 0.9 1.7 0 0 0.9 0.9 012

.912

.9 0 6.9 2.6 5.2 0 0.9 12.9 1.7 1.7 1.7 6.9 0 0 0

38.8 0 0

13.8 9.5 2.6 11.2 0 0 1.7 0 0 0.9 0.9 0 0.9 13.8 0 0 0

12.1 0 1.7 0 5.2 0.9 0

-----

190

65-

-

69 0 2.4 0 1.2 0 0 4.7 0 0 3.6 4.7 1.2 13 20.1 1.2 11.8 3.6 2.4 0 1.2 30.8 1.2 0 3.6 5.9 0 0 1.2 48.5 0 0

10.7

10.7 2.4 20.1 1.2 0 1.2 0 0 4.7 0 0 8.3 17.8 0 0 0

10.7 0 1.2 0 4.7 1.2 0

-----

257

70-

-

74 0 5 1.7 0 0 0 8.3 0 0 8.3 0 1.7 26.4 43 0

11.6 0 9.9 0 1.7 19.8 1.7 0 1.7 16.5 0 0 1.7 43 1.7 1.7 11.6 3.3 3.3 19.8 0 0 3.3 0 0 3.3 0 0 1.7 8.3 0 0 0 3.3 0 1.7 0 6.6 3.3 0

-----

274

75+

0 2.4 0 1.2 0 1.2 1.2 0 0 12 6 0 24 24 010

.8 1.2 2.4 3.6 2.4 26.4 2.4 1.2 2.4 10.8 0 0 1.2 18 2.4 1.2 6 7.2 0 9.6 0 0 0 0 0 4.8 0 0 1.2 4.8 0 0 0 9.6 0 1.2 0 2.4 1.2 0

-----

206

Crud

eRa

te

0 0.4 0.1 0.2 0.1 0.1 0.7 0.1 0 0.7 0.6 0.1 3.2 3.7 0.1 1.8 0.3 0.8 0.2 0.2 3.7 0.2 0.6 0.3 1.4 0 0 0.4 15.5 0.2 0.1 3.5 2.3 0.6 4.8 0 0 0.5 0 0 0.6 0 0.1 1.3 4.4 0 0.1 0.1 2.1 0 0.4 0.3 1.7 1 0

-----

59.6

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

70:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, K

EL

AN

TAN

, AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

200

7-20

11

ASR

Wor

ld 0 0.5 0.1 0.3 0.1 0.1 0.8 0.1 0 0.8 0.6 0.2 3.6 4.2 0.1 2 0.4 0.9 0.2 0.2 4.2 0.3 0.5 0.3 1.6 0 0 0.4 17 0.2 0.1 3.8 2.5 0.7 5.3 0 0 0.6 0 0 0.6 0 0.1 1.4 4.9 0 0.1 0.1 2.3 0 0.4 0.3 1.9 1.1 0---

--65

.8

Page 172: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

150

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

5 38 33 38 15 739

4 20 3 85 238 19 442

357 11 361 38 145 28 106

861 22 42 11 184 0 3 45 17 10 447 31 4

146 5 3

177 2 11 90 50 6 8 28 244 1 28 86 101 30 169

-----

5245

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 4 0 4 0 0 0 0 3 8 0 2 1 0 4 0 0 21 3 9 0---

-- 65

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 1 0 0 1 10 0 0 11 1 4 3---

-- 37

10-

-

14 0 0 0 0 0 0 4 0 0 0 1 0 1 0 0 1 0 0 1 0 0 0 6 0 0 0 0 2 0 0 0 3 0 0 0 0 0 0 0 9 0 0 0 0 10 0 0 8 3 0 0---

-- 49

15-

-

19 0 0 2 1 0 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 1 0 0 0 0 0 0 2 0 0 0 0 1 0 0 4 2 0 0 4 7 0 0 5 5 1 1---

-- 45

20-

-

24 0 0 0 0 0 1 7 0 0 1 0 0 1 0 1 1 0 0 1 1 2 2 6 0 1 0 0 3 0 1 0 3 0 0 0 0 0 0 0 5 2 0 2 4 8 0 0 5 9 0 1---

-- 68

25-

-

29 0 1 1 1 1 0 9 0 0 0 0 0 0 2 0 1 0 0 0 0 7 0 1 0 2 0 1 6 0 0 0 3 0 3 0 0 0 0 0 2 1 0 0 2 5 0 1 5 9 1 3---

-- 68

30-

-

34 0 0 0 1 0 0 19 0 0 1 1 1 2 3 0 4 0 0 0 1 4 0 2 0 3 0 0 3 1 0 1 5 0 1 0 0 2 0 0 6 2 0 1 2 7 0 0 2 3 0 2---

-- 80

35-

-

39 0 2 0 3 0 0 37 0 0 0 5 0 6 8 0 8 0 3 2 1 14 2 0 0 2 0 0 2 0 0 0 6 0 6 0 0 2 0 0 5 4 0 1 2 16 0 1 1 8 1 4---

--15

2

40-

-

44 0 2 1 3 1 0 49 0 0 1 4 1 18 11 0 13 2 8 2 3 19 1 5 0 7 0 2 3 0 0 0 1 0 12 0 0 8 1 0 9 6 0 2 0 9 0 0 3 10 1 9---

--22

7

45-

-

49 0 3 0 4 1 0 58 0 1 8 17 3 29 25 0 21 2 12 3 4 47 1 1 1 10 0 0 3 2 0 4 1 0 21 1 0 8 0 0 7 6 0 0 3 22 0 2 2 6 0 7---

--34

6

50-

-

54 0 5 2 4 1 0 55 1 1 4 25 0 37 46 0 39 5 6 7 9 72 2 4 0 14 0 0 5 0 0 7 1 0 7 0 1 14 0 0 9 4 1 0 5 28 0 1 3 9 2 10 -----

446

55-

-

59 0 8 3 5 3 0 53 3 0 9 20 2 52 44 2 65 9 20 2 11 102 6 4 3 15 0 0 5 1 2 24 0 1 23 1 0 18 0 1 5 4 1 1 3 21 0 3 4 8 1 27 -----

595

60-

-

64 0 5 7 5 5 3 36 1 0 20 37 3 60 57 3 64 3 20 5 19 140 3 2 3 27 0 0 4 2 4 59 2 2 17 0 1 18 0 1 2 5 0 0 0 24 0 6 5 4 3 21 -----

708

65-

-

69 1 3 6 5 1 1 33 2 0 18 32 6 67 52 2 46 5 28 1 22 163 2 1 3 36 0 0 2 3 2

106 0 0 24 1 1 34 0 1 7 9 1 0 2 35 1 5 6 7 2 21 -----

806

70-

-

74 1 3 1 4 1 2 19 7 0 8 35 3 70 39 0 41 5 18 1 19 141 0 0 1 25 0 0 2 4 0

104 0 0 14 0 0 30 1 2 2 1 0 0 0 14 0 5 3 11 3 23 -----

663

75+

3 6 10 2 1 0 10 6 1 15 61 0 99 70 3 54 7 30 3 15 150 2 4 0 41 0 0 3 4 1

142 0 1 14 2 0 42 0 3 7 3 1 0 0 24 0 4 2 5 2 37 -----

890

% of

Total 0.1

0%0.7

0%0.6

0%0.7

0%0.3

0%0.1

0%7.5

0%0.4

0%0.1

0%1.6

0%4.5

0%0.4

0%8.4

0%6.8

0%0.2

0%6.9

0%0.7

0%2.8

0%0.5

0%2.0

0%16

.40%

0.40%

0.80%

0.20%

3.50%

0.00%

0.10%

0.90%

0.30%

0.20%

8.50%

0.60%

0.10%

2.80%

0.10%

0.10%

3.40%

0.00%

0.20%

1.70%

1.00%

0.10%

0.20%

0.50%

4.70%

0.00%

0.50%

1.60%

1.90%

0.60%

3.20% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

71:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

PE

NA

NG

, AL

L R

ESI

DE

NT

S, M

AL

ES,

200

7-20

11

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 173: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

151

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

6 32 43 15 9 212

7 9 3 44 184 14 451

248 21 135 52 119 3 10 341 27 31 19 125 2 0 45

1958 12 11 39

927

3 50 332 3 6 79 3 6 53 1 5 83 124 3 3 15 176 0 24 60 99 24 166

-----

6085

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 3 0 0 1 0 0 0 0 0 0 2 0 0 0 0 1 9 0 1 0 0 1 0 0 16 10 4 3---

-- 53

5-

-

9 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 0 0 0 0 3 0 0 11 4 1 0---

-- 29

10-

-

14 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 1 1 0 0 0 0 0 4 0 0 0 0 0 0 0 0 5 2 0 0 2 4 0 0 7 1 1 1---

-- 37

15-

-

19 0 0 0 1 0 0 4 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 4 0 1 0 0 2 1 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 3 0 0 3 5 0 0 2 6 2 0---

-- 38

20-

-

24 0 0 0 1 0 1 5 0 0 0 0 1 4 2 0 0 0 0 0 0 0 0 1 1 2 0 0 3 4 0 0 1 0 0 7 0 1 0 0 0 0 0 0 4 5 0 1 3 6 0 0 3 5 0 2---

-- 63

25-

-

29 0 1 0 3 0 0 10 0 0 0 0 0 5 1 0 0 0 1 0 0 2 0 0 0 0 0 0 2 20 0 0 7 8 2 13 0 1 1 0 0 0 0 0 5 10 0 0 0 8 0 0 0 1 0 3---

--10

4

30-

-

34 1 1 0 1 0 0 2 0 0 0 4 2 1 5 0 1 0 1 1 0 1 2 4 2 5 0 0 1 60 0 0 9 2 1 4 0 2 2 0 0 0 0 0 4 15 0 0 2 6 0 0 3 2 1 1---

--14

9

35-

-

39 0 0 0 0 0 0 4 0 0 0 5 0 7 3 0 4 1 2 1 2 8 0 1 0 2 0 0 411

0 0 0 36 10 4 16 0 2 4 0 0 3 0 0 4 17 0 0 0 10 0 0 4 5 2 6---

--27

7

40-

-

44 0 5 1 1 2 0 17 0 0 2 8 1 19 11 0 2 0 3 0 0 9 1 5 3 4 0 0 220

7 1 1 42 25 6 21 0 0 1 0 0 0 0 0 6 12 0 0 1 9 0 1 2 9 3 6---

--44

9

45-

-

49 0 1 0 1 0 0 15 3 0 3 15 3 31 15 2 6 4 5 0 0 23 2 3 1 3 0 0 731

5 1 0 44 37 5 64 2 0 8 0 0 4 0 0 5 18 1 0 0 8 0 0 3 9 1 11 -----

679

50-

-

54 1 2 1 1 1 0 12 0 1 4 19 2 45 26 0 7 2 17 0 2 35 1 1 2 4 0 0 331

3 0 1 56 44 3 51 0 0 10 0 1 2 0 1 6 8 1 1 0 24 0 2 1 11 1 13 -----

739

55-

-

59 0 4 5 0 2 0 21 2 0 6 18 2 55 33 1 12 4 12 0 2 53 5 2 1 14 0 0 026

9 2 1 54 44 9 48 0 0 6 0 0 5 1 0 6 9 0 1 2 20 0 4 2 10 2 17 -----

766

60-

-

64 0 5 4 0 2 0 14 0 1 2 17 1 52 29 6 19 10 16 0 1 47 3 1 2 12 1 0 324

7 2 1 43 43 8 39 0 0 13 1 0 9 0 0 8 6 0 0 1 18 0 5 2 7 0 22 -----

723

65-

-

69 0 2 11 0 0 0 10 1 1 7 20 0 60 22 3 20 8 17 0 0 49 5 1 2 24 1 0 515

1 1 2 29 20 1 32 0 0 11 1 2 10 0 1 5 9 0 0 0 18 0 6 1 5 2 21 -----

597

70-

-

74 2 5 11 2 1 1 9 1 0 8 26 0 63 40 3 26 13 13 0 2 39 2 1 2 18 0 0 511

8 4 1 44 19 5 12 0 0 7 1 1 6 0 0 4 2 0 0 1 20 0 4 1 3 1 24 -----

571

75+

1 6 8 3 1 0 4 2 0 12 52 210

8 61 6 37 10 32 1 1 75 5 1 3 35 0 0 414

2 1 3 34 21 6 19 1 0 14 0 2 14 0 2 4 8 0 0 0 16 0 2 2 11 3 36 -----

811

% of

Total

0.10%

0.50%

0.70%

0.20%

0.10%

0.00%

2.10%

0.10%

0.00%

0.70%

3.00%

0.20%

7.40%

4.10%

0.30%

2.20%

0.90%

2.00%

0.00%

0.20%

5.60%

0.40%

0.50%

0.30%

2.10%

0.00%

0.00%

0.70%

32.20

%0.2

0%0.2

0%6.6

0%4.5

0%0.8

0%5.5

0%0.0

0%0.1

0%1.3

0%0.0

0%0.1

0%0.9

0%0.0

0%0.1

0%1.4

0%2.0

0%0.0

0%0.0

0%0.2

0%2.9

0%0.0

0%0.4

0%1.0

0%1.6

0%0.4

0%2.7

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

72:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

PE

NA

NG

, AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

200

7-20

11

Page 174: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

152

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

5 38 33 38 15 739

4 20 3 85 238 19 442

357 11 361 38 145 28 106

861 22 42 11 184 0 3 45 17 10 447 31 4

146 5 3

177 2 11 90 50 6 8 28 244 1 28 86 101 30 169

-----

5245

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0.3 0 0 0 0 0.7 0 0 0 1.4 0 1.4 0 0 0 0 1 2.7 0 0.7 0.3 0 1.4 0 0 7.2 1 3.1 0---

-- 22

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0.3 0 0 0.3 3.2 0 0 3.5 0.3 1.3 1---

-- 12

10-

-

14 0 0 0 0 0 0 1.2 0 0 0 0.3 0 0.3 0 0 0.3 0 0 0.3 0 0 0 1.8 0 0 0 0 0.6 0 0 0 0.9 0 0 0 0 0 0 0 2.8 0 0 0 0 3.1 0 0 2.5 0.9 0 0---

-- 15

15-

-

19 0 0 0.6 0.3 0 0 1.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0.9 0 0.3 0 0 0 0 0 0 0.6 0 0 0 0 0.3 0 0 1.2 0.6 0 0 1.2 2.1 0 0 1.5 1.5 0.3 0.3 ----- 14

20-

-

24 0 0 0 0 0 0.3 2.3 0 0 0.3 0 0 0.3 0 0.3 0.3 0 0 0.3 0.3 0.7 0.7 2 0 0.3 0 0 1 0 0.3 0 1 0 0 0 0 0 0 0 1.7 0.7 0 0.7 1.3 2.7 0 0 1.7 3 0 0.3 ----- 23

25-

-

29 0 0.3 0.3 0.3 0.3 0 2.9 0 0 0 0 0 0 0.6 0 0.3 0 0 0 0 2.3 0 0.3 0 0.6 0 0.3 1.9 0 0 0 1 0 1 0 0 0 0 0 0.6 0.3 0 0 0.6 1.6 0 0.3 1.6 2.9 0.3 1---

-- 22

30-

-

34 0 0 0 0.4 0 0 6.7 0 0 0.4 0.4 0.4 0.7 1.1 0 1.4 0 0 0 0.4 1.4 0 0.7 0 1.1 0 0 1.1 0.4 0 0.4 1.8 0 0.4 0 0 0.7 0 0 2.1 0.7 0 0.4 0.7 2.5 0 0 0.7 1.1 0 0.7 ----- 28

35-

-

39 0 0.7 0 1.1 0 013

.6 0 0 0 1.8 0 2.2 2.9 0 2.9 0 1.1 0.7 0.4 5.1 0.7 0 0 0.7 0 0 0.7 0 0 0 2.2 0 2.2 0 0 0.7 0 0 1.8 1.5 0 0.4 0.7 5.9 0 0.4 0.4 2.9 0.4 1.5 ----- 56

40-

-

44 0 0.8 0.4 1.2 0.4 019

.4 0 0 0.4 1.6 0.4 7.1 4.3 0 5.1 0.8 3.2 0.8 1.2 7.5 0.4 2 0 2.8 0 0.8 1.2 0 0 0 0.4 0 4.7 0 0 3.2 0.4 0 3.6 2.4 0 0.8 0 3.6 0 0 1.2 4 0.4 3.6 ----- 90

45-

-

49 0 1.3 0 1.7 0.4 024

.7 0 0.4 3.4 7.2 1.3 12.3

10.6 0 8.9 0.9 5.1 1.3 1.7 20 0.4 0.4 0.4 4.3 0 0 1.3 0.9 0 1.7 0.4 0 8.9 0.4 0 3.4 0 0 3 2.6 0 0 1.3 9.4 0 0.9 0.9 2.6 0 3

-----

147

50-

-

54 0 2.5 1 2 0.5 0 27 0.5 0.5 212

.3 018

.222

.6 019

.2 2.5 2.9 3.4 4.4 35.4 1 2 0 6.9 0 0 2.5 0 0 3.4 0.5 0 3.4 0 0.5 6.9 0 0 4.4 2 0.5 0 2.5 13.8 0 0.5 1.5 4.4 1 4.9 -----

219

55-

-

59 0 4.7 1.8 3 1.8 031

.5 1.8 0 5.3 11.9 1.2 30.9

26.1 1.2 38.6 5.3 11.9 1.2 6.5 60.5 3.6 2.4 1.8 8.9 0 0 3 0.6 1.2 14.2 0 0.6 13.7 0.6 0

10.7 0 0.6 3 2.4 0.6 0.6 1.8 12.5 0 1.8 2.4 4.7 0.6 16 -----

353

60-

-

64 0 3.7 5.2 3.7 3.7 2.2 26.6 0.7 0

14.8

27.3 2.2 44.3

42.1 2.2 47.2 2.2 14.8 3.7 14

103.3 2.2 1.5 2.2 19.9 0 0 3 1.5 3

43.5 1.5 1.5 12.5 0 0.7 13.3 0 0.7 1.5 3.7 0 0 0

17.7 0 4.4 3.7 3 2.2 15.5 -----

523

65-

-

69 1.1 3.4 6.9 5.7 1.1 1.1 37.9 2.3 0

20.7

36.8 6.9 77 59.8 2.3 52.9 5.7 32.2 1.1 25.3

187.4 2.3 1.1 3.4 41.4 0 0 2.3 3.4 2.3

121.9 0 0

27.6 1.1 1.1 39.1 0 1.1 8

10.3 1.1 0 2.3 40.2 1.1 5.7 6.9 8 2.3 24.1 -----

927

70-

-

74 1.5 4.5 1.5 6.1 1.5 328

.810

.6 012

.1 53 4.510

6.1 59.1 0

62.1 7.6 27.3 1.5 28.8

213.7 0 0 1.5 37.9 0 0 3 6.1 0

157.6 0 0

21.2 0 0

45.5 1.5 3 3 1.5 0 0 0

21.2 0 7.6 4.5 16.7 4.5 34.9 -----

1005

75+ 4.6 9.2 15

.4 3.1 1.5 015

.4 9.2 1.5 23.1

93.9 0

152.3

107.7 4.6 83.1

10.8

46.2 4.6 23.1

230.8 3.1 6.2 0

63.1 0 0 4.6 6.2 1.5

218.5 0 1.5 21.5 3.1 0

64.6 0 4.6 10.8 4.6 1.5 0 0

36.9 0 6.2 3.1 7.7 3.1 56.9 -----

1369

Crud

eRa

te 0.1 1 0.9 1 0.4 0.2 10.8 0.5 0.1 2.3 6.5 0.5 12.1 9.8 0.3 9.9 1 4 0.8 2.9 23.7 0.6 1.2 0.3 5.1 0 0.1 1.2 0.5 0.3 12.3 0.9 0.1 4 0.1 0.1 4.9 0.1 0.3 2.5 1.4 0.2 0.2 0.8 6.7 0 0.8 2.4 2.8 0.8 4.6 -----

144.1

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

73:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, P

EN

AN

G, A

LL

RE

SID

EN

TS,

MA

LE

S, 2

007-

2011

ASR

Wor

ld 0.2 1 1 1 0.4 0.2 10.2 0.6 0.1 2.5 6.9 0.6 12.8

10.2 0.3 10.2 1.1 4.2 0.7 3.1 25.1 0.6 1.1 0.3 5.4 0 0.1 1.2 0.5 0.3 13.8 0.8 0.1 4.1 0.1 0.1 5.2 0.1 0.4 2.5 1.4 0.2 0.2 0.7 6.8 0 0.8 2.7 2.7 1 4.8 -----

150.5

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 175: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

153

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

6 32 43 15 9 212

7 9 3 44 184 14 451

248 21 135 52 119 3 10 341 27 31 19 125 2 0 45

1958 12 11 39

927

3 50 332 3 6 79 3 6 53 1 5 83 124 3 3 15 176 0 24 60 99 24 166

-----

6085

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0.4 0 0 0 0 1.1 0 0 0.4 0 0 0 0 0 0 0.7 0 0 0 0 0.4 3.2 0 0.4 0 0 0.4 0 0 5.8 3.6 1.4 1.1 ----- 19

5-

-

9 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.3 0 0 0 0 1 0 0 3.7 1.3 0.3 0---

-- 10

10-

-

14 0.3 0 0.3 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.6 0 0 0 0 0.3 0.3 0 0 0 0 0 1.3 0 0 0 0 0 0 0 0 1.6 0.6 0 0 0.6 1.3 0 0 2.2 0.3 0.3 0.3 ----- 12

15-

-

19 0 0 0 0.3 0 0 1.2 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 1.2 0 0.3 0 0 0.6 0.3 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0.3 0.9 0 0 0.9 1.6 0 0 0.6 1.9 0.6 0---

-- 12

20-

-

24 0 0 0 0.3 0 0.3 1.6 0 0 0 0 0.3 1.3 0.6 0 0 0 0 0 0 0 0 0.3 0.3 0.6 0 0 1 1.3 0 0 0.3 0 0 2.3 0 0.3 0 0 0 0 0 0 1.3 1.6 0 0.3 1 1.9 0 0 1 1.6 0 0.6 ----- 20

25-

-

29 0 0.3 0 1 0 0 3.2 0 0 0 0 0 1.6 0.3 0 0 0 0.3 0 0 0.6 0 0 0 0 0 0 0.6 6.4 0 0 2.2 2.5 0.6 4.1 0 0.3 0.3 0 0 0 0 0 1.6 3.2 0 0 0 2.5 0 0 0 0.3 0 1---

-- 33

30-

-

34 0.4 0.4 0 0.4 0 0 0.7 0 0 0 1.4 0.7 0.4 1.8 0 0.4 0 0.4 0.4 0 0.4 0.7 1.4 0.7 1.8 0 0 0.4 21.3 0 0 3.2 0.7 0.4 1.4 0 0.7 0.7 0 0 0 0 0 1.4 5.3 0 0 0.7 2.1 0 0 1.1 0.7 0.4 0.4 ----- 53

35-

-

39 0 0 0 0 0 0 1.5 0 0 0 1.8 0 2.6 1.1 0 1.5 0.4 0.7 0.4 0.7 2.9 0 0.4 0 0.7 0 0 1.5 40.2 0 0

13.1 3.7 1.5 5.8 0 0.7 1.5 0 0 1.1 0 0 1.5 6.2 0 0 0 3.7 0 0 1.5 1.8 0.7 2.2 -----

101

40-

-

44 0 1.9 0.4 0.4 0.8 0 6.6 0 0 0.8 3.1 0.4 7.4 4.3 0 0.8 0 1.2 0 0 3.5 0.4 1.9 1.2 1.6 0 0 0.8 80.2 0.4 0.4 16.3 9.7 2.3 8.1 0 0 0.4 0 0 0 0 0 2.3 4.7 0 0 0.4 3.5 0 0.4 0.8 3.5 1.2 2.3 -----

174

45-

-

49 0 0.4 0 0.4 0 0 6.6 1.3 0 1.3 6.6 1.3 13.5 6.6 0.9 2.6 1.7 2.2 0 0 10 0.9 1.3 0.4 1.3 0 0 3.1

137.6 0.4 0

19.2

16.2 2.2 28 0.9 0 3.5 0 0 1.7 0 0 2.2 7.9 0.4 0 0 3.5 0 0 1.3 3.9 0.4 4.8 -----

297

50-

-

54 0.5 1 0.5 0.5 0.5 0 5.8 0 0.5 1.9 9.2 121

.912

.7 0 3.4 1 8.3 0 1 17 0.5 0.5 1 1.9 0 0 1.515

2.3 0 0.5 27.3

21.4 1.5 24.8 0 0 4.9 0 0.5 1 0 0.5 2.9 3.9 0.5 0.5 0

11.7 0 1 0.5 5.4 0.5 6.3 -----

360

55-

-

59 0 2.3 2.9 0 1.2 012

.3 1.2 0 3.5 10.5 1.2 32.2

19.3 0.6 7 2.3 7 0 1.2 31 2.9 1.2 0.6 8.2 0 0 0

157.3 1.2 0.6 31

.625

.7 5.3 28.1 0 0 3.5 0 0 2.9 0.6 0 3.5 5.3 0 0.6 1.2 11.7 0 2.3 1.2 5.8 1.2 9.9 -----

448

60-

-

64 0 3.7 3 0 1.5 010

.3 0 0.7 1.5 12.5 0.7 38.4

21.4 4.4 14 7.4 11.8 0 0.7 34.7 2.2 0.7 1.5 8.9 0.7 0 2.2

182.3 1.5 0.7 31.7

31.7 5.9 28.8 0 0 9.6 0.7 0 6.6 0 0 5.9 4.4 0 0 0.7 13.3 0 3.7 1.5 5.2 0

16.2 -----

534

65-

-

69 0 2.2 11.8 0 0 0

10.8 1.1 1.1 7.5 21.5 0

64.5

23.7 3.2 21.5 8.6 18.3 0 0

52.7 5.4 1.1 2.2 25.8 1.1 0 5.4

162.4 1.1 2.2 31.2

21.5 1.1 34.4 0 0

11.8 1.1 2.2 10.8 0 1.1 5.4 9.7 0 0 0

19.4 0 6.5 1.1 5.4 2.2 22.6 -----

642

70-

-

74 2.8 715

.4 2.8 1.4 1.4 12.6 1.4 0

11.2

36.4 0

88.1 56 4.2 36.4

18.2

18.2 0 2.8 54.6 2.8 1.4 2.8 25.2 0 0 7

165.1 5.6 1.4 61.5

26.6 7

16.8 0 0 9.8 1.4 1.4 8.4 0 0 5.6 2.8 0 0 1.4 28 0 5.6 1.4 4.2 1.4 33.6 -----

799

75+ 1.1 6.7 9 3.4 1.1 0 4.5 2.2 0

13.5

58.4 2.2

121.4 68

.5 6.7 41.6

11.2 36 1.1 1.1 84.3 5.6 1.1 3.4 39.3 0 0 4.5

159.6 1.1 3.4 38.2

23.6 6.7 21.4 1.1 0

15.7 0 2.2 15.7 0 2.2 4.5 9 0 0 0 18 0 2.2 2.2 12.4 3.4 40.5 -----

911

Crud

eRa

te 0.2 0.9 1.2 0.4 0.2 0.1 3.5 0.2 0.1 1.2 5 0.4 12.4 6.8 0.6 3.7 1.4 3.3 0.1 0.3 9.3 0.7 0.8 0.5 3.4 0.1 0 1.2 53.6 0.3 0.3 10.9 7.5 1.4 9.1 0.1 0.2 2.2 0.1 0.2 1.5 0 0.1 2.3 3.4 0.1 0.1 0.4 4.8 0 0.7 1.6 2.7 0.7 4.5 -----

166.7

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

74:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, P

EN

AN

G, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, 2

007-

2011

ASR

Wor

ld 0.2 0.8 1.2 0.4 0.2 0.1 3.3 0.2 0.1 1.1 4.7 0.3 11.7 6.4 0.6 3.6 1.4 3.1 0.1 0.2 8.9 0.7 0.8 0.5 3.3 0.1 0 1.2 50 0.3 0.3 10.1 7 1.3 8.6 0.1 0.1 2.1 0.1 0.2 1.4 0 0.1 2.3 3.1 0.1 0.1 0.4 4.6 0 0.7 1.9 2.7 0.7 4.4 -----

157.8

Page 176: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

154

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

0 16 34 12 5 313

5 7 2 37 65 816

818

5 215

0 18 38 25 33 444 3 38 9 60 2 0 33 6 5

106 20 1 50 0 0 69 1 5 51 41 3 2 11 149 0 13 38 56 22 12 -----

2193

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 2 0 2 0 0 0 0 1 3 0 0 0 0 4 0 0 3 5 4 0---

-- 25

5-

-

9 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0 2 0 0 8 1 1 0---

-- 19

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 1 0 0 0 2 0 2 0 0 2 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 2 2 0 0 2 1 1 0---

-- 19

15-

-

19 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 9 0 0 0 0 4 0 0 0 2 0 0 0 0 0 0 0 6 0 1 0 1 4 0 0 6 3 0 0---

-- 38

20-

-

24 0 0 0 1 0 0 2 0 0 0 0 0 1 0 0 1 0 0 1 0 0 0 3 0 0 0 0 2 0 0 0 4 0 0 0 0 0 0 0 1 0 0 0 0 4 0 0 1 6 1 0---

-- 28

25-

-

29 0 0 0 0 0 0 3 0 0 0 0 0 1 3 0 1 0 0 0 0 1 0 4 0 0 0 0 1 0 0 1 3 0 1 0 0 0 0 0 1 5 0 0 3 4 0 1 4 5 1 0---

-- 43

30-

-

34 0 1 0 0 0 0 2 0 0 0 1 0 4 4 0 2 0 0 0 0 7 0 2 0 0 0 0 0 0 0 0 3 0 0 0 0 1 0 0 5 2 0 0 1 9 0 0 1 2 1 0---

-- 48

35-

-

39 0 0 1 0 0 0 5 0 0 0 3 0 7 2 0 5 1 0 2 2 8 0 2 0 0 0 0 3 0 0 0 2 0 2 0 0 1 0 0 4 1 0 0 0 6 0 0 0 2 3 0---

-- 62

40-

-

44 0 0 0 3 0 0 12 0 0 1 2 1 11 6 0 15 0 0 1 0 12 0 1 1 1 0 0 3 1 0 0 2 0 0 0 0 2 0 1 3 4 0 0 1 5 0 0 2 3 1 1---

-- 96

45-

-

49 0 1 3 1 1 0 28 1 0 2 6 0 19 12 0 13 2 1 3 0 33 1 2 1 3 1 0 4 0 0 0 0 0 5 0 0 5 0 1 2 3 0 0 1 11 0 0 1 4 1 3---

--17

5

50-

-

54 0 5 6 2 0 3 25 0 0 2 5 2 23 26 0 22 1 6 2 0 47 0 1 3 3 0 0 3 1 0 1 1 0 5 0 0 10 0 1 9 4 0 1 1 14 0 1 1 5 0 2---

--24

4

55-

-

59 0 3 6 1 1 0 18 1 0 5 12 1 21 25 0 30 2 5 2 4 50 1 4 0 6 0 0 4 0 0 12 1 1 7 0 0 7 1 0 1 3 0 0 1 15 0 2 5 3 2 0---

--26

3

60-

-

64 0 1 2 1 2 0 17 1 1 5 6 1 24 33 0 23 5 12 8 10 79 1 3 0 7 0 0 3 0 2 18 0 0 7 0 0 10 0 1 7 8 0 0 0 20 0 5 1 8 2 2---

--33

6

65-

-

69 0 2 7 1 1 0 16 2 0 7 12 2 22 35 0 12 2 8 1 7 79 0 1 1 6 0 0 0 2 0 19 0 0 4 0 0 12 0 0 3 2 1 1 0 20 0 1 1 2 2 3---

--29

7

70-

-

74 0 2 6 2 0 0 5 1 0 9 11 1 19 21 2 14 3 3 2 5 68 0 3 1 19 1 0 2 1 2 27 0 0 12 0 0 13 0 0 1 3 1 0 0 12 0 2 2 4 1 1---

--28

2

75+

0 1 3 0 0 0 1 1 0 6 7 0 14 18 0 10 2 3 2 5 59 0 0 2 13 0 0 1 1 1 28 0 0 4 0 0 8 0 0 2 5 0 0 0 17 0 1 0 2 1 0---

--21

8

% of

Total 0.0

0%0.7

0%1.6

0%0.5

0%0.2

0%0.1

0%6.2

0%0.3

0%0.1

0%1.7

0%3.0

0%0.4

0%7.7

0%8.4

0%0.1

0%6.8

0%0.8

0%1.7

0%1.1

0%1.5

0%20

.20%

0.10%

1.70%

0.40%

2.70%

0.10%

0.00%

1.50%

0.30%

0.20%

4.80%

0.90%

0.00%

2.30%

0.00%

0.00%

3.10%

0.00%

0.20%

2.30%

1.90%

0.10%

0.10%

0.50%

6.80%

0.00%

0.60%

1.70%

2.60%

1.00%

0.50% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

75:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

PA

HA

NG

, AL

L R

ESI

DE

NT

S, M

AL

ES,

200

7-20

11

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 177: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

155

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

2 15 21 9 8 1 40 4 1 19 45 313

010

7 2 57 17 27 13 516

4 2 20 8 40 0 0 27 790 3 6

193 78 33 158 2 3 21 0 1 23 0 1 63 96 4 1 6

100 0 16 21 56 19 18 -----

2499

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 3 0 0 0 0 0 5 1 1 0---

-- 14

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 1 1 0 0---

-- 9

10-

-

14 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 3 1 0 0 0 3 0 0 1 5 0 0---

-- 20

15-

-

19 0 0 0 0 1 0 0 0 0 0 1 0 2 0 0 0 0 0 1 0 0 0 2 0 0 0 0 3 1 0 0 0 0 0 2 0 0 1 0 0 0 0 0 1 3 0 0 1 1 0 0 2 4 1 0---

-- 27

20-

-

24 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 4 0 0 0 0 0 3 0 0 1 0 0 1 0 0 5 7 0 0 2 7 0 0 1 2 2 1---

-- 41

25-

-

29 0 1 0 1 0 0 0 0 0 0 1 0 3 3 0 0 0 0 2 0 0 1 1 0 1 0 0 2 10 0 0 1 3 0 5 0 0 0 0 0 0 0 0 6 12 0 0 1 5 0 0 2 3 1 0---

-- 65

30-

-

34 0 0 0 1 1 0 0 0 0 0 1 0 5 2 0 3 0 1 0 0 1 0 3 1 0 0 0 3 39 0 0 2 2 1 8 0 1 1 0 0 1 0 0 0 3 0 0 1 2 0 0 0 10 1 0---

-- 94

35-

-

39 0 0 0 1 0 0 3 0 0 2 3 0 5 2 0 4 0 0 1 1 5 0 1 1 3 0 0 3 65 0 1 20 2 4 10 0 1 1 0 0 0 0 0 3 6 0 0 0 3 0 0 2 3 1 0---

--15

7

40-

-

44 0 0 0 0 0 0 5 0 0 1 0 0 5 10 0 3 0 1 2 0 6 1 4 0 1 0 0 3 95 0 1 26 4 4 20 0 0 0 0 0 1 0 0 8 5 0 0 0 8 0 0 1 5 1 1---

--22

2

45-

-

49 0 4 1 0 1 0 4 0 0 1 1 0 17 12 0 2 3 2 0 0 10 0 0 1 4 0 0 115

5 0 0 28 12 5 22 1 1 0 0 0 2 0 0 5 19 0 0 0 13 0 3 0 5 1 2---

--33

8

50-

-

54 0 3 1 0 1 0 8 0 0 1 6 1 15 8 0 12 0 3 1 0 22 0 1 0 0 0 0 213

9 0 3 33 14 8 27 0 0 4 0 0 2 0 0 5 11 1 0 0 11 0 2 3 4 1 3---

--35

6

55-

-

59 0 1 1 1 1 0 9 0 0 1 4 1 19 14 0 11 6 2 3 1 17 0 2 0 3 0 0 2 97 1 0 27 19 5 25 0 0 2 0 1 1 0 0 9 8 0 1 0 9 0 1 0 5 1 3---

--31

4

60-

-

64 0 1 4 0 0 0 4 1 0 3 7 0 18 20 1 5 3 8 0 0 19 0 1 2 5 0 0 2 59 0 0 22 9 4 12 0 0 3 0 0 1 0 0 4 9 0 0 0 12 0 1 0 3 2 5---

--25

0

65-

-

69 0 0 6 1 1 1 3 0 0 2 9 0 6 10 1 5 1 4 2 2 31 0 0 0 6 0 0 2 70 0 0 14 4 1 8 0 0 2 0 0 0 0 0 0 6 0 0 1 9 0 3 2 2 3 0---

--21

8

70-

-

74 0 4 1 1 1 0 3 2 0 5 4 0 15 16 0 5 2 2 1 0 21 0 0 2 6 0 0 0 29 1 0 12 4 1 8 1 0 1 0 0 5 0 0 6 4 0 0 0 9 0 4 1 3 1 2---

--18

3

75+

2 1 7 2 1 0 1 1 1 3 8 0 19 9 0 7 2 4 0 1 31 0 0 1 11 0 0 1 27 1 1 8 5 0 6 0 0 4 0 0 9 0 0 2 2 0 0 0 8 0 2 0 0 2 1---

--19

1

% of

Total

0.10%

0.60%

0.80%

0.40%

0.30%

0.00%

1.60%

0.20%

0.00%

0.80%

1.80%

0.10%

5.20%

4.30%

0.10%

2.30%

0.70%

1.10%

0.50%

0.20%

6.60%

0.10%

0.80%

0.30%

1.60%

0.00%

0.00%

1.10%

31.60

%0.1

0%0.2

0%7.7

0%3.1

0%1.3

0%6.3

0%0.1

0%0.1

0%0.8

0%0.0

0%0.0

0%0.9

0%0.0

0%0.0

0%2.5

0%3.8

0%0.2

0%0.0

0%0.2

0%4.0

0%0.0

0%0.6

0%0.8

0%2.2

0%0.8

0%0.7

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

76:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

PA

HA

NG

, AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

200

7-20

11

Page 178: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

156

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

0 16 34 12 5 313

5 7 2 37 65 816

818

5 215

0 18 38 25 33 444 3 38 9 60 2 0 33 6 5

106 20 1 50 0 0 69 1 5 51 41 3 2 11 149 0 13 38 56 22 12 -----

2193

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.5 0 0.5 0 0 0 0 0.3 0.8 0 0 0 0 1.1 0 0 0.8 1.3 1.1 0---

-- 7

5-

-

9 0 0 0 0 0 0 0.3 0 0.3 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0.3 0 0 0 0 0 0.5 0 0 0 0 0.5 0 0 2.1 0.3 0.3 0---

-- 5

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.2 0 0 0.2 0 0 0 0.5 0 0.5 0 0 0.5 0 0 0 0 0 0 0 0 0 0 0 0.2 0.2 0 0 0.5 0.5 0 0 0.5 0.2 0.2 0---

-- 5

15-

-

19 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0.2 0 2.2 0 0 0 0 1 0 0 0 0.5 0 0 0 0 0 0 0 1.5 0 0.2 0 0.2 1 0 0 1.5 0.7 0 0---

-- 9

20-

-

24 0 0 0 0.3 0 0 0.6 0 0 0 0 0 0.3 0 0 0.3 0 0 0.3 0 0 0 0.9 0 0 0 0 0.6 0 0 0 1.2 0 0 0 0 0 0 0 0.3 0 0 0 0 1.2 0 0 0.3 1.8 0.3 0---

-- 8

25-

-

29 0 0 0 0 0 0 1 0 0 0 0 0 0.3 1 0 0.3 0 0 0 0 0.3 0 1.3 0 0 0 0 0.3 0 0 0.3 1 0 0.3 0 0 0 0 0 0.3 1.6 0 0 1 1.3 0 0.3 1.3 1.6 0.3 0---

-- 14

30-

-

34 0 0.4 0 0 0 0 0.9 0 0 0 0.4 0 1.8 1.8 0 0.9 0 0 0 0 3.1 0 0.9 0 0 0 0 0 0 0 0 1.3 0 0 0 0 0.4 0 0 2.2 0.9 0 0 0.4 4 0 0 0.4 0.9 0.4 0---

-- 21

35-

-

39 0 0 0.5 0 0 0 2.5 0 0 0 1.5 0 3.5 1 0 2.5 0.5 0 1 1 4 0 1 0 0 0 0 1.5 0 0 0 1 0 1 0 0 0.5 0 0 2 0.5 0 0 0 3 0 0 0 1 1.5 0---

-- 31

40-

-

44 0 0 0 1.6 0 0 6.5 0 0 0.5 1.1 0.5 5.9 3.2 0 8.1 0 0 0.5 0 6.5 0 0.5 0.5 0.5 0 0 1.6 0.5 0 0 1.1 0 0 0 0 1.1 0 0.5 1.6 2.2 0 0 0.5 2.7 0 0 1.1 1.6 0.5 0.5 ----- 52

45-

-

49 0 0.6 1.8 0.6 0.6 016

.6 0.6 0 1.2 3.6 011

.3 7.1 0 7.7 1.2 0.6 1.8 019

.6 0.6 1.2 0.6 1.8 0.6 0 2.4 0 0 0 0 0 3 0 0 3 0 0.6 1.2 1.8 0 0 0.6 6.5 0 0 0.6 2.4 0.6 1.8 -----

104

50-

-

54 0 2.9 3.5 1.2 0 1.7 14.5 0 0 1.2 2.9 1.2 13.3 15 0

12.7 0.6 3.5 1.2 0

27.2 0 0.6 1.7 1.7 0 0 1.7 0.6 0 0.6 0.6 0 2.9 0 0 5.8 0 0.6 5.2 2.3 0 0.6 0.6 8.1 0 0.6 0.6 2.9 0 1.2 -----

141

55-

-

59 0 2.1 4.2 0.7 0.7 012

.7 0.7 0 3.5 8.5 0.7 14.8

17.6 0

21.1 1.4 3.5 1.4 2.8 35.2 0.7 2.8 0 4.2 0 0 2.8 0 0 8.5 0.7 0.7 4.9 0 0 4.9 0.7 0 0.7 2.1 0 0 0.7 10.6 0 1.4 3.5 2.1 1.4 0

-----

185

60-

-

64 0 0.9 1.7 0.9 1.7 014

.8 0.9 0.9 4.4 5.2 0.9 21 28.8 0

20.1 4.4 10.5 7 8.7 69 0.9 2.6 0 6.1 0 0 2.6 0 1.7 15.7 0 0 6.1 0 0 8.7 0 0.9 6.1 7 0 0 0

17.5 0 4.4 0.9 7 1.7 1.7 -----

293

65-

-

69 0 2.7 9.5 1.4 1.4 021

.6 2.7 0 9.5 16.2 2.7 29.7

47.3 0

16.2 2.7 10.8 1.4 9.5

106.8 0 1.4 1.4 8.1 0 0 0 2.7 0

25.7 0 0 5.4 0 0

16.2 0 0 4.1 2.7 1.4 1.4 0 27 0 1.4 1.4 2.7 2.7 4.1 -----

401

70-

-

74 0 3.8 11.3 3.8 0 0 9.4 1.9 0 17 20.8 1.9 35.9

39.6 3.8 26.4 5.7 5.7 3.8 9.4

128.3 0 5.7 1.9 35.9 1.9 0 3.8 1.9 3.8 51 0 0

22.6 0 0

24.5 0 0 1.9 5.7 1.9 0 0

22.6 0 3.8 3.8 7.5 1.9 1.9 -----

532

75+

0 2.2 6.5 0 0 0 2.2 2.2 012

.915

.1 030

.138

.7 021

.5 4.3 6.5 4.3 10.8

126.9 0 0 4.3 28 0 0 2.2 2.2 2.2 60.2 0 0 8.6 0 0

17.2 0 0 4.3 10.8 0 0 0

36.6 0 2.2 0 4.3 2.2 0

-----

469

Crud

eRa

te 0 0.4 0.9 0.3 0.1 0.1 3.7 0.2 0.1 1 1.8 0.2 4.7 5.1 0.1 4.2 0.5 1.1 0.7 0.9 12.3 0.1 1.1 0.2 1.7 0.1 0 0.9 0.2 0.1 2.9 0.6 0 1.4 0 0 1.9 0 0.1 1.4 1.1 0.1 0.1 0.3 4.1 0 0.4 1.1 1.6 0.6 0.3 -----

60.9

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

77:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, P

AH

AN

G, A

LL

RE

SID

EN

TS,

MA

LE

S, 2

007-

2011

ASR

Wor

ld 0 0.5 1.2 0.4 0.2 0.1 4.4 0.3 0.1 1.4 2.3 0.3 5.7 6.5 0.1 5 0.6 1.3 0.8 1.2 15.9 0.1 1.1 0.3 2.2 0.1 0 1 0.2 0.2 4 0.5 0 1.7 0 0 2.5 0 0.2 1.6 1.4 0.1 0.1 0.3 5 0 0.4 1.1 1.7 0.7 0.4 -----

75.1

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 179: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

157

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

2 15 21 9 8 1 40 4 1 19 45 313

010

7 2 57 17 27 13 516

4 2 20 8 40 0 0 27 790 3 6

193 78 33 158 2 3 21 0 1 23 0 1 63 96 4 1 6

100 0 16 21 56 19 18 -----

2499

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0.9 0 0.9 0 0 0 0 0 1.5 0.3 0.3 0---

-- 4

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0.3 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0 0 0 0.3 0.3 0 0---

-- 3

10-

-

14 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.3 0 0 0 0 0 0.8 0.3 0 0 0 0.8 0 0 0.3 1.3 0 0---

-- 5

15-

-

19 0 0 0 0 0.3 0 0 0 0 0 0.3 0 0.6 0 0 0 0 0 0.3 0 0 0 0.6 0 0 0 0 0.8 0.3 0 0 0 0 0 0.6 0 0 0.3 0 0 0 0 0 0.3 0.8 0 0 0.3 0.3 0 0 0.6 1.1 0.3 0---

-- 7

20-

-

24 0 0 0 0 0 0 0 0 0 0 0 0.3 0.3 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0.7 1.3 0 0 0 0 0 1 0 0 0.3 0 0 0.3 0 0 1.7 2.4 0 0 0.7 2.4 0 0 0.3 0.7 0.7 0.3 ----- 14

25-

-

29 0 0.3 0 0.3 0 0 0 0 0 0 0.3 0 1 1 0 0 0 0 0.7 0 0 0.3 0.3 0 0.3 0 0 0.7 3.5 0 0 0.3 1 0 1.7 0 0 0 0 0 0 0 0 2.1 4.2 0 0 0.3 1.7 0 0 0.7 1 0.3 0---

-- 23

30-

-

34 0 0 0 0.5 0.5 0 0 0 0 0 0.5 0 2.5 1 0 1.5 0 0.5 0 0 0.5 0 1.5 0.5 0 0 0 1.5 19.5 0 0 1 1 0.5 4 0 0.5 0.5 0 0 0.5 0 0 0 1.5 0 0 0.5 1 0 0 0 5 0.5 0

----- 47

35-

-

39 0 0 0 0.5 0 0 1.5 0 0 1 1.5 0 2.5 1 0 2 0 0 0.5 0.5 2.5 0 0.5 0.5 1.5 0 0 1.5 32.3 0 0.5 9.9 1 2 5 0 0.5 0.5 0 0 0 0 0 1.5 3 0 0 0 1.5 0 0 1 1.5 0.5 0

----- 78

40-

-

44 0 0 0 0 0 0 2.5 0 0 0.5 0 0 2.5 5.1 0 1.5 0 0.5 1 0 3 0.5 2 0 0.5 0 0 1.5 48.2 0 0.5 13.2 2 2

10.2 0 0 0 0 0 0.5 0 0 4.1 2.5 0 0 0 4.1 0 0 0.5 2.5 0.5 0.5 -----

113

45-

-

49 0 2 0.5 0 0.5 0 2 0 0 0.5 0.5 0 8.7 6.1 0 1 1.5 1 0 0 5.1 0 0 0.5 2 0 0 0.5 79.1 0 0

14.3 6.1 2.6 11.2 0.5 0.5 0 0 0 1 0 0 2.6 9.7 0 0 0 6.6 0 1.5 0 2.6 0.5 1

-----

172

50-

-

54 0 1.7 0.6 0 0.6 0 4.7 0 0 0.6 3.5 0.6 8.7 4.7 0 7 0 1.7 0.6 012

.8 0 0.6 0 0 0 0 1.2 81.1 0 1.7 19.2 8.2 4.7 15.7 0 0 2.3 0 0 1.2 0 0 2.9 6.4 0.6 0 0 6.4 0 1.2 1.7 2.3 0.6 1.7 -----

208

55-

-

59 0 0.7 0.7 0.7 0.7 0 6.7 0 0 0.7 3 0.7 14.2

10.4 0 8.2 4.5 1.5 2.2 0.7 12.7 0 1.5 0 2.2 0 0 1.5 72.4 0.7 0

20.2

14.2 3.7 18.7 0 0 1.5 0 0.7 0.7 0 0 6.7 6 0 0.7 0 6.7 0 0.7 0 3.7 0.7 2.2 -----

234

60-

-

64 0 0.9 3.8 0 0 0 3.8 0.9 0 2.8 6.6 0 17 18.9 0.9 4.7 2.8 7.5 0 0

17.9 0 0.9 1.9 4.7 0 0 1.9 55.7 0 0

20.8 8.5 3.8 11.3 0 0 2.8 0 0 0.9 0 0 3.8 8.5 0 0 0

11.3 0 0.9 0 2.8 1.9 4.7 -----

236

65-

-

69 0 0 9.3 1.6 1.6 1.6 4.7 0 0 3.1 14 0 9.3 15.5 1.6 7.8 1.6 6.2 3.1 3.1 48.1 0 0 0 9.3 0 0 3.1

108.5 0 0

21.7 6.2 1.6 12.4 0 0 3.1 0 0 0 0 0 0 9.3 0 0 1.6 14 0 4.7 3.1 3.1 4.7 0

-----

338

70-

-

74 0 7.6 1.9 1.9 1.9 0 5.7 3.8 0 9.5 7.6 028

.630

.5 0 9.5 3.8 3.8 1.9 0 40 0 0 3.8 11.4 0 0 0

55.2 1.9 0

22.9 7.6 1.9 15.2 1.9 0 1.9 0 0 9.5 0 0

11.4 7.6 0 0 0

17.1 0 7.6 1.9 5.7 1.9 3.8 -----

349

75+ 3.6 1.8 12

.7 3.6 1.8 0 1.8 1.8 1.8 5.5 14.5 0

34.6

16.4 0

12.7 3.6 7.3 0 1.8 56.4 0 0 1.8 20 0 0 1.8 49.1 1.8 1.8 14.5 9.1 0

10.9 0 0 7.3 0 0

16.4 0 0 3.6 3.6 0 0 0

14.5 0 3.6 0 0 3.6 1.8 -----

347

Crud

eRa

te 0.1 0.4 0.6 0.3 0.2 0 1.2 0.1 0 0.6 1.3 0.1 3.8 3.2 0.1 1.7 0.5 0.8 0.4 0.1 4.8 0.1 0.6 0.2 1.2 0 0 0.8 23.3 0.1 0.2 5.7 2.3 1 4.7 0.1 0.1 0.6 0 0 0.7 0 0 1.9 2.8 0.1 0 0.2 2.9 0 0.5 0.6 1.7 0.6 0.5 -----

73.7

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

78:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, P

AH

AN

G, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, 2

007-

2011

ASR

Wor

ld 0.1 0.5 0.8 0.3 0.3 0 1.3 0.2 0 0.7 1.6 0.1 4.4 3.7 0.1 1.9 0.6 1 0.4 0.2 5.9 0.1 0.6 0.3 1.5 0 0 0.8 25.7 0.1 0.2 6.3 2.5 1 5 0.1 0.1 0.7 0 0 0.8 0 0 1.9 3 0.1 0 0.2 3.3 0 0.6 0.7 1.7 0.6 0.6 -----

82.7

Page 180: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

158

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

1 16 5 11 0 2 70 5 1 21 35 411

311

0 415

7 18 36 10 21 313 1 35 5 58 0 0 28 2 0 96 12 1 27 1 1 69 0 5 39 26 2 4 14 93 0 10 11 57 63 55 -----

1668

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 3 1 0 0 0 5 7 0 1 0 1 2 0 0 4 9 12 0---

-- 49

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 1 0 0 0 0 0 0 0 0 2 0 0 0 0 0 5 0 1 0 1 0 0 0 2 3 9 1---

-- 28

10-

-

14 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 4 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 4 0 0 1 2 4 0 0 1 7 4 3---

-- 35

15-

-

19 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 1 4 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 1 1 6 0 0 2 4 8 3---

-- 42

20-

-

24 0 0 1 1 0 0 1 0 0 1 1 0 0 1 0 2 0 0 0 0 3 0 3 0 3 0 0 1 0 0 0 4 0 0 0 0 0 0 0 1 0 0 0 1 6 0 0 0 1 4 2---

-- 37

25-

-

29 0 1 0 0 0 0 2 0 0 0 3 0 1 0 0 1 0 0 0 0 3 0 1 1 2 0 0 3 0 0 0 5 0 0 0 0 0 0 0 3 1 0 1 0 2 0 0 0 3 5 1---

-- 39

30-

-

34 1 1 0 0 0 0 0 0 0 0 0 0 3 5 0 5 0 1 0 0 2 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 4 0 0 1 3 0 0---

-- 30

35-

-

39 0 1 0 2 0 0 3 0 0 1 0 0 1 2 0 8 1 1 1 0 2 0 2 0 1 0 0 0 0 0 0 1 0 0 0 0 2 0 0 1 1 0 0 1 3 0 0 0 2 1 1---

-- 39

40-

-

44 0 0 0 1 0 0 8 0 0 1 1 1 7 7 0 10 0 4 1 0 15 0 2 1 2 0 0 1 0 0 0 0 0 0 0 0 2 0 0 1 3 0 0 2 10 0 1 0 5 3 4---

-- 93

45-

-

49 0 3 1 1 0 1 6 1 0 0 3 0 8 9 0 18 2 7 0 2 28 0 2 0 4 0 0 5 0 0 0 0 0 4 0 0 6 0 0 4 4 0 1 1 8 0 0 0 5 0 5---

--13

9

50-

-

54 0 2 0 2 0 0 18 0 1 1 3 0 9 14 1 28 3 4 4 2 38 1 2 0 3 0 0 0 0 0 5 0 1 7 0 0 5 0 0 6 4 0 0 1 4 0 2 0 1 8 1---

--18

1

55-

-

59 0 1 0 3 0 0 10 2 0 1 3 2 15 15 1 25 4 3 1 3 36 0 1 1 4 0 0 3 2 0 9 0 0 3 0 0 9 0 0 1 3 0 0 0 13 0 2 1 5 3 8---

--19

3

60-

-

64 0 1 0 0 0 0 3 0 0 5 2 0 18 13 2 24 3 7 1 3 46 0 2 0 13 0 0 2 0 0 14 0 0 4 0 0 7 0 0 3 3 0 0 0 10 0 1 0 4 0 7---

--19

8

65-

-

69 0 3 2 1 0 1 4 1 0 3 8 0 16 20 0 10 1 5 1 3 51 0 3 0 7 0 0 4 0 0 18 0 0 3 0 0 13 0 0 2 3 0 0 2 8 0 3 0 0 1 5---

--20

2

70-

-

74 0 1 1 0 0 0 5 1 0 4 7 1 18 17 0 15 3 3 1 2 51 0 1 0 4 0 0 1 0 0 25 0 0 0 0 0 14 0 0 1 1 0 0 0 8 0 1 0 1 1 5---

--19

3

75+

0 2 0 0 0 0 5 0 0 4 4 0 16 7 0 10 1 1 0 6 38 0 4 1 6 0 0 3 0 0 25 1 0 1 0 1 11 0 0 0 1 0 0 0 5 0 0 0 4 4 9---

--17

0

% of

Total 0.1

0%1.0

0%0.3

0%0.7

0%0.0

0%0.1

0%4.2

0%0.3

0%0.1

0%1.3

0%2.1

0%0.2

0%6.8

0%6.6

0%0.2

0%9.4

0%1.1

0%2.2

0%0.6

0%1.3

0%18

.80%

0.10%

2.10%

0.30%

3.50%

0.00%

0.00%

1.70%

0.10%

0.00%

5.80%

0.70%

0.10%

1.60%

0.10%

0.10%

4.10%

0.00%

0.30%

2.30%

1.60%

0.10%

0.20%

0.80%

5.60%

0.00%

0.60%

0.70%

3.40%

3.80%

3.30% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

79:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

TE

RE

NG

GA

NU

, AL

L R

ESI

DE

NT

S, M

AL

ES,

200

7-20

11

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 181: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

159

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

1 12 12 5 1 1 35 5 2 15 33 2 90 83 2 49 14 23 3 211

3 5 29 4 35 0 0 28 534 4 0

120 97 37 173 0 6 19 0 0 15 0 7 41 111 0 1 4 56 0 15 8 52 36 37 -----

1977

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 1 0 0 1 0 2 0 0 0 0 2 0 0 0 0 0 0 0 0 0 4 0 0 0 0 3 3 0 0 0 0 3 0 0 5 5 6 0---

-- 37

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 1 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 4 0 0 0 0 0 0 0 0 3 6 1---

-- 21

10-

-

14 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 4 0 0 0 1 3 0---

-- 20

15-

-

19 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 5 0 2 0 0 7 0 0 0 0 0 0 8 0 0 0 0 0 0 0 0 3 6 0 0 0 3 0 0 1 6 0 1---

-- 44

20-

-

24 0 1 0 0 0 0 3 0 0 0 0 0 1 0 0 0 0 0 0 0 2 1 3 0 0 0 0 0 12 0 0 0 0 0 10 0 1 0 0 0 1 0 0 1 12 0 0 2 3 0 0 0 2 2 3---

-- 60

25-

-

29 0 0 0 0 0 0 1 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 1 0 0 2 13 0 0 3 3 1 4 0 0 0 0 0 1 0 1 1 6 0 0 0 4 0 0 1 1 3 1---

-- 50

30-

-

34 0 2 0 0 0 0 1 1 2 0 0 0 4 1 0 1 0 0 0 0 1 1 1 0 2 0 0 2 25 1 0 2 5 2 11 0 1 0 0 0 0 0 0 2 4 0 0 1 3 0 0 0 4 1 1---

-- 82

35-

-

39 0 1 1 1 0 0 2 0 0 0 2 0 1 3 0 1 0 1 1 0 6 0 1 0 0 0 0 0 39 0 0 4 7 4 9 0 1 2 0 0 2 0 0 3 5 0 0 1 3 0 1 0 4 0 1---

--10

7

40-

-

44 0 2 0 0 0 0 2 1 0 0 1 1 10 6 1 2 0 1 0 0 8 0 1 0 3 0 0 2 72 0 0 14 18 8 14 0 1 1 0 0 0 0 0 1 15 0 1 0 1 0 2 0 2 1 3---

--19

5

45-

-

49 0 1 0 2 0 0 5 1 0 0 3 0 8 6 0 3 1 0 0 0 11 0 3 1 3 0 0 210

6 0 0 24 16 12 26 0 1 1 0 0 1 0 0 5 11 0 0 0 4 0 1 0 2 2 4---

--26

6

50-

-

54 0 2 3 2 0 0 3 0 0 1 6 0 10 15 0 4 3 3 0 0 13 0 2 0 3 0 0 2 95 2 0 19 16 4 24 0 1 2 0 0 1 0 0 5 11 0 0 0 2 0 3 0 5 3 4---

--26

9

55-

-

59 0 0 0 0 0 0 7 0 0 2 4 0 14 8 0 7 2 6 2 2 18 1 1 1 1 0 0 2 72 0 0 18 14 2 17 0 0 1 0 0 0 0 0 1 3 0 0 0 8 0 4 0 5 3 4---

--23

0

60-

-

64 0 1 2 0 0 0 4 1 0 2 4 0 13 14 0 5 1 3 0 0 14 1 0 0 4 0 0 1 41 0 0 15 10 3 13 0 0 2 0 0 0 0 0 4 15 0 0 0 8 0 1 0 4 3 5---

--19

4

65-

-

69 0 0 2 0 0 0 0 1 0 4 2 0 5 13 0 6 3 2 0 0 15 1 0 2 4 0 0 1 26 0 0 8 5 1 22 0 0 4 0 0 4 0 0 5 8 0 0 0 0 0 0 0 2 1 3---

--15

0

70-

-

74 0 0 3 0 0 0 5 0 0 2 3 1 12 10 0 7 3 5 0 0 15 0 2 0 4 0 0 1 16 1 0 8 2 0 7 0 0 2 0 0 2 0 1 0 7 0 0 0 6 0 2 0 3 1 4---

--13

5

75+

1 1 1 0 1 0 1 0 0 4 6 0 12 6 1 11 1 1 0 0 9 0 1 0 7 0 0 1 16 0 0 5 1 0 7 0 0 0 0 0 3 0 0 1 7 0 0 0 4 0 1 1 3 1 2---

--11

7

% of

Total

0.10%

0.60%

0.60%

0.30%

0.10%

0.10%

1.80%

0.30%

0.10%

0.80%

1.70%

0.10%

4.60%

4.20%

0.10%

2.50%

0.70%

1.20%

0.20%

0.10%

5.70%

0.30%

1.50%

0.20%

1.80%

0.00%

0.00%

1.40%

27.00

%0.2

0%0.0

0%6.1

0%4.9

0%1.9

0%8.8

0%0.0

0%0.3

0%1.0

0%0.0

0%0.0

0%0.8

0%0.0

0%0.4

0%2.1

0%5.6

0%0.0

0%0.1

0%0.2

0%2.8

0%0.0

0%0.8

0%0.4

0%2.6

0%1.8

0%1.9

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

80:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

TE

RE

NG

GA

NU

, AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

200

7-20

11

Page 182: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

160

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

1 16 5 11 0 2 70 5 1 21 35 411

311

0 415

7 18 36 10 21 313 1 35 5 58 0 0 28 2 0 96 12 1 27 1 1 69 0 5 39 26 2 4 14 93 0 10 11 57 63 55 -----

1668

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.3 0 0 0.7 0 0 0 0 0 1 0.3 0 0 0 1.7 2.4 0 0.3 0 0.3 0.7 0 0 1.4 3.1 4.2 0---

-- 17

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0.3 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 1.6 0 0.3 0 0.3 0 0 0 0.7 1 3 0.3 ----- 9

10-

-

14 0 0 0 0 0 0 0.3 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 1.3 0 0.3 0 0 0.7 0 0 0 0 0 0 0 0 0 0 0 1.3 0 0 0.3 0.7 1.3 0 0 0.3 2.3 1.3 1---

-- 11

15-

-

19 0 0 0 0 0 0 1.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.6 0.3 1.3 0 0 0.3 0 0 0 0.3 0 0 0 0 0 0 0 0 0.3 0 0.3 0.3 2 0 0 0.7 1.3 2.6 1---

-- 14

20-

-

24 0 0 0.4 0.4 0 0 0.4 0 0 0.4 0.4 0 0 0.4 0 0.8 0 0 0 0 1.2 0 1.2 0 1.2 0 0 0.4 0 0 0 1.6 0 0 0 0 0 0 0 0.4 0 0 0 0.4 2.4 0 0 0 0.4 1.6 0.8 ----- 15

25-

-

29 0 0.5 0 0 0 0 1 0 0 0 1.6 0 0.5 0 0 0.5 0 0 0 0 1.6 0 0.5 0.5 1 0 0 1.6 0 0 0 2.6 0 0 0 0 0 0 0 1.6 0.5 0 0.5 0 1 0 0 0 1.6 2.6 0.5 ----- 20

30-

-

34 0.7 0.7 0 0 0 0 0 0 0 0 0 0 2 3.3 0 3.3 0 0.7 0 0 1.3 0 0 0 1.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0.7 2.7 0 0 0.7 2 0 0---

-- 20

35-

-

39 0 0.7 0 1.5 0 0 2.2 0 0 0.7 0 0 0.7 1.5 0 5.8 0.7 0.7 0.7 0 1.5 0 1.5 0 0.7 0 0 0 0 0 0 0.7 0 0 0 0 1.5 0 0 0.7 0.7 0 0 0.7 2.2 0 0 0 1.5 0.7 0.7 ----- 28

40-

-

44 0 0 0 0.7 0 0 5.8 0 0 0.7 0.7 0.7 5.1 5.1 0 7.3 0 2.9 0.7 010

.9 0 1.5 0.7 1.5 0 0 0.7 0 0 0 0 0 0 0 0 1.5 0 0 0.7 2.2 0 0 1.5 7.3 0 0.7 0 3.6 2.2 2.9 ----- 68

45-

-

49 0 2.2 0.7 0.7 0 0.7 4.5 0.7 0 0 2.2 0 5.9 6.7 013

.4 1.5 5.2 0 1.5 20.8 0 1.5 0 3 0 0 3.7 0 0 0 0 0 3 0 0 4.5 0 0 3 3 0 0.7 0.7 5.9 0 0 0 3.7 0 3.7 -----

103

50-

-

54 0 1.4 0 1.4 0 012

.4 0 0.7 0.7 2.1 0 6.2 9.6 0.7 19.2 2.1 2.7 2.7 1.4 26.1 0.7 1.4 0 2.1 0 0 0 0 0 3.4 0 0.7 4.8 0 0 3.4 0 0 4.1 2.7 0 0 0.7 2.7 0 1.4 0 0.7 5.5 0.7 -----

124

55-

-

59 0 1.1 0 3.4 0 011

.2 2.2 0 1.1 3.4 2.2 16.9

16.9 1.1 28.1 4.5 3.4 1.1 3.4 40.5 0 1.1 1.1 4.5 0 0 3.4 2.2 0

10.1 0 0 3.4 0 0

10.1 0 0 1.1 3.4 0 0 0

14.6 0 2.2 1.1 5.6 3.4 9

-----

217

60-

-

64 0 1.5 0 0 0 0 4.5 0 0 7.5 3 026

.919

.4 335

.8 4.5 10.4 1.5 4.5 68.7 0 3 0

19.4 0 0 3 0 0

20.9 0 0 6 0 0

10.4 0 0 4.5 4.5 0 0 0

14.9 0 1.5 0 6 0

10.4 -----

296

65-

-

69 0 6.6 4.4 2.2 0 2.2 8.8 2.2 0 6.6 17.6 0

35.2 44 0 22 2.2 11 2.2 6.6

112.1 0 6.6 0

15.4 0 0 8.8 0 0

39.6 0 0 6.6 0 0

28.6 0 0 4.4 6.6 0 0 4.4 17.6 0 6.6 0 0 2.2 11 -----

444

70-

-

74 0 3.1 3.1 0 0 015

.6 3.1 012

.521

.9 3.1 56.3

53.1 0

46.9 9.4 9.4 3.1 6.3

159.4 0 3.1 0

12.5 0 0 3.1 0 0

78.1 0 0 0 0 0

43.8 0 0 3.1 3.1 0 0 0 25 0 3.1 0 3.1 3.1 15.6 -----

603

75+

0 5.8 0 0 0 014

.5 0 011

.611

.6 046

.420

.3 0 29 2.9 2.9 017

.411

0.2 011

.6 2.9 17.4 0 0 8.7 0 0

72.5 2.9 0 2.9 0 2.9 31.9 0 0 0 2.9 0 0 0

14.5 0 0 0

11.6

11.6

26.1 -----

493

Crud

eRa

te 0 0.6 0.2 0.4 0 0.1 2.7 0.2 0 0.8 1.3 0.2 4.3 4.2 0.2 6 0.7 1.4 0.4 0.8 11.9 0 1.3 0.2 2.2 0 0 1.1 0.1 0 3.7 0.5 0 1 0 0 2.6 0 0.2 1.5 1 0.1 0.2 0.5 3.5 0 0.4 0.4 2.2 2.4 2.1 -----

63.7

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

81:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, T

ER

EN

GG

AN

U, A

LL

RE

SID

EN

TS,

MA

LE

S, 2

007-

2011

ASR

Wor

ld 0 0.8 0.3 0.5 0 0.1 3.1 0.3 0 1.2 1.9 0.2 6.1 5.7 0.2 7.6 0.9 1.8 0.5 1.1 16.7 0 1.5 0.2 2.9 0 0 1.4 0.1 0 5.6 0.5 0 1.2 0 0.1 3.8 0 0.2 1.6 1.2 0.1 0.1 0.6 4.4 0 0.5 0.4 2.4 2.4 2.7 -----

83.2

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 183: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

161

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

1 12 12 5 1 1 35 5 2 15 33 2 90 83 2 49 14 23 3 211

3 5 29 4 35 0 0 28 534 4 0

120 97 37 173 0 6 19 0 0 15 0 7 41 111 0 1 4 56 0 15 8 52 36 37 -----

1977

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0.4 0 0 0.4 0 0.7 0 0 0 0 0.7 0 0 0 0 0 0 0 0 0 1.5 0 0 0 0 1.1 1.1 0 0 0 0 1.1 0 0 1.8 1.8 2.2 0---

-- 14

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0.3 0 0 0.3 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0.3 1.4 0 0 0 0 0 0 0 0 1 2.1 0.3 ----- 7

10-

-

14 0 0.3 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0.7 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0.7 0.3 0 0 0 1.4 0 0 0 0.3 1 0---

-- 7

15-

-

19 0 0 0 0 0 0 0.3 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 1.7 0 0.7 0 0 2.4 0 0 0 0 0 0 2.7 0 0 0 0 0 0 0 0 1 2.1 0 0 0 1 0 0 0.3 2.1 0 0.3 ----- 15

20-

-

24 0 0.4 0 0 0 0 1.3 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0.9 0.4 1.3 0 0 0 0 0 5.1 0 0 0 0 0 4.3 0 0.4 0 0 0 0.4 0 0 0.4 5.1 0 0 0.9 1.3 0 0 0 0.9 0.9 1.3 ----- 26

25-

-

29 0 0 0 0 0 0 0.6 0 0 0 0.6 0 0 0.6 0 0 0 0 0 0 0 0 0.6 0 0.6 0 0 1.2 7.6 0 0 1.7 1.7 0.6 2.3 0 0 0 0 0 0.6 0 0.6 0.6 3.5 0 0 0 2.3 0 0 0.6 0.6 1.7 0.6 ----- 29

30-

-

34 0 1.4 0 0 0 0 0.7 0.7 1.4 0 0 0 2.8 0.7 0 0.7 0 0 0 0 0.7 0.7 0.7 0 1.4 0 0 1.4 17.7 0.7 0 1.4 3.5 1.4 7.8 0 0.7 0 0 0 0 0 0 1.4 2.8 0 0 0.7 2.1 0 0 0 2.8 0.7 0.7 ----- 58

35-

-

39 0 0.7 0.7 0.7 0 0 1.4 0 0 0 1.4 0 0.7 2.1 0 0.7 0 0.7 0.7 0 4.2 0 0.7 0 0 0 0 027

.2 0 0 2.8 4.9 2.8 6.3 0 0.7 1.4 0 0 1.4 0 0 2.1 3.5 0 0 0.7 2.1 0 0.7 0 2.8 0 0.7 ----- 75

40-

-

44 0 1.4 0 0 0 0 1.4 0.7 0 0 0.7 0.7 6.9 4.2 0.7 1.4 0 0.7 0 0 5.5 0 0.7 0 2.1 0 0 1.4 49.8 0 0 9.7 12.5 5.5 9.7 0 0.7 0.7 0 0 0 0 0 0.7 10.4 0 0.7 0 0.7 0 1.4 0 1.4 0.7 2.1 -----

135

45-

-

49 0 0.7 0 1.5 0 0 3.7 0.7 0 0 2.2 0 5.9 4.4 0 2.2 0.7 0 0 0 8.1 0 2.2 0.7 2.2 0 0 1.5 77.7 0 0

17.6

11.7 8.8 19.1 0 0.7 0.7 0 0 0.7 0 0 3.7 8.1 0 0 0 2.9 0 0.7 0 1.5 1.5 2.9 -----

195

50-

-

54 0 1.8 2.6 1.8 0 0 2.6 0 0 0.9 5.3 0 8.8 13.2 0 3.5 2.6 2.6 0 0

11.5 0 1.8 0 2.6 0 0 1.8 83.7 1.8 0

16.7

14.1 3.5 21.1 0 0.9 1.8 0 0 0.9 0 0 4.4 9.7 0 0 0 1.8 0 2.6 0 4.4 2.6 3.5 -----

237

55-

-

59 0 0 0 0 0 0 8.3 0 0 2.4 4.8 016

.7 9.5 0 8.3 2.4 7.1 2.4 2.4 21.4 1.2 1.2 1.2 1.2 0 0 2.4 85.7 0 0

21.4

16.7 2.4 20.2 0 0 1.2 0 0 0 0 0 1.2 3.6 0 0 0 9.5 0 4.8 0 6 3.6 4.8 -----

274

60-

-

64 0 1.6 3.2 0 0 0 6.4 1.6 0 3.2 6.4 020

.622

.2 0 7.9 1.6 4.8 0 022

.2 1.6 0 0 6.4 0 0 1.6 65.1 0 0

23.8

15.9 4.8 20.6 0 0 3.2 0 0 0 0 0 6.4 23.8 0 0 0

12.7 0 1.6 0 6.4 4.8 7.9 -----

308

65-

-

69 0 0 4.1 0 0 0 0 2.1 0 8.2 4.1 010

.326

.8 012

.4 6.2 4.1 0 030

.9 2.1 0 4.1 8.2 0 0 2.1 53.6 0 0

16.5

10.3 2.1 45.4 0 0 8.2 0 0 8.2 0 0

10.3

16.5 0 0 0 0 0 0 0 4.1 2.1 6.2 -----

309

70-

-

74 0 0 8.5 0 0 014

.1 0 0 5.6 8.5 2.8 33.8

28.2 0

19.7 8.5 14.1 0 0

42.3 0 5.6 0

11.3 0 0 2.8 45.1 2.8 0

22.5 5.6 0

19.7 0 0 5.6 0 0 5.6 0 2.8 0

19.7 0 0 0

16.9 0 5.6 0 8.5 2.8 11.3 -----

380

75+ 2.3 2.3 2.3 0 2.3 0 2.3 0 0 9.1 13

.6 027

.313

.6 2.3 25 2.3 2.3 0 020

.5 0 2.3 015

.9 0 0 2.3 36.4 0 0

11.4 2.3 0

15.9 0 0 0 0 0 6.8 0 0 2.3 15.9 0 0 0 9.1 0 2.3 2.3 6.8 2.3 4.5 -----

266

Crud

eRa

te

0 0.5 0.5 0.2 0 0 1.4 0.2 0.1 0.6 1.3 0.1 3.6 3.3 0.1 2 0.6 0.9 0.1 0.1 4.5 0.2 1.2 0.2 1.4 0 0 1.1 21.4 0.2 0 4.8 3.9 1.5 6.9 0 0.2 0.8 0 0 0.6 0 0.3 1.6 4.4 0 0 0.2 2.2 0 0.6 0.3 2.1 1.4 1.5 -----

79.1

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

82:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, T

ER

EN

GG

AN

U, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, 2

007-

2011 AS

RW

orld 0 0.5 0.6 0.2 0 0 1.7 0.3 0.1 0.8 1.6 0.1 4.5 4.3 0.1 2.5 0.7 1.2 0.1 0.1 5.7 0.2 1.1 0.2 1.7 0 0 1.2 24.8 0.2 0 5.8 4.6 1.7 8.1 0 0.2 1 0 0 0.7 0 0.3 1.9 5.2 0 0 0.2 2.6 0 0.7 0.3 2.3 1.6 1.8 -----

93.8

Page 184: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

162

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

1 24 17 5 6 214

3 9 1 48 98 12 153

240 7

127 14 43 10 35 270 2 13 6 52 0 0 18 8 4

100 24 0 30 0 0 45 0 5 47 19 0 3 22 117 0 15 31 42 13 36 -----

1917

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 3 1 0 0 0 0 2 0 0 5 0 2 0---

-- 14

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0 4 0 0 3 1 1 0---

-- 13

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 1 0 0 0 0 0 0 6 2 1 0---

-- 14

15-

-

19 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 3 2 0 0 3 2 0 0---

-- 17

20-

-

24 0 1 0 0 0 0 0 0 0 0 0 1 0 2 0 1 0 0 0 0 0 0 1 0 0 0 0 4 0 0 0 6 0 0 0 0 0 0 0 4 1 0 0 4 6 0 0 1 1 1 1---

-- 35

25-

-

29 0 0 0 0 0 0 3 0 0 1 1 0 1 1 0 3 0 1 1 0 0 0 0 0 1 0 0 1 0 0 0 5 0 0 0 0 1 0 0 0 1 0 0 4 4 0 0 3 1 1 1---

-- 35

30-

-

34 0 0 0 0 0 0 6 0 0 0 2 1 2 1 0 0 0 1 0 0 2 0 2 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 4 0 0 1 0 0 0---

-- 25

35-

-

39 0 2 0 1 0 0 7 0 0 1 3 0 7 5 0 1 0 0 1 0 5 0 0 0 1 0 0 0 0 0 0 4 0 0 0 0 1 0 0 3 0 0 0 2 8 0 0 0 2 0 0---

-- 54

40-

-

44 0 2 0 1 0 0 18 0 0 0 5 0 5 7 0 8 1 3 1 1 10 1 0 1 3 0 0 3 2 0 0 0 0 3 0 0 2 0 0 1 1 0 1 0 14 0 0 0 3 0 0---

-- 97

45-

-

49 1 2 1 0 0 0 30 0 0 2 5 1 11 15 0 14 1 3 0 4 13 0 2 0 2 0 0 2 2 0 0 4 0 3 0 0 1 0 0 9 1 0 0 0 9 0 4 2 4 0 2---

--15

0

50-

-

54 0 4 3 1 0 0 26 2 0 7 9 2 16 20 0 16 2 8 2 2 29 1 0 0 5 0 0 0 2 0 4 0 0 4 0 0 3 0 0 4 0 0 0 2 12 0 2 3 6 2 6---

--20

5

55-

-

59 0 2 4 0 2 1 16 0 1 12 8 1 20 31 0 20 1 8 1 7 35 0 0 2 7 0 0 1 0 1 9 0 0 6 0 0 4 0 0 5 5 0 0 2 18 0 2 1 2 0 2---

--23

7

60-

-

64 0 5 4 1 1 1 13 2 0 7 11 0 26 38 2 20 4 9 1 9 35 0 0 0 6 0 0 0 0 1 13 2 0 2 0 0 6 0 0 3 0 0 0 2 12 0 4 1 7 1 8---

--25

7

65-

-

69 0 2 0 0 0 0 14 5 0 9 17 3 18 51 2 11 2 3 2 6 46 0 2 2 5 0 0 2 0 0 28 0 0 4 0 0 5 0 0 3 2 0 1 1 8 0 2 1 4 3 4---

--26

8

70-

-

74 0 1 1 0 1 0 6 0 0 2 15 1 28 33 2 16 3 3 1 2 41 0 0 0 6 0 0 3 0 0 26 0 0 4 0 0 7 0 1 4 4 0 0 0 5 0 0 0 3 1 6---

--22

6

75+

0 3 4 1 2 0 3 0 0 7 22 2 19 36 1 17 0 4 0 4 54 0 2 0 16 0 0 0 2 2 20 1 0 3 0 0 15 0 0 5 2 0 0 2 9 0 1 1 4 0 6---

--27

0

% of

Total 0.1

0%1.3

0%0.9

0%0.3

0%0.3

0%0.1

0%7.5

0%0.5

0%0.1

0%2.5

0%5.1

0%0.6

0%8.0

0%12

.50%

0.40%

6.60%

0.70%

2.20%

0.50%

1.80%

14.10

%0.1

0%0.7

0%0.3

0%2.7

0%0.0

0%0.0

0%0.9

0%0.4

0%0.2

0%5.2

0%1.3

0%0.0

0%1.6

0%0.0

0%0.0

0%2.3

0%0.0

0%0.3

0%2.5

0%1.0

0%0.0

0%0.2

0%1.1

0%6.1

0%0.0

0%0.8

0%1.6

0%2.2

0%0.7

0%1.9

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

83:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

NE

GE

RI

SEM

BIL

AN

, AL

L R

ESI

DE

NT

S, M

AL

ES,

20

07-2

011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 185: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

163

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

4 18 42 8 3 2 38 5 1 31 75 517

214

3 7 49 13 36 2 712

2 1 16 7 34 1 0 17 883 3 1

190 96 27 168 2 1 10 0 0 10 0 1 33 43 0 0 19 72 0 11 25 44 7 23 -----

2528

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 4 2 2 0---

-- 12

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 2 0 0---

-- 10

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 2 0 0 0 0 2 0 0 10 1 0 0---

-- 17

15-

-

19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 2 0 0 3 1 0 0 0 5 1 0---

-- 19

20-

-

24 0 0 0 0 0 0 1 0 0 0 1 0 1 1 0 0 0 1 0 0 1 0 0 0 0 0 0 1 1 0 0 2 0 0 8 0 0 0 0 0 0 0 0 3 2 0 0 2 3 0 0 1 2 0 1---

-- 32

25-

-

29 0 1 0 3 0 0 0 0 0 0 1 0 2 0 1 2 0 0 0 0 4 0 0 0 0 0 0 0 15 0 0 2 0 0 6 0 0 1 0 0 0 0 0 1 1 0 0 7 1 0 0 1 3 0 1---

-- 53

30-

-

34 0 2 0 0 0 0 2 0 0 0 1 0 2 3 0 0 0 1 0 0 3 1 1 0 1 0 0 1 27 0 0 9 1 0 8 0 0 0 0 0 0 0 0 2 3 0 0 1 4 0 0 1 2 0 1---

-- 77

35-

-

39 0 0 0 0 0 0 1 0 0 0 4 0 2 1 0 0 1 1 0 0 3 0 0 0 0 0 0 2 52 0 0 12 3 0 8 1 0 1 0 0 0 0 0 0 4 0 0 1 2 0 0 1 2 1 1---

--10

4

40-

-

44 0 1 1 0 1 0 3 0 0 2 7 2 3 3 0 1 0 0 0 0 2 0 1 2 2 0 0 110

9 0 0 7 2 2 14 0 0 0 0 0 0 0 0 1 3 0 0 1 0 0 0 2 4 0 3---

--18

0

45-

-

49 0 2 1 1 0 0 9 0 0 0 6 1 7 18 0 4 2 4 0 0 14 0 0 0 1 0 0 216

0 1 0 24 14 3 25 0 0 0 0 0 1 0 0 2 4 0 0 0 7 0 1 0 4 0 1---

--31

9

50-

-

54 0 4 7 1 1 0 8 1 0 9 6 1 12 20 3 3 1 2 0 0 9 0 0 1 2 1 0 216

2 0 0 28 20 7 35 0 0 1 0 0 1 0 0 3 3 0 0 0 5 0 0 1 4 0 3---

--36

7

55-

-

59 2 0 4 0 0 0 7 1 0 4 10 0 24 16 1 7 1 4 0 2 16 0 5 2 4 0 0 113

6 1 0 35 25 4 18 0 1 1 0 0 0 0 1 4 7 0 0 0 11 0 3 1 3 0 3---

--36

5

60-

-

64 0 1 7 2 1 0 4 3 0 6 11 0 18 13 0 7 1 6 0 2 13 0 1 0 1 0 0 2 86 0 0 26 11 5 14 0 0 0 0 0 0 0 0 3 2 0 0 3 16 0 2 0 4 0 3---

--27

4

65-

-

69 0 2 4 1 0 1 0 0 0 4 11 0 25 28 0 11 2 5 1 0 15 0 2 1 8 0 0 0 54 0 0 18 8 1 13 1 0 1 0 0 1 0 0 5 5 0 0 1 6 0 2 1 1 2 1---

--24

2

70-

-

74 0 3 7 0 0 0 0 0 0 3 9 1 26 23 0 6 4 7 0 1 22 0 0 1 3 0 0 1 40 1 1 16 7 4 10 0 0 3 0 0 3 0 0 1 4 0 0 0 6 0 2 0 3 0 2---

--22

0

75+

2 2 11 0 0 1 3 0 0 3 8 0 50 17 2 7 1 5 1 2 20 0 2 0 11 0 0 3 41 0 0 11 5 1 3 0 0 2 0 0 4 0 0 1 3 0 0 0 8 0 1 0 2 1 3---

--23

7

% of

Total

0.20%

0.70%

1.70%

0.30%

0.10%

0.10%

1.50%

0.20%

0.00%

1.20%

3.00%

0.20%

6.80%

5.70%

0.30%

1.90%

0.50%

1.40%

0.10%

0.30%

4.80%

0.00%

0.60%

0.30%

1.30%

0.00%

0.00%

0.70%

34.90

%0.1

0%0.0

0%7.5

0%3.8

0%1.1

0%6.6

0%0.1

0%0.0

0%0.4

0%0.0

0%0.0

0%0.4

0%0.0

0%0.0

0%1.3

0%1.7

0%0.0

0%0.0

0%0.8

0%2.8

0%0.0

0%0.4

0%1.0

0%1.7

0%0.3

0%0.9

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

84:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

NE

GE

RI S

EM

BIL

AN

, AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

20

07-2

011

Page 186: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

164

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

1 24 17 5 6 214

3 9 1 48 98 12 153

240 7

127 14 43 10 35 270 2 13 6 52 0 0 18 8 4

100 24 0 30 0 0 45 0 5 47 19 0 3 22 117 0 15 31 42 13 36 -----

1917

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 1.3 0.4 0 0 0 0 0.9 0 0 2.2 0 0.9 0---

-- 6

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0.8 0 0 0 0 1.6 0 0 1.2 0.4 0.4 0---

-- 5

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0.8 0.4 0 0 0 0 0 0 2.4 0.8 0.4 0---

-- 6

15-

-

19 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0.4 0 0 0 0.4 0 0 0 0.4 0 0 0 0 0 0 0 0 0.4 0 0 1.2 0.8 0 0 1.2 0.8 0 0---

-- 7

20-

-

24 0 0.4 0 0 0 0 0 0 0 0 0 0.4 0 0.9 0 0.4 0 0 0 0 0 0 0.4 0 0 0 0 1.8 0 0 0 2.6 0 0 0 0 0 0 0 1.8 0.4 0 0 1.8 2.6 0 0 0.4 0.4 0.4 0.4 ----- 15

25-

-

29 0 0 0 0 0 0 1.6 0 0 0.5 0.5 0 0.5 0.5 0 1.6 0 0.5 0.5 0 0 0 0 0 0.5 0 0 0.5 0 0 0 2.7 0 0 0 0 0.5 0 0 0 0.5 0 0 2.2 2.2 0 0 1.6 0.5 0.5 0.5 ----- 19

30-

-

34 0 0 0 0 0 0 3.8 0 0 0 1.3 0.6 1.3 0.6 0 0 0 0.6 0 0 1.3 0 1.3 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0.6 0 2.5 0 0 0.6 0 0 0---

-- 16

35-

-

39 0 1.4 0 0.7 0 0 4.9 0 0 0.7 2.1 0 4.9 3.5 0 0.7 0 0 0.7 0 3.5 0 0 0 0.7 0 0 0 0 0 0 2.8 0 0 0 0 0.7 0 0 2.1 0 0 0 1.4 5.6 0 0 0 1.4 0 0---

-- 38

40-

-

44 0 1.4 0 0.7 0 012

.8 0 0 0 3.5 0 3.5 5 0 5.7 0.7 2.1 0.7 0.7 7.1 0.7 0 0.7 2.1 0 0 2.1 1.4 0 0 0 0 2.1 0 0 1.4 0 0 0.7 0.7 0 0.7 0 9.9 0 0 0 2.1 0 0---

-- 69

45-

-

49 0.7 1.4 0.7 0 0 021

.2 0 0 1.4 3.5 0.7 7.8 10.6 0 9.9 0.7 2.1 0 2.8 9.2 0 1.4 0 1.4 0 0 1.4 1.4 0 0 2.8 0 2.1 0 0 0.7 0 0 6.4 0.7 0 0 0 6.4 0 2.8 1.4 2.8 0 1.4 -----

106

50-

-

54 0 3 2.3 0.8 0 019

.6 1.5 0 5.3 6.8 1.5 12 15 0 12 1.5 6 1.5 1.5 21.8 0.8 0 0 3.8 0 0 0 1.5 0 3 0 0 3 0 0 2.3 0 0 3 0 0 0 1.5 9 0 1.5 2.3 4.5 1.5 4.5 -----

154

55-

-

59 0 1.8 3.6 0 1.8 0.9 14.4 0 0.9 10.8 7.2 0.9 18 27.9 0 18 0.9 7.2 0.9 6.3 31.5 0 0 1.8 6.3 0 0 0.9 0 0.9 8.1 0 0 5.4 0 0 3.6 0 0 4.5 4.5 0 0 1.8 16.2 0 1.8 0.9 1.8 0 1.8 -----

214

60-

-

64 0 6.5 5.2 1.3 1.3 1.3 16.9 2.6 0 9.1 14.3 0

33.8

49.4 2.6 26 5.2 11.7 1.3 11.7

45.5 0 0 0 7.8 0 0 0 0 1.3 16.9 2.6 0 2.6 0 0 7.8 0 0 3.9 0 0 0 2.6 15.6 0 5.2 1.3 9.1 1.3 10.4 -----

334

65-

-

69 0 4 0 0 0 027

.7 9.9 017

.833

.7 5.9 35.6 101 4

21.8 4 5.9 4

11.9

91.1 0 4 4 9.9 0 0 4 0 0

55.5 0 0 7.9 0 0 9.9 0 0 5.9 4 0 2 2

15.8 0 4 2 7.9 5.9 7.9 -----

531

70-

-

74 0 2.5 2.5 0 2.5 0 15 0 0 537

.5 2.5 70 82.5 5 40 7.5 7.5 2.5 5

102.5 0 0 0 15 0 0 7.5 0 0 65 0 0 10 0 0

17.5 0 2.5 10 10 0 0 0

12.5 0 0 0 7.5 2.5 15 -----

565

75+

0 7.5 10 2.5 5 0 7.5 0 017

.5 55 547

.5 90 2.5 42.5 0 10 0 10 135 0 5 0 40 0 0 0 5 5 50 2.5 0 7.5 0 0

37.5 0 0

12.5 5 0 0 5

22.5 0 2.5 2.5 10 0 15 -----

675

Crud

eRa

te 0 1 0.7 0.2 0.2 0.1 5.9 0.4 0 2 4 0.5 6.3 9.9 0.3 5.2 0.6 1.8 0.4 1.4 11.1 0.1 0.5 0.2 2.1 0 0 0.7 0.3 0.2 4.1 1 0 1.2 0 0 1.9 0 0.2 1.9 0.8 0 0.1 0.9 4.8 0 0.6 1.3 1.7 0.5 1.5 ----- 79

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

85:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, N

EG

ER

I SE

MB

ILA

N, A

LL

RE

SID

EN

TS,

MA

LE

S, 2

007-

2011 AS

RW

orld 0 1.1 0.8 0.2 0.3 0.1 6.2 0.5 0 2.2 4.7 0.6 7.2 11.6 0.4 5.8 0.7 1.9 0.5 1.7 12.9 0.1 0.6 0.3 2.4 0 0 0.8 0.3 0.2 5.1 1 0 1.4 0 0 2.2 0 0.2 2 0.8 0 0.1 0.9 5.1 0 0.7 1.3 1.9 0.6 1.7 -----

89.2

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 187: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

165

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

4 18 42 8 3 2 38 5 1 31 75 517

214

3 7 49 13 36 2 712

2 1 16 7 34 1 0 17 883 3 1

190 96 27 168 2 1 10 0 0 10 0 1 33 43 0 0 19 72 0 11 25 44 7 23 -----

2528

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.4 0 0 0 0 0 0 0 1.9 1 1 0---

-- 6

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0.4 0 0 0.4 0 0 0 0 0 0 0.9 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0.9 0.9 0 0---

-- 4

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0.9 0 0 4.3 0.4 0 0---

-- 7

15-

-

19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 1.2 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0 0 0 0 0.4 0.8 0 0 1.2 0.4 0 0 0 2.1 0.4 0---

-- 8

20-

-

24 0 0 0 0 0 0 0.5 0 0 0 0.5 0 0.5 0.5 0 0 0 0.5 0 0 0.5 0 0 0 0 0 0 0.5 0.5 0 0 0.9 0 0 3.7 0 0 0 0 0 0 0 0 1.4 0.9 0 0 0.9 1.4 0 0 0.5 0.9 0 0.5 ----- 15

25-

-

29 0 0.6 0 1.7 0 0 0 0 0 0 0.6 0 1.1 0 0.6 1.1 0 0 0 0 2.3 0 0 0 0 0 0 0 8.6 0 0 1.1 0 0 3.4 0 0 0.6 0 0 0 0 0 0.6 0.6 0 0 4 0.6 0 0 0.6 1.7 0 0.6 ----- 30

30-

-

34 0 1.3 0 0 0 0 1.3 0 0 0 0.6 0 1.3 1.9 0 0 0 0.6 0 0 1.9 0.6 0.6 0 0.6 0 0 0.6 17.5 0 0 5.8 0.6 0 5.2 0 0 0 0 0 0 0 0 1.3 1.9 0 0 0.6 2.6 0 0 0.6 1.3 0 0.6 ----- 50

35-

-

39 0 0 0 0 0 0 0.7 0 0 0 2.7 0 1.4 0.7 0 0 0.7 0.7 0 0 2 0 0 0 0 0 0 1.4 35.5 0 0 8.2 2 0 5.5 0.7 0 0.7 0 0 0 0 0 0 2.7 0 0 0.7 1.4 0 0 0.7 1.4 0.7 0.7 ----- 71

40-

-

44 0 0.7 0.7 0 0.7 0 2 0 0 1.3 4.7 1.3 2 2 0 0.7 0 0 0 0 1.3 0 0.7 1.3 1.3 0 0 0.7 72.7 0 0 4.7 1.3 1.3 9.3 0 0 0 0 0 0 0 0 0.7 2 0 0 0.7 0 0 0 1.3 2.7 0 2

-----

120

45-

-

49 0 1.4 0.7 0.7 0 0 6.1 0 0 0 4.1 0.7 4.7 12.2 0 2.7 1.4 2.7 0 0 9.5 0 0 0 0.7 0 0 1.4

108.5 0.7 0

16.3 9.5 2 17 0 0 0 0 0 0.7 0 0 1.4 2.7 0 0 0 4.7 0 0.7 0 2.7 0 0.7 -----

216

50-

-

54 0 2.9 5.1 0.7 0.7 0 5.9 0.7 0 6.6 4.4 0.7 8.8 14.7 2.2 2.2 0.7 1.5 0 0 6.6 0 0 0.7 1.5 0.7 0 1.5

118.7 0 0

20.5

14.7 5.1 25.6 0 0 0.7 0 0 0.7 0 0 2.2 2.2 0 0 0 3.7 0 0 0.7 2.9 0 2.2 -----

269

55-

-

59 1.9 0 3.8 0 0 0 6.6 0.9 0 3.8 9.4 022

.5 15 0.9 6.6 0.9 3.8 0 1.9 15 0 4.7 1.9 3.8 0 0 0.912

7.7 0.9 032

.923

.5 3.8 16.9 0 0.9 0.9 0 0 0 0 0.9 3.8 6.6 0 0 0

10.3 0 2.8 0.9 2.8 0 2.8 -----

343

60-

-

64 0 1.3 9.3 2.6 1.3 0 5.3 4 0 7.9 14.6 0

23.8

17.2 0 9.3 1.3 7.9 0 2.6 17.2 0 1.3 0 1.3 0 0 2.6

113.9 0 0

34.4

14.6 6.6 18.5 0 0 0 0 0 0 0 0 4 2.6 0 0 4

21.2 0 2.6 0 5.3 0 4

-----

363

65-

-

69 0 3.9 7.8 1.9 0 1.9 0 0 0 7.8 21.4 0

48.6

54.4 0

21.4 3.9 9.7 1.9 0

29.1 0 3.9 1.9 15.5 0 0 0

104.9 0 0 35 15.5 1.9 25.2 1.9 0 1.9 0 0 1.9 0 0 9.7 9.7 0 0 1.9 11.7 0 3.9 1.9 1.9 3.9 1.9 -----

470

70-

-

74 0 6.8 15.9 0 0 0 0 0 0 6.8 20.5 2.3 59.1

52.3 0

13.6 9.1 15.9 0 2.3 50 0 0 2.3 6.8 0 0 2.3 90.9 2.3 2.3 36.4

15.9 9.1 22.7 0 0 6.8 0 0 6.8 0 0 2.3 9.1 0 0 0

13.6 0 4.5 0 6.8 0 4.5 -----

500

75+

4 422

.2 0 0 2 6.1 0 0 6.1 16.2 0

101

34.3 4

14.1 2

10.1 2 4

40.4 0 4 0

22.2 0 0 6.1 82.8 0 0

22.2

10.1 2 6.1 0 0 4 0 0 8.1 0 0 2 6.1 0 0 0

16.2 0 2 0 4 2 6.1 -----

479

Crud

eRa

te 0.2 0.8 1.8 0.3 0.1 0.1 1.6 0.2 0 1.3 3.2 0.2 7.3 6 0.3 2.1 0.5 1.5 0.1 0.3 5.2 0 0.7 0.3 1.4 0 0 0.7 37.4 0.1 0 8 4.1 1.1 7.1 0.1 0 0.4 0 0 0.4 0 0 1.4 1.8 0 0 0.8 3 0 0.5 1.1 1.9 0.3 1

-----

107

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

86:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, N

EG

ER

I SE

MB

ILA

N, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, 2

007-

2011

ASR

Wor

ld 0.2 0.8 1.9 0.4 0.1 0.1 1.5 0.2 0.1 1.4 3.4 0.2 7.6 6.4 0.3 2.3 0.6 1.6 0.1 0.3 5.4 0 0.7 0.3 1.5 0 0 0.7 37 0.1 0 8.2 4.1 1.2 7.1 0.1 0 0.4 0 0 0.4 0 0 1.5 1.8 0 0 0.8 3.2 0 0.5 1.1 1.9 0.4 1---

--10

8.9

Page 188: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

166

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

1 21 6 12 6 011

2 11 1 12 65 414

414

9 512

6 14 46 13 30 343 3 16 3 52 1 0 25 6 4

101 21 0 37 1 1 63 2 3 34 25 3 4 37 108 0 12 44 62 12 10 -----

1811

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 0 1 3 0 1 0 0 0 0 0 15 2 3 0---

-- 29

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 3 0 0 5 2 0 0---

-- 12

10-

-

14 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 1 1 4 1 0 0 2 5 0 0---

-- 22

15-

-

19 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 0 0 0 5 0 0 0 3 2 2 0---

-- 19

20-

-

24 0 0 0 1 0 0 1 0 0 0 1 0 0 1 0 0 0 0 0 0 1 0 2 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 1 2 0 0 3 2 0 1 2 4 0 0---

-- 27

25-

-

29 0 0 1 1 0 0 1 0 0 0 1 0 0 0 0 2 0 0 0 0 0 0 3 0 1 0 0 2 0 0 0 4 0 0 0 0 0 0 0 1 1 1 0 3 3 0 0 4 3 0 0---

-- 32

30-

-

34 0 1 0 1 0 0 5 0 0 0 0 1 3 3 0 1 0 1 0 1 2 0 0 0 2 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 3 2 0 0 2 5 1 0---

-- 36

35-

-

39 0 0 0 1 0 0 12 0 0 1 2 0 4 1 1 3 0 0 0 0 7 1 1 0 1 0 0 1 0 0 0 2 0 0 0 1 0 0 0 1 4 0 0 4 6 0 1 1 6 1 0---

-- 63

40-

-

44 1 2 0 1 0 0 12 0 0 0 2 0 7 8 1 8 0 0 1 1 10 0 1 0 1 0 0 0 1 1 2 3 0 1 0 0 1 0 0 3 3 0 0 1 10 0 0 3 3 0 1---

-- 89

45-

-

49 0 1 1 0 0 0 13 2 0 0 2 0 5 15 1 10 1 3 5 1 16 0 0 1 0 0 0 6 0 0 0 2 0 2 0 0 4 0 0 0 3 0 1 1 9 0 1 1 2 1 1---

--11

1

50-

-

54 0 3 0 2 1 0 16 1 0 1 7 1 12 17 1 24 1 5 3 5 30 0 1 1 4 0 0 0 2 0 1 0 0 1 0 0 7 0 0 7 2 0 1 4 13 0 2 0 7 1 0---

--18

4

55-

-

59 0 4 2 3 0 0 20 2 0 1 7 1 23 26 0 19 5 12 2 4 44 0 0 1 7 0 0 2 0 3 2 0 0 4 0 0 7 0 0 7 3 0 0 3 21 0 1 1 6 1 3---

--24

7

60-

-

64 0 2 0 0 1 0 13 1 0 0 7 0 23 26 0 16 3 9 1 5 58 0 2 0 7 1 0 3 1 0 20 1 0 8 0 0 13 1 0 0 2 0 0 2 11 0 1 2 4 0 0---

--24

4

65-

-

69 0 2 0 0 1 0 6 2 0 1 6 0 17 23 0 15 1 5 1 4 49 0 2 0 8 0 0 4 0 0 19 0 0 9 1 0 9 1 1 3 1 0 0 1 11 0 2 2 4 0 2---

--21

3

70-

-

74 0 3 2 2 0 0 4 2 1 6 14 0 20 17 1 13 1 8 0 2 58 0 0 0 7 0 0 3 1 0 20 0 0 6 0 0 7 0 0 2 2 0 0 3 7 0 2 1 3 0 1---

--21

9

75+

0 3 0 0 3 0 6 1 0 2 16 1 30 12 0 13 2 3 0 7 68 1 0 0 13 0 0 2 1 0 37 2 0 4 0 0 14 0 0 2 2 0 1 0 9 0 1 0 4 2 2---

--26

4

% of

Total 0.1

0%1.2

0%0.3

0%0.7

0%0.3

0%0.0

0%6.2

0%0.6

0%0.1

0%0.7

0%3.6

0%0.2

0%8.0

0%8.2

0%0.3

0%7.0

0%0.8

0%2.5

0%0.7

0%1.7

0%18

.90%

0.20%

0.90%

0.20%

2.90%

0.10%

0.00%

1.40%

0.30%

0.20%

5.60%

1.20%

0.00%

2.00%

0.10%

0.10%

3.50%

0.10%

0.20%

1.90%

1.40%

0.20%

0.20%

2.00%

6.00%

0.00%

0.70%

2.40%

3.40%

0.70%

0.60% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

87:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

ME

LA

KA

, AL

L R

ESI

DE

NT

S, M

AL

ES,

200

7-20

11

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 189: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

167

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

2 9 14 9 2 1 53 3 2 7 58 315

3 93 5 35 18 39 5 3 92 3 16 7 33 2 0 22 731 5 5

162

109 19 161 2 3 12 0 0 13 0 0 27 62 3 3 19 78 2 18 18 58 7 8

-----

2214

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 0 0 6 4 3 1---

-- 21

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 4 0 0 0 0 0 0 0 3 1 1 0---

-- 13

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 2 1 0 0---

-- 7

15-

-

19 0 0 0 1 0 0 2 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 4 0 2 0 0 2 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 1 2 0 0 1 0 0 0 1 2 1 0---

-- 27

20-

-

24 0 0 0 1 0 0 3 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 3 0 0 0 0 0 3 0 1 1 0 0 0 0 0 0 3 0 0 4 5 0 0 1 4 1 0---

-- 33

25-

-

29 0 0 0 1 0 0 1 1 0 0 4 0 1 1 0 1 0 0 0 0 1 0 1 0 0 0 0 0 9 0 0 0 0 0 10 0 1 0 0 0 0 0 0 0 6 0 0 3 6 0 0 1 3 0 0---

-- 51

30-

-

34 0 0 0 1 0 0 0 0 0 0 0 0 4 2 0 0 2 1 0 0 1 0 0 0 0 0 0 0 19 0 0 5 2 0 7 0 0 0 0 0 0 0 0 1 6 0 0 1 3 0 0 0 4 0 0---

-- 59

35-

-

39 0 0 0 1 0 0 6 0 0 0 0 0 2 1 0 0 1 3 1 0 1 0 0 0 0 0 0 0 39 0 0 9 3 2 12 0 1 0 0 0 0 0 0 1 5 0 1 0 2 0 0 1 6 0 0---

-- 98

40-

-

44 0 1 0 1 0 0 9 0 0 1 3 0 4 8 0 1 0 1 0 0 5 0 1 2 2 0 0 3 75 0 1 17 8 0 15 0 0 1 0 0 0 0 0 4 3 0 0 1 5 0 1 1 4 0 0---

--17

8

45-

-

49 0 2 1 1 0 0 4 0 0 0 1 0 6 5 0 3 0 2 0 0 3 0 2 2 1 0 0 513

2 1 3 22 15 6 26 1 0 1 0 0 0 0 0 4 7 0 1 2 8 0 1 0 5 0 1---

--27

4

50-

-

54 0 1 5 0 1 0 8 0 0 1 3 0 15 12 1 3 3 4 1 0 12 1 0 0 3 0 0 311

6 0 1 26 25 5 17 1 0 1 0 0 0 0 0 0 7 0 1 2 9 0 5 1 7 1 1---

--30

3

55-

-

59 0 1 2 0 0 1 7 0 1 1 7 2 23 14 2 5 1 3 1 1 6 1 0 0 1 0 0 212

3 1 0 30 24 3 27 0 0 1 0 0 6 0 0 2 2 0 0 3 10 1 1 0 3 0 1---

--32

0

60-

-

64 0 2 1 1 0 0 5 1 0 1 8 0 23 10 0 5 0 3 0 1 9 0 0 0 3 0 0 110

6 0 0 23 15 1 21 0 0 2 0 0 0 0 0 2 5 1 0 1 7 0 4 0 2 0 0---

--26

4

65-

-

69 1 0 1 1 0 0 4 0 0 0 9 0 18 10 1 2 3 7 1 0 17 1 1 0 4 0 0 2 49 0 0 10 7 1 7 0 0 2 0 0 2 0 0 4 4 0 0 0 8 0 0 0 8 0 1---

--18

6

70-

-

74 0 0 2 0 0 0 3 0 0 1 9 0 23 14 0 5 2 8 0 0 16 0 2 1 9 1 0 0 34 2 0 12 3 1 6 0 0 1 0 0 2 0 0 1 6 0 0 0 6 0 5 1 2 0 0---

--17

8

75+

1 2 2 0 1 0 1 1 1 2 13 1 31 16 1 8 6 7 0 1 21 0 2 1 8 1 0 2 26 1 0 8 7 0 3 0 0 1 0 0 2 0 0 2 6 0 0 1 8 1 1 0 2 0 3---

--20

2

% of

Total

0.10%

0.40%

0.60%

0.40%

0.10%

0.00%

2.40%

0.10%

0.10%

0.30%

2.60%

0.10%

6.90%

4.20%

0.20%

1.60%

0.80%

1.80%

0.20%

0.10%

4.20%

0.10%

0.70%

0.30%

1.50%

0.10%

0.00%

1.00%

33.00

%0.2

0%0.2

0%7.3

0%4.9

0%0.9

0%7.3

0%0.1

0%0.1

0%0.5

0%0.0

0%0.0

0%0.6

0%0.0

0%0.0

0%1.2

0%2.8

0%0.1

0%0.1

0%0.9

0%3.5

0%0.1

0%0.8

0%0.8

0%2.6

0%0.3

0%0.4

0% -----

100.0

0%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

88:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

ME

LA

KA

, AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

200

7-20

11

Page 190: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

168

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

1 21 6 12 6 011

2 11 1 12 65 414

414

9 512

6 14 46 13 30 343 3 16 3 52 1 0 25 6 4

101 21 0 37 1 1 63 2 3 34 25 3 4 37 108 0 12 44 62 12 10 -----

1811

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 1.1 0 0 0 0 0 0 0 0 0.6 0 0.6 1.7 0 0.6 0 0 0 0 0 8.6 1.1 1.7 0---

-- 17

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0.5 0 0 0 0 1.6 0 0 2.6 1.1 0 0---

-- 6

10-

-

14 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0.5 0 0.5 0.5 2 0.5 0 0 1 2.4 0 0---

-- 11

15-

-

19 0 0 0 0 0 0 0.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0.5 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0.9 0 0 0 2.3 0 0 0 1.4 0.9 0.9 0---

-- 9

20-

-

24 0 0 0 0.6 0 0 0.6 0 0 0 0.6 0 0 0.6 0 0 0 0 0 0 0.6 0 1.1 0 0 0 0 0 0 0 0 2.9 0 0 0 0 0 0 0 0.6 1.1 0 0 1.7 1.1 0 0.6 1.1 2.3 0 0---

-- 15

25-

-

29 0 0 0.7 0.7 0 0 0.7 0 0 0 0.7 0 0 0 0 1.3 0 0 0 0 0 0 2 0 0.7 0 0 1.3 0 0 0 2.7 0 0 0 0 0 0 0 0.7 0.7 0.7 0 2 2 0 0 2.7 2 0 0---

-- 22

30-

-

34 0 0.8 0 0.8 0 0 4.2 0 0 0 0 0.8 2.5 2.5 0 0.8 0 0.8 0 0.8 1.7 0 0 0 1.7 0 0 0 0 0 0 0 0 1.7 0 0 0 0 0 0 0 0 0 2.5 1.7 0 0 1.7 4.2 0.8 0---

-- 30

35-

-

39 0 0 0 0.9 0 010

.4 0 0 0.9 1.7 0 3.5 0.9 0.9 2.6 0 0 0 0 6.1 0.9 0.9 0 0.9 0 0 0.9 0 0 0 1.7 0 0 0 0.9 0 0 0 0.9 3.5 0 0 3.5 5.2 0 0.9 0.9 5.2 0.9 0---

-- 55

40-

-

44 0.9 1.7 0 0.9 0 010

.5 0 0 0 1.7 0 6.1 7 0.9 7 0 0 0.9 0.9 8.7 0 0.9 0 0.9 0 0 0 0.9 0.9 1.7 2.6 0 0.9 0 0 0.9 0 0 2.6 2.6 0 0 0.9 8.7 0 0 2.6 2.6 0 0.9 ----- 78

45-

-

49 0 0.9 0.9 0 0 011

.1 1.7 0 0 1.7 0 4.3 12.8 0.9 8.5 0.9 2.6 4.3 0.9 13.6 0 0 0.9 0 0 0 5.1 0 0 0 1.7 0 1.7 0 0 3.4 0 0 0 2.6 0 0.9 0.9 7.7 0 0.9 0.9 1.7 0.9 0.9 ----- 94

50-

-

54 0 3 0 2 1 016

.2 1 0 1 7.1 112

.217

.3 124

.4 1 5.1 3 5.1 30.5 0 1 1 4.1 0 0 0 2 0 1 0 0 1 0 0 7.1 0 0 7.1 2 0 1 4.1 13.2 0 2 0 7.1 1 0

-----

187

55-

-

59 0 5 2.5 3.7 0 024

.8 2.5 0 1.2 8.7 1.2 28.6

32.3 0

23.6 6.2 14.9 2.5 5

54.7 0 0 1.2 8.7 0 0 2.5 0 3.7 2.5 0 0 5 0 0 8.7 0 0 8.7 3.7 0 0 3.7 26.1 0 1.2 1.2 7.5 1.2 3.7 -----

307

60-

-

64 0 3.2 0 0 1.6 020

.6 1.6 0 011

.1 036

.541

.3 025

.4 4.8 14.3 1.6 7.9 92.1 0 3.2 0

11.1 1.6 0 4.8 1.6 0

31.8 1.6 0

12.7 0 0

20.6 1.6 0 0 3.2 0 0 3.2 17.5 0 1.6 3.2 6.4 0 0

-----

387

65-

-

69 0 5 0 0 2.5 0 15 5 0 2.5 15 042

.557

.5 037

.5 2.5 12.5 2.5 10

122.5 0 5 0 20 0 0 10 0 0

47.5 0 0

22.5 2.5 0

22.5 2.5 2.5 7.5 2.5 0 0 2.5 27.5 0 5 5 10 0 5

-----

533

70-

-

74 0 9 6 6 0 011

.9 6 317

.941

.8 059

.750

.8 338

.8 323

.9 0 617

3.2 0 0 020

.9 0 0 9 3 059

.7 0 017

.9 0 020

.9 0 0 6 6 0 0 920

.9 0 6 3 9 0 3---

--65

4

75+

0 9 0 0 9 017

.9 3 0 647

.8 389

.635

.8 038

.8 6 9 020

.9 203 3 0 0

38.8 0 0 6 3 0

110.5 6 0

11.9 0 0

41.8 0 0 6 6 0 3 0

26.9 0 3 0

11.9 6 6

-----

788

Crud

eRa

te 0.1 1.1 0.3 0.6 0.3 0 5.8 0.6 0.1 0.6 3.4 0.2 7.5 7.8 0.3 6.6 0.7 2.4 0.7 1.6 17.8 0.2 0.8 0.2 2.7 0.1 0 1.3 0.3 0.2 5.3 1.1 0 1.9 0.1 0.1 3.3 0.1 0.2 1.8 1.3 0.2 0.2 1.9 5.6 0 0.6 2.3 3.2 0.6 0.5 -----

94.2

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

89:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, M

EL

AK

A, A

LL

RE

SID

EN

TS,

MA

LE

S, 2

007-

2011

ASR

Wor

ld 0.1 1.2 0.3 0.6 0.4 0 6.1 0.6 0.1 0.7 3.8 0.2 8.5 8.7 0.3 7.2 0.8 2.7 0.7 1.8 20.4 0.2 0.9 0.2 3.1 0.1 0 1.5 0.3 0.2 6.4 1.1 0 2.3 0.1 0.1 3.8 0.1 0.2 1.9 1.4 0.2 0.2 1.9 6 0 0.7 2.6 3.3 0.7 0.6 -----

104.7

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 191: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

169

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

2 9 14 9 2 1 53 3 2 7 58 315

3 93 5 35 18 39 5 3 92 3 16 7 33 2 0 22 731 5 5

162

109 19 161 2 3 12 0 0 13 0 0 27 62 3 3 19 78 2 18 18 58 7 8

-----

2214

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.2 0 0 0.6 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 1.2 0 0 0 0 0 3.6 2.4 1.8 0.6 ----- 13

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 1.1 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 2.3 0 0 0 0 0 0 0 1.7 0.6 0.6 0---

-- 7

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0.6 0 0 1.1 0.6 0 0---

-- 4

15-

-

19 0 0 0 0.4 0 0 0.9 0 0 0 0.4 0 0.4 0 0 0 0 0 0 0 0 0 1.8 0 0.9 0 0 0.9 0 0 0 0 0 0 2.7 0 0 0 0 0 0 0 0 0.4 0.9 0 0 0.4 0 0 0 0.4 0.9 0.4 0---

-- 12

20-

-

24 0 0 0 0.5 0 0 1.6 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 1.6 0 0 0 0 0 1.6 0 0.5 0.5 0 0 0 0 0 0 1.6 0 0 2.1 2.6 0 0 0.5 2.1 0.5 0---

-- 17

25-

-

29 0 0 0 0.6 0 0 0.6 0.6 0 0 2.4 0 0.6 0.6 0 0.6 0 0 0 0 0.6 0 0.6 0 0 0 0 0 5.4 0 0 0 0 0 6 0 0.6 0 0 0 0 0 0 0 3.6 0 0 1.8 3.6 0 0 0.6 1.8 0 0---

-- 31

30-

-

34 0 0 0 0.8 0 0 0 0 0 0 0 0 3.1 1.5 0 0 1.5 0.8 0 0 0.8 0 0 0 0 0 0 014

.7 0 0 3.9 1.5 0 5.4 0 0 0 0 0 0 0 0 0.8 4.6 0 0 0.8 2.3 0 0 0 3.1 0 0---

-- 46

35-

-

39 0 0 0 0.9 0 0 5.2 0 0 0 0 0 1.7 0.9 0 0 0.9 2.6 0.9 0 0.9 0 0 0 0 0 0 033

.6 0 0 7.8 2.6 1.7 10.3 0 0.9 0 0 0 0 0 0 0.9 4.3 0 0.9 0 1.7 0 0 0.9 5.2 0 0

----- 84

40-

-

44 0 0.8 0 0.8 0 0 6.8 0 0 0.8 2.3 0 3 6 0 0.8 0 0.8 0 0 3.8 0 0.8 1.5 1.5 0 0 2.3 56.4 0 0.8 12.8 6 0

11.3 0 0 0.8 0 0 0 0 0 3 2.3 0 0 0.8 3.8 0 0.8 0.8 3 0 0

-----

134

45-

-

49 0 1.7 0.8 0.8 0 0 3.3 0 0 0 0.8 0 5 4.1 0 2.5 0 1.7 0 0 2.5 0 1.7 1.7 0.8 0 0 4.110

9.1 0.8 2.5 18.2

12.4 5

21.5 0.8 0 0.8 0 0 0 0 0 3.3 5.8 0 0.8 1.7 6.6 0 0.8 0 4.1 0 0.8 -----

226

50-

-

54 0 0.9 4.6 0 0.9 0 7.4 0 0 0.9 2.8 013

.811

.1 0.9 2.8 2.8 3.7 0.9 011

.1 0.9 0 0 2.8 0 0 2.810

6.9 0 0.9 24 23 4.6 15.7 0.9 0 0.9 0 0 0 0 0 0 6.5 0 0.9 1.8 8.3 0 4.6 0.9 6.5 0.9 0.9 -----

279

55-

-

59 0 1.1 2.3 0 0 1.1 7.9 0 1.1 1.1 7.9 2.3 26 15.8 2.3 5.7 1.1 3.4 1.1 1.1 6.8 1.1 0 0 1.1 0 0 2.3 139 1.1 0

33.9

27.1 3.4 30.5 0 0 1.1 0 0 6.8 0 0 2.3 2.3 0 0 3.4 11.3 1.1 1.1 0 3.4 0 1.1 -----

362

60-

-

64 0 2.6 1.3 1.3 0 0 6.6 1.3 0 1.3 10.5 0

30.3

13.2 0 6.6 0 3.9 0 1.3 11.8 0 0 0 3.9 0 0 1.3

139.5 0 0

30.3

19.7 1.3 27.6 0 0 2.6 0 0 0 0 0 2.6 6.6 1.3 0 1.3 9.2 0 5.3 0 2.6 0 0

-----

347

65-

-

69 2 0 2 2 0 0 8 0 0 0 18 0 36 20 2 4 6 14 2 0 34 2 2 0 8 0 0 4 98 0 0 20 14 2 14 0 0 4 0 0 4 0 0 8 8 0 0 0 16 0 0 0 16 0 2---

--37

2

70-

-

74 0 0 5.3 0 0 0 7.9 0 0 2.6 23.7 0

60.5

36.8 0

13.2 5.3 21.1 0 0

42.1 0 5.3 2.6 23.7 2.6 0 0

89.5 5.3 0

31.6 7.9 2.6 15.8 0 0 2.6 0 0 5.3 0 0 2.6 15.8 0 0 0

15.8 0

13.2 2.6 5.3 0 0

-----

468

75+ 2.1 4.1 4.1 0 2.1 0 2.1 2.1 2.1 4.1 26

.8 2.1 63.9 33 2.1 16.5

12.4

14.4 0 2.1 43.3 0 4.1 2.1 16.5 2.1 0 4.1 53.6 2.1 0

16.5

14.4 0 6.2 0 0 2.1 0 0 4.1 0 0 4.1 12.4 0 0 2.1 16.5 2.1 2.1 0 4.1 0 6.2 -----

417

Crud

eRa

te 0.1 0.4 0.7 0.4 0.1 0 2.6 0.1 0.1 0.3 2.9 0.1 7.6 4.6 0.2 1.7 0.9 1.9 0.2 0.1 4.6 0.1 0.8 0.3 1.6 0.1 0 1.1 36.4 0.2 0.2 8.1 5.4 0.9 8 0.1 0.1 0.6 0 0 0.6 0 0 1.3 3.1 0.1 0.1 0.9 3.9 0.1 0.9 0.9 2.9 0.3 0.4 -----

110.2

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

90:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, M

EL

AK

A, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, 2

007-

2011

ASR

Wor

ld 0.1 0.4 0.7 0.4 0.1 0 2.6 0.1 0.1 0.3 2.8 0.1 7.4 4.5 0.2 1.7 0.9 2 0.3 0.1 4.5 0.2 0.8 0.3 1.6 0.1 0 1.1 35.7 0.2 0.2 7.9 5.2 0.9 7.8 0.1 0.1 0.6 0 0 0.7 0 0 1.4 3 0.2 0.1 0.9 3.8 0.1 0.9 1 2.9 0.4 0.4 -----

108.2

Page 192: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

170

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

0 4 1 0 0 3 23 2 0 8 12 2 34 34 1 20 2 13 3 11 69 1 3 1 5 1 0 3 2 1 24 3 0 7 0 0 26 0 0 9 7 0 0 9 15 0 7 10 16 6 7---

--40

5

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 5 1 2 0---

-- 10

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0---

-- 3

10-

-

14 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0---

-- 3

15-

-

19 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 2 0 0---

-- 6

20-

-

24 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0---

-- 9

25-

-

29 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0---

-- 2

30-

-

34 0 0 0 0 0 0 1 0 0 0 0 0 0 2 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0---

-- 7

35-

-

39 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 0 0---

-- 7

40-

-

44 0 0 0 0 0 0 1 0 0 0 0 0 3 0 0 0 0 2 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 1 0 0---

-- 12

45-

-

49 0 0 0 0 0 1 5 0 0 0 0 2 4 4 0 4 0 2 1 2 4 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 4 0 0 0 1 0 0 0 2 0 0 0 0 0 0---

-- 37

50-

-

54 0 0 1 0 0 0 0 0 0 1 1 0 3 2 0 4 0 4 1 0 5 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 2 0 0 1 0 0 0 1 1 0 0 0 3 0 0---

-- 32

55-

-

59 0 2 0 0 0 0 6 1 0 0 0 0 6 4 0 3 0 1 0 2 6 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 1 0 0 0 0 0 0 0 2 0 2 0 3 0 0---

-- 42

60-

-

64 0 0 0 0 0 1 0 0 0 1 1 0 5 3 0 3 0 1 1 4 10 0 1 0 1 0 0 0 0 0 1 0 0 0 0 0 4 0 0 1 2 0 0 1 2 0 2 2 0 1 3---

-- 51

65-

-

69 0 1 0 0 0 0 4 0 0 1 2 0 6 9 0 3 1 1 0 1 12 0 0 0 1 0 0 2 1 1 5 1 0 2 0 0 4 0 0 1 1 0 0 1 2 0 0 1 1 0 0---

-- 65

70-

-

74 0 0 0 0 0 0 2 0 0 2 3 0 3 5 0 1 1 1 0 1 14 0 0 1 1 0 0 0 0 0 7 0 0 1 0 0 6 0 0 0 2 0 0 4 3 0 1 0 1 0 2---

-- 62

75+

0 1 0 0 0 1 1 1 0 3 5 0 4 3 1 1 0 1 0 1 12 0 0 0 2 1 0 1 0 0 7 0 0 0 0 0 5 0 0 0 0 0 0 0 1 0 1 1 0 1 2---

-- 57

% of

Total 0.0

0%1.0

0%0.2

0%0.0

0%0.0

0%0.7

0%5.7

0%0.5

0%0.0

0%2.0

0%3.0

0%0.5

0%8.4

0%8.4

0%0.2

0%4.9

0%0.5

0%3.2

0%0.7

0%2.7

0%17

.00%

0.20%

0.70%

0.20%

1.20%

0.20%

0.00%

0.70%

0.50%

0.20%

5.90%

0.70%

0.00%

1.70%

0.00%

0.00%

6.40%

0.00%

0.00%

2.20%

1.70%

0.00%

0.00%

2.20%

3.70%

0.00%

1.70%

2.50%

4.00%

1.50%

1.70% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

91:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

PE

RL

IS, A

LL

RE

SID

EN

TS,

MA

LE

S, 2

007-

2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 193: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

171

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

1 9 4 5 3 0 3 0 1 3 6 0 29 18 0 11 4 8 4 3 27 1 0 3 4 0 0 415

1 2 1 55 20 13 23 1 1 4 0 0 4 0 1 14 20 1 0 8 5 0 5 4 3 4 4---

--49

5

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0 1 0 0 1 0 3 0---

-- 9

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0---

-- 2

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0---

-- 2

15-

-

19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 1 0 0 2 0 0 0 0 0 0 0---

-- 6

20-

-

24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0---

-- 4

25-

-

29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 3 0 0 1 0 0 0 0 0 0 0---

-- 8

30-

-

34 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 1 1 1 1 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1---

-- 14

35-

-

39 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13 0 0 5 1 2 0 0 0 3 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0---

-- 28

40-

-

44 0 1 0 1 0 0 0 0 0 0 0 0 0 2 0 1 0 1 0 0 0 1 0 0 0 0 0 0 18 0 0 7 0 0 1 0 0 0 0 0 1 0 0 1 3 0 0 1 0 0 0 0 0 0 0---

-- 39

45-

-

49 0 0 1 1 0 0 2 0 0 0 0 0 2 1 0 1 0 0 0 1 2 0 0 0 0 0 0 1 27 0 0 9 1 4 2 1 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 0 1 1 0---

-- 61

50-

-

54 1 2 0 0 1 0 0 0 1 0 0 0 5 3 0 0 0 0 1 0 3 0 0 0 1 0 0 0 22 1 0 10 3 0 4 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 1 1 0 0---

-- 62

55-

-

59 0 2 1 0 0 0 0 0 0 1 2 0 3 3 0 0 1 1 1 0 1 0 0 0 0 0 0 1 24 0 0 9 4 4 3 0 0 1 0 0 1 0 0 3 2 1 0 0 1 0 2 0 0 0 0---

-- 72

60-

-

64 0 0 2 2 0 0 1 0 0 0 0 0 4 3 0 2 2 1 1 0 9 0 0 0 0 0 0 0 19 0 0 8 4 1 3 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 2 0 0 0 0---

-- 66

65-

-

69 0 0 0 1 0 0 0 0 0 1 1 0 1 3 0 1 0 0 0 1 2 0 0 0 0 0 0 1 10 0 0 3 2 1 3 0 0 0 0 0 1 0 0 1 2 0 0 0 0 0 1 0 0 0 0---

-- 36

70-

-

74 0 1 0 0 0 0 0 0 0 0 2 0 4 2 0 3 0 1 1 0 4 0 0 1 0 0 0 0 8 0 0 1 0 0 1 0 0 0 0 0 0 0 0 1 1 0 0 1 2 0 0 0 0 0 2---

-- 36

75+

0 2 0 0 2 0 0 0 0 1 1 0 9 0 0 3 1 3 0 1 6 0 0 1 3 0 0 0 4 1 1 2 3 0 0 0 0 0 0 0 1 0 0 1 0 0 0 1 1 0 0 0 1 0 1---

-- 50

% of

Total

0.20%

1.80%

0.80%

1.00%

0.60%

0.00%

0.60%

0.00%

0.20%

0.60%

1.20%

0.00%

5.90%

3.60%

0.00%

2.20%

0.80%

1.60%

0.80%

0.60%

5.50%

0.20%

0.00%

0.60%

0.80%

0.00%

0.00%

0.80%

30.50

%0.4

0%0.2

0%11

.10%

4.00%

2.60%

4.60%

0.20%

0.20%

0.80%

0.00%

0.00%

0.80%

0.00%

0.20%

2.80%

4.00%

0.20%

0.00%

1.60%

1.00%

0.00%

1.00%

0.80%

0.60%

0.80%

0.80% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

92:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

PE

RL

IS, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, 2

007-

2011

Page 194: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

172

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

0 4 1 0 0 3 23 2 0 8 12 2 34 34 1 20 2 13 3 11 69 1 3 1 5 1 0 3 2 1 24 3 0 7 0 0 26 0 0 9 7 0 0 9 15 0 7 10 16 6 7---

--40

5

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 2 0 0 0 0 0 0 010

.1 2 4 0---

-- 20

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.9 3.8 0---

-- 6

10-

-

14 0 0 0 0 0 0 1.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.4 0 0 0 0 0 0 0 0 0 0 0---

-- 5

15-

-

19 0 0 0 0 0 0 1.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.4 0 0 0 0 0 0 0 0 1.4 0 0 0 1.4 0 0 0 0 2.8 0 0---

-- 8

20-

-

24 0 0 0 0 0 0 1.9 0 0 0 0 0 0 0 0 0 0 0 0 0 3.7 1.9 3.7 0 0 0 0 0 0 0 0 1.9 0 1.9 0 0 0 0 0 0 0 0 0 0 0 0 0 1.9 0 0 0---

-- 17

25-

-

29 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0---

-- 1

30-

-

34 0 0 0 0 0 0 3.5 0 0 0 0 0 0 7 0 3.5 0 0 0 0 3.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.5 0 0 0 0 3.5 0 0 0 0 0 0---

-- 25

35-

-

39 0 0 0 0 0 0 0 0 0 0 0 0 0 3.6 0 0 0 0 0 0 7.3 0 0 0 0 0 0 0 3.6 0 0 0 0 0 0 0 0 0 0 0 3.6 0 0 0 0 0 0 0 7.3 0 0---

-- 25

40-

-

44 0 0 0 0 0 0 3.1 0 0 0 0 0 9.4 0 0 0 0 6.3 0 0 3.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.1 0 0 0 3.1 3.1 0 3.1 0 3.1 0 0---

-- 38

45-

-

49 0 0 0 0 0 3.1 15.4 0 0 0 0 6.2 12.3

12.3 0

12.3 0 6.2 3.1 6.2 12.3 0 0 0 0 0 0 0 0 0 0 0 0 3.1 0 0

12.3 0 0 0 3.1 0 0 0 6.2 0 0 0 0 0 0

-----

114

50-

-

54 0 0 3.3 0 0 0 0 0 0 3.3 3.3 0 10 6.7 013

.3 013

.3 3.3 016

.7 0 0 0 0 0 0 0 0 0 0 0 0 6.7 0 0 6.7 0 0 3.3 0 0 0 3.3 3.3 0 0 0 10 0 0---

--10

7

55-

-

59 0 7.8 0 0 0 023

.5 3.9 0 0 0 023

.515

.7 011

.8 0 3.9 0 7.8 23.5 0 0 0 0 0 0 0 0 0

11.8 0 0 0 0 0 3.9 0 0 0 0 0 0 0 7.8 0 7.8 0

11.8 0 0

-----

165

60-

-

64 0 0 0 0 0 4.9 0 0 0 4.9 4.9 024

.414

.6 014

.6 0 4.9 4.9 19.5

48.8 0 4.9 0 4.9 0 0 0 0 0 4.9 0 0 0 0 0

19.5 0 0 4.9 9.8 0 0 4.9 9.8 0 9.8 9.8 0 4.9 14.6 -----

249

65-

-

69 0 6.7 0 0 0 026

.7 0 0 6.7 13.3 0 40 60 0 20 6.7 6.7 0 6.7 80 0 0 0 6.7 0 0

13.3 6.7 6.7 33.3 6.7 0

13.3 0 0

26.7 0 0 6.7 6.7 0 0 6.7 13.3 0 0 6.7 6.7 0 0

-----

433

70-

-

74 0 0 0 0 0 017

.4 0 017

.426

.1 026

.143

.5 0 8.7 8.7 8.7 0 8.712

1.8 0 0 8.7 8.7 0 0 0 0 060

.9 0 0 8.7 0 052

.2 0 0 017

.4 0 034

.826

.1 0 8.7 0 8.7 017

.4 -----

539

75+

0 8.3 0 0 0 8.3 8.3 8.3 0 25 41.7 0

33.3 25 8.3 8.3 0 8.3 0 8.3 100 0 0 0

16.7 8.3 0 8.3 0 0

58.3 0 0 0 0 0

41.7 0 0 0 0 0 0 0 8.3 0 8.3 8.3 0 8.3 16.7 -----

475

Crud

eRa

te 0 0.5 0.1 0 0 0.3 2.6 0.2 0 0.9 1.4 0.2 3.9 3.9 0.1 2.3 0.2 1.5 0.3 1.3 7.9 0.1 0.3 0.1 0.6 0.1 0 0.3 0.2 0.1 2.7 0.3 0 0.8 0 0 3 0 0 1 0.8 0 0 1 1.7 0 0.8 1.1 1.8 0.7 0.8 -----

46.2

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

93:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, P

ER

LIS

, AL

L R

ESI

DE

NT

S, M

AL

ES,

200

7-20

11

ASR

Wor

ld 0 0.7 0.2 0 0 0.5 4 0.3 0 1.4 2.1 0.4 6.1 6.1 0.2 3.6 0.4 2.3 0.5 212

.4 0.1 0.5 0.2 0.9 0.2 0 0.6 0.4 0.2 4.2 0.6 0 1.2 0 0 4.7 0 0 1.6 1.3 0 0 1.6 2.7 0 1.2 2.1 2.7 1.2 1.3 -----

72.8

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 195: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

173

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

1 9 4 5 3 0 3 0 1 3 6 0 29 18 0 11 4 8 4 3 27 1 0 3 4 0 0 415

1 2 1 55 20 13 23 1 1 4 0 0 4 0 1 14 20 1 0 8 5 0 5 4 3 4 4---

--49

5

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.1 4.2 0 0 0 0 2.1 0 0 2.1 0 6.3 0---

-- 19

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0---

-- 4

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.7 0 0 0---

-- 3

15-

-

19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.5 0 0 0 0 0 0 0 0 1.3 1.3 0 0 2.5 0 0 0 0 0 0 0---

-- 8

20-

-

24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0---

-- 8

25-

-

29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.7 0 0 0 0 0 2.7 0 0 0 0 2.7 0 0 0 2.7 0 0 0 0 0 0 0 0 0 0 0 8.1 0 0 2.7 0 0 0 0 0 0 0---

-- 22

30-

-

34 0 3.4 0 0 0 0 0 0 0 0 0 0 0 3.4 0 0 0 0 0 0 0 0 0 0 0 0 0 013

.6 0 0 3.4 3.4 3.4 3.4 0 3.4 0 0 0 0 0 0 0 3.4 0 0 0 0 0 0 3.4 0 0 3.4 ----- 47

35-

-

39 0 0 0 0 0 0 0 0 0 0 0 0 3.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 044

.1 0 0 17 3.4 6.8 0 0 010

.2 0 0 0 0 0 010

.2 0 0 0 0 0 0 0 0 0 0---

-- 95

40-

-

44 0 2.9 0 2.9 0 0 0 0 0 0 0 0 0 5.9 0 2.9 0 2.9 0 0 0 2.9 0 0 0 0 0 052

.9 0 020

.6 0 0 2.9 0 0 0 0 0 2.9 0 0 2.9 8.8 0 0 2.9 0 0 0 0 0 0 0---

--11

5

45-

-

49 0 0 2.9 2.9 0 0 5.9 0 0 0 0 0 5.9 2.9 0 2.9 0 0 0 2.9 5.9 0 0 0 0 0 0 2.9 79.4 0 0

26.5 2.9 11.8 5.9 2.9 0 0 0 0 0 0 0 2.9 2.9 0 0 2.9 0 0 0 0 2.9 2.9 0

-----

179

50-

-

54 3.2 6.4 0 0 3.2 0 0 0 3.2 0 0 015

.9 9.5 0 0 0 0 3.2 0 9.5 0 0 0 3.2 0 0 069

.9 3.2 031

.8 9.5 012

.7 0 0 0 0 0 0 0 0 3.2 0 0 0 3.2 0 0 0 3.2 3.2 0 0---

--19

7

55-

-

59 0 7.5 3.8 0 0 0 0 0 0 3.8 7.5 011

.311

.3 0 0 3.8 3.8 3.8 0 3.8 0 0 0 0 0 0 3.8 90.6 0 0 34 15.1

15.1

11.3 0 0 3.8 0 0 3.8 0 0

11.3 7.5 3.8 0 0 3.8 0 7.5 0 0 0 0

-----

272

60-

-

64 0 0 10 10 0 0 5 0 0 0 0 0 20 15 0 10 10 5 5 0 45 0 0 0 0 0 0 0 95 0 0 40 20 5 15 0 0 0 0 0 0 0 0 0 10 0 0 0 0 0 10 0 0 0 0---

--33

0

65-

-

69 0 0 0 6.7 0 0 0 0 0 6.7 6.7 0 6.7 20 0 6.7 0 0 0 6.7 13.3 0 0 0 0 0 0 6.7 66.7 0 0 20 13.3 6.7 20 0 0 0 0 0 6.7 0 0 6.7 13.3 0 0 0 0 0 6.7 0 0 0 0

-----

240

70-

-

74 0 8 0 0 0 0 0 0 0 0 16 0 32 16 0 24 0 8 8 0 32 0 0 8 0 0 0 0 64 0 0 8 0 0 8 0 0 0 0 0 0 0 0 8 8 0 0 8 16 0 0 0 0 0 16 -----

288

75+

011

.8 0 011

.8 0 0 0 0 5.9 5.9 052

.9 0 017

.6 5.9 17.6 0 5.9 35.3 0 0 5.9 17.6 0 0 0

23.5 5.9 5.9 11.8

17.6 0 0 0 0 0 0 0 5.9 0 0 5.9 0 0 0 5.9 5.9 0 0 0 5.9 0 5.9 -----

294

Crud

eRa

te 0.2 1.6 0.7 0.9 0.5 0 0.5 0 0.2 0.5 1 0 5.1 3.1 0 1.9 0.7 1.4 0.7 0.5 4.7 0.2 0 0.5 0.7 0 0 0.7 26.4 0.3 0.2 9.6 3.5 2.3 4 0.2 0.2 0.7 0 0 0.7 0 0.2 2.4 3.5 0.2 0 1.4 0.9 0 0.9 0.7 0.5 0.7 0.7 -----

86.4

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

94:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, P

ER

LIS

, AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

200

7-20

11

ASR

Wor

ld 0.2 1.4 0.7 1 0.4 0 0.6 0 0.2 0.5 0.9 0 4.5 3.2 0 1.8 0.7 1.3 0.7 0.5 4.5 0.2 0 0.5 0.5 0 0 0.8 26.4 0.3 0.1 9.6 3.4 2.3 3.9 0.2 0.2 0.8 0 0 0.6 0 0.3 2.5 3.7 0.2 0 1.2 0.8 0 0.9 0.8 0.5 0.9 0.6 ----- 85

Page 196: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

174

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

0 0 0 0 0 0 9 0 0 2 3 0 5 5 0 2 0 2 0 1 5 0 0 0 1 0 0 0 0 0 2 3 0 0 0 0 2 0 1 3 0 0 0 0 5 0 0 0 0 0 2---

-- 53

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 1

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0---

-- 1

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

15-

-

19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0---

-- 2

20-

-

24 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 1

25-

-

29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

30-

-

34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0---

-- 1

35-

-

39 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0---

-- 4

40-

-

44 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 3

45-

-

49 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1---

-- 4

50-

-

54 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0---

-- 4

55-

-

59 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0---

-- 7

60-

-

64 0 0 0 0 0 0 3 0 0 0 1 0 1 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 8

65-

-

69 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0---

-- 7

70-

-

74 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 5

75+

0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1---

-- 5

% of

Total 0.0

0%0.0

0%0.0

0%0.0

0%0.0

0%0.0

0%17

.00%

0.00%

0.00%

3.80%

5.70%

0.00%

9.40%

9.40%

0.00%

3.80%

0.00%

3.80%

0.00%

1.90%

9.40%

0.00%

0.00%

0.00%

1.90%

0.00%

0.00%

0.00%

0.00%

0.00%

3.80%

5.70%

0.00%

0.00%

0.00%

0.00%

3.80%

0.00%

1.90%

5.70%

0.00%

0.00%

0.00%

0.00%

9.40%

0.00%

0.00%

0.00%

0.00%

0.00%

3.80% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

95:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

W.P

. LA

BU

AN

, AL

L R

ESI

DE

NT

S, M

AL

ES,

200

7-20

11

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 197: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

175

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

1 0 0 0 0 0 1 0 0 2 2 0 2 1 0 0 0 1 0 0 1 0 0 0 0 0 0 0 17 0 0 7 2 0 2 0 0 0 0 0 0 0 0 1 0 0 0 1 5 0 0 0 4 0 1---

-- 51

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0---

-- 1

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0---

-- 1

15-

-

19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

20-

-

24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 1

25-

-

29 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 1

30-

-

34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0---

-- 4

35-

-

39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1---

-- 5

40-

-

44 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 1 0 0---

-- 5

45-

-

49 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0---

-- 9

50-

-

54 0 0 0 0 0 0 0 0 0 0 1 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 7

55-

-

59 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0---

-- 7

60-

-

64 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 3

65-

-

69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0---

-- 2

70-

-

74 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 3

75+

1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 2

% of

Total

2.00%

0.00%

0.00%

0.00%

0.00%

0.00%

2.00%

0.00%

0.00%

3.90%

3.90%

0.00%

3.90%

2.00%

0.00%

0.00%

0.00%

2.00%

0.00%

0.00%

2.00%

0.00%

0.00%

0.00%

0.00%

0.00%

0.00%

0.00%

33.30

%0.0

0%0.0

0%13

.70%

3.90%

0.00%

3.90%

0.00%

0.00%

0.00%

0.00%

0.00%

0.00%

0.00%

0.00%

2.00%

0.00%

0.00%

0.00%

2.00%

9.80%

0.00%

0.00%

0.00%

7.80%

0.00%

2.00% ---

--10

0.00%

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

96:

NU

MB

ER

OF

NE

W C

AN

CE

R C

ASE

S B

Y S

ITE

S A

ND

AG

E G

RO

UP,

W.P

. LA

BU

AN

, AL

L R

ESI

DE

NT

S, F

EM

AL

ES,

200

7-20

11

Page 198: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

176

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stPe

nisPr

ostat

eTe

stis

Othe

r male

genit

alKi

dney

Rena

l Pelv

isUr

eter

Blad

der

Othe

r Urin

ary o

rgan

sEy

eBr

ain, N

ervo

us sy

stem

Thyro

idAd

rena

l glan

dOt

her E

ndoc

rine

Hodg

kin di

seas

eNo

n-Ho

dgkin

lymp

homa

Immu

nopr

olifer

ative

dis.

Multip

le My

eloma

Lymp

hoid

Leuk

aemi

aMy

eloid

Leuk

aemi

aLe

ukae

mia u

nspe

c.Ot

her &

unsp

ecifie

d

All s

ites T

otal

All

Ages

0 0 0 0 0 0 9 0 0 2 3 0 5 5 0 2 0 2 0 1 5 0 0 0 1 0 0 0 0 0 2 3 0 0 0 0 2 0 1 3 0 0 0 0 5 0 0 0 0 0 2---

-- 53

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 4

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.9 0 0 0 0 0 0 0 0 0 0 0---

-- 5

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

15-

-

19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5.4 0 0 0 0 0 0 0 5.4 0 0 0 0 0 0 0 0 0 0 0---

-- 11

20-

-

24 0 0 0 0 0 0 4.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 5

25-

-

29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

30-

-

34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6.9 0 0 0 0 0 0 0 0 0 0 0 0---

-- 7

35-

-

39 0 0 0 0 0 0 8 0 0 0 0 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 0 0 0---

-- 32

40-

-

44 0 0 0 0 0 0 8.3 0 0 0 0 0 8.3 0 0 0 0 8.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 25

45-

-

49 0 0 0 0 0 0 0 0 0 8.7 0 0 0 0 0 8.7 0 8.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.7 ----- 35

50-

-

54 0 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0---

-- 50

55-

-

59 0 0 0 0 0 0 0 0 0 20 20 0 0 20 0 0 0 0 0 20 20 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20 0 0 0 0 20 0 0 0 0 0 0---

--14

0

60-

-

64 0 0 0 0 0 010

0 0 0 033

.3 033

.333

.3 0 0 0 0 0 066

.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

--26

7

65-

-

69 0 0 0 0 0 0 50 0 0 0 0 0 50 50 0 0 0 0 0 0 50 0 0 0 0 0 0 0 0 0 50 0 0 0 0 0 50 0 0 0 0 0 0 0 50 0 0 0 0 0 0---

--35

0

70-

-

74 0 0 0 0 0 0 0 0 0 066

.7 066

.7 0 0 0 0 0 0 0 0 0 0 066

.7 0 0 0 0 066

.7 0 0 0 0 066

.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

--33

3

75+

0 0 0 0 0 0 0 0 0 0 0 066

.766

.7 066

.7 0 0 0 066

.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 066

.7 -----

333

Crud

eRa

te 0 0 0 0 0 0 4.5 0 0 1 1.5 0 2.5 2.5 0 1 0 1 0 0.5 2.5 0 0 0 0.5 0 0 0 0 0 1 1.5 0 0 0 0 1 0 0.5 1.5 0 0 0 0 2.5 0 0 0 0 0 1---

--26

.5

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C6

0C6

1C6

2C6

3C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

97:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, W

.P. L

AB

UA

N, A

LL

RE

SID

EN

TS,

MA

LE

S, 2

007-

2011

ASR

Wor

ld 0 0 0 0 0 0 8.1 0 0 1.3 3.5 0 6 5.4 0 1.9 0 1 0 0.8 6.3 0 0 0 1.3 0 0 0 0 0 2.8 1.5 0 0 0 0 2.8 0 0.4 1.8 0 0 0 0 4 0 0 0 0 0 1.9 -----

50.9

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 199: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

177

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Site Lip Tong

ueMo

uthSa

livar

y glan

dsTo

nsil

Othe

r Oro

phar

ynx

Naso

phar

ynx

Hypo

phar

ynx

Phar

ynx u

nspe

c.Oe

soph

agus

Stom

ach

Small

intes

tine

Colon

Rectu

mAn

usLiv

erGa

llblad

der e

tc.Pa

ncre

asNo

se, s

inuse

s etc.

Laryn

xTr

ache

a,Bro

nchu

s,Lun

gOt

her T

hora

cic or

gans

Bone

Melan

oma o

f Skin

Othe

r Skin

Meso

thelio

maKa

posi

sarco

maCo

nnec

tive,S

oft tis

sue

Brea

stVu

lvaVa

gina

Cervi

x Uter

iCo

rpus

Uter

iUt

erus

unsp

ec.

Ovar

yOt

her F

emale

Gen

ital

Plac

enta

Kidn

eyRe

nal P

elvis

Urete

rBl

adde

rOt

her U

rinar

y org

ans

Eye

Brain

, Ner

vous

syste

mTh

yroid

Adre

nal g

land

Othe

r End

ocrin

eHo

dgkin

dise

ase

Non-

Hodg

kin ly

mpho

maIm

muno

proli

ferati

ve di

s.Mu

ltiple

Myelo

maLy

mpho

id Le

ukae

mia

Myelo

id Le

ukae

mia

Leuk

aemi

a uns

pec.

Othe

r & un

spec

ified

All s

ites T

otal

All

Ages

1 0 0 0 0 0 1 0 0 2 2 0 2 1 0 0 0 1 0 0 1 0 0 0 0 0 0 0 17 0 0 7 2 0 2 0 0 0 0 0 0 0 0 1 0 0 0 1 5 0 0 0 4 0 1---

-- 51

Age

Unk.

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

0-

-

4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.8 0 0---

-- 5

5-

-

9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

10-

-

14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5.1 0 0 0 0 0 0---

-- 5

15-

-

19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 0

20-

-

24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 5

25-

-

29 0 0 0 0 0 0 0 0 0 0 4.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 4

30-

-

34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7.4 0 014

.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7.4 0 0 0 0 0 0 0---

-- 30

35-

-

39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 8 0 8---

-- 40

40-

-

44 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5 0 0 9.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 019

.1 0 0 0 9.5 0 0---

-- 48

45-

-

49 0 0 0 0 0 011

.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 055

.6 0 011

.1 0 011

.1 0 0 0 0 0 0 0 011

.1 0 0 0 0 0 0 0 0 0 0 0---

--10

0

50-

-

54 0 0 0 0 0 0 0 0 0 011

.8 023

.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 047

.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

-- 82

55-

-

59 0 0 0 0 0 0 0 0 0 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 75 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0---

--17

5

60-

-

64 0 0 0 0 0 0 0 0 0 0 0 0 0 40 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 80 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

--12

0

65-

-

69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 50 0 0---

--10

0

70-

-

74 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 010

0 0 0 0 0 0 0 0 0 0 010

0 0 0 010

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

--30

0

75+ 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---

--10

0

Crud

eRa

te 0.5 0 0 0 0 0 0.5 0 0 1.1 1.1 0 1.1 0.5 0 0 0 0.5 0 0 0.5 0 0 0 0 0 0 0 8.9 0 0 3.7 1.1 0 1.1 0 0 0 0 0 0 0 0 0.5 0 0 0 0.5 2.6 0 0 0 2.1 0 0.5 -----

26.8

ICD

(10th

)

C00

C01-

C02

C03-

C06

C07-

C08

C09

C10

C11

C12-

C13

C14

C15

C16

C17

C18

C19-

C20

C21

C22

C23-

C24

C25

C30-

C31

C32

C33-

C34

C37-

C38

C40-

C41

C43

C44

C45

C46

C47;C

49C5

0C5

1C5

2C5

3C5

4C5

5C5

6C5

7C5

8C6

4C6

5C6

6C6

7C6

8C6

9C7

0-C7

2C7

3C7

4C7

5C8

1C8

2-C8

5;C96

C88

C90

C91

C92-

C94

C95

Othe

r

All

APP

EN

DIX

98:

CA

NC

ER

IN

CID

EN

CE

BY

SIT

ES

AN

D A

GE

GR

OU

P, W

.P. L

AB

UA

N, A

LL

RE

SID

EN

TS,

FE

MA

LE

S, 2

007-

2011

ASR

Wor

ld 1 0 0 0 0 0 0.7 0 0 2 0.9 0 1.2 1.6 0 0 0 2 0 0 1.5 0 0 0 0 0 0 012

.6 0 0 6.3 2.5 0 1.7 0 0 0 0 0 0 0 0 0.7 0 0 0 0.4 3.1 0 0 0 3.1 0 0.5 -----

41.7

Page 200: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

178

APPENDIX 99: MORPHOLOGICALLY VERIFIED CASES BY HISTOLOGY TYPES, ALL SITES, MALAYSIA, 2007-2011

ICD10C00 LIP

41

65241311111

85

4.71.2

76.52.44.71.23.51.21.21.21.21.2

100.0

8010 Carcinoma, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8140 Adenocarcinoma, NOS8147 Basal cell adenocarcinoma8200 Adenoid cystic carcinoma8430 Mucoepidermoid carcinoma8480 Mucinous adenocarcinoma8550 Acinar cell carcinoma8800 Sarcoma, NOS8850 Liposarcoma, NOS

C01-C02 TONGUE1

381

25213

7299215

25112112112

854

0.14.40.12.90.20.10.4

85.41.10.20.10.62.90.10.10.20.10.10.20.10.10.2

100.0

8001 Tumor cells, malignant8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8032 Spindle cell carcinoma, NOS8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8260 Papillary adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8810 Fibrosarcoma, NOS8852 Myxoid liposarcoma8900 Rhabdomyosarcoma, NOS8980 Carcinosarcoma, NOS

C03-C06 MOUTH1

3427

17

71011532111

381

1812

261312311211111211

913

0.13.73.00.10.8

77.81.20.50.30.20.10.10.14.20.12.00.10.22.80.10.30.10.20.30.10.10.20.10.10.10.10.10.20.10.1

100.0

8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8032 Spindle cell carcinoma, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8076 Squamous cell carcinoma, microinvasive8082 Lymphoepithelial carcinoma8083 Basaloid squamous cell carcinoma8140 Adenocarcinoma, NOS8147 Basal cell adenocarcinoma8200 Adenoid cystic carcinoma8263 Adenocarcinoma in tubulovillous adenoma8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8480 Mucinous adenocarcinoma8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8562 Epithelial-myoepithelial carcinoma8800 Sarcoma, NOS8802 Giant cell sarcoma8830 Malignant fibrous histiocytoma8850 Liposarcoma, NOS8851 Liposarcoma, well differentiated8852 Myxoid liposarcoma8920 Alveolar rhabdomyosarcoma8940 Mixed tumor, malignant, NOS8941 Carcinoma in pleomorphic adenoma8980 Carcinosarcoma, NOS9170 Lymphangiosarcoma9581 Alveolar soft part sarcoma

Sites No. %Histology

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 201: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

179

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

C07-C08 SALIVARY GLANDS18

4221

21151

87131

1063

542

162

65151

271511

1857

11

487

0.21.68.60.40.24.30.21.00.2

17.90.20.60.22.1

12.91.08.60.21.20.4

13.30.21.00.25.50.21.00.20.23.7

11.70.20.2

100.0

8000 Neoplasm, malignant8001 Tumor cells, malignant8010 Carcinoma, NOS8011 Epithelioma, malignant8013 Large cell neuroendocrine carcinoma8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8022 Pleomorphic carcinoma8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8075 Squamous cell carcinoma, adenoid8082 Lymphoepithelial carcinoma8140 Adenocarcinoma, NOS8147 Basal cell adenocarcinoma8200 Adenoid cystic carcinoma8201 Cribriform carcinoma, NOS8290 Oxyphilic adenocarcinoma8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8500 Infiltrating duct carcinoma, NOS8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8562 Epithelial-myoepithelial carcinoma8802 Giant cell sarcoma8830 Malignant fibrous histiocytoma8940 Mixed tumor, malignant, NOS8941 Carcinoma in pleomorphic adenoma8980 Carcinosarcoma, NOS8982 Malignant myoepithelioma

C09 TONSIL941

149442

142111

192

4.72.10.5

77.62.12.11.07.31.00.50.50.5

100.0

8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8800 Sarcoma, NOS8801 Spindle cell sarcoma9581 Alveolar soft part sarcoma

C10 OTHER OROPHARYNX13

277

217111131

110

11.81.8

70.01.80.96.40.90.90.90.92.70.9

100.0

8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8070 Squamous cell carcinoma, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8076 Squamous cell carcinoma, microinvasive8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8890 Leiomyosarcoma, NOS8980 Carcinosarcoma, NOS9120 Hemangiosarcoma

C11 NASOPHARYNX131

8872,143

4151

22594

77

0.00.10.0

17.742.7

0.10.00.10.00.4

11.81.5

8000 Neoplasm, malignant8001 Tumor cells, malignant8002 Malignant tumor, small cell type8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8022 Pleomorphic carcinoma8032 Spindle cell carcinoma, NOS8033 Pseudosarcomatous carcinoma8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS

Page 202: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

180

C12-C13 HYPOPHARYNX1517

111

19349191

252

6.06.70.40.40.4

76.61.63.60.43.60.4

100.0

8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8032 Spindle cell carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8075 Squamous cell carcinoma, adenoid8140 Adenocarcinoma, NOS8900 Rhabdomyosarcoma, NOS

C14 PHARYNX UNSPEC145

3227111

54

1.97.49.3

59.33.7

13.01.91.91.9

100.0

8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8070 Squamous cell carcinoma, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8140 Adenocarcinoma, NOS8810 Fibrosarcoma, NOS8890 Leiomyosarcoma, NOS8910 Embryonal rhabdomyosarcoma, NOS

C15 OESOPHAGUS1

10932

11

5677

1111

3811311163

10323

1,146

0.19.52.80.10.1

49.50.61.00.10.1

33.20.10.30.10.10.10.50.30.90.30.20.3

100.0

8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8033 Pseudosarcomatous carcinoma8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8076 Squamous cell carcinoma, microinvasive8140 Adenocarcinoma, NOS8144 Adenocarcinoma, intestinal type8145 Carcinoma, diffuse type8200 Adenoid cystic carcinoma8240 Carcinoid tumor, NOS8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8480 Mucinous adenocarcinoma8490 Signet ring cell carcinoma8560 Adenosquamous carcinoma8936 Gastrointestinal stromal sarcoma8980 Carcinosarcoma, NOS

94154

115

111

21410

12113121311

305,024

18.71.10.00.30.00.00.04.30.20.00.00.00.00.10.00.00.00.10.00.00.6

100.0

8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8082 Lymphoepithelial carcinoma8083 Basaloid squamous cell carcinoma8120 Transitional cell carcinoma, NOS8121 Schneiderian carcinoma8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8230 Solid carcinoma, NOS8260 Papillary adenocarcinoma, NOS8440 Cystadenocarcinoma, NOS8490 Signet ring cell carcinoma8800 Sarcoma, NOS8840 Myxosarcoma8851 Liposarcoma, well differentiated8890 Leiomyosarcoma, NOS8900 Rhabdomyosarcoma, NOS8910 Embryonal rhabdomyosarcoma, NOS8920 Alveolar rhabdomyosarcoma8980 Carcinosarcoma, NOS

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 203: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

181

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

C16 STOMACH922

2271

6712

92321

2,4331

5262

73226321

353

1372154111117

185127

3,377

0.30.10.16.70.02.00.00.12.70.10.10.0

72.00.01.51.80.20.10.10.10.20.10.10.01.00.14.10.10.00.10.10.00.00.00.00.00.25.50.00.10.2

100.0

8001 Tumor cells, malignant8002 Malignant tumor, small cell type8003 Malignant tumor, giant cell type8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8032 Spindle cell carcinoma, NOS8070 Squamous cell carcinoma, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8140 Adenocarcinoma, NOS8141 Scirrhous adenocarcinoma8144 Adenocarcinoma, intestinal type8145 Carcinoma, diffuse type8153 Gastrinoma, malignant8211 Tubular adenocarcinoma8214 Parietal cell carcinoma8240 Carcinoid tumor, NOS8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8263 Adenocarcinoma in tubulovillous adenoma8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8481 Mucin-producing adenocarcinoma8490 Signet ring cell carcinoma8510 Medullary carcinoma, NOS8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8800 Sarcoma, NOS8801 Spindle cell sarcoma8810 Fibrosarcoma, NOS8830 Malignant fibrous histiocytoma8852 Myxoid liposarcoma8853 Round cell liposarcoma8890 Leiomyosarcoma, NOS8936 Gastrointestinal stromal sarcoma8941 Carcinoma in pleomorphic adenoma8963 Malignant rhabdoid tumor8980 Carcinosarcoma, NOS

C17 SMALL INTESTINE1

23413

13821118132353

40240

0.49.61.70.41.3

57.50.80.40.40.43.30.41.30.81.32.11.3

16.7100.0

8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8070 Squamous cell carcinoma, NOS8140 Adenocarcinoma, NOS8144 Adenocarcinoma, intestinal type8145 Carcinoma, diffuse type8153 Gastrinoma, malignant8211 Tubular adenocarcinoma8240 Carcinoid tumor, NOS8245 Adenocarcinoid tumor8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8480 Mucinous adenocarcinoma8800 Sarcoma, NOS8890 Leiomyosarcoma, NOS8936 Gastrointestinal stromal sarcoma

C18-C21 COLORECTAL10

11

90311

2271

153

2181

0.10.00.06.70.00.01.70.00.10.01.60.0

8001 Tumor cells, malignant8003 Malignant tumor, giant cell type8004 Malignant tumor, spindle cell type8010 Carcinoma, NOS8013 Large cell neuroendocrine carcinoma8014 Large cell carcinoma with rhabdoid phenotype8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS

Page 204: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

182

C22 LIVER3

10228

112

1411

120289

332

2,52431

243

162111111131

0.13.10.90.00.00.10.40.00.03.78.90.11.0

77.41.00.11.30.00.20.10.00.00.00.00.00.00.00.10.0

8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8030 Giant cell and spindle cell carcinoma8033 Pseudosarcomatous carcinoma8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8082 Lymphoepithelial carcinoma8140 Adenocarcinoma, NOS8160 Cholangiocarcinoma8161 Bile duct cystadenocarcinoma8162 Klatskin tumor8170 Hepatocellular carcinoma, NOS8171 Hepatocellular carcinoma, fibrolamellar8172 Hepatocellular carcinoma, scirrhous8180 Combined hepatocellular carcinoma and cholangiocarcinoma8200 Adenoid cystic carcinoma8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8480 Mucinous adenocarcinoma8500 Infiltrating duct carcinoma, NOS8560 Adenosquamous carcinoma8800 Sarcoma, NOS8805 Undifferentiated sarcoma8852 Myxoid liposarcoma8890 Leiomyosarcoma, NOS8891 Epithelioid leiomyosarcoma

1311333

11,4434

1842

2028

482

56122

1426

61044

117

2617

51311

1151125181

3113,490

0.00.00.00.00.00.00.0

84.80.00.10.00.00.10.20.00.10.00.40.00.00.00.10.20.00.10.30.00.00.11.90.10.40.00.00.00.10.00.00.00.00.00.00.10.00.2

100.0

8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8075 Squamous cell carcinoma, adenoid8076 Squamous cell carcinoma, microinvasive8082 Lymphoepithelial carcinoma8084 Squamous cell carcinoma, clear cell type8120 Transitional cell carcinoma, NOS8123 Basaloid carcinoma8140 Adenocarcinoma, NOS8141 Scirrhous adenocarcinoma8144 Adenocarcinoma, intestinal type8145 Carcinoma, diffuse type8147 Basal cell adenocarcinoma8210 Adenocarcinoma in adenomatous polyp8211 Tubular adenocarcinoma8215 Adenocarcinoma of anal glands8220 Adenocarcinoma in adenomatous polyposis 8221 Adenocarcinoma in multiple adenomatous polyps8240 Carcinoid tumor, NOS8243 Goblet cell carcinoid8244 Composite carcinoid8245 Adenocarcinoid tumor8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8261 Adenocarcinoma in villous adenoma8262 Villous adenocarcinoma8263 Adenocarcinoma in situ tubulovillous adenoma8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8481 Mucin-producing adenocarcinoma8490 Signet ring cell carcinoma8560 Adenosquamous carcinoma8573 Adenocarcinoma with apocrine metaplasia8574 Adenocarcinoma with neuroendocrine differentiation8720 Malignant melanoma, NOS8800 Sarcoma, NOS8804 Epithelioid sarcoma8821 Aggressive fibromatosis8851 Liposarcoma, well differentiated8890 Leiomyosarcoma, NOS8900 Rhabdomyosarcoma, NOS8936 Gastrointestinal stromal sarcoma8941 Carcinoma in pleomorphic adenoma8980 Carcinosarcoma, NOS

Page 205: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

183

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

3411412

3,260

1.00.00.00.10.00.1

100.0

8970 Hepatoblastoma8981 Carcinosarcoma, embryonal8991 Embryonal sarcoma9120 Hemangiosarcoma9130 Hemangioendothelioma, malignant9170 Lymphangiosarcoma

C23-C24 GALLBLADDER ETC.1

1022

267

25317

1274

36112111161

779

0.113.1

0.33.30.93.2

40.70.1

35.20.40.80.10.10.30.10.10.10.10.80.1

100.0

8001 Tumor cells, malignant8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8140 Adenocarcinoma, NOS8141 Scirrhous adenocarcinoma8160 Cholangiocarcinoma8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8262 Villous adenocarcinoma8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8490 Signet ring cell carcinoma8500 Infiltrating duct carcinoma, NOS8503 Intraductal papillary adenocarcinoma with invasion8504 Intracystic carcinoma, NOS8560 Adenosquamous carcinoma8800 Sarcoma, NOS

C25 PANCREAS12

3281

932231

531

943243434

236211

1062

151

1081

217

1,573

0.820.9

0.15.90.10.10.20.13.40.1

59.90.10.30.20.30.20.31.50.40.10.10.10.60.40.11.00.10.60.50.11.30.4

100.0

8001 Tumor cells, malignant8010 Carcinoma, NOS8013 Large cell neuroendocrine carcinoma8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8033 Pseudosarcomatous carcinoma8050 Papillary carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8140 Adenocarcinoma, NOS8141 Scirrhous adenocarcinoma8150 Islet cell carcinoma8152 Glucagonoma, malignant8154 Mixed islet cell and exocrine adenocarcinoma8200 Adenoid cystic carcinoma8240 Carcinoid tumor, NOS8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8263 Adenocarcinoma in tubulovillous adenoma8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8440 Cystadenocarcinoma, NOS8452 Solid pseudopapillary carcinoma8453 Intraductal papillary-mucinous carcinoma, invasive8480 Mucinous adenocarcinoma8490 Signet ring cell carcinoma8500 Infiltrating duct carcinoma, NOS8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8971 Pancreatoblastoma8980 Carcinosarcoma, NOS

C30- C31 NOSE, SINUSES ETC.3148

3155

1011411

7.812.0

0.838.8

2.52.81.00.30.3

8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8074 Squamous cell carcinoma, spindle cell8076 Squamous cell carcinoma, microinvasive

Page 206: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

184

C32 LARYNX121

6627

542

7418

112211

3912311111

924

0.10.20.17.12.90.50.40.2

80.20.91.20.20.20.10.14.20.10.20.30.10.10.10.10.1

100.0

8000 Neoplasm, malignant8001 Tumor cells, malignant8004 Malignant tumor, spindle cell type8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8076 Squamous cell carcinoma, microinvasive8083 Basaloid squamous cell carcinoma8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8560 Adenosquamous carcinoma8800 Sarcoma, NOS8810 Fibrosarcoma, NOS8890 Leiomyosarcoma, NOS8894 Angiomyosarcoma8941 Carcinoma in pleomorphic adenoma8980 Carcinosarcoma, NOS

1149

437

23231351113132112

162

400

0.30.31.02.3

10.81.85.80.50.80.30.81.30.30.30.30.80.30.80.50.30.30.54.00.5

100.0

8082 Lymphoepithelial carcinoma8083 Basaloid squamous cell carcinoma8120 Transitional cell carcinoma, NOS8121 Schneiderian carcinoma8140 Adenocarcinoma, NOS8147 Basal cell adenocarcinoma8200 Adenoid cystic carcinoma8260 Papillary adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8510 Medullary carcinoma, NOS8720 Malignant melanoma, NOS8800 Sarcoma, NOS8801 Spindle cell sarcoma8803 Small cell sarcoma8813 Fascial fibrosarcoma8900 Rhabdomyosarcoma, NOS8910 Embryonal rhabdomyosarcoma, NOS8980 Carcinosarcoma, NOS9120 Hemangiosarcoma9371 Chondroid chordoma9520 Olfactory neurogenic tumor9521 Olfactory neurocytoma9522 Olfactory neuroblastoma9523 Olfactory neuroepithelioma

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

C33- C34 TRACHEA, BRONCHUS, LUNG1

18221

1,16520

1148

3083179

823941

38503

3311

0.00.20.00.00.0

11.90.21.20.13.10.00.00.10.18.40.10.00.00.45.10.30.00.0

8000 Neoplasm, malignant8001 Tumor cells, malignant8002 Malignant tumor, small cell type8003 Malignant tumor, giant cell type8004 Malignant tumor, spindle cell type8010 Carcinoma, NOS8011 Epithelioma, malignant8012 Large cell carcinoma, NOS8013 Large cell neuroendocrine carcinoma8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8030 Giant cell and spindle cell carcinoma8032 Spindle cell carcinoma, NOS8033 Pseudosarcomatous carcinoma8041 Small cell carcinoma, NOS8042 Oat cell carcinoma8043 Small cell carcinoma, fusiform cell8044 Small cell carcinoma, intermediate cell8045 Combined small cell carcinoma8046 Non-small cell carcinoma8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8052 Papillary squamous cell carcinoma

Page 207: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

185

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

C37-C38 OTHER THORACIC ORGANS51

17141

2411

1021116511

57128131121

10

1.80.46.00.41.40.48.50.40.4

35.90.40.40.42.11.80.40.4

20.10.40.72.80.41.10.40.40.70.43.5

8001 Tumor cells, malignant8002 Malignant tumor, small cell type8010 Carcinoma, NOS8013 Large cell neuroendocrine carcinoma8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8082 Lymphoepithelial carcinoma8140 Adenocarcinoma, NOS8141 Scirrhous adenocarcinoma8231 Carcinoma simplex8240 Carcinoid tumor, NOS8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8490 Signet ring cell carcinoma8560 Adenosquamous carcinoma8580 Thymoma, malignant, NOS8581 Thymoma, type A, malignant8584 Thymoma, type B2, malignant8586 Thymic carcinoma, NOS8589 Carcinoma showing thymus-like element8800 Sarcoma, NOS8805 Undifferentiated sarcoma8830 Malignant fibrous histiocytoma8900 Rhabdomyosarcoma, NOS8980 Carcinosarcoma, NOS9064 Germinoma

1,909123718

2811

4,445316

1118

2138

532

2810

41

11121

24217111111412

221211

9,826

19.40.10.40.20.00.10.00.0

45.20.00.00.10.10.20.01.40.10.00.00.30.10.00.00.10.00.00.00.20.00.00.10.00.00.00.00.00.00.00.00.00.20.00.00.00.0

100.0

8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8074 Squamous cell carcinoma, spindle cell8075 Squamous cell carcinoma, adenoid8082 Lymphoepithelial carcinoma8083 Basaloid squamous cell carcinoma8140 Adenocarcinoma, NOS8141 Scirrhous adenocarcinoma8147 Basal cell adenocarcinoma8200 Adenoid cystic carcinoma8240 Carcinoid tumor, NOS8246 Neuroendocrine carcinoma, NOS8249 Atypical carcinoid tumor8250 Bronchiolo-alveolar adenocarcinoma, NOS8251 Alveolar adenocarcinoma8252 Bronchiolo-alveolar carcinoma, non-mucinous8253 Bronchiolo-alveolar carcinoma, mucinous8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8481 Mucin-producing adenocarcinoma8490 Signet ring cell carcinoma8510 Medullary carcinoma, NOS8560 Adenosquamous carcinoma8570 Adenocarcinoma with squamous metaplasia8574 Adenocarcinoma with neuroendocrine differentiation8800 Sarcoma, NOS8803 Small cell sarcoma8830 Malignant fibrous histiocytoma8850 Liposarcoma, NOS8851 Liposarcoma, well differentiated8854 Pleomorphic liposarcoma8890 Leiomyosarcoma, NOS8900 Rhabdomyosarcoma, NOS8963 Malignant rhabdoid tumor8972 Pulmonary blastoma8980 Carcinosarcoma, NOS9130 Hemangioendothelioma, malignant9133 Epithelioid hemangioendothelioma, malignant9364 Peripheral neuroectodermal tumor9580 Granular cell tumor, malignant

Page 208: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

186

C43 MELANOMA OF SKIN294

617321321

320

91.91.90.32.20.90.60.30.90.60.3

100.0

8720 Malignant melanoma, NOS8721 Nodular melanoma8730 Amelanotic melanoma8742 Lentigo maligna melanoma8744 Acral lentiginous melanoma, malignant8745 Desmoplastic melanoma, malignant8761 Malignant melanoma in giant pigmented nevus8770 Mixed epithelioid and spindle cell melanoma8772 Spindle cell melanoma, NOS8780 Blue nevus, malignant

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

115319112

284

0.40.41.81.10.43.20.40.40.7

100.0

9065 Germ cell tumor, nonseminomatous9070 Embryonal carcinoma, NOS9071 Yolk sac tumor9080 Teratoma, malignant, NOS9082 Malignant teratoma, undifferentiated9085 Mixed germ cell tumor9120 Hemangiosarcoma9150 Hemangiopericytoma, malignant9540 Malignant peripheral nerve sheath tumor

C40-C41 BONE1

10221

245212888

122361218111

4036213511

2261

124312

501

811

161124411

802

0.11.20.20.20.13.00.60.20.10.21.01.01.01.50.20.40.70.10.20.11.00.10.10.1

50.20.70.20.10.40.60.10.12.77.60.10.20.50.40.10.26.20.1

10.10.12.01.40.20.50.50.10.1

100.0

8000 Neoplasm, malignant8001 Tumor cells, malignant8002 Malignant tumor, small cell type8004 Malignant tumor, spindle cell type8012 Large cell carcinoma, NOS8800 Sarcoma, NOS8801 Spindle cell sarcoma8803 Small cell sarcoma8804 Epithelioid sarcoma8806 Desmoplastic small round cell tumor8810 Fibrosarcoma, NOS8812 Periosteal fibrosarcoma8830 Malignant fibrous histiocytoma8850 Liposarcoma, NOS8852 Myxoid liposarcoma8854 Pleomorphic liposarcoma8890 Leiomyosarcoma, NOS8895 Myosarcoma8900 Rhabdomyosarcoma, NOS8910 Embryonal rhabdomyosarcoma, NOS9040 Synovial sarcoma, NOS9120 Hemangiosarcoma9130 Hemangioendothelioma, malignant9133 Epithelioid hemangioendothelioma, malignant9180 Osteosarcoma, NOS9181 Chondroblastic osteosarcoma9182 Fibroblastic osteosarcoma9183 Telangiectatic osteosarcoma9184 Osteosarcoma in Paget disease of bone9185 Small cell osteosarcoma9186 Central osteosarcoma9192 Parosteal osteosarcoma9200 Aggressive osteoblastoma9220 Chondrosarcoma, NOS9221 Juxtacortical chondrosarcoma9230 Chondroblastoma, malignant9231 Myxoid chondrosarcoma9240 Mesenchymal chondrosarcoma9242 Clear cell chondrosarcoma9243 Dedifferentiated chondrosarcoma9250 Giant cell tumor of bone, malignant9251 Malignant giant cell tumor of soft parts9260 Ewing sarcoma9261 Adamantinoma of long bones9270 Odontogenic tumor, malignant9310 Ameloblastoma, malignant9330 Ameloblastic fibrosarcoma9364 Peripheral neuroectodermal tumor9370 Chordoma, NOS9371 Chondroid chordoma9581 Alveolar soft part sarcoma

Page 209: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

187

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

C47, C49 CONNECTIVE, SOFT TISSUE311

20312

71823

46

0.40.10.1

26.01.50.90.11.00.30.45.9

8001 Tumor cells, malignant8002 Malignant tumor, small cell type8003 Malignant tumor, giant cell type8800 Sarcoma, NOS8801 Spindle cell sarcoma8802 Giant cell sarcoma8803 Small cell sarcoma8804 Epithelioid sarcoma8805 Undifferentiated sarcoma8806 Desmoplastic small round cell tumor8810 Fibrosarcoma, NOS

C46 KAPOSI SARCOMA1818

100.0100.0

9140 Kaposi sarcoma

C45 MESOTHELIOMA35

33

41

85.47.37.3

100.0

9050 Mesothelioma, malignant9051 Fibrous mesothelioma, malignant9053 Mesothelioma, biphasic, malignant

C44 OTHER SKIN3

5615

151719

14773

1315

42

1915

1,246344

101124

4519

16111541

2552213113

673241

2,423

0.12.30.60.00.20.00.30.00.40.6

31.90.50.60.20.10.80.00.2

51.40.10.20.20.40.00.00.10.21.90.80.00.20.00.00.00.20.20.01.00.20.10.10.00.10.00.00.12.80.10.10.20.0

100.0

8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8022 Pleomorphic carcinoma8031 Giant cell carcinoma8032 Spindle cell carcinoma, NOS8033 Pseudosarcomatous carcinoma8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8081 Bowen disease8082 Lymphoepithelial carcinoma8083 Basaloid squamous cell carcinoma8090 Basal cell carcinoma, NOS8091 Multifocal superficial basal cell carcinoma8092 Infiltrating basal cell carcinoma, NOS8093 Basal cell carcinoma, fibroepithelial8094 Basosquamous carcinoma8095 Metatypical carcinoma8098 Adenoid basal carcinoma8102 Trichilemmocarcinoma8110 Pilomatrix carcinoma8140 Adenocarcinoma, NOS8147 Basal cell adenocarcinoma8200 Adenoid cystic carcinoma8247 Merkel cell carcinoma8260 Papillary adenocarcinoma, NOS8263 Adenocarcinoma in tubulovillous adenoma8310 Clear cell adenocarcinoma, NOS8390 Skin appendage carcinoma8402 Nodular hidradenoma, malignant8403 Malignant eccrine spiradenoma8410 Sebaceous adenocarcinoma8430 Mucoepidermoid carcinoma8480 Mucinous adenocarcinoma8542 Paget disease, extramammary8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8562 Epithelial-myoepithelial carcinoma8821 Aggressive fibromatosis8830 Malignant fibrous histiocytoma8832 Dermatofibrosarcoma, NOS8833 Pigmented dermatofibrosarcoma protuberans8940 Mixed tumor, malignant, NOS8980 Carcinosarcoma, NOS9364 Peripheral neuroectodermal tumor

Page 210: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

188

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

734

493

969

261

103

5123

4710

111611

2332813711

274215225

3514

22

781

0.90.40.56.30.4

12.31.23.30.11.30.46.50.30.46.01.30.11.40.80.10.12.90.40.31.00.10.40.90.10.13.50.50.30.10.60.30.30.64.51.80.30.3

100.0

8811 Fibromyxosarcoma8814 Infantile fibrosarcoma8821 Aggressive fibromatosis8830 Malignant fibrous histiocytoma8840 Myxosarcoma8850 Liposarcoma, NOS8851 Liposarcoma, well differentiated8852 Myxoid liposarcoma8853 Round cell liposarcoma8854 Pleomorphic liposarcoma8858 Dedifferentiated liposarcoma8890 Leiomyosarcoma, NOS8894 Angiomyosarcoma8895 Myosarcoma8900 Rhabdomyosarcoma, NOS8901 Pleomorphic rhabdomyosarcoma, adult type8902 Mixed type rhabdomyosarcoma8910 Embryonal rhabdomyosarcoma, NOS8920 Alveolar rhabdomyosarcoma8963 Malignant rhabdoid tumor8990 Mesenchymoma, malignant9040 Synovial sarcoma, NOS9041 Synovial sarcoma, spindle cell9043 Synovial sarcoma, biphasic9044 Clear cell sarcoma, NOS9064 Germinoma9071 Yolk sac tumor9080 Teratoma, malignant, NOS9082 Malignant teratoma, undifferentiated9085 Mixed germ cell tumor9120 Hemangiosarcoma9150 Hemangiopericytoma, malignant9240 Mesenchymal chondrosarcoma9251 Malignant giant cell tumor of soft parts9252 Malignant tenosynovial giant cell tumor9364 Peripheral neuroectodermal tumor9370 Chordoma, NOS9500 Neuroblastoma, NOS9540 Malignant peripheral nerve sheath tumor9560 Neurilemoma, malignant9580 Granular cell tumor, malignant9581 Alveolar soft part sarcoma

C50 BREAST1111

5421

71332111

671

7211121

328861

142116112

0.10.00.03.00.00.40.00.00.00.00.00.00.40.00.40.00.00.00.00.01.80.00.00.00.10.00.00.00.00.00.00.0

8001 Tumor cells, malignant8003 Malignant tumor, giant cell type8004 Malignant tumor, spindle cell type8010 Carcinoma, NOS8013 Large cell neuroendocrine carcinoma8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8022 Pleomorphic carcinoma8032 Spindle cell carcinoma, NOS8033 Pseudosarcomatous carcinoma8034 Polygonal cell carcinoma8050 Papillary carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8074 Squamous cell carcinoma, spindle cell8075 Squamous cell carcinoma, adenoid8076 Squamous cell carcinoma, microinvasive8123 Basaloid carcinoma8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8201 Cribriform carcinoma, NOS8210 Adenocarcinoma in adenomatous polyp8211 Tubular adenocarcinoma8230 Solid carcinoma, NOS8246 Neuroendocrine carcinoma, NOS8251 Alveolar adenocarcinoma8260 Papillary adenocarcinoma, NOS8315 Glycogen-rich carcinoma8430 Mucoepidermoid carcinoma8440 Cystadenocarcinoma, NOS

Page 211: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

189

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

C52 VAGINA1158

382111

2112111111

8.947.2

2.46.51.60.80.80.8

17.10.81.60.80.80.80.80.80.8

8010 Carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8076 Squamous cell carcinoma, microinvasive8083 Basaloid squamous cell carcinoma8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8560 Adenosquamous carcinoma8800 Sarcoma, NOS8890 Leiomyosarcoma, NOS

1511

14,882113

642

10212

2671,267

11626

288213154131123712

5794

218,258

0.80.0

81.50.10.00.40.00.60.00.01.56.90.60.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.30.50.0

100.0

8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8481 Mucin-producing adenocarcinoma8500 Infiltrating duct carcinoma, NOS8501 Comedocarcinoma, NOS8502 Secretory carcinoma of breast8503 Intraductal papillary adenocarcinoma with invasion8504 Intracystic carcinoma, NOS8510 Medullary carcinoma, NOS8512 Medullary carcinoma with lymphoid stroma8513 Atypical medullary carcinoma8520 Lobular carcinoma, NOS8521 Infiltrating ductular carcinoma8522 Infiltrating duct and lobular carcinoma8523 Infiltrating duct mixed with other types of carcinoma8530 Inflammatory carcinoma8540 Paget disease, mammary8541 Paget disease and infiltrating duct carcinoma8543 Paget disease and intraductal carcinoma 8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8573 Adenocarcinoma with apocrine metaplasia8575 Metaplastic carcinoma, NOS8800 Sarcoma, NOS8802 Giant cell sarcoma8810 Fibrosarcoma, NOS8821 Aggressive fibromatosis8850 Liposarcoma, NOS8851 Liposarcoma, well differentiated8852 Myxoid liposarcoma8890 Leiomyosarcoma, NOS8894 Angiomyosarcoma8935 Stromal sarcoma, NOS8980 Carcinosarcoma, NOS9020 Phyllodes tumor, malignant9120 Hemangiosarcoma

C51 VULVA92

722215811131

102111

123

7.31.6

58.51.61.60.84.16.50.80.80.82.40.88.11.60.80.80.8

100.0

8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8083 Basaloid squamous cell carcinoma8090 Basal cell carcinoma, NOS8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8430 Mucoepidermoid carcinoma8481 Mucin-producing adenocarcinoma8542 Paget disease, extramammary8560 Adenosquamous carcinoma8720 Malignant melanoma, NOS8804 Epithelioid sarcoma8830 Malignant fibrous histiocytoma8890 Leiomyosarcoma, NOS9580 Granular cell tumor, malignant

Page 212: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

190

C54 CORPUS UTERI121

135

111

191

38182

7801723

2955

8

5.60.01.60.00.00.00.90.01.80.00.40.1

35.90.81.10.1

44.00.4

8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8022 Pleomorphic carcinoma8032 Spindle cell carcinoma, NOS8050 Papillary carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8140 Adenocarcinoma, NOS8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8320 Granular cell carcinoma8380 Endometrioid adenocarcinoma, NOS8381 Endometrioid adenofibroma, malignant

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

14111

123

0.83.30.80.80.8

100.0

8901 Pleomorphic rhabdomyosarcoma, adult type8980 Carcinosarcoma, NOS8990 Mesenchymoma, malignant9071 Yolk sac tumor9364 Peripheral neuroectodermal tumor

C53 CERVIC UTERI31

24441

931111

1416

1,673195862

4215

37321

857111

2742

311

47112

2611

745218125

214,324

0.10.05.60.10.02.20.00.00.00.00.30.00.1

38.74.5

19.91.00.00.10.90.10.00.0

19.80.00.00.00.60.10.00.70.01.10.30.00.60.00.01.70.10.00.00.20.00.00.10.5

100.0

8001 Tumor cells, malignant8003 Malignant tumor, giant cell type8010 Carcinoma, NOS8013 Large cell neuroendocrine carcinoma8015 Glassy cell carcinoma8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8032 Spindle cell carcinoma, NOS8033 Pseudosarcomatous carcinoma8041 Small cell carcinoma, NOS8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8074 Squamous cell carcinoma, spindle cell8075 Squamous cell carcinoma, adenoid8076 Squamous cell carcinoma, microinvasive8083 Basaloid squamous cell carcinoma8098 Adenoid basal carcinoma8123 Basaloid carcinoma8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8231 Carcinoma simplex8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8262 Villous adenocarcinoma8263 Adenocarcinoma in tubulovillous adenoma8310 Clear cell adenocarcinoma, NOS8320 Granular cell carcinoma8380 Endometrioid adenocarcinoma, NOS8384 Adenocarcinoma, endocervical type8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8481 Mucin-producing adenocarcinoma8482 Mucinous adenocarcinoma, endocervical type8560 Adenosquamous carcinoma8570 Adenocarcinoma with squamous metaplasia8800 Sarcoma, NOS8810 Fibrosarcoma, NOS8890 Leiomyosarcoma, NOS8900 Rhabdomyosarcoma, NOS8933 Adenosarcoma8950 Mullerian mixed tumor8980 Carcinosarcoma, NOS

Page 213: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

191

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

C56 OVARY

2111

3112

891256

7411

766311

0.60.00.09.10.12.60.41.60.20.10.00.0

22.50.10.00.0

8001 Tumor cells, malignant8002 Malignant tumor, small cell type8003 Malignant tumor, giant cell type8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8075 Squamous cell carcinoma, adenoid8076 Squamous cell carcinoma, microinvasive8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8210 Adenocarcinoma in adenomatous polyp8211 Tubular adenocarcinoma

14

112911211

166012

111

1811

132,171

0.00.20.50.10.40.00.00.10.00.00.72.80.60.00.00.00.80.00.00.6

100.0

8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8560 Adenosquamous carcinoma8570 Adenocarcinoma with squamous metaplasia8800 Sarcoma, NOS8803 Small cell sarcoma8804 Epithelioid sarcoma8810 Fibrosarcoma, NOS8814 Infantile fibrosarcoma8850 Liposarcoma, NOS8890 Leiomyosarcoma, NOS8930 Endometrial stromal sarcoma, NOS8931 Endometrial stromal sarcoma, low grade8933 Adenosarcoma8935 Stromal sarcoma, NOS8940 Mixed tumor, malignant, NOS8950 Mullerian mixed tumor8951 Mesodermal mixed tumor8963 Malignant rhabdoid tumor8980 Carcinosarcoma, NOS

C55 UTERUS UNSPEC.11

42732

26141

1957181

11011171

11111

1011321417

20575

0.20.27.31.20.50.34.50.20.70.2

33.91.20.21.40.2

19.10.20.20.21.20.21.90.20.20.2

17.60.20.50.30.20.70.21.23.5

100.0

8001 Tumor cells, malignant8002 Malignant tumor, small cell type8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8140 Adenocarcinoma, NOS8260 Papillary adenocarcinoma, NOS8262 Villous adenocarcinoma8310 Clear cell adenocarcinoma, NOS8323 Mixed cell adenocarcinoma8380 Endometrioid adenocarcinoma, NOS8381 Endometrioid adenofibroma, malignant8384 Adenocarcinoma, endocervical type8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8560 Adenosquamous carcinoma8800 Sarcoma, NOS8805 Undifferentiated sarcoma8840 Myxosarcoma8852 Myxoid liposarcoma8890 Leiomyosarcoma, NOS8891 Epithelioid leiomyosarcoma8896 Myxoid leiomyosarcoma8900 Rhabdomyosarcoma, NOS8901 Pleomorphic rhabdomyosarcoma, adult type8933 Adenosarcoma8940 Mixed tumor, malignant, NOS8950 Mullerian mixed tumor8980 Carcinosarcoma, NOS

Page 214: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

192

C57 OTHER FEMALE GENITAL51

141613413

39

12.82.6

35.92.6

15.42.67.7

10.32.67.7

100.0

8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8140 Adenocarcinoma, NOS8260 Papillary adenocarcinoma, NOS8380 Endometrioid adenocarcinoma, NOS8440 Cystadenocarcinoma, NOS8441 Serous cystadenocarcinoma, NOS8460 Papillary serous cystadenocarcinoma8480 Mucinous adenocarcinoma9100 Choriocarcinoma, NOS

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

316

42225

54

24131

270356

28191

29199

26122

262211

682732211

1011263

101234

2718

22

6085

215

1349215

3,408

0.10.00.21.26.60.10.17.10.10.07.9

10.40.85.60.95.80.83.60.10.20.10.10.00.02.00.10.20.10.10.10.00.00.30.00.00.10.20.10.30.00.10.10.10.80.50.10.11.82.50.10.00.10.40.10.30.10.00.1

100.0

8240 Carcinoid tumor, NOS8243 Goblet cell carcinoid8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8313 Clear cell adenocarcinofibroma8320 Granular cell carcinoma8380 Endometrioid adenocarcinoma, NOS8381 Endometrioid adenofibroma, malignant8384 Adenocarcinoma, endocervical type8440 Cystadenocarcinoma, NOS8441 Serous cystadenocarcinoma, NOS8450 Papillary cystadenocarcinoma, NOS8460 Papillary serous cystadenocarcinoma8461 Serous surface papillary carcinoma8470 Mucinous cystadenocarcinoma, NOS8471 Papillary mucinous cystadenocarcinoma8480 Mucinous adenocarcinoma8481 Mucin-producing adenocarcinoma8490 Signet ring cell carcinoma8560 Adenosquamous carcinoma8562 Epithelial-myoepithelial carcinoma8570 Adenocarcinoma with squamous metaplasia8600 Thecoma, malignant8620 Granulosa cell tumor, malignant8621 Granulosa cell-theca cell tumor8631 Sertoli-Leydig cell tumor, poorly differentiated8640 Sertoli cell carcinoma8670 Steroid cell tumor, malignant8800 Sarcoma, NOS8810 Fibrosarcoma, NOS8850 Liposarcoma, NOS8890 Leiomyosarcoma, NOS8891 Epithelioid leiomyosarcoma8935 Stromal sarcoma, NOS8940 Mixed tumor, malignant, NOS8950 Mullerian mixed tumor8951 Mesodermal mixed tumor8980 Carcinosarcoma, NOS8990 Mesenchymoma, malignant9000 Brenner tumor, malignant9014 Serous adenocarcinofibroma9015 Mucinous adenocarcinofibroma9060 Dysgerminoma9064 Germinoma9065 Germ cell tumor, nonseminomatous9070 Embryonal carcinoma, NOS9071 Yolk sac tumor9080 Teratoma, malignant, NOS9082 Malignant teratoma, undifferentiated9083 Malignant teratoma, intermediate9084 Teratoma with malignant transformation9085 Mixed germ cell tumor9090 Struma ovarii, malignant9100 Choriocarcinoma, NOS9101 Choriocarcinoma combined with other germ cell elements9110 Mesonephroma, malignant9580 Granular cell tumor, malignant

Page 215: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

193

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

12

14421

695

194149

51

0.20.4

29.50.40.2

14.11.03.98.4

10.01.00.2

8910 Embryonal rhabdomyosarcoma, NOS8940 Mixed tumor, malignant, NOS9061 Seminoma, NOS9062 Seminoma, anaplastic9063 Spermatocytic seminoma9064 Germinoma9065 Germ cell tumor, nonseminomatous9070 Embryonal carcinoma, NOS9071 Yolk sac tumor9080 Teratoma, malignant, NOS9081 Teratocarcinoma9082 Malignant teratoma, undifferentiated

C58 PLACENTA12

5225

62

1.63.2

83.93.28.1

100.0

8010 Carcinoma, NOS8890 Leiomyosarcoma, NOS9100 Choriocarcinoma, NOS9101 Choriocarcinoma combined with other germ cell elements9104 Placental site trophoblastic tumor

C60 PENIS1823

84312421111

114

0.97.01.82.6

73.72.60.91.83.51.80.90.90.90.9

100.0

8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8081 Bowen disease8090 Basal cell carcinoma, NOS8140 Adenocarcinoma, NOS8542 Paget disease, extramammary8720 Malignant melanoma, NOS8800 Sarcoma, NOS8832 Dermatofibrosarcoma, NOS8910 Embryonal rhabdomyosarcoma, NOS

C62 TESTIS3

256

2229

112

1012125

0.65.11.24.55.90.20.20.42.00.20.40.20.41.0

8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8070 Squamous cell carcinoma, NOS8140 Adenocarcinoma, NOS8480 Mucinous adenocarcinoma8550 Acinar cell carcinoma8631 Sertoli-Leydig cell tumor, poorly differentiated8640 Sertoli cell carcinoma8650 Leydig cell tumor, malignant8800 Sarcoma, NOS8830 Malignant fibrous histiocytoma8890 Leiomyosarcoma, NOS8900 Rhabdomyosarcoma, NOS

C61 PROSTATE8

2352

60111

291

202

2,645111229

64112

3,089

0.37.60.11.90.00.00.00.90.00.60.1

85.60.00.00.00.10.10.32.10.00.00.1

100.0

8001 Tumor cells, malignant8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8041 Small cell carcinoma, NOS8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8120 Transitional cell carcinoma, NOS8130 Papillary transitional cell carcinoma8140 Adenocarcinoma, NOS8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8320 Granular cell carcinoma8480 Mucinous adenocarcinoma8490 Signet ring cell carcinoma8500 Infiltrating duct carcinoma, NOS8550 Acinar cell carcinoma8802 Giant cell sarcoma8810 Fibrosarcoma, NOS8900 Rhabdomyosarcoma, NOS

Page 216: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

194

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

C65 RENAL PELVIS11392211

20

5.05.0

15.045.010.010.0

5.05.0

100.0

8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8070 Squamous cell carcinoma, NOS8120 Transitional cell carcinoma, NOS8130 Papillary transitional cell carcinoma8310 Clear cell adenocarcinoma, NOS8800 Sarcoma, NOS8810 Fibrosarcoma, NOS

C66 URETER23

222

29

6.910.375.9

6.9100.0

8010 Carcinoma, NOS8070 Squamous cell carcinoma, NOS8120 Transitional cell carcinoma, NOS8130 Papillary transitional cell carcinoma

34311

488

7.00.60.20.2

100.0

9085 Mixed germ cell tumor9100 Choriocarcinoma, NOS9102 Malignant teratoma, trophoblastic9120 Hemangiosarcoma

C63 OTHER MALE GENITAL311627122111111

31

9.73.23.2

19.46.5

22.63.26.56.53.23.23.23.23.23.2

100.0

8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8090 Basal cell carcinoma, NOS8140 Adenocarcinoma, NOS8480 Mucinous adenocarcinoma8542 Paget disease, extramammary8850 Liposarcoma, NOS8858 Dedifferentiated liposarcoma8910 Embryonal rhabdomyosarcoma, NOS9061 Seminoma, NOS9064 Germinoma9071 Yolk sac tumor9081 Teratocarcinoma

C64 KIDNEY15

7918

819

12

744

3915

122818

410

41411211112

5017213

1,302

0.10.46.11.40.61.50.10.25.70.33.01.29.4

62.80.30.80.30.10.30.10.10.20.10.10.10.10.23.80.10.50.20.10.2

100.0

8000 Neoplasm, malignant8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8120 Transitional cell carcinoma, NOS8130 Papillary transitional cell carcinoma8140 Adenocarcinoma, NOS8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8312 Renal cell carcinoma, NOS8317 Renal cell carcinoma, chromophobe type8318 Renal cell carcinoma, sarcomatoid8320 Granular cell carcinoma8510 Medullary carcinoma, NOS8800 Sarcoma, NOS8801 Spindle cell sarcoma8840 Myxosarcoma8850 Liposarcoma, NOS8858 Dedifferentiated liposarcoma8860 Angiomyolipoma8900 Rhabdomyosarcoma, NOS8901 Pleomorphic rhabdomyosarcoma, adult type8959 Malignant cystic nephroma8960 Nephroblastoma, NOS8963 Malignant rhabdoid tumor8964 Clear cell sarcoma of kidney8980 Carcinosarcoma, NOS9110 Mesonephroma, malignant9364 Peripheral neuroectodermal tumor

Page 217: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

195

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

C67 BLADDER8

1383

5112

551

5333

1,20511

146135

173213121111112131111

1,842

0.47.50.22.80.10.13.00.12.90.20.2

65.40.10.17.97.30.10.40.20.10.10.20.10.10.10.10.10.10.10.10.10.10.20.10.10.10.1

100.0

8001 Tumor cells, malignant8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8032 Spindle cell carcinoma, NOS8033 Pseudosarcomatous carcinoma8050 Papillary carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8120 Transitional cell carcinoma, NOS8122 Transitional cell carcinoma, spindle cell8123 Basaloid carcinoma8130 Papillary transitional cell carcinoma8140 Adenocarcinoma, NOS8210 Adenocarcinoma in adenomatous polyp8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8481 Mucin-producing adenocarcinoma8490 Signet ring cell carcinoma8550 Acinar cell carcinoma8570 Adenocarcinoma with squamous metaplasia8800 Sarcoma, NOS8804 Epithelioid sarcoma8851 Liposarcoma, well differentiated8852 Myxoid liposarcoma8890 Leiomyosarcoma, NOS8900 Rhabdomyosarcoma, NOS8910 Embryonal rhabdomyosarcoma, NOS8980 Carcinosarcoma, NOS9130 Hemangioendothelioma, malignant9580 Granular cell tumor, malignant9581 Alveolar soft part sarcoma

C68 OTHER URINARY ORGAN411231

122

26

15.43.83.87.7

11.53.8

46.27.7

100.0

8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8120 Transitional cell carcinoma, NOS8130 Papillary transitional cell carcinoma8140 Adenocarcinoma, NOS8980 Carcinosarcoma, NOS

C69 EYE11514

2913

2421

10311112

69211

155

0.60.63.20.62.6

18.78.41.32.61.30.66.51.90.60.60.60.61.3

44.51.30.60.6

100.0

8001 Tumor cells, malignant8003 Malignant tumor, giant cell type8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8070 Squamous cell carcinoma, NOS8140 Adenocarcinoma, NOS8147 Basal cell adenocarcinoma8200 Adenoid cystic carcinoma8430 Mucoepidermoid carcinoma8480 Mucinous adenocarcinoma8720 Malignant melanoma, NOS8900 Rhabdomyosarcoma, NOS8901 Pleomorphic rhabdomyosarcoma, adult type9120 Hemangiosarcoma9150 Hemangiopericytoma, malignant9170 Lymphangiosarcoma9500 Neuroblastoma, NOS9510 Retinoblastoma, NOS9511 Retinoblastoma, differentiated9512 Retinoblastoma, undifferentiated9513 Retinoblastoma, diffuse

Page 218: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

196

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

C73 THYROID1

121195351

212

0.05.40.82.42.30.10.00.1

8001 Tumor cells, malignant8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8030 Giant cell and spindle cell carcinoma8032 Spindle cell carcinoma, NOS8033 Pseudosarcomatous carcinoma

C70-C72 BRAIN, NERVOUS SYSTEM64

321

1312231

6814926418181

1626

1114

62742

23652

6814

34311425719

493

73

3412

273

1196

32415

210

91651

4

61,925

3.30.20.10.10.70.10.10.10.20.13.50.10.20.50.10.30.20.10.40.10.40.18.40.30.60.10.23.20.40.20.1

12.32.70.30.40.10.2

17.80.62.23.01.00.24.80.40.21.80.60.13.80.10.10.50.3

16.80.80.10.50.50.82.60.2

0.3100.0

8001 Tumor cells, malignant8002 Malignant tumor, small cell type8003 Malignant tumor, giant cell type8720 Malignant melanoma, NOS8800 Sarcoma, NOS8801 Spindle cell sarcoma8802 Giant cell sarcoma8806 Desmoplastic small round cell tumor8963 Malignant rhabdoid tumor9060 Dysgerminoma9064 Germinoma9070 Embryonal carcinoma, NOS9071 Yolk sac tumor9080 Teratoma, malignant, NOS9081 Teratocarcinoma9085 Mixed germ cell tumor9120 Hemangiosarcoma9130 Hemangioendothelioma, malignant9150 Hemangiopericytoma, malignant9170 Lymphangiosarcoma9364 Peripheral neuroectodermal tumor9370 Chordoma, NOS9380 Glioma, malignant9381 Gliomatosis cerebri9382 Mixed glioma9383 Subependymoma9390 Choroid plexus carcinoma9391 Ependymoma, NOS9392 Ependymoma, anaplastic9393 Papillary ependymoma9394 Myxopapillary ependymoma9400 Astrocytoma, NOS9401 Astrocytoma, anaplastic9411 Gemistocytic astrocytoma9420 Fibrillary astrocytoma9423 Polar spongioblastoma9430 Astroblastoma9440 Glioblastoma, NOS9441 Giant cell glioblastoma9442 Gliosarcoma9450 Oligodendroglioma, NOS9451 Oligodendroglioma, anaplastic9460 Oligodendroblastoma9470 Medulloblastoma, NOS9471 Desmoplastic nodular medulloblastoma9472 Medullomyoblastoma9473 Primitive neuroectodermal tumor, NOS9480 Cerebellar sarcoma, NOS9490 Ganglioneuroblastoma9500 Neuroblastoma, NOS9501 Medulloepithelioma, NOS9503 Neuroepithelioma, NOS9505 Ganglioglioma, anaplastic9508 Atypical teratoid/rhabdoid tumor9530 Meningioma, malignant9531 Meningothelial meningioma9537 Transitional meningioma9538 Papillary meningioma9539 Meningeal sarcomatosis9540 Malignant peripheral nerve sheath tumor9560 Neurilemoma, malignant9561 Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation9580 Granular cell tumor, malignant

Page 219: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

197

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

9561

1136

111

101111

24625

4204

101

13923

3

42.50.00.51.60.00.00.04.50.00.00.0

10.90.10.2

18.70.20.40.06.21.00.1

8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8076 Squamous cell carcinoma, microinvasive8140 Adenocarcinoma, NOS8190 Trabecular adenocarcinoma8241 Enterochromaffin cell carcinoid8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8263 Adenocarcinoma in tubulovillous adenoma8290 Oxyphilic adenocarcinoma8330 Follicular adenocarcinoma, NOS8331 Follicular adenocarcinoma, well differentiated8332 Follicular adenocarcinoma, trabecular8335 Follicular carcinoma, minimally invasive8340 Papillary carcinoma, follicular variant8341 Papillary microcarcinoma8346 Mixed medullary-follicular carcinoma

213

22124

2,249

0.10.00.11.00.00.10.2

100.0

8350 Nonencapsulated sclerosing carcinoma8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8510 Medullary carcinoma, NOS8550 Acinar cell carcinoma8850 Liposarcoma, NOS8980 Carcinosarcoma, NOS

C75 OTHER ENDOCRINE39122

551311

3211211

101112

19111

153

2.05.90.71.31.3

35.90.72.00.70.7

20.90.70.71.30.70.76.50.70.70.71.3

12.40.70.70.7

100.0

8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8022 Pleomorphic carcinoma8070 Squamous cell carcinoma, NOS8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8210 Adenocarcinoma in adenomatous polyp8263 Adenocarcinoma in tubulovillous adenoma8270 Chromophobe carcinoma8272 Pituitary carcinoma, NOS8280 Acidophil carcinoma8281 Mixed acidophil-basophil carcinoma8430 Mucoepidermoid carcinoma8710 Glomangiosarcoma8711 Glomus tumor, malignant9064 Germinoma9070 Embryonal carcinoma, NOS9080 Teratoma, malignant, NOS9085 Mixed germ cell tumor9361 Pineocytoma9362 Pineoblastoma9380 Glioma, malignant9400 Astrocytoma, NOS9580 Granular cell tumor, malignant

C74 ADRENAL GLAND1913191

171

1311

2987

1.110.3

1.13.41.1

10.31.1

19.51.1

14.91.11.1

33.3100.0

8000 Neoplasm, malignant8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8070 Squamous cell carcinoma, NOS8140 Adenocarcinoma, NOS8260 Papillary adenocarcinoma, NOS8370 Adrenal cortical carcinoma8510 Medullary carcinoma, NOS8700 Pheochromocytoma, malignant8850 Liposarcoma, NOS9120 Hemangiosarcoma9500 Neuroblastoma, NOS

Page 220: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

198

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

27411

789125

3293

1591,362

559130

0.60.10.00.0

17.32.70.72.03.5

29.812.2

2.8

9827 Adult T-cell leukemia/lymphoma (HTLV-1 positive)9832 Prolymphocytic leukemia, NOS9833 Prolymphocytic leukemia, B-cell type9834 Prolymphocytic leukemia, T-cell type9835 Precursor cell lymphoblastic leukemia, NOS9836 Precursor B-cell lymphoblastic leukemia9837 Precursor T-cell lymphoblastic leukemia9840 Acute myeloid leukemia, M6 type9860 Myeloid leukemia, NOS9861 Acute myeloid leukemia, NOS9863 Chronic myeloid leukemia, NOS9866 Acute promyelocytic leukemia

C81-C85, C96 LYMPHOMA1

7011,652

152528

271315

313

5918

478

4574

1,3951733

4163

0.013.130.9

2.89.90.50.20.30.10.00.11.10.00.10.90.10.80.10.1

26.10.30.60.13.0

9530 Meningioma, malignant9590 Malignant lymphoma, NOS9591 Malignant lymphoma, non-Hodgkin, NOS9596 Composite Hodgkin and non-Hodgkin lymphoma9650 Hodgkin lymphoma, NOS9651 Hodgkin lymphoma, lymphocyte-rich9652 Hodgkin lymphoma, mixed cellularity, NOS9653 Hodgkin lymphoma, lymphocyte depletion, NOS9659 Hodgkin lymphoma, nodular lymphocyte predominance9661 Hodgkin granuloma9662 Hodgkin sarcoma9663 Hodgkin lymphoma, nodular sclerosis, NOS9664 Hodgkin lymphoma, nodular sclerosis, cellular phase9665 Hodgkin lymphoma, nodular sclerosis, grade 19670 Malignant lymphoma, small B lymphocytic, NOS9671 Malignant lymphoma, lymphoplasmacytic9673 Mantle cell lymphoma9675 Malignant lymphoma, mixed small and large cell, diffuse9679 Mediastinal large B-cell lymphoma9680 Malignant lymphoma, large B-cell, diffuse, NOS9684 Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS9687 Burkitt lymphoma, NOS9689 Splenic marginal zone B-cell lymphoma9690 Follicular lymphoma, NOS9691 Follicular lymphoma, grade 29695 Follicular lymphoma, grade 19698 Follicular lymphoma, grade 3

66

163044

3167

1915

971479

19641

11311

5,348

0.10.10.30.60.80.13.10.40.00.11.80.00.10.10.20.40.10.10.00.20.10.00.0

100.0

9699 Marginal zone B-cell lymphoma, NOS9700 Mycosis fungoides9701 Sezary syndrome9702 Mature T-cell lymphoma, NOS9705 Angioimmunoblastic T-cell lymphoma9708 Subcutaneous panniculitis-like T-cell lymphoma9709 Cutaneous T-cell lymphoma, NOS9714 Anaplastic large cell lymphoma, T cell and Null cell type9717 Intestinal T-cell lymphoma9718 Primary cutaneous CD30+ T-cell lymphoproliferative disorder9719 NK/T-cell lymphoma, nasal and nasal-type9727 Precursor cell lymphoblastic lymphoma, NOS9728 Precursor B-cell lymphoblastic lymphoma9729 Precursor T-cell lymphoblastic lymphoma9740 Mast cell sarcoma9741 Malignant mastocytosis9754 Langerhans cell histiocytosis, disseminated9755 Histiocytic sarcoma9756 Langerhans cell sarcoma9758 Follicular dendritic cell sarcoma

C90 MULTIPLE MYELOMA40

67942

725

5.593.7

0.60.3

100.0

9731 Plasmacytoma, NOS9732 Multiple myeloma9733 Plasma cell leukemia9734 Plasmacytoma, extramedullary

C91-C95 LEUKAEMIA126659

4105124

85

2.814.4

0.12.32.71.9

9800 Leukemia, NOS9801 Acute leukemia, NOS9805 Acute biphenotypic leukemia9820 Lymphoid leukemia, NOS9823 B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma9826 Burkitt cell leukemia

Page 221: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

199

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

111519111113

133

0.10.10.10.50.10.80.10.10.10.10.10.31.20.3

8500 Infiltrating duct carcinoma, NOS8521 Infiltrating ductular carcinoma8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8680 Paraganglioma, malignant8800 Sarcoma, NOS8801 Spindle cell sarcoma8802 Giant cell sarcoma8803 Small cell sarcoma8810 Fibrosarcoma, NOS8821 Aggressive fibromatosis8830 Malignant fibrous histiocytoma8850 Liposarcoma, NOS8851 Liposarcoma, well differentiated

3626

121159

26768

211811115

4,570

0.80.00.10.30.00.00.10.20.60.20.10.20.50.40.20.20.1

100.0

9867 Acute myelomonocytic leukemia9870 Acute basophilic leukemia9871 Acute myeloid leukemia, with abnormal marrow eosinophils9872 Acute myeloid leukemia, minimal differentiation9873 Acute myeloid leukemia without maturation9874 Acute myeloid leukemia with maturation9875 Chronic myelogenous leukemia, BCR/ABL positive9876 Atypical chronic myeloid leukemia, BCR/ABL negative9891 Acute monocytic leukemia9895 Acute myeloid leukemia with multilineage dysplasia9896 Acute myeloid leukemia, t(8;21)(q22;q22)9910 Acute megakaryoblastic leukemia9930 Myeloid sarcoma9931 Acute panmyelosis with myelofibrosis9940 Hairy cell leukemia9945 Chronic myelomonocytic leukemia, NOS9946 Juvenile myelomonocytic leukemia

71

654113

1331

1853

1111123

285114113

101522521

171

134

0.60.16.00.40.10.10.31.20.30.1

17.10.31.00.10.10.10.20.3

26.30.10.10.40.10.10.30.90.10.50.20.20.50.20.11.60.11.20.4

8012 Large cell carcinoma, NOS8013 Large cell neuroendocrine carcinoma8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8022 Pleomorphic carcinoma8031 Giant cell carcinoma8032 Spindle cell carcinoma, NOS8041 Small cell carcinoma, NOS8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8082 Lymphoepithelial carcinoma8083 Basaloid squamous cell carcinoma8120 Transitional cell carcinoma, NOS8140 Adenocarcinoma, NOS8141 Scirrhous adenocarcinoma8153 Gastrinoma, malignant8200 Adenoid cystic carcinoma8210 Adenocarcinoma in adenomatous polyp8211 Tubular adenocarcinoma8240 Carcinoid tumor, NOS8246 Neuroendocrine carcinoma, NOS8249 Atypical carcinoid tumor8260 Papillary adenocarcinoma, NOS8263 Adenocarcinoma in tubulovillous adenoma8290 Oxyphilic adenocarcinoma8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8440 Cystadenocarcinoma, NOS8461 Serous surface papillary carcinoma8470 Mucinous cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8490 Signet ring cell carcinoma

OTHER & UNSPEC.2

39323

217

0.23.60.30.20.3

20.1

8000 Neoplasm, malignant8001 Tumor cells, malignant8002 Malignant tumor, small cell type8003 Malignant tumor, giant cell type8004 Malignant tumor, spindle cell type8010 Carcinoma, NOS

Page 222: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

200

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

11286

43122181

113153217362

1,093

0.10.10.20.70.64.00.10.20.20.10.70.11.00.30.10.50.30.20.10.60.30.50.2

100.0

8852 Myxoid liposarcoma8854 Pleomorphic liposarcoma8858 Dedifferentiated liposarcoma8890 Leiomyosarcoma, NOS8900 Rhabdomyosarcoma, NOS8936 Gastrointestinal stromal sarcoma8940 Mixed tumor, malignant, NOS8963 Malignant rhabdoid tumor8980 Carcinosarcoma, NOS8981 Carcinosarcoma, embryonal9064 Germinoma9071 Yolk sac tumor9080 Teratoma, malignant, NOS9085 Mixed germ cell tumor9100 Choriocarcinoma, NOS9170 Lymphangiosarcoma9364 Peripheral neuroectodermal tumor9370 Chordoma, NOS9372 Dedifferentiated chordoma9500 Neuroblastoma, NOS9760 Immunoproliferative disease, NOS9761 Waldenstrom macroglobulinemia9762 Heavy chain disease, NOS

Page 223: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

201

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

APPENDIX 100: CANCER NOTIFICATION FORM

Page 224: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

202

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Please Notify a) All case of cancers (i.e. carcinomas, sarcomas, leukaemias and all other malignant tumours) diagnosed or treated in your hospital, clinic or practice. b) Confirmed cases of cancer as well as cases of ‘probable cancer’ in which the diagnosis is based only on clinical finding (i.e. without histological, radiological or other methods of confirmation). c) All cases diagnosed in Malaysia regardless of citizenships or place of domicile of the patient. d) Cancer cases referred to your hospital/clinic/practice which may have already been notified by the previous attending doctor. e) Follow up cases; please use the same form (Fill in name, I/C number, source of information and any other information that is different from the original previous notification form). You may choose to notify only once.

PROCEDURE 1. Patient Identification No. - For Malaysian patient with new I/C No. fill up all the 12 digits and the old I/C No. if available - For patient with only old I/C No. fill up his/her I/C No. in the Identification No. boxes. - Children below 12 years without NRIC, insert patient’s I/C No. with additional M or F in the appropriate boxes indicating mother or father NRIC was used (e.g. A 1234567M) - Passport No. Police/ Arm Forces Identification Card Number to be used for foreigners/ police/ arms personnel. (please indicate) Name – Full name in block letters as in NRIC/ passport Usual Resident Address: Address where the patient usually resides at least for 6 months [Note: The address NRIC may not be the same] Date of birth: Insert date of birth of patient into boxes. [If not available insert year of birth] Sex, Ethnic Group, Citizenship : Tick appropriate box

2. Source of Information (refers to Hospital/ Clinic the notifying doctor is working in)

3. Diagnosis (If insufficient space, write the information on a piece of paper and attach as appendix)

Diagnosis (Site for topography): This refers to the diagnosis at the time of notification Please write in words with as much detail as possible.

Pathological Diagnosis (Morphology): Please write in words with as much detail as possible

4. Date of Diagnosis: Insert date of diagnosis made (Date that can be verified from records) and follow IARC definition*

5. Basis of diagnosis: Tick appropriate box(es) 6. Stage of Disease at the time of diagnosis: Fill in and tick appropriate box(es) 7. Type of treatment: Tick appropriate box(es) and fill in date of first treatment 8. Present status: Tick the appropriate box and fill in relevant details. 9. Date of notification: Insert the date into the appropriate box

APPENDIX 101: EXPLANATORY NOTES FOR COMPLETING CANCER NOTIFICATION FORM

Page 225: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

*Definition of Incidence Date 1. Date of first histological or cytological confirmation a) Date when the specimen was taken (biopsy or operation) b) Date of receipt by the pathologist c) Date of the pathology report. 2. Date of admission to the hospital because of this malignancy. 3. Date of first consultation at the outpatient clinic (only). 4. Date of diagnosis, other than 1, 2 or 3. 5. Date of death, if no information than that the patient has died because of a malignancy. 6. Date of death, if the malignancy is discovered at autopsy.

203

MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011

Page 226: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the
Page 227: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the
Page 228: MOH/P/IKN/01.16 (AR) - crc.gov.my · causes such as early detection, screening programmes, changing exposure to . v MESSAGE In 2013, World Health Organization (WHO) had launched the

National Cancer Institute, Ministry of HealthNo. 4, Jalan P7, Presint 7, 62250 Putrajaya

Tel : (603) 8892 5555 Fax : (603) 8892 5625